cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,2.41205631759595
MDST8,654092,-1.4293910300938224,-0.4188401951803794
RKO,52947716,-6.611161073849914,-0.9414239279192677
RKO,56963564,0.5825206420774123,0.14380410392080303
Granta-519,107970,1.5911312599666134,2.041664176364923
HEL,12003241,-0.3954740832299299,-1.4970842973352274
SK-HEP-1,445091,4.514173662724111,4.295127136985031
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,3.119167757422768
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,0.40329972605175596
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,1.4635317203193723
HCC15,24775005,4.257174534281358,3.8333449981299856
HuP-T3,6450551,3.7588607556856006,2.8529534884199115
SaOS-2,72376,-1.862865015628177,-1.725844494307303
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.443657761618851
Panc 02.03,3062316,2.5231792980774,1.0818798188297345
MOLP-8,6918837,-6.2821371699611515,-3.8640269201445556
SW48,1242560,3.5610164041067645,3.317226391615005
RCC10RGB,3062316,3.7206614033239833,0.9648381793398572
IA-LM,25262965,-3.1838216959830796,-1.1249730624865044
BICR 22,3038522,1.9324211832044784,2.9738899000008705
SW1573,4096211,3.236722527011662,1.9095206057298981
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-1.152565088947446
NCI-H2452,2733526,3.4563089712221,4.106601989003776
WM115,44197249,3.814304480361476,3.7408338791205256
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.7733972300515124
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,0.8320857710573791
SW948,216345,3.8478701746280506,4.005212773776685
RKN,2858523,3.2318364946727653,3.0576689257314964
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.2957303301533434
LCLC-97TM1,17759555,4.8791087487812606,3.6772703772455047
ALL-SIL,24771867,-3.516684419884963,0.4048206291322284
WM115,11455910,0.9860510612095932,1.2009228580125875
MOLP-8,11485656,1.8270206697288176,1.7949994442680532
MOLM-13,9866186,-0.4750218873797177,0.15557057302466515
Daudi,445091,3.707432883595851,3.952184951589745
RERF-LC-MS,9907093,3.840365222907794,4.072835301367154
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,3.359128557736797
IA-LM,49836020,4.225846480888235,2.7362868850555926
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.3871779803549654
HuP-T3,445643,4.0158423100173986,4.070895549895361
RKO,5351362,1.5688417029382893,1.3169684763103913
SU-DHL-1,25262965,-0.1887460090186497,-2.232351817375892
MOLP-8,3552672,2.5417747800161483,2.8099753834258085
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,2.9256279103389766
HCC15,24771867,-1.1106317715549263,2.475395611350153
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-3.858501691066965
COR-L95,25161177,5.647598761093448,4.2135361764315125
BFTC-909,16219061,3.736019824418232,3.453537810361861
LCLC-97TM1,3503,2.904492448420953,2.1689454467504956
RKN,5287620,-2.679516494579474,-1.8024260358215733
IA-LM,5281321,-0.2514769440259956,-0.9363039903916217
SK-HEP-1,24964624,3.121305411780932,2.436529591423786
SaOS-2,9884685,-0.6485333929619777,0.9398939913238772
MOLP-8,44566777,0.3680572795114795,0.4278968624978653
K-562,3081361,1.217245739162405,2.292817873007443
HuP-T3,53392493,2.0684681956337654,2.685308252008684
SW48,11404337,-1.6842588085779022,-0.7053616924023096
RKO,24771867,6.323343540042099,1.4231331050548053
MDST8,11497983,4.366208744407351,3.780792577251159
Daudi,6918638,-1.8107043721369585,-0.15524788130461903
RERF-LC-MS,107970,3.001301355490032,2.2232663916707476
NCI-H2452,56963564,2.315469414243469,0.5825687074022409
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,0.8447396769527254
MOLM-13,4259181,-1.5110532495146267,-0.18312731062050933
RERF-LC-MS,5566,3.05978093065268,3.0009958347689922
HEL,44607531,1.529117499700861,1.3854044328547264
BFTC-909,25262965,-1.7887871070762158,-1.2361121168115141
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-1.2599376527055814
BICR 31,46191454,1.7584497327325264,1.362532422396241
UACC-812,426756,4.999419351863596,4.426891541371605
SW1271,9911463,3.695583497273472,3.757159831837065
COR-L105,219104,4.205860409291191,3.7594618989465416
MOLP-8,46943432,-0.8980695552897974,1.352285716429563
MOLM-13,11626560,-0.3289224093786886,1.4278845512028278
SU-DHL-1,73707398,0.2992121771474305,0.8449074226700712
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-0.6745668644195395
HCC1500,9907093,4.182225492860836,4.106595938958633
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,0.928061198352545
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,1.918328797285887
NCI-H1568,5746,-0.0019321539800122,1.215692346983833
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.2599754946609523
HEL,10385095,1.0320529067741009,1.0490643559260617
P31/FUJ,374536,-2.654779926412406,1.77654497685748
KU-19-19,119607,4.136898976237774,5.119220328401554
HCC1500,11656518,1.3375266797474916,1.7681677521486758
NCI-H1568,44819697,-2.651253194329211,-0.4540853053868525
COR-L105,6918328,0.8369476830507139,-0.2948202854331275
PaTu 8988t,1750826,2.46453979570572,-1.0517960796858445
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.096979252418352
HCC1500,6438330,2.8683818740810088,2.1784268226123378
HEL,11214940,0.9295508638766669,1.547736470619349
HCC15,104842,-2.640027553911029,-2.5590302295470373
BICR 22,53495165,-1.022289455565369,-0.5977847890820991
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,1.1620159795696896
SW948,11167602,-0.1815305116238505,2.345376090413435
SaOS-2,119607,5.401113896800015,5.232165371896914
SW1271,444795,4.935671262335122,4.262796465362487
LS411N,107970,2.4864618038552724,2.179972829157334
RERF-LC-MS,3025944,4.157794890121567,4.241859832155042
IGROV-1,5282054,3.614574021382022,3.7087348925927817
MOLP-8,5284373,1.9803114216772224,2.3930395833226386
SW1271,46907787,1.639327018501732,2.4141490057081088
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,3.9317154657915423
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.21801330466252
ALL-SIL,5351362,0.9273092220520184,1.2061003971760473
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-2.732098009299894
LCLC-97TM1,54618164,4.1848187977728,4.086807648708331
SK-HEP-1,123631,3.617013696107864,2.577661398735486
LS180,1641662,3.031869457755623,3.489773608521786
LCLC-97TM1,46199207,3.402623883365983,3.177461424233964
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.43268231627126147
ALL-SIL,168312962,1.491579787235829,1.4760080944461305
IGROV-1,135398516,1.9751898057484376,1.9417865908267244
SK-OV-3,4261,3.2658157069367615,1.53015806231075
Panc 02.03,11707110,-0.717341284128793,0.723832773502105
P31/FUJ,4261,-0.12536828191131,1.3599338199319715
Daudi,53481919,2.490259403593742,3.576243848218607
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,0.883562434780603
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,1.820763628137522
SW1573,12003241,-0.6702221198842615,-0.9419353164231339
COR-L95,11238147,1.8523673489534709,2.6124712573996134
SW48,452548,-3.152923699933953,-0.5098529689911424
ALL-SIL,46224516,1.508509192124363,2.2047637780449865
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.4398862843772444
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.15890481054512
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-3.0899548315634804
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,0.684635737500433
Daudi,6918837,-6.333799665630375,-3.391317299601775
K-562,57330099,5.557476297558147,4.080857902312103
MOLM-13,3038522,-2.559283473550591,2.8793791796626946
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.5809319158892073
SU-DHL-6,9903786,1.8029536633965553,2.491795534740378
Daudi,151289,0.3893937359913983,0.662063934292704
MOLP-8,51037431,3.96461280344528,2.7332471426327585
BICR 31,11152667,-0.7818812516610519,-0.5128422558737114
LS180,46907787,-0.2837252988913812,0.846008450541446
PaTu 8902,16725315,5.393152185048805,4.292976641961753
Panc 02.03,6914657,-4.005158687469553,-3.7029106841320782
HuP-T3,54613361,5.307179038572215,0.30347706790301165
PaTu 8902,107970,2.826401466277882,2.215066050412684
RKO,25183872,-1.1635703485572924,-1.187965382136383
RCC10RGB,135659046,5.776465120313546,3.746938781361359
BICR 31,16725315,5.360398456728244,4.171100962871124
IA-LM,216239,1.6797579071033788,2.566810548449975
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.8622708743234468
COR-L105,6610216,4.21117605455994,4.307084119729769
COR-L105,10427712,4.508625829006449,4.331661155805147
NCI-H2452,6610355,4.992583267176856,4.37707242383396
PaTu 8988t,11364421,0.0778741703331701,-1.3441121480274885
RKN,3552672,1.948192158503618,2.6705925204217897
Granta-519,46174525,4.2506809125564615,4.033624675980173
SW1271,44819697,-0.8585090240358869,-0.5173502561009763
WM115,44486219,4.206639028474801,3.8497959525072667
MOLP-8,6918736,-3.613498069188207,-2.5400486434035465
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-0.6775015283145184
LS411N,49836020,4.501659667614969,2.5766751993879478
WM115,9927531,5.125567810288171,4.644795484948933
SW1271,24797083,1.5469513987685792,1.1636845313982043
HCC1500,1566236,1.5057997400762737,2.112262176109675
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.1048041126894117
LCLC-97TM1,5566,3.3253657103683976,2.937177098762417
NCI-H1568,1242560,2.6554382745340046,3.6007376519096637
RKO,11717001,3.92417498432234,3.862516274331034
SW1271,11612883,2.3755529899406604,2.9463815612777546
Daudi,11396600,1.6595042173405945,2.8018426919137913
P31/FUJ,60700,-1.8341903870446763,-0.5047998940854791
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,0.5337296399466593
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.6003349018757428
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.0118577459682867
IGROV-1,3552672,2.134472496867482,2.4552023691890343
Granta-519,637858,1.0013506713179747,1.4842081453715326
RERF-LC-MS,24753719,5.208830602571573,4.182939458194965
BICR 22,10385095,0.7738978245677988,1.1935434672492844
IA-LM,216468,5.467489395679956,3.176084405601624
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.6014942243789934
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,0.9171131057765995
SK-HEP-1,5738263,4.7811273930471065,3.3090114301825158
SU-DHL-1,44632017,-0.1440136540504316,0.8168973677594705
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,1.3460910435342606
PaTu 8902,11152667,1.2355675895718252,-0.3903335114721488
RCC10RGB,53245473,3.741106102916085,3.291517286177403
RERF-LC-MS,637858,3.156110522031532,1.7452477845611174
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.9170753840076054
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,2.404004381299599
MOLP-8,23635314,-4.658988245687028,-2.792180510049986
HCC1500,241158,4.347158152842418,3.975061601869768
NCI-H1568,16065773,2.3280951044534923,2.351556339965793
COR-L105,24771867,3.297975412837562,2.4426591095002372
COR-L105,11625818,4.2515796910784385,4.587024140491651
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,1.3616155586883019
IGROV-1,2841722,3.834853118277962,4.291494412702934
SaOS-2,51039095,1.985897726070115,2.6611647301153454
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.4788391208179155
COR-L105,44589607,3.154557065472522,2.711722889243669
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.5283438738279465
LS411N,9911463,4.267700407985282,3.677292813771241
IGROV-1,4378219,2.016502068118561,2.4674149161720633
Daudi,135659046,3.1156448500687923,3.4682451130319563
KU-19-19,16722836,2.3762239171314894,1.8032641752948018
IGROV-1,10410894,3.2660402181528263,3.351431739070601
Panc 02.03,49793307,-1.288996397670963,-2.743003715732945
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-1.2423531360267388
MOLM-13,3136844,3.815118683612459,3.8683270512199432
MOLP-8,6914657,-3.275680842626438,-4.437700405298787
K-562,9887053,4.062685534067952,3.7448536691262007
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,1.1244676867528383
NCI-H1568,52947716,-4.502411459776945,-0.6136806599744564
BFTC-909,11178236,-2.4757289909406683,-3.099687104895091
Daudi,6610355,3.6984054922795906,4.253787265011039
HuP-T3,10184653,2.026243337908569,1.4702603762070123
IA-LM,36462,3.5803800151684384,2.367525637588008
SU-DHL-6,46907787,-0.6700724490980451,0.8552536403005778
HCC15,10231331,4.227224330005602,2.4464591087550773
LS180,135398516,1.9815935031047112,2.139448319364503
MDST8,53495165,-1.6914230136545845,0.5844117818154266
SW48,135411,0.1882785626851766,0.5821007651307167
COR-L105,11485656,1.8131666015075352,2.311152031100232
HCC15,1239801,5.074899811919598,3.888929273143436
SK-CO-1,11497983,-2.036472499029009,3.7077366949253663
Granta-519,2742550,3.255820788990773,3.4124667361438923
ALL-SIL,16720766,-0.6951675656481376,0.4393227005231619
COR-L105,11175137,3.2551565890936165,2.668449848135527
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.5495317668357027
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.8434947267159733
IGROV-1,409805,5.990596261907717,4.8115058059313185
Panc 02.03,11485656,5.602754460209725,2.3466506492923704
Granta-519,54619267,3.910643053444693,3.649665143134341
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-1.823865171297944
BICR 22,6252,-0.1324642168432157,0.4218109408226167
MDST8,11404337,0.5498361952050128,-0.4416199320619526
SaOS-2,60750,-3.1697993298632183,-2.124884856405076
SW948,11717001,4.275182691709766,4.056505821476843
MDST8,11175137,2.5746086097463974,2.6204132842975985
IGROV-1,322968,4.140599241163106,3.4500796643951577
HCC1500,1242560,3.704354238917139,3.397039077295574
MOLM-13,9911830,-0.5537570191991712,2.0203640944421357
COR-L105,16038120,1.5247864010803889,1.1056448943374875
COR-L105,45279963,3.905008730311125,3.630717675910572
WM115,148198,-2.543343591950365,-3.501697380365436
IGROV-1,2749,2.0319044408234954,1.9448071091986001
K-562,4477,-0.1635303329058878,0.5723168394866819
SK-HEP-1,25227462,1.4628952719758763,0.39561439454728314
Panc 02.03,23582824,1.3457270338170706,0.7376049319177853
SK-HEP-1,241158,4.116654148222159,4.13751309133582
SK-CO-1,168313047,0.9150038640573646,2.3513900237398317
Granta-519,9823820,3.571742016367909,3.7883836923483307
SK-CO-1,159324,2.1120355222347738,2.9479465330712697
SK-CO-1,10385095,1.4661007046294967,1.4758057086703547
NCI-H2452,71304818,2.7948147605911218,2.5502190448195936
MOLP-8,4578,4.125075782233611,3.9540897635261616
NCI-H2452,11455910,0.7111396076654327,1.586652516024627
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-4.5570155250342905
LS180,10074640,3.3464344717087333,3.044056337024005
MDST8,71466578,3.80352554053155,4.480904735616184
LS411N,6184667,3.0967158778150465,3.204948359306751
SW948,11317348,1.1175502037929408,2.573179417735617
MDST8,119607,4.705186592802013,5.233733158939683
SW48,11507802,0.6466338181730511,1.3835877159728907
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.3383460000773688
WM115,5702613,3.6693021536028367,3.138686141807282
SK-CO-1,23725625,2.337747507524157,4.597112587382814
K-562,2749,1.8349792189296796,1.6516010084273034
IA-LM,3825829,4.571991496451351,3.935482371438699
KU-19-19,104842,-1.861779032385676,-2.795926755006027
SK-HEP-1,12001922,2.448252559355595,2.077180733743185
HEL,135440466,1.1488755358131115,1.9633546354473654
Panc 02.03,6918328,1.3018368822202735,0.04197114538560004
SaOS-2,72734382,4.901362762899978,4.352750462457526
HuP-T3,135421197,1.625440100707307,1.7830634706823165
HCC1500,3384730,2.626558190955656,2.590355954668719
IGROV-1,51037431,5.669320749085174,3.1924044287591262
BFTC-909,4917,2.929839520827846,3.1407629462833295
WM115,637858,1.77843641117838,2.1295695682524003
MDST8,44589607,2.007770745404649,2.7843174410824196
LCLC-97TM1,5282054,3.1900504557345664,3.7242722323760717
HuP-T3,46199207,3.4499209547515433,3.208541186767617
BICR 31,25262965,-3.4333038857773093,-1.7214822448333695
LCLC-97TM1,6914657,-1.7973267784986633,-4.048781103298168
MOLM-13,9823820,-0.5140029045699521,3.5106799214274194
RCC10RGB,327653,3.228661308812885,3.202920051349646
NCI-H1568,4705,2.022283964907955,3.2449469372011506
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,1.9244681830917916
RKO,6914657,-2.9196237708628505,-4.563110351323618
WM115,72734382,5.455243998512052,4.59332805293256
SW48,46398810,2.2376864399879,2.303617575758236
LS411N,2945648,3.381909997555915,2.8555753915396354
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.269127104509939
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.6569388466796706
ALL-SIL,421610,2.937759224643201,2.934886284004631
COR-L95,11404337,0.1032061359669597,-0.3574759468918122
WM115,11427553,3.734660617826416,2.6451781819637628
HCC15,122327,4.313110702061898,4.47060517029588
Daudi,9444,3.424690286905087,3.52139286465994
Granta-519,4521392,4.382822475618979,4.031659739371292
SW48,31703,-4.626106549902408,-1.6774381498858175
RKN,10127622,5.371150210721622,4.24398358533876
ALL-SIL,71466445,2.2002248480614925,2.9381453861674203
MDST8,656346,0.9697505348816438,1.1031981902290666
Daudi,71680916,3.7291665773697,4.18896861219287
HEL,135398516,1.4688857829361923,1.8787220117432932
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,1.8133417770769091
P31/FUJ,9936388,-7.166815071220185,-2.3123755663604055
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.511918911138685
HCC15,11625818,4.624206979967606,4.211781701631569
LCLC-97TM1,42611257,3.4642891468760957,3.387822185226166
LCLC-97TM1,5311,1.9621633752287055,1.327350585711169
RERF-LC-MS,52912189,3.970931922009392,1.8239732461683011
BICR 22,9915743,0.3047863731286212,0.2521931463194227
Granta-519,11612883,3.2575401906490895,2.359653735975275
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,3.1704773373524775
NCI-H2452,3543504,4.306818718463235,4.37805929696501
SK-CO-1,676352,2.6575015884388704,2.075168359625037
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-2.459008890875748
RKN,71304818,2.008207131108322,2.5043072703313736
IGROV-1,67156097,0.1763939852409119,-1.1048612696311317
IGROV-1,51039095,1.7163430299301403,2.5770219965037797
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,0.9905503859698538
IGROV-1,72193861,2.0623829231433293,1.6050248589902691
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,1.8494454885125682
NCI-H1568,11167602,1.5259281753697294,2.668197923449368
NCI-H1568,52912189,3.4016367932827563,2.0536872696839144
SU-DHL-1,107985,-3.306496987383706,-3.862773424175689
P31/FUJ,73707386,2.311695228129917,2.981129005031661
WM115,9884685,-1.925323313513864,0.5990458475625163
SaOS-2,16722836,0.8662367041162377,1.4604550621026573
PaTu 8902,46843906,4.340257675131653,2.7200275985909017
BFTC-909,656346,-0.1018552101429806,0.7888922638291358
COR-L95,54618305,4.5292428127427575,4.629674554321943
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.367510244996827
Daudi,24772860,-3.9771177154169304,-2.377699361579854
BFTC-909,9911463,4.114346930944119,3.9185424361155317
LCLC-97TM1,44197249,3.7483906325702545,3.899363584666047
BFTC-909,6918837,-1.9878509916437357,-2.7664943023827764
RERF-LC-MS,24797083,0.2985814331764478,1.3451982401658633
P31/FUJ,135928012,4.893710575363991,4.385972507829279
P31/FUJ,53232,3.343897726239282,2.7960116996065913
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.8551708098300582
MOLP-8,25062766,1.6722099464266416,1.9171386707200546
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,0.6188882623411005
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.6364941385091548
SK-CO-1,262093,3.1807391377127376,3.0112830144309366
LS180,72376,-2.8322202153843703,-2.395082119106002
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,2.8709627670629283
KU-19-19,6918328,0.0154884073180988,-0.03622602539891247
SK-HEP-1,107985,-2.2891993358893856,-3.4124497547411288
PaTu 8988t,216239,1.832862266271042,2.346536448188624
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,1.0721603235668737
PaTu 8902,156414,2.7243668654536206,1.1883120040902915
Daudi,16659841,2.946181230411034,3.573079656739671
LS180,123631,2.1427319304120624,2.0080288673567255
BFTC-909,10385095,0.9839595624316404,1.3370785689936944
NCI-H1568,241158,1.943489424131273,3.882928906018403
UACC-812,44589607,1.3537953197929582,3.0134650159948837
Granta-519,11960529,3.2261057296158593,3.965122057681356
LCLC-97TM1,25062766,2.2139494005881293,2.164596927537174
LCLC-97TM1,5291,3.6350350305332424,3.675835696825365
MOLM-13,44491742,3.7695621371445975,3.9307348392129517
P31/FUJ,3025986,-2.3655111331800067,-0.8642830294054271
PaTu 8988t,2749,1.558615062570056,1.9507759037245134
IGROV-1,2113511,5.982902824257526,5.224377451676191
Daudi,54639126,5.221444108043,3.3553183567322704
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.7479804658220353
HCC15,9868037,2.5640614102548556,3.3323964956931444
PaTu 8902,6918837,-2.118913626513807,-2.849055192748475
ALL-SIL,23725625,2.2136327630148736,4.160665192211619
COR-L105,11455910,0.425998653780944,1.4074906996723444
K-562,16013152,3.768503882504226,3.8846765284358957
Daudi,67156097,-2.7448600083467163,-1.8022451994741198
SW48,6610216,4.461301788418361,4.163128719903627
BICR 22,11977753,-1.1105881150796446,-1.6537043166332788
Daudi,753704,2.787779434331829,4.286815104696589
COR-L105,46943432,2.471907312248233,2.216287686966054
IA-LM,16736978,1.926640001137528,1.96120151766729
IGROV-1,176870,1.8349827429681411,3.0686769916755163
SK-CO-1,148198,-1.1611262776602205,-3.4264621480660202
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,3.8081954048623485
IGROV-1,46943432,4.105714883822214,2.0035587077774615
LS411N,168312962,3.224541058203402,1.3902977922405695
LS411N,1641662,3.6634193785306337,3.3276909169022115
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,0.3930779518943911
LCLC-97TM1,26596,-2.266692800551727,-1.5523634376207582
HEL,151289,0.2321343459174182,0.6148790683205622
Daudi,1285940,3.7558538743643792,3.3209289236545434
MOLP-8,2749,1.3302247490678565,1.365460152704626
RERF-LC-MS,10427712,4.250983789220692,4.280600987156371
WM115,16725315,4.630500047502962,4.21859859349691
Granta-519,9840324,5.864872193260208,5.667487277841035
HuP-T3,25262965,3.989652761156405,-1.515874361691097
NCI-H2452,11719255,2.41462187851326,3.372946741909759
COR-L105,1641662,3.72017777917812,3.594171485547107
SaOS-2,89928392,1.2892186505806515,1.3933218116918247
LS411N,969516,3.2917111714105647,2.7265995280595066
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,2.8567675254672764
NCI-H2452,327653,3.049758242791241,3.209965840004295
LS180,4521392,3.9983682640735094,4.183118278698081
IA-LM,2113511,5.955012720035456,5.419126205479937
HCC15,11167602,2.587200682435675,2.430133132356982
RCC10RGB,9911830,4.5526597563763795,2.479630642470685
P31/FUJ,168312962,2.530788243280419,1.7797540983068882
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,4.22684146885783
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,2.791417646945057
Granta-519,9933475,1.54115480203428,1.769902878781616
HuP-T3,73707398,1.153693297692098,1.2206121908776826
SaOS-2,409805,5.764413924489168,4.7217462410428634
KU-19-19,984333,-0.867877464903324,1.0649532412974891
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.491494958088207
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.7010507371151835
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-0.9966164515130932
SW48,6918837,-4.354568378072889,-3.151316898713201
LCLC-97TM1,16741245,5.12826814210941,3.949799446725265
NCI-H2452,11507802,3.578778888517491,1.7650232107603037
HEL,11175137,3.15338888234114,2.267661917386202
BICR 22,60750,-4.532323865382038,-2.056855962544592
Granta-519,44491742,4.018752292224149,4.015423412963342
SK-HEP-1,12003241,-1.7510835313415607,-0.8689888812336188
SU-DHL-6,36314,1.1358641594844867,-2.0073731794564638
HuP-T3,11152667,0.3145958176635,-0.3285490563651002
Granta-519,15547703,2.599412791530534,2.832203784504013
IA-LM,25126798,4.097105087874825,3.512524923865362
MOLP-8,119182,-1.11255726511749,-1.6244329952188161
BICR 31,65064,5.259646525120305,4.863399766436668
COR-L105,6917907,-5.504495586582428,-4.3382131037008005
LCLC-97TM1,11238147,1.840896458617422,2.81615668216612
HEL,51039095,2.698396554100347,2.609989080830035
PaTu 8902,44185566,2.9137350944736653,2.3779187379329967
Daudi,53495165,-3.885820769064659,-0.6708466743115556
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,3.4370094840506566
MOLP-8,439501,-2.9296652389863267,-2.32927738085486
Panc 02.03,4259181,2.0313571914007604,0.4112592716394413
PaTu 8902,126941,-2.2828817630557228,-2.4430465608441168
RKN,5328940,2.201806852003849,1.8322966473292452
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-0.9864861250720541
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.7823489547923357
COR-L95,246676,4.317733637680926,4.188566335106266
K-562,135928012,4.4390204871751004,4.101062718386774
MOLP-8,56946209,-6.528820954061854,-4.627055369853149
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,2.6077642675865333
COR-L105,135421197,1.9442341701951136,2.1364602846007448
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,2.186403213522625
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,1.5766254240790605
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,3.025726079665923
RCC10RGB,5280436,4.525748645562069,3.5848442817703368
NCI-H1568,31703,-1.6950574450364193,-0.5845142308036082
SW1271,148198,-2.630785543453804,-3.2548979590889586
Granta-519,11964036,1.5223427206827596,0.9486400247726187
MOLM-13,16725315,3.788691115651132,4.1322491284042435
Panc 02.03,1716436,3.766168811644757,3.015426317270492
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.436617572275633
K-562,1566236,1.8179642124055264,1.664105443244938
RCC10RGB,409805,6.020159348453613,4.997608401607561
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,1.1566627622824601
HCC1500,11175137,2.755904594476177,2.8761621745437895
HCC1500,11494412,1.8019649514762912,1.702325950736574
HCC15,10127622,3.735977541508184,3.5368723894642455
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,1.7894248654874472
SK-HEP-1,168312962,-1.3309808369359073,2.1826563461069126
COR-L105,24180719,3.693037976394381,3.530971700058147
Daudi,46943432,0.8866201698678313,1.4677023797570876
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.4817987458062807
Granta-519,24180125,1.2477770260094014,2.684659413259035
RKN,9967941,2.6996754619948065,3.710716859228358
RKN,135398516,1.9656218312143572,2.236554592971481
KU-19-19,16115403,-3.194116920729502,-3.7442976465037487
SW948,56949517,5.5880132005349505,4.259321873377255
NCI-H1568,44632017,0.9967277604489184,1.0567204363788694
COR-L95,11175137,2.52315362607855,2.6323726052291287
NCI-H1568,676352,1.7505105304855018,2.1984353994073103
NCI-H2452,126941,-2.0674603287446964,-2.6553953409189903
NCI-H2452,4477,0.2060981637085811,0.606451457883261
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,1.0427255651807037
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,3.0195029107852593
BICR 31,11647372,2.8607835505972035,1.2057519108379804
WM115,52912189,2.2242444616857417,1.6015129357226872
COR-L105,2729026,3.0417945234466863,2.8630445796034887
COR-L95,65064,3.24172080303354,4.762977557816084
IGROV-1,54613361,1.0826132998561049,0.178982376647644
NCI-H1568,53232,2.5527200815554587,2.7157581342413897
IGROV-1,9884685,-0.088911709267569,0.6377364952764413
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-2.7160630159217307
SW948,16720766,3.3510678765666517,0.8149953953713315
ALL-SIL,135928012,2.5698772014589992,4.074535230508785
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.5712890964627638
COR-L95,56946209,-6.902335125637694,-4.679760167929607
IA-LM,49867926,4.185996432673056,4.041901407318083
SW948,11625818,3.962309646097391,4.415951086642155
IA-LM,4259181,2.3536383664390734,0.4510074797400673
NCI-H1568,4259181,0.5766231269303183,0.04650616869602346
SW948,6438330,3.286047925562068,2.318951630089147
P31/FUJ,15547703,2.950164329068843,3.0727435739531472
COR-L95,1750826,-0.7485912803642704,-2.042259169016317
HEL,51037431,1.91843497941606,2.8806802694562146
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,1.3970658823552164
Granta-519,462382,0.1364457210972633,0.31759075595863173
LCLC-97TM1,11719255,2.8064116850649774,3.1608803467091
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-0.9846737735432315
MOLP-8,1242560,2.9421278446513393,3.3331528623659246
WM115,9911463,2.5241618652619007,3.7043979243041685
RKO,3025986,-0.6013959236761957,-1.1363440521463168
PaTu 8902,5335621,4.440333682211631,4.556372479050348
NCI-H2452,19582717,3.9299005055458793,4.273878903542098
NCI-H2452,171352865,2.832902682703541,2.857039898348035
COR-L105,5566,3.258554573596101,2.9861978804532017
BFTC-909,11647372,1.2423847125416496,1.0396418938539087
Daudi,3503,0.8148417795144576,2.0218644759369324
COR-L105,25183872,-0.7403581245059931,-0.6104666902194371
ALL-SIL,375860,-1.552794194023853,-0.17401135192564618
HuP-T3,72193861,3.3106720937076233,1.4517356584686252
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.816614547904798
SW1271,6438330,2.1351654373433764,2.189366297315027
SU-DHL-6,25262965,-2.983432395440536,-1.4789221815759621
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,1.929644554008736
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.0007459188876024
SU-DHL-1,44489367,4.533806271256096,4.542851265350468
MDST8,31703,-1.4422735490012837,-1.1931004410670918
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.7294802745752024
IA-LM,10302451,4.177351274859187,2.531318115724098
SW48,11214940,3.1705360221414134,1.6742074889939282
RCC10RGB,10074640,3.4095283906874956,3.111819808604103
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.398565602560706
COR-L105,25227462,0.5095099099095757,0.3944635639721661
COR-L95,66577038,3.0490878420221934,2.8313760557337826
LS180,46191454,1.5509574675684803,1.1859901322904356
RCC10RGB,65064,5.251967206688168,4.816161252326329
IGROV-1,72376,-2.111352545322758,-2.2017219221481663
MOLM-13,89183176,2.661461024404157,3.497764097808231
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-0.9454563542117695
RKO,3384730,1.0492755436091918,2.1736001464485004
SW948,11656518,-0.9054812480406104,1.503802568746591
ALL-SIL,2949965,1.286096946783907,2.3309360837072894
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,2.5037230623748865
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,3.748825421492047
K-562,5287620,-0.244838249137823,-2.0242913478093696
Granta-519,3825829,3.4773445434270243,3.940027336889736
MOLP-8,10385095,0.909191851453096,1.0955160682564309
COR-L95,135928012,3.4969711227856397,4.188894148508619
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.3879367961717466
UACC-812,25161177,3.457735095549926,4.300770381082437
SK-HEP-1,11178236,-5.847785565222589,-3.337839475147837
SW1573,16741245,2.047879460545898,3.889861766340545
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,0.8173150806756514
K-562,89183176,3.981701702250952,3.7494977265280984
P31/FUJ,9915743,-0.8907797257006451,0.5146049188774083
WM115,3503,1.3325075362119865,2.309977861602945
PaTu 8988t,44202524,3.9754310935930968,2.568457367963637
SW948,9952709,2.6604018004594514,3.013886957485972
Granta-519,56946209,-6.359988120178517,-4.501473942054965
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.641381130812222
Daudi,613000,1.9882519691431488,2.2141394366309144
RERF-LC-MS,374536,3.716253113618047,2.34557631184433
LS180,72734382,4.032476699930466,4.219064720622086
Daudi,1566236,1.0534301581716357,1.7543978819703556
BFTC-909,9868037,3.24226767674478,2.9355201687722787
HuP-T3,107985,-4.90392348596967,-3.4069402806909035
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,2.210266712700362
IGROV-1,168312962,3.022863957843741,1.3929855108249425
IGROV-1,3081361,0.99973562532788,2.228525528613763
BFTC-909,5311,1.6846521587280363,1.4598483992076206
NCI-H2452,2841722,4.2339337769073175,4.359220998552044
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-0.6960776941553388
RERF-LC-MS,5278396,3.382202757419261,3.639643341745321
COR-L95,44607531,1.1147625805359247,1.3238560075677868
SaOS-2,135440466,1.1747227113697256,2.4160018637650866
RCC10RGB,285033,2.114091727684993,-1.8949995260234187
SW1573,448949,2.6434946381292703,2.096708815969907
SK-CO-1,11964036,1.41955554287601,1.3825965760027525
SK-HEP-1,24901704,5.545234809796251,3.255302609932936
RERF-LC-MS,71751553,4.213964581210796,4.507985144494404
SW1573,11178236,-2.507507612037206,-3.2692536828917405
HCC15,6450551,1.6627728253820353,2.7050422513158963
SU-DHL-1,54619267,3.144461009217004,3.729735292452114
P31/FUJ,11626560,0.2148563033664798,1.33881206950841
COR-L105,119607,5.370152891195211,5.315514002485798
NCI-H2452,11427553,2.818972077820031,2.7083340600530703
HuP-T3,2871966,0.5817483683031975,0.572507926342498
Granta-519,439501,-6.00499370561019,-2.5588456527278978
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,1.8189389699283445
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,1.5577055672242763
BICR 22,2945648,3.5832925483527625,2.655468195402861
NCI-H1568,11228183,4.140816994678141,2.1017886615848638
COR-L95,89928392,1.3878824566143364,1.3624239088475674
BICR 22,2871966,0.0284401826322965,0.5586074934737306
HEL,46199207,2.3973871372245372,3.070832920021191
HCC1500,52912189,2.5783780690097857,1.9071435648626898
KU-19-19,52947716,-4.518413756843173,-0.7829872503594838
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.472251626753571
NCI-H1568,7326481,2.864470016727109,2.7707052462820405
RKN,53232,2.2291100881655037,2.704290894098883
KU-19-19,4477,-0.0533500132034658,0.42533868487998
SK-OV-3,107970,2.5604111984812152,2.3266448997695384
BICR 22,1242560,3.7933374150058015,3.3798066566025073
ALL-SIL,5738263,2.854339564213428,3.11440981204991
HEL,5329102,1.6539669706420914,1.4991734030187849
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,3.718996648824631
SaOS-2,3854666,0.6354016080385003,1.8435278117994418
P31/FUJ,107985,-4.114404549725097,-3.5594894366872576
SK-HEP-1,54619267,4.307302877095537,4.185401901129843
MOLP-8,11213558,1.2108381509164672,1.2828288683580964
LS180,6914657,-4.58065814502937,-4.029317499438923
HEL,71466380,3.121887792191312,4.190654057576969
COR-L105,25154868,4.769445801979145,4.464345715686082
LCLC-97TM1,25105715,3.527934306265534,3.29971718369579
SW1271,16013152,5.485365595141675,4.374580474495
ALL-SIL,1750826,-2.8707446972397483,-1.892572805470673
SW48,44632017,-0.021210675828241,1.0688819524263824
NCI-H1568,4578,4.166510450069308,4.509802899949725
SW948,24180125,1.460789729891403,3.022599867269607
COR-L105,25161177,3.712985248467103,4.050387203696968
P31/FUJ,57519531,1.451496749892495,2.203296424190941
ALL-SIL,6918837,-4.772645295536399,-2.8794857314033027
RKO,16720766,-1.2722083569090707,0.3058376039853458
Daudi,11707110,2.6257952816009498,0.21965114460353022
PaTu 8988t,24785538,3.127280515757933,1.616207620950644
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,1.7889972892249724
HEL,46174525,3.393297616528365,3.6962197429207913
MDST8,17759555,5.018522859633252,3.704524996558388
SW1271,53392493,2.79081275696651,2.6415642826145365
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.231340021697756
SU-DHL-1,9927531,2.969590320438058,4.466736691601076
Daudi,445455,3.7530002864178416,4.225420851094728
SW948,24951314,0.7675285489701543,1.2962751033744413
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,2.0282633276252047
SK-CO-1,9866186,-0.7388742913087788,0.7679319914759772
RERF-LC-MS,60700,0.497286081450591,-0.7585974483965042
BFTC-909,11364421,-5.034674750215906,-1.6030927834781303
SW1573,49766530,-2.79322841384178,-0.6376851098988761
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,3.0826620053450555
MDST8,25126798,3.890491738661291,3.8268421621016584
HCC1500,3543504,4.272332537756205,4.2824183553701
COR-L95,25062766,3.209944577871265,1.9552166241918316
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.681676034806729
SK-CO-1,44632017,0.9847861620501556,1.1294892916860566
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,1.6190896347130561
NCI-H2452,445455,4.8000860101003235,4.60023232393564
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,2.609573672887933
HuP-T3,439501,-2.469428626730465,-1.979850207147288
RERF-LC-MS,9884685,0.4531053665233772,0.5619871439437344
RKO,5281321,1.9988379902215376,-1.3599779908978047
NCI-H2452,10410894,4.350169635958685,3.110924654185405
HuP-T3,24951314,1.4235135044150102,1.4959854410781228
SaOS-2,71466445,4.363709574185696,3.3720016196686573
BICR 31,44185566,3.0664042381745946,2.6096228053581636
NCI-H1568,11625818,3.359978935972883,4.443123598396426
BICR 31,3552672,2.13577451695998,2.9489297737910123
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,2.051189048106874
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.2425552627517096
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.831271785478399
LCLC-97TM1,119182,-0.294501899208461,-0.8338166116143697
ALL-SIL,52947716,-0.7216046839402591,-1.284864451097835
RKO,11640390,5.295981617059328,3.09285619078883
RKO,25150857,2.5785304193211247,2.317079535062688
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,2.6786238522477333
ALL-SIL,1716436,3.0252724323132374,2.6792456313984974
RCC10RGB,262093,2.8343922904091134,2.944729905642875
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.7923913931234202
SK-HEP-1,439501,-2.4482777943885856,-2.2052796111535087
RKN,71466380,6.199959456698308,4.545016431250241
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,4.202776552078231
RERF-LC-MS,1242560,3.610791422912421,3.477417190073126
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.5992984211165173
Panc 02.03,66577038,3.3089612685646985,3.030138274014192
LCLC-97TM1,52947716,-3.0616129604635565,-0.9972116137026462
SU-DHL-1,20959075,-3.3128713931491087,-3.158551028038616
BICR 22,2113511,7.552062733189383,5.31927321909415
SW948,25126798,3.357341035223679,3.9491579990411254
HEL,3854666,0.8085723321900852,1.2769781834420235
HCC15,168313047,3.1265794948701338,2.3547727383948285
WM115,107985,-2.5041726579949857,-3.509345613051421
WM115,42611257,-0.3600732192588895,2.903946550908557
HCC15,60700,-1.3823438115431317,-0.10020543365145557
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,0.0647587702319831
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,1.0661477775855943
SW48,60750,-4.2221568193195225,-2.154860144619444
NCI-H1568,262093,2.8880881470868585,2.9894004292184544
PaTu 8902,53392493,3.316041661234319,2.7011622757691702
Granta-519,11647372,1.7523915142224398,0.5661711579639294
SK-HEP-1,8515,5.0523689066797495,3.992570471308097
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,2.0458175277343527
LS180,702558,5.586038369213652,4.568354818059811
IGROV-1,15983966,1.7101486625531308,-1.263194751983571
SK-CO-1,6505803,-2.970063061644963,-0.6469554914204539
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.456356110436028
PaTu 8988t,11485656,1.82057121616084,2.1856909254467634
KU-19-19,2874250,6.302627434426347,4.325119002967261
MOLM-13,11175137,0.3158641445144168,1.931864731137663
WM115,644241,2.021542714802758,2.4673703408354224
SW48,52947716,1.8444935422046616,-1.2092110491586463
NCI-H1568,10302451,3.040030486332468,3.2212129212059235
COR-L95,44185566,2.2555949878605484,2.5497262420070905
LS411N,16725315,5.1123164266785714,4.088690007156214
BICR 22,25195348,4.085059979970886,3.2035166160384647
SaOS-2,5311281,0.944453452900516,2.2026901586007996
SW1271,613753,3.197731710568041,3.0356903499114827
IA-LM,9840324,5.344700856558617,5.9606314045267785
LCLC-97TM1,439501,-2.367039612081251,-2.2332053657722963
LS180,9825149,2.508714096118433,1.750247221936061
COR-L105,9911830,1.908645944756667,2.388532009394703
Granta-519,25126798,3.857539921377872,3.5202540339780826
K-562,11238147,1.4367734907149323,2.591751678304841
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-1.3632443937819938
IGROV-1,4705,3.3098412390054603,3.173424044454372
RERF-LC-MS,1716436,4.437154842045929,2.8187137502360353
COR-L95,6918638,0.5429028056483723,0.2477154921097182
BICR 22,11507802,1.0844954054416946,1.256819333071809
Daudi,54626689,2.8292455243221264,4.427106762772296
COR-L105,148124,3.589067174421039,-1.7273673431512941
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,1.033255397462982
IGROV-1,9825149,2.5588021380929553,2.409516380738001
LS180,2113511,7.0742493322433955,5.509128451179785
MOLP-8,16038120,-1.6086793301450355,0.5750982869941768
KU-19-19,67291369,2.2261044123877656,2.6157890037239633
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,2.4793238389802936
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.6215051621565987
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.3390394751346115
Granta-519,44462760,4.300929542453815,3.3894646139794298
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.1982752378727026
KU-19-19,17755052,6.06318579738538,1.4572005916433395
MDST8,11214940,-0.3312007430689519,1.6036263154172
SaOS-2,57519531,1.7793183342968584,2.4188115373145633
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,3.203570554846958
LCLC-97TM1,44493528,4.18527882332477,4.345878424690703
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,1.2278917706392098
SW48,10231331,-2.95597966611556,1.9257600529851655
SW948,24797083,1.9027092264791332,1.4724172289633417
IGROV-1,11238147,2.1723642292765084,2.5526743472778817
COR-L95,17755052,2.817022282186957,1.3792852543339291
LS180,25126798,3.79328534931886,3.7612792421766916
IGROV-1,71304818,2.4878074097553378,2.336862131463908
SK-HEP-1,10302451,4.165168773877425,3.1676491108545504
HCC15,25102847,1.68346873279249,2.387231845957055
SK-OV-3,15983966,-3.6834707194333927,-1.3915354319575144
HCC1500,54143018,1.195335139641603,0.5102678186159019
COR-L105,11364421,-0.5536252833264237,-1.9416273405110862
RKN,148198,-1.0178445286580065,-3.345724525069498
KU-19-19,400769,-0.482585358097733,-0.5184570594372577
COR-L105,7326481,3.3886978035876547,3.3082686893025306
COR-L105,44819697,1.466179589978979,-0.1707790848617321
SW1271,5281672,5.179464513143849,4.478550080184457
PaTu 8988t,3634881,3.651211463421112,3.4809914323183198
IA-LM,11404337,0.4340662777154989,-0.5109355555623075
NCI-H1568,5287969,-2.4053225408736405,-1.9286729129236846
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-2.134535635442611
COR-L105,54619267,4.07987987500145,3.9399622961484067
SK-OV-3,9907093,4.994966956142975,4.326485724258225
ALL-SIL,11167602,0.1759872916057691,2.4049636347627485
MOLM-13,49836020,-0.1965532240483963,3.187137780801745
HCC15,52947716,3.127529556956005,-0.07473791486235264
SW1573,4261,3.544037815747042,1.7774197880598601
MOLM-13,6184667,1.666374934082413,2.5457371202167365
SK-HEP-1,3854666,3.0622551399292264,2.1432963202235733
Granta-519,241158,3.1692083740262373,3.213151778517735
MOLP-8,5978,-7.284134927472065,-3.088549627873716
LS180,10302451,1.4669812473297774,2.8052547554749303
RKO,16065773,3.3120716405166615,2.2779423119855333
MOLM-13,24964624,0.892926396159225,1.8016742132298058
KU-19-19,11427553,3.4053411651543035,2.6395836491313935
SK-CO-1,44137675,3.0714779264964074,3.431088779455708
P31/FUJ,6852167,1.016015239887951,2.6628231955814683
HCC1500,5351362,1.2955308259083285,1.3590865093266675
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.4054702929953542
MOLM-13,252682,7.80657372951634,6.474800664195678
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,4.271193155518669
HCC1500,44607530,1.2894809747133489,1.7333138059279074
SW1271,3025944,4.184087558749553,4.215826277938888
HCC15,44493528,4.34604946513687,4.483022582904079
P31/FUJ,6918736,-1.9353169891324984,-2.2128117091983905
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,4.592343483504993
K-562,24856436,0.0017034666231649,0.26903650222564574
LS180,216468,-0.2416288368660945,2.2553789117692298
SU-DHL-6,11507802,0.7208159532280615,1.2281789182242617
SW948,5291,4.046310039203204,3.7066545373854565
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.411838699810201
HCC15,11152667,0.1037945221143532,-0.42231501553365064
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,1.236134908344825
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.5233243428787606
SaOS-2,49766530,0.3706728408995327,-0.7035320385267722
SU-DHL-1,168313016,5.361416197440646,4.599201592937569
HCC15,168312962,2.4994502868710677,1.6686820117664127
IGROV-1,24797083,1.5319862293819655,1.4051753602706483
WM115,71751553,4.133313051647094,4.48921389175755
SW1271,24951314,2.0404240106098723,1.300209738712739
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-1.744975561809712
SaOS-2,676352,2.2074841133021432,1.9867768168757953
P31/FUJ,322968,1.4419696378870497,3.543073000683837
SU-DHL-1,10127622,2.7675483211751466,3.751694959215657
COR-L105,44137675,1.808161252080405,3.7051296484897125
PaTu 8988t,11625818,4.482422780967983,4.051638955516406
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.5025274762285605
Panc 02.03,16038120,1.606654693103348,1.233173426746198
BICR 22,3854666,0.9977305103930704,1.9777196581094016
Daudi,46398810,1.6020476162665716,2.3336535149975135
COR-L95,984333,1.162546188419483,0.4071739986739681
WM115,1317464,3.7806694387813753,3.2395484235875656
K-562,71680916,4.727537128358906,4.51382683850055
BICR 31,25183872,-0.4870171412848909,-0.60704345938033
COR-L105,11626560,2.2911739511823503,1.6533233640618277
SW1271,9936388,2.2656701786136315,-1.2691944625266736
MOLM-13,135421197,0.945680487717708,1.385659466850096
SK-HEP-1,136227924,3.6301481247272287,3.152359192189824
K-562,375860,-0.3542925626582329,-0.44632976396167817
SK-OV-3,9887053,4.42879128381072,4.194688010442561
LS180,9936388,-5.017955750811216,-3.444231661009484
SW48,9935249,1.3330175828473068,2.629287354694971
SW1271,11214940,1.5931636594582963,1.892462198903678
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.109254639714442
RKO,67156097,-1.3338800856316015,-1.3470023658023025
LCLC-97TM1,51039095,2.799665973949055,2.830923749327658
MOLM-13,54143018,-1.3895840664016086,-0.1567228561674984
Granta-519,5738263,2.4520737989935246,3.034644430050516
SW1271,2828334,6.430891789984985,6.108798459467692
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,4.808289506477322
HCC15,3136844,4.306118753112888,4.2470445246715025
IGROV-1,54454,2.453541831966438,2.5749396607567085
BICR 22,9935249,5.2884064452137585,2.9693794806357463
BICR 22,72376,-2.4643814155147634,-2.330363611926182
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.621019768504647
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.1927892472915893
SK-OV-3,25022340,0.9085118587340768,2.5276853600999423
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.201529981063726
P31/FUJ,11238147,2.0504580426090286,2.5653324147110137
NCI-H2452,44607531,1.7526351480007742,1.6210740397124883
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.780001148344891
WM115,119607,3.834781850796951,5.263329262414056
IGROV-1,71466445,2.3758001916617797,3.193706490900208
SaOS-2,54618164,4.337585482929099,4.0328306960419695
SaOS-2,46843906,2.56299568717197,2.946189920107384
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,1.5190266710238156
LCLC-97TM1,2841722,4.284298549740087,4.164760627636078
LS411N,36462,3.380504085081747,1.7559053409160414
COR-L95,637858,1.3348673917451612,1.8141692963087628
HuP-T3,10113978,4.191114511390656,3.2549577525201454
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,2.290385559134003
MOLM-13,24772860,-4.1681928866236415,-2.6249623918668643
WM115,9823820,4.472944540337913,3.971480904499411
MOLM-13,3676137,4.483658238026924,4.263634653358142
MOLP-8,49766530,-0.668776240648524,-1.220269545939059
SW1271,107970,2.3235168881670285,2.47130266793804
PaTu 8988t,16065773,3.154821962511545,2.3516094891373265
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,4.268138177714275
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,0.9707788392678637
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,2.9291472064451556
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.676913386901773
NCI-H2452,11364421,-0.8742390414707,-1.8730458680385036
NCI-H2452,4788,5.30317679490816,5.765233921873842
P31/FUJ,11396600,3.188193103342261,3.4592604429400704
SW48,2130404,2.4705566813277215,3.3414740176330637
SU-DHL-6,322968,0.8712022459195665,2.963900271033292
BICR 22,107985,-3.867593954539223,-3.508627220038345
COR-L105,46215462,2.588599789838095,1.920997739698049
PaTu 8988t,5287969,-2.0890298278516513,-1.5148104586842357
SaOS-2,9866186,1.0217998308229927,0.6296114488213462
SW948,16065773,2.2305150921307653,2.4054968739483154
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,4.55935817383606
WM115,10127622,-0.9383410403940764,2.9437618448629275
WM115,2733526,4.043531113233861,3.8921004950874765
PaTu 8902,49850262,5.593248228762752,3.4572235050464246
HCC1500,54613361,2.498230028210423,0.2816514651776961
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.46400911419355445
Daudi,5746,-2.3170879531966273,0.6989034005436511
MDST8,6610355,3.7892287954147457,4.344219403542244
SK-OV-3,219104,6.736269406359778,3.76803685010556
MOLP-8,49793307,-5.094504062696007,-3.9121330670942625
NCI-H1568,54626689,4.298451601405369,4.677740547097046
IGROV-1,156414,1.4212019235656712,1.2584318538722123
Daudi,4477,-0.8111056564008632,0.5595486187396342
K-562,135398738,1.706304792848783,3.677687667150908
MOLM-13,57330099,4.105312173478173,3.926157307570112
SW1271,42642645,0.8738549597199083,0.9614154731455906
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.5472057937898955
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,3.2544383442243974
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.3992471696157476
Granta-519,16725315,3.130545070245978,4.105238693253701
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,3.274993446117079
RKO,3854666,1.2691133577357363,1.673242660299685
SaOS-2,119182,-1.602754826097209,-1.0671351494470398
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-2.7810274633875487
Granta-519,9843750,4.294258272153345,3.4754575824406486
MDST8,5329102,2.639161266907228,1.909060456372759
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,0.9372325106502382
SW48,36314,-6.6979677874770065,-1.4656677393442796
RKO,9825149,2.459088339864112,2.013877779956172
MOLM-13,9911463,2.5287579203643986,3.360086211432217
RERF-LC-MS,44566777,0.4059341966526995,0.7691360718065191
SK-OV-3,10184653,1.9718742380811307,0.27053430989800864
HCC1500,16219061,2.7461663809715375,3.2360316660605744
SK-HEP-1,9926054,1.934364320328667,2.0361109426373174
IGROV-1,24901704,3.0789156375765936,2.991870520126908
BICR 31,9933475,1.7480026685414405,1.8991836695327768
COR-L95,3552672,1.407232830890507,2.6127053637446465
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.8677743701912974
COR-L105,66577038,3.4359280481345755,2.972042271414282
COR-L105,24753719,4.356648297258706,4.435972875373964
ALL-SIL,24978538,-2.389127379896269,-0.43013950212391244
SU-DHL-1,3025986,-2.176216514163443,-0.7758940966378869
IA-LM,3062316,1.9598487648076035,0.48920903179382
MOLP-8,448949,2.0087568721459146,1.8199179790836393
HCC15,89928392,2.045660123087396,1.7063759926485802
SK-CO-1,16720766,-0.9325558438762483,0.7743103520937231
IGROV-1,11485656,1.900409616013456,2.099946220068879
HCC15,44137675,4.493981948720765,3.6135717487843357
SaOS-2,5284373,3.659507244236858,2.555195081832732
COR-L95,44589607,1.7004659608333377,2.6174448650938507
PaTu 8988t,16659841,4.413190590676007,3.7200268828898233
MDST8,5311,1.1196330054843209,1.3908452947799939
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,3.96829727506645
K-562,168313200,4.769830643466651,3.12925010950334
SU-DHL-1,36314,4.070517798024083,-1.6974031238085008
COR-L95,219104,2.3748233222255144,3.498823095888214
Granta-519,44566777,1.2837383493022634,0.35794401906270606
WM115,45279963,3.6868070952026506,3.6269356027357618
HuP-T3,10127622,4.169685865232827,3.958093379276529
SaOS-2,54454,3.299905279612609,2.411036594923809
COR-L105,71466445,5.452991683251573,3.688482884123935
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,1.9845946958287055
COR-L105,19582717,3.403236730524823,3.9610782729921543
K-562,11625818,4.129982389727392,4.066428404994975
LCLC-97TM1,3384730,2.793888789676347,2.398731316751762
BICR 31,4917,3.733916426719056,3.1947196912443525
PaTu 8902,54619267,4.2510877724746585,3.7488357992644334
ALL-SIL,25102847,-0.1309610459144975,2.4867926805820044
MOLM-13,23939,5.7894293981406,3.5244641988131225
COR-L95,2828334,5.963676169995917,5.921369472562697
PaTu 8988t,44137675,4.243997881661858,3.5927688628381587
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.491070103477357
SW948,5978,-3.22198817122066,-1.6118736358942325
RKN,375860,0.0559819210079563,-0.33540783146889974
NCI-H1568,49836020,3.1231470101883336,2.980694252301654
NCI-H1568,12001922,1.1909466973303815,1.9874464329852461
HuP-T3,135411,0.8125735513868637,0.7585929636042849
NCI-H1568,119607,3.825066299684422,5.252531575606615
WM115,9825149,1.8328544820090609,2.0768920757718696
WM115,104842,-0.2362637011987665,-2.744152481041989
P31/FUJ,327653,2.543614095842417,3.069394156905897
RKO,11396600,3.504834935214814,3.353258675679018
SK-CO-1,135440466,-1.3303352220830715,2.211774564338812
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.9632408541346948
P31/FUJ,23635314,-1.6494447832357666,-1.999433667154573
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,2.426606994641477
SW1271,46215462,2.0233113088179406,2.111189074975573
MOLP-8,969516,1.8716619229833695,2.4207397979993313
K-562,135999136,3.657737204061429,3.611840007153035
SW1271,9866186,1.0057234740027048,1.0594002654867278
BICR 31,5278396,4.450921628721945,3.519624343418063
HuP-T3,462382,0.4397112913332706,0.5940185689480516
SW48,44202524,0.7134579720144102,1.831181670858331
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.238925840678319
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.316187863818474
LCLC-97TM1,3025944,4.079230434060959,4.306470584873952
SW48,46174525,4.111785915347283,4.156377372808905
HCC15,11396600,3.725702968544969,3.7890218854278372
SaOS-2,2949965,2.5764816921436067,2.760144161281101
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,1.7962720291943675
NCI-H1568,10296883,3.9462373745058863,3.969843347464141
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-1.244649852919879
Panc 02.03,216345,4.682043945218969,4.199686612619011
Daudi,26596,-3.612902475241139,-1.441156912595215
NCI-H2452,262093,3.2163720661137942,2.8394065296143562
PaTu 8902,9936388,2.1491039356268966,-2.1111294404434067
SaOS-2,4477,0.5134457679146515,0.7187795623788579
RERF-LC-MS,4096211,1.8582313750529689,1.9279654477327224
SK-HEP-1,53232,2.505434368946379,2.987319711921661
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,1.6513343826791962
KU-19-19,439501,-2.2192304341921205,-1.9419195125119806
SW48,11222830,1.1015320686905217,1.3851524632132715
P31/FUJ,71680916,4.420716560192731,4.442912523210786
IGROV-1,73707398,0.8848064516600974,1.1347722612781994
BICR 31,176870,3.2718013899021607,3.0726102230799306
PaTu 8902,72193861,3.6637635590803384,1.5085452178983962
SW48,10427712,4.323791553226545,3.954936170828836
HuP-T3,5470400,-0.4965810223867313,0.03890950709256135
BFTC-909,3385,6.578023483143935,3.9910408038767202
LS411N,5278396,4.113687735714835,3.4423041840160518
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.529863740066959
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.06859512731107492
P31/FUJ,36462,-0.6599401629031103,1.9406048656154804
IA-LM,24964624,2.660053298461781,1.6568219913558346
Granta-519,4477,0.7960263088071861,0.3997557915316567
WM115,675434,4.127717546006753,4.349943693074553
SW48,2708,3.1864056833879726,4.617561971842566
P31/FUJ,11964036,1.0580497047985076,1.0055897326063705
SK-CO-1,4096211,1.2314360568652074,1.9608180273950149
Granta-519,24748573,3.0643863299071668,1.896121629518021
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,4.9545889920544415
MDST8,6918736,-3.3936356144084066,-1.5753662271348339
IGROV-1,3062316,-2.2361832227909075,0.8973583415730638
Daudi,136227331,3.813653547789358,3.6211391038545635
MDST8,3385,6.506797592159471,3.761036899561298
MOLP-8,3101542,4.39402228569031,3.2111233677638067
PaTu 8988t,19582717,5.440280671607156,3.96143935060431
ALL-SIL,54618771,-0.3818526805852408,0.7498401481489267
SW948,9911463,3.099005262739027,3.8795182800397816
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.5116427058859752
HEL,4259181,-1.3539346499127438,-0.026448236637052626
Panc 02.03,702558,5.477624163348055,5.1880891814172125
RCC10RGB,9911463,4.415558893727306,3.8206687046027916
P31/FUJ,2828334,6.241721397046506,6.071022217078739
BFTC-909,53232,2.9810373365160316,2.8476323274618642
KU-19-19,1750826,-1.6748688873644846,-1.4559169690051015
WM115,54454,3.1744679186495963,2.4377642837473945
LS180,5329102,2.7428602070947266,1.8150565069880056
K-562,25102847,1.0686863962440132,2.2383397510018357
NCI-H2452,51039095,3.311280338748592,2.890618639602806
SaOS-2,107985,-4.209612864808627,-3.4881200199605864
RERF-LC-MS,24180719,3.6010609924552455,3.5632645900981066
P31/FUJ,9967941,3.859476565836545,3.577762086632701
ALL-SIL,19582717,3.9660864037028793,3.629602786961385
BICR 31,448949,3.395825088667814,2.2441972859480517
IGROV-1,9926054,1.8111808945519428,2.027874043958518
MOLM-13,44632017,0.3571286974750209,0.8863634343009479
RKO,984333,1.1849980625737155,0.3547684286851862
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,4.508148251363778
LS180,5311281,2.3621140012684014,1.970515747829476
IGROV-1,5328940,0.347812751869877,1.588968131356079
SU-DHL-1,126941,-4.504729002827146,-2.940269684376812
LS180,49850262,4.041689005821524,3.2441813436895193
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,1.4081164643468895
SW48,10113978,2.97157913395206,2.7098307775791675
COR-L95,227681,2.232633220711044,3.280754743561465
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,2.2713215856000746
SW1271,65064,3.2018268639765908,4.890001726104045
Daudi,2733487,3.89488184101632,5.989694900307753
MDST8,4096211,1.945430248625456,2.1369430949797596
MOLM-13,56963564,-0.6687647359934185,-0.21498502507446837
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,0.7223810322472854
Daudi,216468,0.1519487612341026,2.2126467350934864
COR-L105,11494412,3.277457630260471,1.7946649391649612
BICR 31,31703,-0.4867862372580436,-0.8589202400791158
P31/FUJ,49793307,-4.015617000908982,-3.354508800062248
ALL-SIL,6450551,-1.4599471288533186,2.0130051656532033
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,0.6511794353832407
SW1271,36462,1.4389686814792042,2.2248755008388956
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.3879367961717466
SW1271,17755052,4.188603356762487,1.6626602377262203
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.227166460333385
Granta-519,9967941,4.009641048767512,3.375688506684211
HCC1500,25105715,3.368057340132644,3.4919345750932926
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,0.3967635404979727
HEL,2858523,2.985624119180162,2.8788118072753894
SaOS-2,3543504,4.845259948636094,4.606719276365759
HEL,71466578,3.2881122758034413,3.45067522241051
MOLM-13,44185566,-0.1979234147827578,1.9540427487678764
RKO,46215462,1.869666408515056,1.6708827223121918
PaTu 8988t,16720766,0.7633491404380248,0.7034046068642175
MDST8,17755052,0.7758841708349149,2.0023785259915825
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-0.6470321544613539
Granta-519,16741245,4.459375532286075,3.5134869239417434
LCLC-97TM1,36462,0.8347023875377979,1.8779522235372448
HEL,24785538,4.025400084811953,1.2497598796948997
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.5506255056408293
SK-CO-1,54613361,-1.1953747905350511,0.021201382236157463
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,1.4513775733589713
Daudi,25105715,2.455657378323054,3.2147365296068697
SK-CO-1,3038522,3.74499401693701,3.092102896655112
LS411N,11625818,4.428513603720294,4.177397065925042
SW948,445643,4.022773961540602,3.979008474565974
COR-L105,135984461,4.336047626093702,3.8504094677057865
NCI-H1568,71466578,4.264938806787537,4.407212201228204
HuP-T3,11364421,1.6783982807514195,-1.5635718143656885
Daudi,49867926,3.659415180241599,3.7244260121984643
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-1.125751455862685
SW948,11404337,1.0073661261070797,-0.41625851555486393
SU-DHL-6,5278396,3.0928075812605123,3.161601228320281
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,0.7556205885628229
PaTu 8988t,24964624,3.238300662516523,2.4386559976786755
Granta-519,135411,0.2246473977843227,0.12420347281777619
LS411N,3025986,-2.0648766502168843,-0.9694470100006284
HEL,BRD-K58730230,4.651487565209977,3.3038377654951394
K-562,148124,-7.41486725283878,-2.4174597835037863
K-562,10302451,0.1323934402367818,3.227539658341052
K-562,1641662,2.591871767435193,3.1214608013708314
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.193541440336791
Daudi,156422,2.1936092532092295,3.897999198867477
BFTC-909,44491742,4.0640318167931255,4.221751800798653
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-0.8741265181288241
MOLP-8,135398744,7.476327693514706,6.274977571851689
IGROV-1,54618164,4.2184521751950115,4.069941595301567
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,2.3991022036606435
PaTu 8988t,4259181,-1.3402011211504403,0.4223292108395201
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,1.9455237334884998
KU-19-19,31703,-0.69897788572983,-0.8599296458520074
SK-HEP-1,5460769,6.10306620405049,2.75001509017274
K-562,11404337,1.5978316825317844,-0.2675536803501271
NCI-H2452,9840324,6.282829349463256,5.874158451751848
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,0.8891127315383534
KU-19-19,11214940,3.3843502872937106,2.137373762024316
MOLM-13,3815108,3.4784839929418343,2.3909634531362327
IGROV-1,16065773,3.3717508464278585,2.4362071390253006
Daudi,6252,0.2227136884944618,-0.7209247023898968
SK-OV-3,1641662,4.382504296977698,3.6143876722969197
MOLP-8,11238147,1.6731293567937424,2.40410207541556
K-562,44462760,3.6560426907742896,3.616641033504355
RKO,9911463,3.963116579454927,3.6758229353330294
KU-19-19,387447,-3.0100561484626738,-4.073777551831161
LS180,219104,3.901138037988577,3.4019710472566764
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,2.9800953553395266
LS180,11609586,3.254650235567635,2.460805126124869
RKO,3025944,4.391654014934833,4.107763749719258
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.8531959093454131
SW1573,11640390,3.5338327701281176,3.6506549961221357
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-4.574390316796822
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.6371517833237119
LCLC-97TM1,2708,5.63991197078878,4.911589545999357
HuP-T3,262093,3.018266583248783,3.0233685174866944
PaTu 8902,3503,3.0706473844938422,2.3812786032805504
HCC15,6918328,-0.0257689511183662,0.036038783472551524
COR-L105,24797083,1.0360227961267732,1.394250637286845
P31/FUJ,9887053,2.876589254443052,3.7275844124675293
WM115,446155,1.535185995815247,3.01715919804905
COR-L105,613753,3.1601590793812,3.279933016472993
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.7063052593977652
IGROV-1,10385095,1.0670946713416192,1.4404906277243188
NCI-H2452,6252,4.582294901932163,1.1308459838013798
MOLP-8,72193861,1.011292170776,0.6232888671232334
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,0.7338621005769197
IGROV-1,26596,2.910298792762654,-1.1615437274992408
RERF-LC-MS,11640390,2.8932892314821927,3.4561508775162197
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,3.3161216601798857
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,3.995804107917362
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,1.658996178134921
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,3.7414149349833736
SK-OV-3,168313047,2.892407732266751,2.4240220978812435
Daudi,9926054,1.7776420054693636,1.8354566625381836
COR-L105,2749,1.1758378373045044,1.851129256825863
SK-CO-1,6918837,-2.3986996753086305,-3.0345688258953936
IGROV-1,12003241,-2.0122972114546904,-0.8633002020434121
HCC15,9866186,0.9811967871114916,0.8638835419961253
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,2.9681358032535696
WM115,9887053,3.7520086754622657,3.9325526902112187
COR-L105,9933475,1.7212192557919994,1.7802009244117045
MDST8,9967941,4.864965348465847,3.398431687437752
KU-19-19,5566,3.5813761109507154,3.115075224928222
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-0.8127157379357023
ALL-SIL,168313016,2.945013463521221,4.447976883324201
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,1.28983494552336
LCLC-97TM1,216239,3.3274661005628636,2.20054423449668
UACC-812,9935249,3.1921366544842,3.199844480927249
KU-19-19,46398810,3.059016393641159,2.484472882174549
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.1444658310199234
Daudi,24901704,1.6931015271472445,2.8163067439370297
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.7699043787099717
SU-DHL-1,135440466,0.4118800450630493,2.121897942568949
IGROV-1,5311,1.0068816368200209,1.4323314085774574
RERF-LC-MS,5329102,2.8374518121885637,1.90863765765687
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.76239127230153
Granta-519,10302451,3.667767303482806,3.0076394562419257
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,0.3335712403331453
NCI-H1568,4096211,1.8643847121139272,1.9559045394216255
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,2.793992110963131
LS180,44487872,4.564049669792266,4.4628605244001
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,0.1388025749726676
SW948,135411,1.551236240082995,0.5992889322572266
PaTu 8988t,216345,4.148994433618168,4.007847619106407
LS180,9935249,3.57280690269837,2.2397283365584486
UACC-812,46926350,-4.425607795744521,-4.133244740365701
K-562,46224516,3.0237589268452396,2.386923207693777
SW948,16013152,4.211275799279611,4.0219056577554895
BICR 22,10074640,3.373223414806136,3.1019763182295517
Granta-519,54618164,3.794628352719798,3.7514226977078295
K-562,49793307,-5.346924391172112,-3.1026423544685717
IGROV-1,54678924,1.4704159748793169,2.0682258847883856
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,3.177661340505356
IA-LM,24785538,2.950939703376364,1.5957439858589748
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.498069144527804
ALL-SIL,262093,0.6753795238054565,2.1062513913691134
SK-HEP-1,49793307,-1.6219654789172164,-2.404161315382889
UACC-812,9915743,-6.921665690083625,0.11271920043083745
MOLP-8,24964624,0.5129160642166024,1.610691176435038
SW48,16725315,4.089936042929296,3.9988014613218557
P31/FUJ,25102847,1.6695774391929423,2.4204982842624103
MOLM-13,216468,0.0785275755512733,1.7481602501572067
HCC1500,135421197,1.2704457907642457,1.7625333807237942
COR-L95,445643,4.015431140089913,3.901182649698785
Granta-519,9826308,-1.279512827450026,0.0640089493854639
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.138765054073871
HCC15,44589607,3.4730057914725005,3.1036129693571453
SK-CO-1,73707398,0.894037962240185,1.2123867767140808
RERF-LC-MS,46191454,1.934559197398404,1.5822095225791475
PaTu 8902,44491742,4.263402068757711,4.157109492289132
PaTu 8902,53481919,4.066569856261274,3.758773202640508
HCC1500,4521392,5.662319691471263,4.284206144571109
BICR 22,11364421,-5.708558910936986,-1.9321438308711634
LCLC-97TM1,6610216,4.478615539127516,4.241633494502866
BICR 22,52912189,1.443997008169696,1.6117952161617612
SW1271,11404337,-3.6050810245472382,0.02231226067301934
IGROV-1,969516,2.460805405371151,2.6569211525654355
LS411N,25062766,1.7796504921777256,1.7216373459063867
IGROV-1,11977753,-2.2284230058029433,-1.2936635320544756
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.2705364653200035
IA-LM,54618164,4.43488746250501,4.22725693476297
SU-DHL-1,135398738,3.5570959576905983,3.193187266276912
HCC1500,23725625,5.012282150953445,4.88603641497859
SW948,56973724,2.5267361451247647,2.7706855179593703
COR-L105,2742550,3.8597521863519257,3.9153397359638094
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,1.5635831270420033
SW948,11485656,1.7814283284456571,2.121226478608146
LS180,56963564,-0.4927248320174067,0.2840847237461653
RKO,9866186,0.3829002704071885,0.5915907982450823
Daudi,44202524,1.1056351253600936,1.7954119981780494
NCI-H1568,11964036,0.8982081488420575,1.2850941844249875
MOLM-13,9915743,0.7456385275428815,0.3067752012170095
Panc 02.03,4788,6.040807258084593,5.796665783196577
SU-DHL-1,10410894,1.885737679840171,3.0473551794804767
WM115,3062316,1.2654694678882143,0.8331014702317787
HuP-T3,148198,-3.5090934063696153,-3.1375198483794535
HCC1500,24748573,2.217224851211772,2.406464351635145
RKN,44185566,3.394049733904779,2.5574369925596008
WM115,73707371,4.316198918387243,4.881242693372999
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,1.89744239713578
COR-L95,119607,5.444677320305195,5.107836424124209
SW1271,3543504,5.279434126076659,4.27001444051988
RKN,613753,3.037549827357118,3.1326200463613367
MOLP-8,9933475,1.6461417731910544,1.595314150997536
SU-DHL-1,374536,2.32669265560356,1.915035573122095
NCI-H2452,11222830,1.0864314168284432,1.6504223704038354
BICR 31,16736978,1.5520316002325725,1.8257326148601514
BFTC-909,11656518,3.71751997684089,1.4512787359075903
SW48,49793307,-4.357023521296349,-3.292491237014086
HCC15,676352,2.734399334153108,2.2057645336134324
K-562,9933475,1.5582186007451084,1.7676047739512613
COR-L105,1716436,2.5827881779858797,2.9848589654045394
MOLP-8,71751553,4.257415338539138,4.269040053503251
MOLP-8,11427553,-1.470461076327197,2.0824187129566756
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,1.9225982269043689
HCC1500,65064,3.4319990575629484,4.789907336360634
BICR 22,54678924,2.835542995017498,2.1150047110671153
SaOS-2,52947716,3.1327874038156636,-0.2235634996915291
RERF-LC-MS,327653,4.17889189356682,3.0184354071451556
RERF-LC-MS,216468,3.2358353560937267,2.6334063629677873
LS180,637858,2.1359320280537704,1.4468585714622428
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,0.1880623114216222
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.8500331513024326
HCC15,25154868,4.699010678354358,4.54088654507453
BFTC-909,1716436,3.115342072857748,3.1290856542350935
WM115,208908,3.0871953707393662,2.2297780344016194
COR-L95,5287969,-1.974656124599848,-1.94340048185511
MOLP-8,9907093,3.7363465424365567,3.8377459188499348
RCC10RGB,5738263,4.593697299478501,3.3807625199049833
SU-DHL-1,446155,1.7989638936827528,2.6502386971727305
Granta-519,51037431,4.032962229357369,3.095385584825016
BFTC-909,24771867,4.730369684143592,2.6186504714468946
SW1271,9926054,1.9992649208496855,2.2942382627805133
IA-LM,46843906,4.034671652936036,2.7032213786781383
PaTu 8902,3634881,3.736044150449037,3.323016508055836
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.3142664656254164
COR-L105,89928392,1.7234999745886912,1.6547071325728746
Panc 02.03,6917907,-5.450554920776264,-5.461185636666488
ALL-SIL,216345,2.7239648031314108,3.519318335340437
Granta-519,5311281,1.2060114833285496,2.1541595540086798
RKN,25150857,2.829513348324473,2.49901124431316
RERF-LC-MS,702558,6.005509402748126,5.120283172119014
Granta-519,44202524,0.8355806814666445,1.6098491625696039
IGROV-1,65064,4.920352624378345,4.80172601574533
HCC15,82146,4.430619158397189,3.7563976273176314
IGROV-1,135984461,4.285945029851472,3.690144212864764
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,2.1321107969427673
RKN,25183872,-1.1518449365963386,-0.40778176610276323
SW1271,6450551,2.703162256598128,2.592333905762026
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.4953210543257143
RKN,656346,1.677354805367284,0.9489387195818754
MOLP-8,3503,1.781914224283778,1.9800755677250823
COR-L105,2828334,6.248355208389406,6.098667009784626
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-3.200295516220223
MOLP-8,135875424,3.0291075959050233,3.5006269639500727
HCC15,24748573,2.004363812639911,2.4299578158025046
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.2265887823675468
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.7001057254957666
IGROV-1,56649450,0.515518984822669,3.3123628933953
KU-19-19,9444,4.28834999434395,4.033271974231409
Granta-519,3552672,2.198733357723822,2.329016108714253
SW948,66577038,2.9537896679300655,3.0568680657092084
NCI-H2452,119607,5.591396796149955,5.300732366276136
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,3.842941747468739
HuP-T3,2729026,2.9922624267509317,2.786655928663368
SK-HEP-1,71466578,6.341226391578653,4.408550051686055
Daudi,24785538,-0.3082535888445589,1.0562942934832749
IGROV-1,5280436,3.2616766817665086,3.4112386090559825
RERF-LC-MS,7251185,3.4578262740878976,2.3948346375119427
HCC15,156414,2.365134958139565,1.5467431313810613
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.6438132471019984
BICR 31,10127622,3.719060323270891,3.85733594482942
SaOS-2,15547703,3.066966974063678,3.202063637712279
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,1.5534313684023997
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,0.7115351544317606
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,4.18211289215379
SU-DHL-1,3689413,-2.511818154735677,-0.46248379864263733
COR-L105,56946209,-4.798718381888378,-3.971037065534125
IGROV-1,5978,-1.5618214380165825,-1.409970807085074
BFTC-909,11222830,1.7098036316197358,1.5675249377996587
IGROV-1,216239,2.21703825410177,2.251708247289265
MDST8,135440466,3.3221976295713342,1.992480519754177
P31/FUJ,44632017,0.6534437162154956,1.154153101252917
IGROV-1,219104,3.803083685328391,3.6348680929839032
SaOS-2,637858,1.716758511666406,1.960137196120393
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.7642232813901106
COR-L95,24753719,4.203119149122614,4.127234567428902
HCC1500,3025944,3.928139296588046,4.190771450974058
Panc 02.03,56946209,-4.513446270471167,-4.190112002351708
HuP-T3,25126798,3.926602492728053,3.861618758144542
PaTu 8988t,3011155,4.341218756124128,3.7911614275286016
SW48,20959075,-3.67297247887529,-3.2652632370782793
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.4913497024478677
BICR 22,44486219,3.936553836391045,4.123420900568166
RERF-LC-MS,6918736,-1.8242544668906209,-1.9896864055416474
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,3.4967728739415667
RKO,44137675,4.282234128328841,3.114833992207171
IA-LM,11626560,2.8197095065502515,1.6504926159565532
SW948,2746,1.2183078272507333,3.159978317500494
NCI-H1568,168313200,3.516432771095034,2.7718674153188267
IA-LM,262093,2.9896562434219627,2.924895082017617
MOLP-8,4261,-0.435327551985223,1.0102748038906704
HEL,2708,3.2519957529556716,3.829171855117161
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,3.3323479646471883
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,3.049258756417859
MOLM-13,51039095,-0.7255439577713276,2.4683656521161756
IGROV-1,426756,6.142776526139055,4.14194468858204
NCI-H2452,25154868,4.866167054223791,4.473927430241687
PaTu 8902,4705,3.6244040622068256,3.078746191827705
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.207418331929936
Daudi,135421197,0.2989842149032058,1.5663633164669357
IGROV-1,10427712,3.944243047938238,4.323529603139886
COR-L95,24978538,-1.547703636473998,0.5963827714533924
SaOS-2,52912189,2.036463757447864,2.052803481222692
PaTu 8902,452548,0.9739796251952438,-0.19175264769808786
IGROV-1,52912189,2.3966568144845666,1.8104421856225474
SU-DHL-1,387447,-5.562438756444553,-4.754616836079404
HCC15,135398516,2.1695814103654696,2.197019230247032
SK-CO-1,6610216,4.838209270425191,4.316402999070346
MOLM-13,5351362,0.6925875902125201,1.1076397385075274
HCC15,46191454,1.8626809755345697,1.6660382688866924
SW948,9825149,1.8114941973110277,2.0489645590784082
Daudi,54639665,4.383406013207389,3.2194085396139296
HEL,2828334,6.1216048061751795,5.968826493138987
BICR 22,71466445,3.433479198461154,3.398012648118079
ALL-SIL,9826308,-0.8056632694679019,0.0302467460778163
NCI-H2452,57519531,1.3990882913061125,2.6692076288164266
BICR 22,54613361,0.4978505675466737,-0.17925438156456852
SK-OV-3,135440466,2.5162908691834405,2.358236111394803
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.1901148649190443
SW48,6852167,2.2630322871527913,2.7529531839909795
RKO,11404337,-0.3534280477619294,-0.5278351441370022
ALL-SIL,5291,-1.9713425457655045,3.2511731405609505
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.832560991022205
IGROV-1,24771867,1.9944882740161016,1.9129989295946743
MOLM-13,46224516,1.6904951862054391,2.316048354394396
SW48,119607,5.387394946551996,4.832264893742304
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.6766850907260534
BICR 22,49836020,2.6142262300183305,3.1653728758316824
BICR 22,16720766,0.4876582946813295,0.6334539514266406
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,2.7393580041230092
SK-CO-1,123631,1.846760097113305,2.3773291234479186
BFTC-909,36462,4.374665451212183,2.280319386380517
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,2.9674506991293415
RKO,5328940,1.7974237645790871,1.4648277732212645
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.8370055371157384
ALL-SIL,5281321,-2.461016259028612,-1.8246014684449219
P31/FUJ,568763,-0.9310646254211032,0.24124159886814478
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,3.1736441638482145
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,1.9759245600389812
WM115,3081361,1.7542351340434374,2.4764035555018293
Panc 02.03,676352,3.0262590525496895,2.162088955334413
Panc 02.03,44462760,5.147948611944762,3.8935938295530206
COR-L95,11228183,-1.8408108773608771,1.8261911335475502
WM115,56973724,4.208743527700851,2.876644007766542
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,3.0906460841693
HEL,65628,4.10911337005638,3.8128900182407865
Daudi,11612883,1.1925703345745973,2.287590057811087
RCC10RGB,24856436,4.070420512574028,0.5298762385974292
COR-L105,46199207,3.6604959991625825,3.1469844766802724
Granta-519,25195348,3.9328442274761217,3.0609231653266082
NCI-H1568,1750826,-3.116085482779225,-1.4139621923525467
IA-LM,12001922,1.9531449792239188,1.9180036549822004
IGROV-1,19582717,6.764352444432722,3.95616592934019
HCC15,10113978,2.260363506948615,3.5118081160651387
SK-HEP-1,10074640,3.7857764861964935,3.227558761807743
PaTu 8988t,6918328,1.905296387062238,-0.3488225323465042
HuP-T3,24785538,1.540895569713237,1.4000129305690177
BICR 31,5281321,1.1837918014475457,-1.6105743645401132
MOLM-13,216345,0.0865178974102724,3.211694348416284
HCC15,448949,2.8674184346568414,2.0847183133790503
K-562,44566777,1.311822236929868,0.2888932597915638
HEL,452548,-1.769607447996444,-0.7861702314996812
SU-DHL-1,11507802,0.9378608618407872,0.9016505950867484
SU-DHL-6,2113511,5.89050983447184,5.122063129033737
SaOS-2,54613361,0.0035364978270003,-0.14033739426504555
SaOS-2,24748573,1.7294478830476196,2.125579710927042
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,2.9964792115923418
HuP-T3,49766530,1.2218451996302029,-0.5309087084577332
HEL,262093,2.3252232523203995,2.6618375518948487
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,2.3404155104359097
MOLP-8,675434,3.835070621627746,4.206216500815284
RKN,16725315,3.256745916563384,4.191897839330334
RERF-LC-MS,5746,1.1068525081764873,1.1944892000554852
SaOS-2,11964036,0.5086023979470407,1.3567329775100863
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,1.8462092757145387
LCLC-97TM1,126941,-2.218385477362075,-2.598229656176573
HCC15,54618771,1.6567762934530044,1.2000843911241994
RKO,2113511,4.623772297498578,5.26715160048641
RKN,9929138,7.419607622812729,5.236304939659579
HCC1500,5460769,5.1304942195737935,2.6864461498980154
COR-L95,31703,-3.0462560513884203,-0.943844304111072
HCC1500,46224516,1.0534131743048871,2.5352786199563266
Panc 02.03,5328940,2.397017671249583,1.7664845406542111
LCLC-97TM1,11404337,-1.4043223473519348,-0.4329458457557084
HCC1500,42642645,1.451455976812008,1.1126957166505833
IGROV-1,51037431,5.669320749085174,3.1924044287591262
SW1573,107970,2.0608182724975266,2.4151545356706956
SW948,46191454,4.338482378206047,1.8083609817120956
Granta-519,11455910,0.302072347623865,0.896778845358411
COR-L105,2113511,6.080993735084838,5.334948449095586
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.6601161986759965
IGROV-1,448949,2.098499309472767,2.219392189237119
NCI-H1568,107970,1.680617581032042,2.2916758362670135
SK-OV-3,24797083,1.6169926593639932,1.4199475700185513
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.2500046699706737
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,3.5573760162855264
IGROV-1,4259181,0.1937358171291443,0.11808810178713863
LS180,135875424,4.384751932486372,3.6588609271244996
UACC-812,54765302,2.961863639252158,4.173050737692728
SW1271,49867926,6.0238397416149345,4.061055513343566
SU-DHL-1,3025944,3.851371371046294,4.03263367855353
SW48,9967941,4.423983829284398,3.197399410974724
SW1573,11609586,3.686627979451031,2.749626868708566
Panc 02.03,16065773,3.1661848504472023,2.3074615139419983
RCC10RGB,135421197,4.393109316582631,1.9345536765416995
IGROV-1,24785538,1.106246320450551,1.416587249654369
HuP-T3,5278396,4.193223405360703,3.6089278264356692
IA-LM,24901704,3.940918836251392,3.0198395827365663
SK-HEP-1,11214940,1.8009666315936252,2.011500641387102
K-562,11364421,-5.792707438494169,-2.6554591707182658
LS411N,3384730,4.573317632228089,2.279905225545583
LCLC-97TM1,568763,-0.0784771886342085,0.41471455455468953
HCC1500,9936388,-2.5304598124234365,-0.7447995738132269
HCC15,5311,0.7792586953300233,1.4716175348597311
SU-DHL-1,54686904,3.5039759810509676,3.265567233979203
PaTu 8988t,11626560,2.010870886496287,1.850509529726223
HuP-T3,2749,2.009482044490881,1.8597087568703328
RKO,60750,-2.2331483998906654,-2.2927360548317908
HCC15,5287620,-1.6098111318920385,-1.7934914436475995
HEL,654092,-1.523294365181231,-0.8473650633145892
SK-HEP-1,71304818,1.6350171624170464,2.630507717359066
SU-DHL-1,448949,1.2808073887625644,1.8691418492282728
K-562,5281321,0.5422415972342122,-1.3922194959397054
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,1.634527579002266
LCLC-97TM1,5351362,1.316382729979947,1.2685585222718565
MOLP-8,5460769,1.8843864880791628,2.249868131400352
SaOS-2,56963564,-0.1924881408966614,0.22107628293499185
RKN,446155,3.7628691651204234,2.746260991087177
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-1.8962172914798068
NCI-H1568,16038120,0.8714631615296456,1.0827299584007668
Daudi,25102847,1.3031740879242997,2.2150005171362643
LS411N,25154868,4.929077040033465,4.247928494332821
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,1.9749107599117175
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,4.071769793116618
LS411N,9915743,2.8294092926119028,0.7136824217523465
Panc 02.03,BRD-K55473186,4.513191364064351,4.039536449530894
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,1.08948439844427
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,1.8317876380533142
SU-DHL-6,4917,2.9501994456287792,2.8788638472377266
Daudi,16741245,3.410771008602035,3.6597089398667726
MOLP-8,3062316,1.3489297980566397,1.1035344409031114
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,2.855408127110532
RERF-LC-MS,25183872,-0.4545636564638026,-0.9162603279832447
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,0.8921272698972469
MOLP-8,60700,-2.8082015295780858,-1.0472952750113773
NCI-H2452,637858,1.8545349692582156,2.1631231799650443
LCLC-97TM1,11626560,0.938916298027116,1.8286829772058448
HuP-T3,136227924,2.888640375816574,2.9465433765563476
IA-LM,5284329,5.1954673618886655,3.1580522521087517
RKO,104842,-2.5196749638548,-3.0515313321167246
SaOS-2,11494412,0.4895123820960489,1.3418380243890404
IA-LM,9926054,3.212619063516659,2.1465755167895675
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-2.286390002297105
MDST8,23635314,-2.200660522590374,-1.421883276539786
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,-0.016134680997248754
RKN,4261,1.529955054772996,1.7180419109570344
SW48,11396600,3.829401994456863,3.5271346936311225
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.5795252119514149
HCC1500,16659841,5.303826701580757,3.7752881741641233
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.1880790016067677
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,0.8356171877153034
MOLP-8,10231331,1.2198029486879254,1.1188289631605615
COR-L95,16725315,5.004914745056217,4.190847623128372
HEL,16115403,-4.756245139541522,-4.307030494741318
WM115,11717001,-1.1241138002933555,3.589722516601469
SaOS-2,11626560,1.1465195781021866,1.5995352307105242
BFTC-909,9907093,4.635414583134371,4.151281423157432
HCC1500,66577038,2.9555971550997935,3.0107683384176793
IA-LM,285033,0.5092837727748464,-1.9147685168222879
IA-LM,4917,4.737499942891754,2.8885902458128796
BICR 22,44632017,0.9263322393180023,1.292884957100888
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-0.741043376511266
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-2.818681620942088
SW1573,89928392,2.032641459256584,1.7500977891203189
MOLP-8,119607,5.472499710124238,4.905319328143022
COR-L105,46398810,3.2483226376094194,2.665126178315435
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,1.739360125973211
HCC1500,135999136,4.086589117257826,3.890618771296519
WM115,11497983,4.51521868458229,3.477009768135303
SK-HEP-1,46926350,-4.110479335135347,-4.059645879668804
RKO,322968,3.8471310775605216,3.4351479389314266
LS180,25262965,-0.0916364033105869,-1.7137771687102705
HCC1500,246676,4.424448695399937,4.428809680607797
COR-L105,104842,-0.9230389281504464,-2.5870785014609647
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,1.5875418575771931
SK-CO-1,6610355,4.767157937449789,4.459838656707359
IGROV-1,676352,2.310492141650647,2.1386164399714302
SW48,262093,2.726859331273406,2.646532457070326
HCC15,55508,3.481008151195261,3.3255147444825126
HCC1500,2126,3.801078614960916,4.708457940650736
PaTu 8988t,24951314,3.0808050806085188,1.4750550953714867
RKN,11455910,3.815213247766997,1.2892084384121112
SW1573,3062316,2.075650426956439,1.1069268930822775
SK-HEP-1,5287620,-1.0463187584720948,-2.0145088052859057
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.394656228517539
MOLP-8,24779724,4.381900106399647,4.421484044851286
Panc 02.03,107985,-4.238430695688479,-3.6545615484089513
IA-LM,322968,2.7570489193637018,3.5385279463908406
K-562,448949,1.070656561881704,1.7452178603970878
LS180,54649381,3.823257143411622,3.6496626836655843
IGROV-1,5281321,-1.4962463697398798,-0.7985380739008409
NCI-H1568,42642645,1.4281976900349445,1.002764334008548
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.530389149341128
K-562,44185566,1.8580861510177096,2.3984339233939944
SW48,637858,1.3097623359774897,1.7560211601221365
SK-HEP-1,613753,3.3794099216210203,3.320589646455632
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,3.1226136938291638
COR-L105,11234052,4.539846823478364,4.115849907250634
IGROV-1,72193861,2.0623829231433293,1.6050248589902691
SW1271,3503,3.0280256153278606,2.311896301463383
NCI-H1568,57330099,4.373464200171548,4.249318456451916
MOLM-13,1750826,-3.2515027143289728,-2.6133426888409628
SW1271,11222830,1.3106603955640226,1.8647265788236411
RERF-LC-MS,445091,4.218142840499499,4.150270904337247
BICR 31,3062316,-1.406162609577698,0.8987333654028846
HEL,25126798,0.3968700607761156,3.580400233509479
COR-L95,5738263,2.419040765220329,3.1937637105844994
SK-CO-1,36462,0.7476665664464673,2.3679475455853596
WM115,49766530,-0.6421157759153451,-0.3789157806584278
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.5780557902258378
BFTC-909,46901937,4.445112058189045,3.894412289731456
SW1271,136227331,4.376300443457216,4.211416959043737
COR-L95,25262965,1.4716002732306153,-1.830882809399444
COR-L105,5281672,4.46136628199001,4.518185883864597
WM115,73707398,1.178086440828875,1.2803993295910536
Granta-519,6852167,2.2648312753409887,2.512797005454808
RERF-LC-MS,46174525,5.020740506928848,4.261856859407526
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,1.125923552278214
RCC10RGB,44202524,4.922768729279552,2.2335681413962094
BFTC-909,BRD-K27188169,5.152610673434624,3.478576378542834
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,1.9375560985769857
IA-LM,439501,-4.16745845294267,-1.6633381537559808
RKN,25262965,-0.5506090189051945,-1.3589955737880959
SW48,3385,1.919145280274203,3.2206509924839257
RERF-LC-MS,12001922,2.43602915295576,1.8347813962009791
IGROV-1,568763,0.665047061839467,0.3248248768585404
P31/FUJ,10385095,1.5135865779060806,1.1755895677596326
HuP-T3,12001922,2.3367896101102907,2.1175260545311945
HCC1500,1641662,3.3816027924522487,3.4731478687389354
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.152098310968279
P31/FUJ,1242560,3.8275456086274127,3.510192521719235
NCI-H1568,57519531,1.3161148530355309,2.661236583142017
SW1271,42611257,4.308869978455437,3.421052378347464
Daudi,10184653,1.026270071695755,0.9670453017348293
K-562,2858523,2.745068324935018,3.021779141055802
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.692342740537232
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.5609461969543773
BICR 22,12001922,2.2523981699696165,1.7912035173338259
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.6608827531415824
UACC-812,5978,-2.554443854158195,-1.3057195074211443
MOLP-8,753704,3.0200894206550877,4.611015262240188
ALL-SIL,5394,4.4345454375843625,3.618961354077656
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,1.9244632204157468
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,1.946521625218484
NCI-H2452,44137675,2.6709050374584846,3.549050717739137
BICR 31,52912189,2.5113420173615464,1.9859246342584587
WM115,72199292,4.562209520612744,0.7307983877139557
BICR 22,25154868,5.114547534217177,4.27594177878583
SW48,25262965,-0.5589271325062998,-1.5016255577625017
IGROV-1,4705,3.3098412390054603,3.173424044454372
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.8204520147118233
COR-L95,11955716,-2.3894028875885778,-1.2760882013993244
BICR 31,241158,4.31214680273537,3.964169075987304
RCC10RGB,25062766,2.0619451400109265,2.1848911728646265
HCC1500,25262965,-5.244904140838402,-1.1644041999035328
PaTu 8988t,285033,-2.1993510069972215,-1.8313101485259324
PaTu 8988t,44566777,-0.8532538772982161,0.7955163305792583
SW948,71466445,3.954398511848749,3.635979536399293
IGROV-1,6610216,4.310938387105607,4.143858380833176
PaTu 8902,11497983,4.394920409770125,3.626291785911846
SW48,11612883,0.3553002535249436,2.521175944169027
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.6730777148014545
HEL,9868037,2.50949616555346,2.431072667802702
HEL,11178236,-0.8324730036537664,-3.38788848262756
RERF-LC-MS,60750,-4.1612389836176,-2.8427711006717935
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,1.8450394699592874
SaOS-2,24901704,3.518814077302041,3.110141793417816
COR-L95,6914657,-4.192308975603822,-4.326765134939671
COR-L105,262093,2.940873643596252,3.025685183278554
LS180,44486219,4.325065743764261,4.073997213526741
RKN,10074640,3.313081701902331,3.2601953460138566
BFTC-909,5746,0.5111824642409613,1.1486086369477193
K-562,8515,4.039482215632923,3.7909033037422653
PaTu 8988t,31703,0.1373281877500042,-0.4762601526916726
MDST8,135984461,4.124255066625015,3.9408007926924826
WM115,107970,1.780812210779262,2.2847559963928665
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.6914629358327953
IGROV-1,327653,3.667792542405671,3.232538324158233
P31/FUJ,89183176,3.539325961528454,4.130186526125876
RCC10RGB,6438330,2.9900078425794385,2.335473163476427
RKN,5280436,4.161667428331563,3.268372851068571
COR-L105,445455,4.3186388426275535,4.534825457911736
LS411N,24785538,0.7817075732213645,1.427568328256688
Daudi,11152667,-2.9472151872913104,-1.5560056072550252
P31/FUJ,448949,2.0159916590055067,1.8610993266426292
Daudi,11609586,-0.3532025604686024,2.2055100004005204
SW948,46926350,-4.641976408237662,-4.044984832109781
SW1271,72193861,2.914678902909763,1.3625842313500975
PaTu 8902,25126798,4.210533326596683,3.9292704837558703
COR-L105,11955716,-2.257823880116287,-1.241850365247847
HCC15,46224516,2.679221759698836,2.3889129967930653
HCC15,135423438,2.37991378319322,2.2881827264877295
Daudi,421610,1.7509728437935097,2.784427147427762
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.0445334820595527
SaOS-2,11238147,2.85636627636287,2.7364048396095932
IGROV-1,374536,0.7022324251593053,1.9531632533523782
SU-DHL-1,51039095,1.7422871999086744,2.4350574668100187
IA-LM,72193861,3.820444995189443,1.796665784660939
HEL,5738263,3.378820716395454,3.003196307166448
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,0.61920450785977
SW948,6852167,2.188206161672083,2.8313008864980707
K-562,71751553,5.367911183247371,4.410053361275062
BFTC-909,71304818,3.116417285157316,2.5071198420601557
SW948,25227462,-0.2382390684396511,0.4303926356607733
SK-OV-3,637858,3.830307013284548,1.923708042741669
RKN,49766530,-3.8574490235665584,-0.9718206407397925
NCI-H1568,9933475,1.8521331470520848,1.949539933351093
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,1.3905150451552637
KU-19-19,17759555,3.7275461226555566,3.626696282482247
LS411N,44589607,3.372730635507476,2.467485652432129
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.8239127409438782
SW1271,5278396,3.101008990901291,3.5168586705337033
LCLC-97TM1,46398810,1.8633773855233131,2.543359517280064
SK-CO-1,6852167,2.111498553552754,2.948255869393589
SW1573,5479543,3.675213844165782,3.4608448390564974
COR-L95,12003241,2.921570030601445,-0.8283980271125654
Panc 02.03,9911463,4.953148943637795,3.9701828648599244
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,1.4465483506809054
RERF-LC-MS,3384730,3.247206310046507,2.611779938688639
IGROV-1,51039095,1.7163430299301403,2.5770219965037797
KU-19-19,89928392,2.8864230284497747,1.460679398816633
SK-CO-1,216468,0.6363757446548435,2.765756557585702
LCLC-97TM1,3038522,2.979698040139259,3.1232920929989856
BICR 22,6914657,-3.057028291966878,-3.975261748992135
MDST8,3815108,3.655140825789689,2.759094538816005
HEL,11364421,-3.0976744543470067,-2.6944766787382024
SW1573,10074640,3.956421484938757,3.2061401881161835
LS180,6610355,3.640469161520063,3.957497477377774
Daudi,2858523,2.224035136584194,2.94391876400833
BICR 22,135875424,4.925705128316808,3.8396648907528204
SK-OV-3,23582824,0.9299959314677436,1.0370725199918394
K-562,5282054,3.5952240521498062,3.4625755003601864
NCI-H2452,44589607,3.0010828964799208,2.814334387347485
LS180,638278,3.5544678930796656,3.0022283190264822
MOLP-8,426756,3.5390437920539117,4.143734341234793
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.28417427732171
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.204205160867151
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,2.780716981802429
BICR 31,71466380,5.422644788319504,4.439736597797023
PaTu 8988t,53392493,3.5279637137541524,2.5727287954400877
UACC-812,6610216,4.947422623598504,4.234821621371559
SW1271,16038120,0.5203426502283315,0.6812067486519713
IGROV-1,67156097,0.1763939852409119,-1.1048612696311317
UACC-812,216239,2.3945159107119767,2.223070890357474
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.0525965424283843
ALL-SIL,36462,-1.376242093473402,0.07193383416934646
BICR 31,1750826,0.6511109819152475,-1.6886538616314513
IGROV-1,56649450,0.515518984822669,3.3123628933953
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,2.8907907481557715
PaTu 8988t,6918837,-0.8891471976747255,-2.764417210214804
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-1.297186027037104
NCI-H1568,2828334,5.9155051642717,6.095623081569354
MOLP-8,56973724,1.5171827826362807,2.4876611945298213
MOLP-8,2729026,2.779201693602774,2.5307358111306604
P31/FUJ,753704,3.2802738483106766,4.660147833446332
SaOS-2,25183872,-0.102413301755783,-0.9825357170180056
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,1.5719181009417085
LCLC-97TM1,9825149,1.404394440199107,2.114140469244601
WM115,9929138,6.7694003006369226,4.851602760171402
RERF-LC-MS,2746,3.2731211053052647,3.1039916213168883
COR-L95,5351362,0.837381680047442,1.3411473341584417
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.793665865007258
RCC10RGB,3101542,4.48788654191394,3.662242935030826
BICR 31,44566777,1.4466588952743178,0.5302406461346802
WM115,5746,-0.962904812763719,1.3025487998539698
HEL,9903786,1.206049982415758,2.210854132793345
NCI-H1568,44486219,3.435494584556288,4.202933284379887
SK-CO-1,124202324,2.795373404058925,2.3657423914945546
MOLM-13,5329102,-5.212236525427112,1.708098715555804
SaOS-2,10427712,4.893681366378875,4.336173736203246
SW48,409805,3.4729287041870127,4.685411332917181
HCC15,216345,4.3772403070959705,4.080229502760739
NCI-H2452,46215462,2.291566037713401,2.08890871348737
SU-DHL-1,55283,1.0511806970329092,2.6545619469668833
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,0.9889806985381057
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-3.7865024051649976
MDST8,24821094,3.627663013095859,2.6484549872647034
HCC15,9911463,3.642862209488471,3.9472775904900526
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-0.8842114651825704
SW948,11178236,-0.7120713487548671,-2.7400248825741134
HCC1500,5329102,1.6369795361395487,2.091240684808456
SU-DHL-1,11364421,-4.160715855029451,-2.7732974612536645
SU-DHL-1,176870,3.225718242496366,2.978972376341199
WM115,2742550,3.774256401917875,3.8613791607367864
SW48,12003241,-0.9746028071684796,-1.2198796212772556
NCI-H1568,11494412,0.631822071405162,1.7016489406789221
WM115,25102847,1.9091464851380515,2.286103415118359
COR-L105,23725625,5.8274909459435165,5.051544345111443
Granta-519,9956119,4.186560294974692,3.4037675623748407
COR-L95,72193861,1.6807669427950571,1.2121429981665919
IA-LM,6917907,0.442667441503668,-4.2803661838210205
SW1573,53232,-0.4627324496874346,2.7688205759074838
Panc 02.03,19582717,5.117031119305748,4.424803380048186
RCC10RGB,227681,3.758665689171896,3.2687734418532726
WM115,24901704,3.629786211252992,3.0489897593695736
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.4576294526179118
K-562,637858,1.3097643671251342,1.7472233084829378
SW948,613753,3.0653891790249617,3.195825141032339
Granta-519,9926054,1.8135939424605243,1.825294120261018
SK-CO-1,55508,3.57241133457179,3.2913304912093895
HCC1500,5426,4.174536858194301,3.6753074866445354
IGROV-1,4521392,5.131794979216607,4.332884797788121
UACC-812,6918878,3.827620339158657,2.689852951439552
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.3983526180857344
KU-19-19,72193861,2.401782330602402,1.262847177305599
WM115,5281321,0.1495893125543727,-1.199954088009877
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,3.01016924040612
P31/FUJ,31703,-2.5575864334968976,-0.955324887447018
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,0.38770594982327333
ALL-SIL,44589607,0.5481515481681011,2.1845252160635216
PaTu 8988t,11955716,-2.6731660557009267,-0.7789259434507834
IGROV-1,5738263,4.037832478240785,3.3077405372778084
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.702694788075723
BFTC-909,650361,3.8112149600795706,3.8006736578968985
SW948,16725315,5.2631267850751335,4.422526896347649
Panc 02.03,25102847,3.3458680072040603,2.555609817930404
BICR 31,216239,4.655547148927136,2.253372828479838
SK-HEP-1,51039095,3.60670356936783,2.8055755371879934
IGROV-1,9907093,2.687959785702283,4.096377042489595
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-2.77634637286726
LCLC-97TM1,49766530,0.6419783818490065,-0.6763600018785013
Granta-519,2113511,5.634502761977105,4.979273411185906
COR-L95,322968,2.331837213900703,3.4959360446756813
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.47057282509683296
SW48,60700,-1.9747801062936423,-0.48774504828146276
SaOS-2,46907787,1.5905885991562354,1.4224201390876996
LS411N,5311,1.0830647686053458,1.2889389773989033
NCI-H1568,5278396,3.684546625455108,3.4575236334917854
P31/FUJ,2858523,2.921593087757198,3.0207239961686456
MOLP-8,25102847,1.798391543473315,2.080477225226281
HCC15,57330099,4.175732386995395,4.03437630962952
LCLC-97TM1,16013152,5.423690206414697,4.10605311414652
SW1271,16065773,2.6188234772001886,2.278571969984343
RERF-LC-MS,52947716,-5.597592816818683,-0.2775756822216095
MOLM-13,11167602,-1.7638454235436123,1.9567948222456197
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,3.2203888169284833
Granta-519,3038522,1.8764454398289976,2.8505310590241737
SW1573,54626689,3.958399976383255,4.612193960157707
K-562,445455,4.202279962055385,4.387703380227289
SK-CO-1,25262965,-3.291258197582341,-1.426282389341976
Granta-519,54618771,-0.1786557603441652,0.5144644397030838
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,4.114899379368591
HuP-T3,42642645,1.566786855324099,0.8600770791458175
MOLM-13,44589607,2.917529465117915,2.373609861840442
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.333820889352377
SU-DHL-6,753704,4.418086475877281,4.5844860196532515
SU-DHL-6,6918837,-4.716152603392634,-3.7920701712505474
P31/FUJ,46199207,2.4446101047156215,3.2368061617380404
SaOS-2,156422,4.313289259132858,4.188048661984406
BFTC-909,5282054,4.21714099973987,3.9313084873207322
RCC10RGB,9803433,4.221770064596342,4.542440075476373
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,0.6191361130869998
RKN,89183176,6.327700475537756,4.516595966991802
BFTC-909,16038120,1.74161234898449,1.1702423366431263
HCC1500,71466445,3.970736335461394,3.7415698735534217
Granta-519,25062766,1.8322611726564384,1.7509664951985686
SK-OV-3,216345,4.761928129554225,3.83448362222543
Granta-519,11609586,-2.485330170292811,2.3288818787864556
SK-HEP-1,6918878,4.4325993547595655,2.799654096261544
P31/FUJ,676352,1.6175160353980318,1.9949472172763874
UACC-812,25227462,-0.2916299121927669,0.3433636928287686
RERF-LC-MS,54596558,4.400747096440468,4.533828158201568
Daudi,9911830,-0.0057102646081846,2.0374130704109374
COR-L95,72376,-2.5853838467146493,-2.093070592199196
LCLC-97TM1,135875424,3.9585615026829823,3.9315414425038777
P31/FUJ,49850262,2.7073676452568427,3.5898233117185367
HEL,10410894,1.686960620182283,3.014855844412563
LS180,10127622,1.4423864514133429,2.756047909035507
LS411N,16038120,1.458068935835204,0.8056769261207724
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,2.7920162290381385
IGROV-1,11214940,1.360660548899077,2.1402135414664896
Panc 02.03,969516,3.806573436208542,2.8678197407104324
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,0.9891465072336465
SW48,656346,-0.2718986936332406,0.7267394294358971
SW948,285033,-0.875487938395224,-1.6999362593524696
Panc 02.03,4261,3.516583077320981,1.7201400079377256
SW48,49766530,3.606492941369466,-0.841691522054936
SW48,16038120,-1.7922421690180796,0.7990256789380474
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,0.8656661880922333
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.1613118017171074
WM115,2945648,2.5851994154769025,2.885722884755411
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,3.1842753714509477
BICR 22,25227462,-3.180570489875023,-0.05088336120025793
IGROV-1,5460769,1.6083174601829917,2.5705620072703437
K-562,753704,4.7227938780788525,4.763034171681892
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.5878131208046014
HuP-T3,4788,5.894927949545096,5.680656490002945
SK-OV-3,42642645,1.640931292575566,0.672626249097765
PaTu 8988t,11222830,1.761666424308375,1.8150193052466352
BFTC-909,448949,2.818327130228084,2.1416916403231743
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,1.8528902347686176
WM115,5281672,6.287836255113029,4.6303178247302705
Daudi,3384730,1.441294292217556,2.3350643819863177
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-1.1073554914758674
LS180,6252,-0.5438897009285958,0.46323257159735937
SaOS-2,3025944,4.435896212894107,4.220472374633182
SaOS-2,25161177,4.43427627730954,4.023154840288376
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,0.8909444584996612
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,-0.3237004272849816
BFTC-909,11228183,3.298719229946038,1.98164842245974
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,1.6433632058327265
Granta-519,135659046,3.900512348834848,3.607152227341774
LS180,126941,-2.6871715133008385,-2.7006474297198206
MOLM-13,3081361,0.9632978577503784,2.1157634817220683
WM115,9936388,-1.175666523167262,-0.9073049395498894
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-0.8081871017406308
IGROV-1,15953870,2.712793598656007,3.4882322728177195
RKN,10410894,1.511663597063748,3.41349478817073
IA-LM,6918638,0.61198230609435,0.17180231472674365
SW1271,56946209,-4.174123648346971,-3.5586160718664384
BICR 22,67156097,-1.5899611273150889,-0.9264285954175512
SW1271,2749,2.846909316544141,1.9343005212558422
KU-19-19,65628,4.405271017285275,4.461364685797889
MOLM-13,5566,2.591289759721003,2.9233595987858485
HCC1500,89928392,1.0051530188155344,1.5042284021751002
SW948,25102847,1.6816963863778185,2.5056873274493396
ALL-SIL,10427712,3.5706749567785625,4.057976049760144
IGROV-1,2749,2.0319044408234954,1.9448071091986001
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,2.899743112671181
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-0.8748521269688715
SaOS-2,1242560,3.6046854082724034,3.4344767450341647
RCC10RGB,123631,3.672101761387351,2.7246324611769666
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.6473786161480373
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,1.9539075857704753
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.31912162893176044
MOLM-13,23725625,2.3173082013566204,4.571321328548532
SK-CO-1,15547703,3.920131639479481,3.118241561744106
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-0.6291099159886362
SaOS-2,71729975,2.29546286795302,1.6584863955368234
KU-19-19,12003241,-0.0608702413973226,-0.8110666953443616
SK-CO-1,568763,0.0338205510733868,0.4222622223958319
SU-DHL-1,984333,1.5848171755072842,0.44754626500828143
RERF-LC-MS,49766530,0.7744144603938863,-0.9700629838073881
SU-DHL-6,11152667,-4.5064226702829,-0.65367267862448
HCC15,2130404,2.6093174666871293,3.397476289326775
RKN,11626560,2.593417875894138,1.9448502642187868
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,0.9450268891921008
Daudi,44137675,1.0044684727898117,3.2730802933646004
SW948,54619267,3.654776559833868,4.030313766293531
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.7710644461811738
RCC10RGB,4259181,1.719089746142662,0.2882135193266057
SU-DHL-1,9887053,2.0473441666614156,3.901662407189507
SK-OV-3,9911463,4.2249846626647125,3.8833957854297707
HCC15,49766530,0.5190445493569186,-0.6907471743949195
Granta-519,3385,2.090684083959823,3.5060618775491923
RKO,54613361,0.2998145946125954,-0.006004438102086304
HEL,3384730,1.593743887858678,2.0309759645987837
NCI-H1568,11977753,-3.4091025242198696,-1.0062305165606793
SK-OV-3,285033,-0.1977879636486448,-1.51174868642136
Daudi,3385,1.70419989930712,3.029259038690197
NCI-H1568,9825149,1.6639399446813206,2.1508335222362884
IGROV-1,654092,-1.340387623873854,-0.13259113688512408
SW1271,126941,-2.215477966101826,-2.284472449510954
IGROV-1,6852167,1.5305143027352028,2.7096955370709095
HEL,11626560,1.0872099702081388,0.9964218055004658
SW948,126941,-3.436390914894009,-2.4070649721440085
RKN,107985,-3.0900461086436404,-3.508196043576155
P31/FUJ,12001922,1.6134382673725098,1.7919343104220689
Daudi,11404337,-3.064654238522792,-0.8281689384922807
SaOS-2,6438330,2.0981522234577064,2.2298621955079736
LS411N,126941,-2.790198017582557,-2.469508080645561
HCC1500,10302451,3.7658874637842135,3.320052524447851
BICR 31,4259181,2.3774772051226685,0.3788487517273403
MOLM-13,11656518,1.5202718128538335,1.0894148406511246
COR-L95,148124,-0.3758104123213183,-3.3048477552689417
MOLP-8,53232,1.5052202963885184,2.4885400569875116
NCI-H2452,3038522,3.3601174997652725,3.090232263997405
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,3.0930613232997826
SW948,16722836,1.2939108289094092,1.700814167934516
HEL,439501,-2.350875236844296,-2.317653848122428
NCI-H2452,445091,5.08182727911324,4.493671963704163
RKO,9840324,5.302067215897717,5.6497873036253035
SaOS-2,44489675,3.960447273667139,3.934432873073303
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,1.662371272937843
BICR 22,46901937,4.667354689676901,3.534004112077861
LCLC-97TM1,2746,2.92478275020961,3.1352156448457515
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,1.0799765561074672
Daudi,44491742,3.5549145676591314,4.08604941741545
BICR 31,374536,2.383890315264743,2.2832136544306483
NCI-H2452,17759555,4.398260875691204,3.7500887188388963
LS411N,25183872,0.0970121311419586,-0.8792020048341871
Panc 02.03,23725625,6.172373492037936,4.829814154373849
Granta-519,65064,2.9178387202883735,4.2652728365910715
COR-L105,11222830,1.704570553497338,1.820626578967769
NCI-H1568,5394,4.198509108960074,3.7272702098328794
P31/FUJ,135984461,4.1454221372139894,3.9214194662033237
K-562,49836020,4.414855158615189,3.1120629993329083
HEL,4788,5.03605552733545,5.186932859603193
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,1.2692625674057907
LS411N,6610216,4.962940577428159,4.219017647982875
NCI-H1568,23635314,-3.8228905075414055,-2.082091856653584
HCC1500,5328940,1.924598719414512,1.7707847047647483
BFTC-909,44589607,3.3115887945185496,2.9735114423848965
MOLM-13,5281321,-2.338854439084819,-1.9652540553476285
MOLP-8,71466380,3.4619880715079603,4.014692712520785
K-562,439501,-2.3563528898814905,-2.2965535763743783
LCLC-97TM1,44819697,0.4394946813834864,-0.4988985026219548
HCC1500,9956119,4.194319271525248,3.6339740931456044
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.3867877536365918
HCC1500,6505803,-1.3038553273576796,-0.9222981598406454
SK-CO-1,16038120,-1.5377645940979283,0.9911517316634141
MOLP-8,46398810,1.7248083632166018,1.9818635310514
RKN,73707386,3.296207724675486,2.7878939791067285
HuP-T3,6918638,1.0959798369911515,0.469478067394723
SK-CO-1,72734382,5.327408257337546,4.578088830954521
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,0.28991448797309444
SU-DHL-1,23725625,3.354193732931358,4.631195402480392
SW948,4378219,2.7444419460246716,2.32398544884287
Granta-519,6610216,4.381057854502396,4.146868375015103
SaOS-2,25126798,4.16568157244383,3.769989960810262
MOLP-8,11719255,2.3085103352777057,2.6757362485105487
SU-DHL-1,969516,2.44648475018104,2.6158427031952516
HuP-T3,9884685,1.9355517940144655,0.622853243315894
SU-DHL-1,54618164,3.660876980117255,3.8295438066507064
P31/FUJ,4788,5.1911977113578285,5.516193273469138
IGROV-1,10074640,3.2681490579824426,3.1224113548010193
LS180,46224516,3.8200366067107714,2.3012069886568822
K-562,24753719,4.107201496626299,4.0472783558857435
HCC1500,46926350,-3.99988450675712,-4.001477883566158
LS411N,11175137,2.6624545374598,2.5914761545199734
IGROV-1,71466578,4.017291197092763,3.819078111841705
Granta-519,10184653,0.998312657126817,1.1508635953849105
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.079800790631804
MOLP-8,6918328,-3.583816044173495,-0.8842953895317278
SW948,56649450,1.940604714075546,3.233897991432213
BFTC-909,374536,2.594742723017773,2.386577708183408
KU-19-19,44185566,3.361767971446376,2.6965913417923106
NCI-H2452,1750826,0.2631697114156899,-1.5675539258392923
LCLC-97TM1,24180719,3.1823264447338837,3.5724310026998585
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-3.0331083676525656
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,1.4544870866301505
RKO,675434,4.252493680505022,4.285107150071896
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.1708097681889587
HCC15,25105715,3.3758270019314147,3.524348590617245
HuP-T3,6610216,4.722811341582641,4.296858830010762
MOLP-8,156422,3.6985484587412394,3.926515705156326
SK-HEP-1,6917907,-0.2672796642005143,-4.553626674989234
SW948,984333,0.954004982504914,0.8883070304432613
PaTu 8988t,51039095,3.672985699080835,2.705743405159236
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.7957011557619946
MOLM-13,10385095,0.2048351805935088,0.9642061671094422
WM115,2842253,4.366205978966029,4.822453387906586
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.4678067406757183
IGROV-1,135423438,0.764137689665023,2.163866642700267
RKO,16725315,5.119694523443236,4.112942977232797
MDST8,11609586,4.829072296940778,2.9165670715978806
COR-L95,7251185,1.1216187825494426,2.463051548918518
RERF-LC-MS,51039095,3.2453184174795324,2.7914722931536273
P31/FUJ,17759555,3.626728737883383,3.751811946143228
HCC1500,5113032,4.590685122922873,4.92001658459812
P31/FUJ,16741245,4.043144814115882,3.909752937734781
HCC15,5746,0.6503914795852271,1.5231630507030594
RKO,10074640,2.8357111382750646,3.207047579645415
WM115,10322450,3.651827454662003,4.01643553448021
LS180,11404337,-0.0678179476465551,-0.7122048813377501
Daudi,46191454,-0.8094751773550651,0.7099092527873068
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,3.5569127128615885
P31/FUJ,44202524,1.0280075167408849,1.5813044015598958
ALL-SIL,44185566,1.0410692737439569,1.9108378071800498
PaTu 8902,54618164,4.284638344065584,3.820945923343564
COR-L95,46224516,1.2687748324677306,2.3318353303128485
COR-L105,56949517,4.666554440626914,4.199295835546842
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,1.6398630927236995
BICR 22,45279963,3.757910341256097,3.55915375272317
HEL,9911463,3.4775133545177774,3.463669822617796
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,1.4300459298715382
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.0871682086007044
Granta-519,5287969,-2.420005986832857,-1.9923478635744483
IGROV-1,71466578,4.017291197092763,3.819078111841705
Daudi,1323703,3.9745876209629354,1.4766314074655178
COR-L95,9956119,3.960527548011759,3.634026704951767
SW48,15953870,2.1672009909649415,3.372053096109438
SW48,5278396,2.530949009900888,3.3523295896301963
WM115,10296883,3.9273376390568138,3.7076671554024556
NCI-H2452,10302451,4.286596307748033,3.257300796892086
SW948,9915743,1.1952390119197474,0.46596736469576305
SW1271,9903786,4.005340236032604,2.8071682652116623
LS411N,49793307,-3.1894754739686455,-3.023530551768188
Daudi,126941,-4.413815937813151,-3.1216877113910457
SU-DHL-1,89183176,5.662525063156772,3.4696484739331415
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-1.5862708562851235
SK-CO-1,216239,2.5779715954988656,2.2110628694573973
SaOS-2,24889392,3.914866726590468,4.06087070773243
LS180,3025944,4.8838055311701805,4.077550265786457
SW48,11626560,-0.4765255311776857,1.623086560376743
RKN,168313047,2.366456695786382,2.3432769749087243
NCI-H1568,4788,5.820003751306211,5.638260113234869
RKN,65628,4.337575078598336,4.5696211406882075
LS411N,5311281,3.759327828108219,2.1379043220936973
RKN,23725625,4.172652901782409,4.811471916319084
BFTC-909,168312962,2.436518653578315,1.9328570031326848
K-562,56946209,-4.819463057676977,-4.429690894667663
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,1.5496742943364357
Daudi,11647372,-0.1839602824658907,0.4317974853379081
SW948,5479543,0.3482839273666757,3.5301978760780504
SU-DHL-1,11626560,-1.697644171575415,1.4089399388700503
BICR 22,71466380,4.042212978424107,4.210016181201997
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,3.273287611974219
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,2.0431268241564293
MOLP-8,9967941,2.6295638429027206,3.2661489847808287
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.8873597040130985
NCI-H2452,25183872,0.970145395005522,-0.8206975307401336
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,0.9925162414884798
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,0.13545660685498728
HCC15,8515,2.8931769079597767,4.111868539952006
SK-HEP-1,7251185,3.0945137710223687,2.9027672495904913
HuP-T3,3689413,-1.422602865458103,-0.1181300022496449
HCC1500,2113511,4.626117550925971,5.463980704359813
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.274288465453037
SW1573,5351362,2.395315345585997,1.2614731066273763
SaOS-2,16725315,3.258166087647875,4.0658594214156425
SK-HEP-1,44566777,0.1035402456781041,0.9920892005568102
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,3.7592892985561637
NCI-H2452,54618771,2.226699645078912,1.3341267728828043
RKN,5329102,3.127163305072316,1.9485568074195865
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,0.9942817203587273
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.0445334820595527
NCI-H1568,5287620,-3.0605655272876104,-1.9524950809411468
IGROV-1,5329102,1.2794664511054334,1.983972772863884
SU-DHL-1,71680916,6.473574001994787,4.148613932110375
COR-L105,25262965,-4.3344847799771,-0.9822444795765932
SW48,3503,2.2068347221848605,2.0544294724598835
BICR 31,36462,3.088359748996336,2.1139989227813962
SK-HEP-1,24753719,4.401042857593667,4.455693379307714
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-0.734865412761533
IA-LM,16659841,3.92216274325252,3.8530889784361735
WM115,24771867,3.628628048718056,2.0098935039949324
SK-CO-1,67156097,0.6545128366700663,-0.7265780575926059
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.5222323395627195
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.367833705122142
IGROV-1,71466380,4.863636874274779,4.2768788912304165
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,3.277601911705931
Daudi,5281321,-4.970506938945455,-1.8089619362016298
BFTC-909,12003241,-0.8371396827795129,-0.802018254069629
SaOS-2,44185566,3.018169617675811,2.4955886996779872
SW48,54619238,4.554849733994691,4.3764162378494005
Granta-519,25227462,-6.0432717278136066,-0.6693039664236796
HCC1500,72376,-0.7270592073375387,-1.743604180147854
SK-OV-3,3689413,0.6002437290843657,-0.10851019996864357
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.65763453804335
COR-L105,71466380,4.962997689396809,4.39008946239894
K-562,56649450,4.352548214039191,3.1067858159180277
ALL-SIL,2828334,5.780519190951295,5.9355446714477536
MOLP-8,5746,-0.9490954024297016,0.4873592860173435
LS411N,9935249,3.5378716054356927,2.4808172258862173
KU-19-19,148198,-3.572091199224797,-3.5800284355602976
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,0.9868793483236761
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,0.2828436041166998
RERF-LC-MS,54619267,3.9836959677109354,3.935517728965504
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.744877486929778
SK-CO-1,445455,4.388752059403359,4.543787610386382
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.337951447112929
BFTC-909,6914657,-4.61933610547547,-3.962945938391499
IGROV-1,54619267,3.9701367924453455,3.937119025281442
NCI-H2452,6918289,-3.5458030779688277,2.3925250779369005
SW48,654092,0.3720639788768654,-0.2271651260798077
LS180,10184653,1.1411409682713576,0.8698714317075278
SW1573,4259181,2.0061423198913766,0.009161715424723604
BICR 22,5978,-3.054007840707858,-1.6076266763415918
SK-CO-1,446155,2.509492168961503,2.6395768716757835
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,1.8994874178770704
MOLP-8,6917907,-6.199761218038622,-5.6141876753366775
WM115,6610216,3.675624927368402,4.25243667515887
BICR 22,11964036,1.4111698106068242,1.1459903583406732
IGROV-1,135440466,0.9791523710816318,2.2914830981632557
SU-DHL-1,46224516,1.9664047258697153,2.4907631924630813
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,0.9006522954604164
NCI-H2452,156422,4.888821376667332,4.008856408707687
BICR 22,446155,3.7361559304721106,2.8217709194850733
BFTC-909,3038522,3.685618431455981,3.216618174877004
RKO,46907787,4.104881837237831,0.9878644011618598
IGROV-1,123631,1.7694522866439453,2.4116912081048896
LS411N,5280436,4.183720769167266,3.1958723959692774
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-2.1346500325965025
HEL,5311,0.0816485968486221,0.8415396794125091
SU-DHL-1,327653,2.51842673185387,2.9830633237577984
MOLM-13,8515,0.8268618162227004,3.500570364351672
MOLP-8,25183872,-1.6811002192977054,-1.5381843704502085
Granta-519,11228183,-2.3490545548585335,1.4751984635508135
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.8125909901573307
SaOS-2,5470400,4.204063595869918,-0.5842898548182351
BFTC-909,5738263,3.1091802601858185,3.316275603816617
SK-CO-1,20959075,-3.269929661945314,-3.017872174709672
SK-OV-3,9956119,5.08600620496794,3.518573041771292
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,1.9600659755904852
BICR 31,5978,2.6862960741960693,-2.025153992833147
RERF-LC-MS,375860,-0.2896823379882159,-0.1713704778017688
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,2.844441583949047
COR-L105,44202524,4.8543272504702895,2.05452154188328
MOLP-8,44137675,1.775364766844489,3.0192293780959343
IGROV-1,9907093,2.687959785702283,4.096377042489595
LCLC-97TM1,10385095,1.2595894653665305,1.3435412695365079
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,2.030671779968638
P31/FUJ,3038522,3.230912995410489,3.1415892534985765
PaTu 8988t,5281321,0.6032906637165831,-0.7715782006427233
HEL,9866186,-1.054303819018661,0.4890598004444117
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,2.7670661222323423
SW948,2708,5.7755473109613265,5.028951171873262
PaTu 8988t,3025944,4.261130932115319,4.411110640796185
SK-HEP-1,3689413,-2.4602386660304143,-0.10193624964168484
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,3.613795234467058
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,2.52349270011656
RKO,6252,0.5352436981906653,0.2838212975177995
SU-DHL-1,4521392,5.192178694848648,4.183080903147832
Daudi,72376,-4.854665282210012,-2.8142916334178962
RKN,4259181,0.9508926940780028,0.4580247242453964
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,2.0207894479667283
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,0.048868309228953424
SW1271,36314,-4.053350989931705,-1.06478016330253
COR-L105,1750826,-1.9007119452090728,-0.9945493049319438
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,4.815951247459647
Granta-519,46215462,0.9491023197189584,1.556371814774026
SW1271,3676137,4.713113076263269,4.4405625072427135
IA-LM,5278396,3.9030690758091904,3.541266998389389
NCI-H2452,24775005,5.579264227156813,3.6040266257110374
K-562,23635314,-4.3400265171433725,-2.202806093625494
COR-L105,6852167,2.71981320036177,2.8805472142482156
Panc 02.03,16741245,4.354855972582246,3.915377086285508
SU-DHL-1,2733487,6.186604270067288,6.270568575495276
Granta-519,26596,-3.6955660538224784,-2.0139810814472154
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.6922104525418615
ALL-SIL,176870,2.444675771693443,2.910355008793071
LCLC-97TM1,19582717,4.783105330370089,4.1617694889854455
HuP-T3,119607,5.841541098284191,5.220516329887521
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,3.1359099795992313
P31/FUJ,637858,0.7903103947120294,1.8262492090582882
COR-L95,5329102,1.6379635813529434,1.9560416528636058
BICR 31,5291,3.978522058600436,3.669398696371351
LS180,6852167,2.255231171645259,2.401865087145625
IA-LM,89928392,1.436934436501384,1.6214113437788895
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-3.6872523257954692
BICR 22,9903786,3.2901982519836213,2.784313819365589
SK-CO-1,3384730,3.2619898650330272,2.6158424255384825
SW48,17755052,-0.4852421045975616,1.3525583652847157
COR-L105,568763,0.9810834095142736,0.31849623218647455
HCC1500,9866186,3.137309558941867,0.6614526030521732
HCC15,124202324,2.163317754038658,2.5189943394571688
HCC1500,6917907,-5.345696307345718,-5.352941536353963
HCC1500,23635314,-1.1425681705854864,-1.7950403330127003
Granta-519,126941,-4.311277898608593,-2.827972909786814
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,4.478440776993036
SW948,24771867,-2.1331828785420166,2.6697926725113477
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.065584310775829
LCLC-97TM1,10410894,3.7243046596553344,3.1929619341138973
COR-L95,11609586,-0.6075050167057128,2.5877875580510175
MOLM-13,9952709,2.652499766566874,2.7215646976882204
HCC15,24951314,1.20775234306688,1.6067048611474803
BFTC-909,11175137,1.859642091823866,2.7259972789135656
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.7683111192099439
SaOS-2,9444,4.299296809659387,4.128012134347719
Daudi,71576739,4.751042411789338,3.2767984002033854
SU-DHL-1,6505803,-0.92520479323989,-0.6112016247011065
SU-DHL-1,11214940,-0.4959690036226346,1.7611650429916152
IA-LM,71466578,5.490140561499378,4.2649013374711195
RERF-LC-MS,262093,3.104487938727744,2.8147309543475
SW1271,71466380,4.990835020791986,4.54831027487175
Panc 02.03,135411,0.8368106867561712,0.7903324832020554
RERF-LC-MS,8515,3.770178660744851,3.9215537235258746
HCC15,45100309,5.717971650422449,3.2762773901846423
COR-L95,54618771,1.9587299059916856,1.0950386702122796
LCLC-97TM1,16736978,1.4629436365964008,1.6271118490843974
IGROV-1,9825149,2.5588021380929553,2.409516380738001
IGROV-1,227681,3.5439813498262347,3.1891957052759325
RERF-LC-MS,44489675,3.7548789887197183,3.951558051952795
MOLP-8,3136844,3.797428854524256,3.926754264021117
COR-L95,5746,-1.1189080553056585,0.8374063938540749
BICR 22,135398516,2.7677082767193117,2.0318319213531164
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-0.8647255012577384
ALL-SIL,57330099,4.126515702027515,3.7233763525011376
SW48,135398738,2.3509294796071454,3.463711452424016
WM115,2113511,5.303490143807845,5.336818555850445
Daudi,2729026,1.2833432455886875,2.334334595575418
P31/FUJ,100016,5.4217002529902185,6.071512089980761
IGROV-1,71466445,2.3758001916617797,3.193706490900208
ALL-SIL,6918878,-0.682122479171039,1.4529687493113768
Daudi,73707371,3.866210661620395,4.5202508853635806
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,-0.6527083646766889
SW48,11364421,-4.967269122022574,-2.6195890862697637
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.1211027245845855
LS411N,135411,0.7383506227122603,0.5563513510214317
K-562,3634881,3.4419902111623473,3.227146514217814
KU-19-19,969516,2.8919422545546043,2.8352510120139307
Daudi,135999136,4.063293138043838,3.231474087545912
SU-DHL-1,12001922,1.0574025128990867,1.7370640729573583
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.3372936000980253
MDST8,11427553,3.108888701151444,2.525669281899148
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-0.864951545994025
HuP-T3,9840324,6.187364891887578,5.746025464126023
RERF-LC-MS,5281321,-2.2570738048063257,-1.509223837945733
UACC-812,16725315,4.601797708491857,4.3197686666084545
WM115,53481919,3.625694730030069,3.647418668065011
WM115,3136844,4.4781621433894925,4.201603006265611
SK-HEP-1,135999136,5.290710201924687,4.044338892506604
SK-OV-3,72734382,4.397767647147488,4.130658181904114
SU-DHL-1,4096211,0.0680701310214702,1.6530690040212068
SK-CO-1,2749,0.8616454488616467,1.8955094228469007
COR-L105,4477,0.3499366832640422,0.4648152877525728
SW948,24785538,-1.2786696026485709,1.3933524776007682
BICR 22,25161177,4.685384367036766,3.8918243668961288
Granta-519,11955716,-3.0537796337487064,-1.4455115607797862
ALL-SIL,10127622,5.469150259822909,3.596237971777723
SK-CO-1,11238147,1.2924304468719774,2.910248884422345
IGROV-1,11427553,2.926316692603687,2.3560158336980375
BICR 22,54618164,4.171441086739322,3.917726730363019
BFTC-909,57519531,3.2286550647211025,2.475764444334269
SaOS-2,1750826,-1.0374385524430834,-1.9132355743839289
SU-DHL-1,71466445,3.7763473385017994,2.8458160925046934
SW1271,6852167,3.737297660761554,2.9294860809892977
SW948,9549297,1.722924191719054,2.0551122191983926
BICR 31,72376,-0.802396523967939,-1.9546387617499001
SK-HEP-1,56946209,-4.57873882670014,-3.921259074230607
RKO,24964624,3.0430796891613903,2.368826760901359
NCI-H2452,54143018,0.9899128272921088,0.773465353274881
SU-DHL-6,60750,-4.821248170588626,-2.752094698749145
HEL,44259,1.31343744649104,0.5178467333676191
MDST8,3038522,4.546677862508445,3.1032179652814103
Daudi,72193861,0.2314245956601211,0.9266539932413684
NCI-H2452,4096211,2.487981551988898,2.312268362714042
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,2.4534508560051616
Daudi,208908,1.616008502166041,1.750924000561179
LS411N,46191454,1.665967132338862,1.5105559767998895
Panc 02.03,262093,3.467425891303458,3.040687544082537
COR-L95,462382,0.8255977399878551,0.5045186361094105
IGROV-1,16736978,0.1982875499977011,1.656364228852122
MDST8,107985,-3.301997074358414,-3.3808712728593746
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-1.4656216027678486
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,4.789339673127983
RKO,54618164,4.0326978900214705,3.8313761281044543
MOLP-8,5311,0.4432260076750803,0.872310347948194
SK-HEP-1,5291,4.1108608913621545,3.722843732222705
SaOS-2,107970,2.235066344736828,2.3099392851317697
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,1.862069839122187
Granta-519,6252,-5.172240666242431,-0.5543282142220449
IGROV-1,285033,-1.3538783590767758,-1.7101957932910752
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,2.027795703415574
NCI-H1568,46191454,1.7726304550427152,1.7347684415185651
PaTu 8902,24856436,4.585148807200659,0.5851078484721365
WM115,5351362,0.9981168658111552,1.5568777413529602
IA-LM,387447,-4.406032561698067,-3.735031496378894
MOLM-13,656346,-0.3431029585418202,0.681847457905643
COR-L105,637858,2.3247583240908405,1.7465880237126705
Daudi,448949,1.1283153338590814,1.838073192208927
SW948,42642645,-0.386998084672917,0.8972412061288358
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,2.117308339332328
HCC1500,52947716,-7.376885049387286,-0.5547498856012097
MDST8,439501,-2.351670240427255,-2.1777958268160105
RERF-LC-MS,25161177,4.303824118845859,4.021311213444397
SU-DHL-1,3634881,1.9377929493272257,2.9449412477813173
RKO,46398810,2.934390735401444,2.404625973761697
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,2.858455158796703
HCC15,159324,2.6315252421023536,3.224279895316919
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,1.9664529197208171
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,2.7506050239709263
Daudi,2949965,1.2926680931891954,2.5647433066939227
RKO,23725625,3.9986828157613616,4.756171933219249
HEL,16722836,0.561669465799647,1.1351486051499509
Panc 02.03,11175137,3.7353172411310696,2.8086657890453517
KU-19-19,6918878,0.8609723302141853,2.912603220490726
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-4.172223596556358
SW48,3854666,0.5343434371102147,1.8146215195121729
SK-HEP-1,11626560,2.7034566874481745,1.8582321101561001
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,1.5732054085655844
NCI-H2452,3825829,3.8827569930751937,4.199679963726639
BFTC-909,126941,-2.0975077483758415,-2.6543756398228813
NCI-H2452,24951314,1.9717681393720747,1.5458446083582411
HCC15,54454,0.5186235809490349,2.464618392570178
BICR 31,4096211,1.2121831781068038,2.0001917890002336
SK-CO-1,6914657,-1.8836208914019363,-3.8096181285218456
SW48,44493528,3.8128145383765992,4.269874247754758
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,1.464283669158107
SW1271,168312962,3.6054980890180746,1.4573816271641673
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,2.9852773476390326
Panc 02.03,135440466,3.0724615257354153,2.3473251306034264
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.6503747164306022
BFTC-909,11427553,2.7610941057010754,2.8568358720353957
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.5677944877940496
SW1271,44493528,4.286060334293371,4.173805438876395
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,0.8124471255676511
LS180,49836020,0.6204023867713871,3.3508885402872455
HEL,148198,-3.399100076616297,-3.38609204353944
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,4.077528380274733
Granta-519,3543504,5.0961511485487705,4.086855405456023
HCC1500,3038522,2.0060085934463108,3.14240443093359
RKO,4917,3.097539294413192,2.9895313269718446
RCC10RGB,168312962,4.335962117924443,1.7937481452921376
SaOS-2,104842,-4.966916923279438,-2.874141408918486
Panc 02.03,753704,5.09544361232119,5.13027701846268
PaTu 8988t,439501,-3.4446792284706347,-1.8422471691374682
LS180,5282054,4.115839158247494,3.295364320172752
IA-LM,5287620,-0.8479822353163541,-1.585490834828645
RCC10RGB,6610216,4.531223922644925,4.324771732064246
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,2.9996210278581974
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,3.5894615510673917
SW1271,9911830,2.7072275961126997,2.4546071509260976
WM115,11719255,3.1992621528929166,3.1984514708417024
RCC10RGB,42642645,2.104174802814935,0.965143173431925
K-562,72376,-2.627875463605781,-2.4740061695591025
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.4478756084530544
HCC1500,9549297,1.8848953505663728,1.966044152696813
HCC1500,44241473,4.374636754710865,4.8344129262541795
HuP-T3,2708,5.229598766149438,4.767420650008663
P31/FUJ,9866186,-0.5408158091236333,0.7012950693318571
RERF-LC-MS,11657048,4.330866638894723,3.80381598585503
HEL,119182,-2.1951032337756935,-1.8388317586513785
RCC10RGB,10296883,4.350673741830848,3.9970449564859005
MDST8,10385095,1.2575537617816142,1.4675286251344724
SK-CO-1,23635314,-1.3218098525260824,-1.9996535270340552
BICR 22,72199289,4.441607504718354,2.902736722820698
MOLP-8,9911830,1.992368688928045,2.221238795444688
SW48,24772860,-4.097111396936187,-2.005491388336713
COR-L105,8515,4.561371818511258,4.175667843171241
IGROV-1,15547703,3.339928221860449,3.1692887990679335
SU-DHL-1,656346,-0.4085927723055031,0.6153484444074029
COR-L105,168313200,3.683873258385797,3.1690538680636178
Daudi,46224516,0.8162026590632436,2.3208338235967703
Granta-519,5287620,-2.8216901996678985,-2.337364767298898
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,0.7520852310796817
UACC-812,11640390,4.086462739167014,3.4542866380611157
K-562,17755052,3.8994339695870326,1.8595937838590848
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.5231041539041692
LS180,656346,-0.0089884994203474,0.6078751269246883
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,2.8370864368653916
SU-DHL-1,5311281,2.996662642824561,2.14509994296544
RCC10RGB,25161177,5.612412997721579,4.198287349095284
K-562,3854666,0.2872946014041473,1.5685837390949338
P31/FUJ,9825149,2.400010374644864,2.2055900090746006
SW1271,11964036,1.1602803966527862,1.5371431368240849
LCLC-97TM1,176870,1.9757247403033509,3.1816116892902837
K-562,168313016,4.482960220744853,4.459976557760005
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,3.1083160860687062
SW1573,285033,-0.3175288260868649,-1.8437867577381755
BICR 31,4788,6.181654669045445,5.6941337032122465
LS411N,11404337,-0.9351547419605356,-0.4478763177440666
RERF-LC-MS,9967941,1.5454786965180345,3.5366382400400225
Granta-519,56973724,1.8473061894805545,2.874127867885033
K-562,11507802,0.4095176942133114,1.1648673257445141
SW1271,1750826,-3.093550008900348,-1.350242869396153
P31/FUJ,135398738,-0.0291234665218711,3.9176400349233473
WM115,5329102,1.7959886386080517,2.0317795449690994
MOLM-13,5470400,-0.3466627309634489,-0.1849314239216211
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,1.7243397006904315
Granta-519,44607531,0.7355881041308102,1.3351400877900357
RCC10RGB,5566,3.997570642857795,3.159378996672394
KU-19-19,24964624,3.8522438290321768,2.506128733458384
WM115,1641662,3.4019570651475557,3.4561049703332953
BICR 22,5282054,4.223594396310054,3.75627238800697
BICR 31,10231331,3.776464743887352,1.3298627936141096
RKO,3825829,4.017808531984142,3.544577621808129
Daudi,10322450,2.3131627402631905,3.5450393899933075
BICR 22,285033,-4.068757657270757,-1.9708279973303728
SU-DHL-1,5281321,-1.7372628502658949,-1.7804767020536598
RKO,5287620,-1.9975210326345276,-2.3841327541190096
Panc 02.03,53232,6.367991743549877,2.7013279257985134
SaOS-2,9826308,0.4955218987390744,0.2834097073566885
HuP-T3,10074640,3.8159838645365807,3.169187564535154
SW948,4259181,0.2292867461834122,0.3794746437410682
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.572549390886715
IGROV-1,568763,0.665047061839467,0.3248248768585404
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,1.0336268029060525
MOLM-13,322968,2.556875190594409,2.5103695695148374
ALL-SIL,9903786,1.532435199339551,2.3399468917125654
SW1573,409805,6.568626512075582,4.713941372942637
LS180,1750826,1.061711606063746,-1.9737451883705248
HuP-T3,46191454,1.9484889201022677,1.507187202432857
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.1209952748961234
HEL,216345,3.87635579429504,3.7056010562426387
BICR 31,2749,2.2358137088107033,1.9079216247935635
SaOS-2,3385,7.1536746080698395,3.8673653560507346
WM115,11626560,1.643291568999912,1.5903047537344304
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.5884433785972296
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,2.0369949903597995
Granta-519,24964624,2.975569692960617,1.8537315610494947
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,0.891901138047729
COR-L105,6918638,0.8528151020185122,0.426848101503391
RCC10RGB,9825149,2.634802111166888,2.126708469903221
HCC1500,44493528,4.240662848371031,4.354973825132445
COR-L105,44489675,3.747818158649104,4.0577214842463425
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,3.3839498425575965
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,2.9786523374684855
BICR 31,2746,4.041774334142006,3.0991741016644676
MDST8,51037431,3.453193232905579,3.114853207282809
K-562,676352,1.515837042857868,1.9817373598423953
LCLC-97TM1,73707386,3.587652793939767,3.066886416111717
SK-CO-1,54618164,4.180915062416914,3.8603661066499275
SaOS-2,5329102,1.942826181308244,1.8845870393227038
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-1.7184929430794964
LCLC-97TM1,151289,0.9235530786043882,0.9682285229443691
BICR 22,400769,0.1100780529561809,-0.6887133771380813
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-2.8603251952092243
SK-CO-1,400769,-0.6897300489229926,-0.5971498756159369
SW1271,56973724,2.58013716529859,3.330940665118732
LCLC-97TM1,2945648,2.6479910997037934,2.9082343325667477
SU-DHL-1,439501,-2.3864560258185916,-2.55520714234612
NCI-H1568,148198,-4.9953315451672005,-3.3778830237749036
RKO,11507802,1.7455765117352984,1.2708960092200232
Panc 02.03,216239,3.7763245170365183,2.316687698499268
HCC1500,9825149,1.9829642871568696,2.227612277359457
NCI-H2452,53232,3.5381177646863837,2.8887520825686526
MOLP-8,11494412,0.4734092912657368,0.8777343794082781
Granta-519,9911463,3.5000933341892733,3.7431414218623136
SK-CO-1,10410894,3.775604170297083,3.082325801188684
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-1.0774600107198529
MDST8,5328940,2.138158341424683,1.7299949829197334
SaOS-2,1716436,3.427239396926117,2.9509870208179128
HuP-T3,9887053,4.07990532641299,4.055656228761447
NCI-H1568,24772860,2.3104914540479324,-2.075229468966495
LCLC-97TM1,135999136,4.356650968290631,3.952885891686536
IGROV-1,4378219,2.016502068118561,2.4674149161720633
BICR 22,46199207,3.899734747403315,3.093805164520045
BICR 31,9915743,-0.3251640044425866,0.3368339163812699
NCI-H2452,613753,2.817247196569438,3.2455204961999407
P31/FUJ,46174525,2.51911302821391,4.018787969423109
P31/FUJ,5335621,3.2282922271331613,4.620372221989712
IGROV-1,5278396,3.119031774261392,3.594313142043719
HuP-T3,16038120,1.51216352382263,1.2605499616511364
LCLC-97TM1,17755052,0.1986775459223547,1.6874175240324356
PaTu 8988t,66577038,3.1818565141070625,2.9243799684422953
PaTu 8988t,54618771,0.599962301527202,1.2494684989954898
SK-CO-1,46191454,1.747962727561699,1.6191584546059758
SW48,46907787,-1.5740012638710297,1.413141592752956
ALL-SIL,11485656,1.390704841990788,1.871964466110892
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,3.126905508221569
SK-CO-1,4788,5.843658659854095,5.634593448212096
IGROV-1,16725315,4.890680859998698,4.259191289093518
SW1271,24821094,3.627509655063773,2.6283264531292594
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-1.2489682629336667
WM115,216468,3.848857711215856,2.9587275563863216
SaOS-2,24779724,4.377738848523283,4.419863206775011
HCC15,675434,4.852455641097197,4.606197562308976
SK-CO-1,46398810,2.9216967746168625,2.7535320639148857
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,0.4092202005629037
Panc 02.03,123631,3.5560371664842325,2.6542802141145785
SK-CO-1,448949,1.9523830928265349,1.989962056513417
RKO,285033,-2.0365968290915393,-2.3396196869932653
SW48,2749,0.8385534684858028,1.8763694176892196
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-1.4101111739157732
HCC1500,54618164,3.7944844711277264,3.9762280193938437
Panc 02.03,2858523,3.458791746781272,3.0926820610196812
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,1.9577415431713896
COR-L95,4261,0.3666433774913241,1.3964304439580986
HEL,126941,-3.7945695708983664,-3.1973137470010484
HCC1500,54596490,4.413271545106012,4.61746517819793
BFTC-909,375860,-1.1901103647211757,-0.12254158805008139
COR-L95,9866186,0.0204391385842873,0.5309579436027231
BICR 22,66577038,2.5300885228037813,2.950754364494095
SW948,9826308,0.2428169991227084,0.10901694890359064
MOLM-13,73707440,5.976327057082507,4.29789382030171
PaTu 8902,5291,3.72219732976082,3.7086037275786885
RERF-LC-MS,5470400,2.5584942331402623,-0.11813720155745752
SW1573,16725315,3.253832365815957,4.1293347597854195
SU-DHL-1,3552672,1.9257473882600096,2.8432447326132557
HCC15,60750,0.68669542572171,-2.4296481727199444
SW48,5328940,0.1162920415883012,1.5406860692475144
PaTu 8988t,4378219,1.99751885903338,2.6538775973313333
HEL,241158,3.370113308144609,3.1324410548580888
MOLP-8,53495165,-2.6639864548579535,-0.9901337241878698
LS411N,46943432,5.879073426568822,2.095522856877983
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.5167691041012145
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,2.994025766420929
Panc 02.03,4521392,4.25988041093388,4.339948343285036
SW1271,5951923,6.143368489838077,4.2933805698861995
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,2.946100248961527
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.3762289341255176
RERF-LC-MS,11717001,4.567893424272946,4.0922738617307575
NCI-H1568,25102847,1.8020479238639409,2.3999154787227095
MOLM-13,44137675,1.768154079183361,2.850123075155831
RKO,10427712,4.823698606341804,3.8043429462228255
BICR 22,6852167,2.9570859917106533,2.6503681579760583
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,-0.2434032807531441
SW1271,124202324,3.327062905972079,2.027682769238694
WM115,400769,0.2375153529743729,-0.4608382942584378
RKN,3038522,4.332475047921768,3.125036626017293
SW1271,4096211,3.040458805184357,1.9213786306918892
BICR 31,60700,1.4006980690412227,-0.5212581653417863
Granta-519,448949,1.64880276038625,1.6621907855234006
HEL,11964036,0.787171767074348,1.0287479056614597
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,1.9996738322036378
BICR 22,11485656,1.7887481250962165,2.0454609622264415
HEL,44202524,1.7623585771552046,1.6890216061410541
COR-L105,3503,2.4932686195421625,2.299745573069005
LS180,4788,5.917574515812926,5.5990926035641735
IGROV-1,219104,3.803083685328391,3.6348680929839032
IGROV-1,11152667,-1.4116509977729443,-0.11987650401850933
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.3007057493201424
HuP-T3,11485656,3.0565489144797224,2.34509073716149
NCI-H1568,9907093,3.7800753982052697,4.140790963113273
LCLC-97TM1,10184653,1.174063194948861,1.199107061208702
MDST8,16038120,1.9679009346440888,1.1744945304767815
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.4081476582372343
NCI-H1568,216239,1.54277692538335,2.4299624259233052
LCLC-97TM1,5280436,3.0011603005672804,3.3393551451582706
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.0954849263297946
Granta-519,5281321,-3.900138103622144,-1.7191943868423083
NCI-H2452,6917907,-3.4621989648593696,-4.894772653573374
HCC1500,135659046,2.9858139057826905,3.5364126342282614
P31/FUJ,3825829,3.1586120375796516,3.897354303085003
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,3.0927863284197734
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,1.1157151399017011
SK-HEP-1,7326481,2.0213225214426505,3.0325904316722614
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,0.9318710554126091
HCC1500,3634881,3.181593200231373,3.2378960984525094
HuP-T3,5311,2.274555641774389,1.3522534227093361
P31/FUJ,969516,2.490551298955204,2.6620020049181425
LCLC-97TM1,25183872,-1.9138026924081315,-0.6464234361439098
WM115,54619267,3.5599503094850244,3.795986937471852
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,2.8847952194710196
SaOS-2,17755052,-0.5339241699834809,1.872369959133261
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,1.4354443708891471
SaOS-2,19582717,4.316823865856345,3.943412667383002
COR-L105,25105715,3.731140483220641,3.410796828850455
SK-HEP-1,5278396,4.037206436677834,3.419533908371186
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,3.1256246139080894
COR-L105,6918837,-2.1114263163326177,-2.639621740700785
IGROV-1,25262965,-3.18785020602057,-1.0243735748856255
HuP-T3,6505803,1.3238670991795596,-0.5320438774117108
NCI-H1568,11214940,1.6761106979183067,1.93543400772881
HCC15,44543605,4.452652862359365,4.016332859845035
SW48,46199207,2.9489751610364405,2.9582717656008493
P31/FUJ,104842,-4.465734156959207,-2.963480422298158
MOLM-13,24180719,3.226510234308061,3.20947512708838
HCC15,12003241,-1.0460858766179792,-1.1117416704240946
IGROV-1,10231331,1.9104831176724932,1.6295677724382642
IGROV-1,107970,2.287061680908213,2.406603443888824
LCLC-97TM1,46907787,1.8795083111860824,1.8755189599487658
IGROV-1,5278396,3.119031774261392,3.594313142043719
SK-CO-1,5329102,2.034917542642271,1.8807324807122103
SK-HEP-1,11152667,2.375581084403437,-0.587603570021951
WM115,2126,3.806678244062894,4.454778004906281
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,2.111815020083209
K-562,6918736,-3.666344542032524,-1.8657887862294837
Granta-519,6450551,1.162651959279597,1.7660495670175596
NCI-H2452,5479543,3.804245584293823,3.506366297505591
Daudi,11497983,1.6119133198716458,2.4527154311676758
WM115,4521392,4.32247006400087,4.373170509016217
MOLM-13,24901704,-2.733844077576574,3.0336028030347357
Daudi,56973724,1.9677776982823123,2.3790437083957587
HCC1500,613753,3.153964202511791,3.094547719724192
Granta-519,5460769,2.1422187145203897,2.593733079924105
RCC10RGB,53495165,3.554009618530711,-0.002274940618289083
PaTu 8902,3854666,4.137852419807088,2.038344995345008
Granta-519,151289,0.2062194994497177,0.6536315871994526
MOLP-8,5479543,3.0970965636903327,3.068439911500127
LCLC-97TM1,4096211,1.6170661636178802,1.9385612218493835
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.3696463882537495
SW48,9907093,2.826389946725867,3.965666417830131
MOLP-8,5281672,3.2641398124752063,4.376847286679311
SW948,6610355,3.913576061403015,4.3784129860437515
SU-DHL-1,5746,-2.2023974745237815,0.8581325299471848
MOLM-13,10410894,3.311191932806664,3.0988637136857604
SW1573,3384730,1.5192292760027193,2.8759070315462623
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.1970517898789799
NCI-H2452,54649381,5.966732082850981,3.920151415175224
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,1.212548978920143
BFTC-909,9444,3.603329432205708,4.063525272013485
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-1.2208070788484713
SW1271,9952709,3.6093754742197706,3.034116705246061
IGROV-1,4788,5.801051990484709,5.508150882954566
K-562,3825829,2.9396673791475587,3.878708459827675
COR-L105,53232,1.738169806280081,2.9672735804802226
Daudi,25195348,1.3194617548918357,2.818541720451707
NCI-H1568,46199207,1.8853593558521984,3.084641946751867
RCC10RGB,135440466,4.497503570362309,2.251657795636454
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,0.9378034200476963
NCI-H1568,3062316,1.133797551734723,1.1765517683398092
Panc 02.03,56649450,3.905458120664549,3.2664463874009932
RKN,44589607,3.09715941328701,3.1232032261877123
MOLM-13,568763,-0.9067431163570788,0.20151416726369997
MOLP-8,444795,3.9342801961368417,3.5416970627109685
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.8023219367739773
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,3.3275776413400684
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,0.998794396923337
IGROV-1,6918878,1.6706182189896102,2.4478017299433605
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,1.8738135187508498
BICR 22,5280436,0.2666608642372045,3.438195445860881
BFTC-909,3081361,3.110656330811392,2.333207135221928
PaTu 8988t,45279963,4.21642269895433,3.6253075898126133
MDST8,613753,3.2461287764543085,3.315324408466095
LS411N,6917907,-5.419583860239815,-4.874175002762781
HCC15,5335621,5.428336568471036,4.449997186061333
SW48,71466380,4.3724837890251935,4.208848984004746
SK-OV-3,66577038,3.416512813520814,2.991988474605655
RCC10RGB,49766530,-1.6086406954404375,-0.5919788863642114
HuP-T3,16722836,1.72068374216493,1.6838375957366936
MOLM-13,168313016,3.5509192860421592,4.182975563337289
SU-DHL-1,675434,3.83709506639581,4.286085334802231
P31/FUJ,9911463,3.6551866379259743,3.808040008636527
P31/FUJ,445455,5.725867195241275,4.396892181782946
MOLP-8,285033,-4.447286141218139,-2.8442144024394422
RKN,107970,2.600341318615175,2.3870892662048155
IA-LM,4788,5.899787929501101,5.364477115005541
RKO,71680916,5.910552922648844,4.442350648110662
K-562,9825149,1.660902694463834,2.119829366165708
RCC10RGB,4261,3.441062261939301,1.8885277832603093
IGROV-1,387447,-3.9508602289798658,-3.960830085793881
WM115,54618164,3.776567993994872,3.93216481742338
LS180,44607531,1.744731406430345,1.2032305140456734
NCI-H2452,123631,2.1406097245383062,2.65336745364638
K-562,262093,3.1056763935044813,2.7629972364911284
MDST8,24180719,2.4870372971011374,3.052539865111161
WM115,66577038,2.911239385644133,2.787691652233526
SU-DHL-1,6918328,-0.7249486298416586,-0.8911099085140273
NCI-H2452,135999136,4.5117873079445205,3.849466502372642
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,3.5491653477373233
PaTu 8902,11609586,3.6092581559147185,2.951163756362108
IGROV-1,11497983,4.37450324471555,3.0085038410221445
RKN,387447,-2.9807645129134066,-3.9205331571721653
LS180,6184667,4.288388758455988,3.014874601938096
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.7463445226335739
NCI-H1568,5460769,1.1324377767406906,2.507465497870502
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,2.1293501060320996
HuP-T3,3025986,0.0333046209415895,-0.8821819677792392
IGROV-1,11625818,2.877471533668122,4.1878056176764265
SaOS-2,122327,5.211292969638739,4.612607809589465
BICR 31,46943432,4.176233154169203,1.9536201289102535
HCC1500,10427712,5.196976599700856,4.234258813300521
K-562,9866186,0.7861847855254385,0.6471194486180188
RKO,10231331,2.816804700080647,1.7198505188234452
NCI-H1568,126941,-1.411149621431801,-2.2362681191953677
HCC1500,9933475,1.9677534910437375,1.8711820249827238
ALL-SIL,53245473,2.8781179496967666,2.7101943911824242
K-562,135423438,0.8826240773524879,1.8781236136030168
BFTC-909,9956119,4.255413767268681,3.817020503504457
HCC1500,9884685,1.9086372211674376,0.4954658531305708
P31/FUJ,71304818,2.235751993715144,2.2996401399221837
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.5928712016728584
MOLP-8,5470400,0.1664110443814662,0.02972012896163424
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,3.687798907410322
SW48,44819697,-2.186530212001632,-0.4770839956588301
SW48,12001922,1.4259296039497584,1.9125228275570225
NCI-H1568,24951314,0.6613293075425478,1.3006329678400388
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.0348724004806638
SW1573,51039095,4.568767182944777,2.4005173344594115
BFTC-909,46224516,1.8849058086882595,2.395023192396442
SU-DHL-1,52947716,-4.8688827763192135,-0.49135736260031654
IGROV-1,262093,3.169376516915595,2.8350749323810236
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,2.9007251897273814
WM115,24821094,1.6911725066550027,2.997350570597013
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,3.8372303125348544
SaOS-2,53325874,4.45514535643454,4.525219093997609
SaOS-2,4261,1.4562926555721387,1.4777700274277743
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,4.175211302965876
SK-CO-1,9907093,3.652313916117519,4.101940994284701
SaOS-2,613753,3.192322830330122,3.1828265682467696
BFTC-909,148198,-2.03933057080943,-3.163911484547082
MOLM-13,49793307,-4.691237884437231,-3.7807305108216918
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-1.1238576055135325
COR-L105,135411,0.974173137304268,0.6377250200860128
RERF-LC-MS,135411,0.496828330774242,0.6462055773393707
SK-OV-3,16725315,5.283554915030345,3.985920952324303
SK-CO-1,3854666,3.8596661393399927,2.1614153554046855
LS180,51039095,2.999333495393298,2.5792423862802845
RERF-LC-MS,135440466,2.007932851474071,2.198881795669041
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.1129892927851197
LS411N,446155,3.6642844723827266,2.7106183229014285
HCC15,72193861,-0.2523453521741511,1.446545358469508
BFTC-909,52947716,3.1995758728854224,-0.5567733141549706
SK-HEP-1,9933475,2.440596541444364,2.061445299899041
MOLM-13,702558,4.671896667990455,4.2639270964682865
P31/FUJ,375860,-1.2092771030706315,-0.28340833208661675
Panc 02.03,57519531,5.330694472788803,2.638867596924447
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,3.4546944942500715
HCC1500,11238147,3.2515653100317023,2.8534924781769258
RKO,11427553,3.456895276763714,2.6537667640281395
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,1.9595449248665207
HCC15,9927531,3.758901572486559,4.548362526205334
Panc 02.03,107970,3.0394503344184214,2.365013760875151
BICR 22,6917907,-5.724798000333263,-5.360822445010561
P31/FUJ,219104,1.0946129740431632,3.4511597685527238
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,4.165998682356799
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.1829048673876543
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-1.6789654067764577
COR-L105,23582824,0.3539942370445449,0.8091076379880151
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.424799076019616
NCI-H1568,135999136,4.3721543597322405,3.9349102849634328
HuP-T3,11404337,1.0495167124251128,-0.1772982570590062
MOLM-13,2729026,2.3347481789683564,2.490541163007338
IGROV-1,9935249,3.330117761231163,2.5644209066975203
IGROV-1,16038120,0.2864038103759729,0.9447411779638588
NCI-H2452,11167602,2.565240148317103,2.454228593171644
Granta-519,4788,5.939837006566146,5.602000931775533
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,2.7393580041230092
Daudi,2842253,3.640131040983124,4.662532505847554
PaTu 8988t,9911463,4.367264855700764,3.8959711987245624
IA-LM,613753,3.1957676281974328,2.994241769496976
HCC1500,168312962,0.9454061370050444,1.6934413420363306
Granta-519,52912189,-1.096728840522365,1.317294745758343
K-562,67291369,1.5957287334193675,2.1332710972028663
HuP-T3,1750826,-1.878047057258104,-1.8728576845156895
RCC10RGB,24180125,2.398663234613943,3.0503900606868743
SW1271,5566,3.0013167075914344,3.010487486842069
P31/FUJ,126941,-4.476387704672624,-2.9981337256171385
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,1.664904545768936
HCC1500,44486219,3.883233561942222,4.22870811084547
SW1573,24964624,5.100144587499453,2.6705251724615606
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.871801186129072
Daudi,42642645,-0.8700738631175318,0.4132183390156697
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,2.5872855637746857
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,0.7202618398101975
SW1271,969516,2.705669665349302,2.7655236532425733
COR-L95,6918837,-4.56092327324237,-3.6349459014334586
SK-CO-1,25154868,4.619527339846263,4.282635981870229
RKO,159324,3.5523933893017583,2.4886020385927448
HCC1500,168313200,1.6452616775244175,2.849628372862633
IGROV-1,4788,5.801051990484709,5.508150882954566
KU-19-19,5746,1.6270456089520258,1.16602633190564
RERF-LC-MS,46398810,3.3112335021243977,2.596354016316354
IGROV-1,6438330,2.7487580937365683,2.2146220333292503
PaTu 8988t,123631,3.803217986992814,2.2512442209693777
LCLC-97TM1,5278396,4.167561166456711,3.577481046983871
WM115,71680916,4.535911767348542,4.517677302000789
NCI-H2452,322968,3.869715934392993,3.8087022828648536
NCI-H1568,2708,3.449118605167301,4.856944890594009
Daudi,5470400,3.6690588756853706,-0.17955012337163304
NCI-H1568,3038522,2.281352774411324,3.1936563409219216
K-562,24951314,0.9405452740645998,1.1013687426091647
BICR 31,44137675,3.031084694210408,3.4299089953125286
SaOS-2,82146,4.466197629976123,3.4274194668633133
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,0.6153185882368973
HuP-T3,5738263,4.055810266621769,3.4210112881529393
COR-L95,11494412,1.7619372096243109,1.517149955230385
Granta-519,11507802,0.4974969144595386,1.1794462529851015
WM115,2949965,2.619280368742809,2.7653603120543773
HCC15,613753,3.363668001401703,3.2975687893991057
HCC1500,107985,-3.8501888791364034,-3.5874826289958435
WM115,54678924,1.8194282087981308,2.1474329073575524
Daudi,135398516,-0.2737475793919353,1.6779337988603198
PaTu 8902,5280436,5.000479378124589,3.2103991273393153
RKN,439501,-1.5558449248177562,-2.0109187055084075
RCC10RGB,5287620,-0.3857243809023412,-2.0868286012033392
Daudi,5566,2.2518803351891616,2.8358580062412484
COR-L105,31703,0.0245204691354453,-0.8139673353356914
LS180,44507138,3.917968702075208,2.285857065170357
Daudi,11964036,0.3747037141940179,1.0907308809800005
K-562,16659841,3.212428083743772,3.71175950239099
MOLM-13,54618771,-0.6841479707721928,0.44532548582625414
NCI-H1568,49793307,-3.5648882234860895,-2.326099715135795
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.0765520129267332
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.3509291661134695
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,3.3408801865090556
SW1271,107985,-2.924919788256343,-3.550872263653235
COR-L95,2746,2.78697970441755,2.978489707753901
IGROV-1,104842,-1.6690343627553987,-2.3248601124592563
COR-L95,16038120,0.5843691628917023,1.2019853764989734
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.2363089162739676
HCC1500,123631,1.5682585338280497,2.551236935911526
PaTu 8902,322968,4.547287257097872,3.472028916145278
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.162250839965365
Daudi,11167602,1.0022899570414256,2.115288037563346
ALL-SIL,10074640,-0.3353589360570669,2.7562668267094472
COR-L95,57519531,1.325264870307383,2.118258285883727
LCLC-97TM1,46191454,0.3820919964810073,1.3923703163691243
ALL-SIL,439501,-2.349752310116714,-2.2716524890827845
IGROV-1,25126798,3.9275606774720817,3.6119106949581776
WM115,24753719,4.6734048968266775,4.17257191091431
HCC15,36314,-6.084589216701663,-0.862246762722357
HEL,16720766,-1.3120587580234824,0.048240272809863496
SU-DHL-1,11222830,1.179409628644554,1.2795008149535718
HuP-T3,3634881,3.0028113890745707,3.2542730422569206
K-562,5738263,2.3545721599917027,3.18432432905293
SK-CO-1,16725315,3.5012946679092853,4.16199383881507
RKN,327653,3.2518035953304434,3.084845145922058
RKO,24772860,-3.046302255649564,-2.1175598536889066
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-1.2872398901707067
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,1.7880662862350833
SK-CO-1,15953870,2.1343083972614725,3.5110670681348806
BICR 22,71751553,4.276876209585518,4.261711466017768
K-562,24964624,2.9615918690112717,2.140559905355762
RKO,11222830,1.6656419736189183,1.4716311898907455
RCC10RGB,25105715,3.76392637454814,3.375634278991572
ALL-SIL,54618164,3.625474128679928,3.627067639853178
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.6867234094981302
SU-DHL-1,49793307,-4.256389272054101,-3.3977344368594578
SK-HEP-1,9915743,2.4580731883892293,1.3321698419050636
SaOS-2,10410894,2.56650375580144,3.23209266364057
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,2.0385314311092095
COR-L95,44491742,4.146782751375218,4.251551523607571
SK-OV-3,44137675,2.687297746540291,3.744029059954026
SU-DHL-1,4477,-0.6876815909262691,0.5849128161186085
RKN,5311,1.8833679583763572,1.382272560592072
COR-L105,11640390,3.408966388045623,3.3524983239684656
RCC10RGB,637858,2.3286326267725084,2.1911079746766564
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.6241471121830122
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.7325091120474436
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.0482769591147356
SU-DHL-1,6852167,2.266746993939426,2.582399412371065
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,2.9287883304085964
HuP-T3,49793307,-5.3581383477853555,-2.8051249795529984
SK-CO-1,5282054,3.655593178279643,3.7572105219908605
RKO,2841722,4.522769482159767,4.274199179213777
Granta-519,65628,2.6603144373939154,3.7407211545728556
SU-DHL-1,637858,0.6782178889909583,1.5186628282797476
RKN,9911830,3.6623648245681744,2.461765147357395
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,0.9645403597089934
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.5303987698315015
BICR 22,9884685,0.2149660223226223,0.4525688852302008
COR-L105,46907787,0.7742744471044445,2.017743158511668
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.8139217460689738
RKO,54618771,2.3159310195777985,0.8402721301805112
HCC1500,6450551,2.2317386689521816,2.8301176562736274
BICR 22,10296883,3.888864516393213,3.6510523555580057
Daudi,10302451,1.2926011902861492,2.820372671614008
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-1.0160210108584466
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,1.4414132913807012
Granta-519,216239,2.502983600228736,1.9251488313585938
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.281428576749186
NCI-H2452,4521392,4.554150979099382,4.383129134982793
IGROV-1,123631,1.7694522866439453,2.4116912081048896
IGROV-1,5566,3.174346862827938,2.933444836903223
MDST8,72193861,1.790495642839322,1.7294132111776659
COR-L95,400769,-0.6446482680437077,-0.6837861392732368
SaOS-2,5287620,-1.8033063725700844,-2.265132801248976
COR-L95,6917907,-5.619348954097505,-5.606404680705149
WM115,9840324,5.544544164897635,5.697085111883673
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,3.047215262680193
SW948,10322450,3.138867511839475,3.8206108802157583
K-562,25126798,3.746183025237492,3.705026237801599
LS180,5335621,4.412574333730147,4.428458293710552
SK-CO-1,9911830,2.5560928673864676,2.621546895125822
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.5765927592150475
SK-CO-1,9825149,2.4273154495027147,2.0038840774768176
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,2.353670654257864
KU-19-19,10074640,3.725362653690234,3.13326864394305
NCI-H1568,24901704,3.012455129702266,3.239429550710324
PaTu 8902,216345,4.855612410794221,3.9448381075373415
LCLC-97TM1,44202524,1.0559659544617075,1.7807534694067575
MOLP-8,9884685,-1.6145757941110517,0.1402168601858839
SaOS-2,11656518,3.53164758658959,1.4979782931696557
ALL-SIL,5280436,2.610850174870569,2.6768927215104252
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,1.842325993693129
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,0.811538569039524
COR-L105,16659841,4.469572921203622,3.9122039547658414
SW48,11625818,2.5740084903132914,3.84340031578731
COR-L95,135875424,3.0866900102445816,3.692573516118356
NCI-H2452,10074640,3.4255764700713685,3.3204504353160393
SK-CO-1,60750,-4.4937571478067495,-2.137776977492011
BICR 22,374536,2.9550889228261386,2.336183553950144
MOLP-8,2126,5.134995770793403,4.3758853445140655
NCI-H2452,5566,2.960608772215372,3.068609563579063
Daudi,54618771,-0.114332288085178,0.5543488858092842
NCI-H1568,44137675,2.485428235347338,3.4168901104993057
BICR 31,24771867,6.325583215176513,2.511504528459368
HCC1500,135875424,3.5744445956281483,3.690497273676618
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,2.9981739283562097
IGROV-1,753704,6.461140333581179,4.74992720439229
SW48,11497983,-4.007853458767396,2.649682278136571
MOLM-13,25195348,1.114215790958376,3.0046655840342935
Daudi,441298,1.3514709590925575,2.4543528435344246
SK-OV-3,124202324,3.0713957973247186,2.3670753291773328
BFTC-909,23635314,-1.3241610546701814,-2.0816570317955096
COR-L95,71304818,2.943301589855332,2.3197692113675243
SW1271,44607530,2.17277245139498,1.82469167164999
RERF-LC-MS,219104,4.628133490361187,3.116149329343535
NCI-H2452,31703,-0.2834256058580119,-0.739708032020929
Daudi,462382,-0.0525304302162242,0.1378532853517577
SU-DHL-1,25183872,-2.297532702486321,-1.9520019282618086
K-562,54618164,3.946994253297547,3.940897612414854
SK-HEP-1,568763,1.0235069184223942,0.4287769666092639
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-3.475764599666913
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,1.2205945047729347
Panc 02.03,2828334,6.385741192046609,6.0450710826927825
HCC15,5702613,2.8473188935914835,2.8700414982115108
PaTu 8902,11625818,4.430115392870615,4.337594078477349
COR-L105,53392493,2.0389615313780256,2.705364427755023
RKN,3062316,2.6330403907451863,1.220909926029301
UACC-812,6505803,-4.59801553223132,-0.604996354680741
UACC-812,16736978,0.0217391388778129,1.7450487898142055
BFTC-909,5278396,3.473037688340168,3.6183490961730604
SW948,73707398,1.7510146080607218,1.1944336821320578
BICR 22,107970,2.71438120007047,2.330842068329562
SW1271,984333,0.5174855517327741,0.6299007658691356
IGROV-1,9967941,2.9735049794712545,3.478110615316944
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.612970118676793
SW948,135984461,4.375312800732864,3.824338346215478
LS180,5280436,4.14000298943632,3.1370753579621042
MOLP-8,219104,2.0853040324344536,2.7848281047309844
MOLP-8,1716436,2.7387406442001287,2.4273576968301604
MOLM-13,171352865,4.594115651620468,2.5956361109360775
KU-19-19,10127622,1.068304480617998,3.6044933774967594
KU-19-19,5460769,4.3332822587900255,2.6609740768712826
LS180,675434,4.417044491450032,4.211798918388006
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,3.057199738741742
SK-HEP-1,66577038,3.45712203265648,2.835884422690317
SW1271,3689413,-1.2412691685690602,0.22848750252256217
COR-L95,10296883,4.074268886544182,3.892305344185218
HCC1500,5287620,-3.8084705838741306,-2.0715190753091006
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,1.0259484131842906
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,1.8384514805341778
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,1.1537108527722404
SW1271,46843906,3.0036733058278298,3.2302138514010363
SW1271,10184653,2.439662406391272,1.2212427427627608
SK-CO-1,31703,-2.259601900898513,-0.811440001550044
COR-L105,10074640,3.626128603914542,3.191710949196677
MOLP-8,11152667,-1.9226575172330305,-1.3004938186860568
SW948,56646779,5.261847054930003,3.727228928672543
MOLP-8,9825149,0.6088991704164435,1.7517374135141315
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.5147411354412892
RKN,1641662,3.781184529562369,3.5593527037713035
Daudi,1750826,-5.008838903624334,-2.293123131222226
RERF-LC-MS,24856436,0.2419222597799965,0.6347758438166864
COR-L105,6184667,3.4155069342084916,3.0886518037841437
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,0.9612878310688031
MOLP-8,568763,-0.8505432933185847,0.24228978490342196
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.4856237921666418
SK-OV-3,54618771,2.5849230632376923,1.1204509772738314
SW1271,135398516,2.256973153183445,2.0013278157306833
MOLM-13,44819697,-1.7672663076184636,-0.8834881227691723
LCLC-97TM1,24748573,2.1629406196043894,2.1026845743070965
NCI-H1568,10113978,1.8126489257310032,3.3670328056658456
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-1.9911657696597123
COR-L95,1566236,1.7351682171374878,1.9909306905176933
PaTu 8988t,54619267,4.243668204976347,4.057607802703509
BICR 31,73707398,2.635299985295534,0.9799309009866426
P31/FUJ,24978538,-1.1674360999825653,0.5249874599968439
HuP-T3,25227462,0.1487181406442073,0.11609288912795716
Daudi,439501,-2.973914496380735,-2.5437760183876206
NCI-H1568,67156097,-1.7914617240991686,-0.8453812540250716
WM115,36314,3.85550299796777,-1.093146449139697
MOLP-8,409805,3.552664043240888,4.374717995409701
SW48,24753719,4.052743892866938,3.935304424917609
SW48,3825829,3.1303188593692854,3.6619756803344887
PaTu 8988t,54613361,0.5051194448617704,0.2656442656687612
SK-CO-1,44493528,4.973545843770428,4.300179423066374
MOLP-8,44202524,1.1617664844294235,1.3835416444772881
P31/FUJ,11656518,-0.8295634521320199,1.4847836498263707
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.335260213858755
LS180,36314,2.4476112429633403,-1.4677615545493004
SK-CO-1,119182,-2.3548964470523974,-0.8948612081831964
LS411N,72376,-2.6969507034435236,-2.459289362458719
BICR 31,51037431,4.633533363663127,3.2382808326353882
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-1.8390209520296006
HCC1500,46907787,2.786329845885891,1.8134128497816777
MOLP-8,2708,2.5820066460748015,4.20329174593813
HEL,10113978,2.6394190696879662,2.8410947018492227
HEL,1641662,3.192273244328466,2.924734066925709
LS411N,12001922,2.0246848718715604,1.7637213540432524
ALL-SIL,56963564,-1.2928564241979046,0.4921576682273852
ALL-SIL,168313047,1.973173862571291,2.1121402933009987
COR-L95,3038522,2.051786867518871,3.0145779714413963
LS411N,25102847,2.9606059837222767,2.314131514657825
SW48,5566,2.216391660090734,2.9668029218413015
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,2.0248209786764897
SW48,6917907,-5.957551707769467,-5.300948826137156
RKN,246676,4.414592383854902,4.5370133713153855
IGROV-1,285033,-1.3538783590767758,-1.7101957932910752
PaTu 8988t,11609586,2.9135578891851233,2.7639064470318266
P31/FUJ,19582717,2.23583270668625,3.9607318786975103
SK-OV-3,71304818,3.289226671933847,2.2979511706569045
SW48,9903786,0.6824641791663469,2.504069028335074
SW48,107985,-4.220376672084107,-3.673255079929479
ALL-SIL,49836020,-3.56746653346715,2.6761662538071613
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-1.9877934446732146
MOLM-13,7326481,3.309466894819375,2.662043140069642
PaTu 8988t,387447,-4.215036300164339,-3.836405818862839
IGROV-1,10231331,1.9104831176724932,1.6295677724382642
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,4.770524952173063
WM115,6852167,1.3860811523021286,2.5367415918615843
SW48,11175137,0.8049020199472112,2.4605435824320763
NCI-H1568,6918837,-3.937828464321892,-2.7418616700626997
ALL-SIL,409805,3.511042482554543,4.312089054185251
BFTC-909,11485656,2.882750602975944,2.316135710502715
HCC1500,6610216,3.984830656845064,4.247528817236863
MDST8,46191454,-0.3052251724831438,1.796046098152904
NCI-H2452,52947716,2.3907771066336543,0.007440160351564997
COR-L95,135411,0.6709946332822974,0.6061994421707808
RERF-LC-MS,11497983,4.204546577264711,3.707040009280359
MDST8,3025986,-2.3601391308628368,-0.48719411761991827
K-562,10113978,1.9599198523990544,3.0066516689175455
MDST8,66577038,3.4472401917824387,2.755133395855061
RCC10RGB,6917907,3.54732574828972,-3.8494980373256062
SU-DHL-1,54618305,4.34503505735179,4.255337620427378
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,1.8091996957291314
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,1.516036330485977
WM115,448949,1.6539360415615445,1.8307276936948074
ALL-SIL,216239,1.0502640873271551,2.2951744333421042
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-3.3170640322425355
IA-LM,53325874,6.131967715828746,4.42607052424373
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.3792678929166993
P31/FUJ,119182,-2.8125390579467244,-1.399096771863102
SU-DHL-1,11717001,3.585470860794662,4.072179720966014
MOLP-8,168313016,3.7646553629166304,4.399235650695432
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.371116538261106
SW1271,9823820,4.369434873409536,3.509462427543007
SK-CO-1,51037431,2.025162533854422,3.146344790443002
SW48,11964036,-0.90016316876993,0.9930011161240256
Granta-519,702558,4.9740995052838874,4.573256609536335
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,0.8239764784959437
NCI-H1568,6918328,-2.169641972219076,-0.1250200222385918
Daudi,637858,0.7785119720749748,1.362436156175766
SW948,53495165,0.2015090818079991,-0.037766912994290386
SW1573,46398810,3.5765453048302933,2.5071040644103486
MOLP-8,637858,0.6022882265593398,1.4419664882872618
NCI-H1568,3825829,3.749474944576795,4.050378108790853
MOLM-13,4788,4.00969340257961,5.467745114415916
SU-DHL-1,135398516,1.716785738144405,1.4268219847477597
HCC1500,2945648,3.001490751925554,2.7932239695143966
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.642911730372372
HEL,46943432,0.8947528664895825,1.465525496814766
RKN,3689413,-4.085525957083088,-0.6250040415377204
COR-L95,45279963,4.007720953160328,3.623036854151365
LS180,11364421,-2.9792456594346945,-1.8498139150840307
SW948,51039095,-2.1737453378627567,2.8605308073990807
HEL,135421197,2.810551353794614,1.722506024776207
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-0.9557816453854677
HuP-T3,5351362,1.4959503226370765,1.4230135379693578
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,2.894481581108566
SU-DHL-1,6623618,1.9512254956144048,2.028568469161832
BICR 22,31703,-2.104947288409208,-0.9475398331234456
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,1.722513353297214
IA-LM,17755052,4.247702528352723,1.5524523083314972
IGROV-1,17755052,-1.0246415273055465,1.4841664570261066
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.370260622831949
IGROV-1,3503,2.453392942972796,2.432633710958026
BICR 31,10302451,2.0763164615496232,2.7314652369089587
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.8360446359988546
MOLM-13,2841722,4.084965304911922,4.140781164321279
COR-L105,9549297,5.541569761250669,2.4894870254331543
COR-L95,4705,3.007858501345706,3.1639310834283196
SK-HEP-1,54626689,5.252317432323977,4.729951859897813
BICR 22,24964624,2.8366894332481127,2.3216852365902834
K-562,3384730,2.2830550335302555,2.2697384238077674
RKN,46224516,3.695788234754723,2.707707067227231
Panc 02.03,44607531,1.9299895981807216,1.4582848022874686
MOLM-13,11317348,-4.1893096196029465,1.8606943166957055
LS411N,60700,1.793788628592944,-0.50917354265295
ALL-SIL,9967941,3.4348481015027628,3.207917429114693
SK-HEP-1,46907787,5.1061569205326505,2.19946391971561
RKN,5351362,2.529766574998156,1.4895812719578418
HuP-T3,31703,0.4675615226322689,-0.6230469657895025
SaOS-2,6610355,4.596244040557677,4.405460608030721
BICR 31,25195348,4.130650271984148,3.084914678711034
MOLP-8,73707438,3.908454567487333,4.1680087847914
MDST8,3503,3.3556251865549065,2.3148478901318263
COR-L95,439501,-1.1523844892623298,-2.302348319504525
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,2.962878795478557
P31/FUJ,5281321,-2.503740446113486,-1.639862204956139
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,2.630983586554661
BICR 22,2729026,3.062923067871907,2.717038770124444
SW1573,51037431,1.8928004764191728,3.1794354175414306
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-2.1800181311168187
RERF-LC-MS,16741245,3.282184197465347,3.869307844966387
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.756825157565044
SK-HEP-1,11427553,3.604603983851784,2.8094428046777065
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,0.6903036286710622
SaOS-2,36462,1.0480120523183942,2.1772575250403623
IGROV-1,124202324,2.2563058955522157,2.111060585507935
P31/FUJ,54618771,-0.1557090961755644,0.9449753271372652
HCC15,6918837,-3.491973763742546,-2.48609568399811
RERF-LC-MS,10302451,4.085913110869725,3.3255532127445324
WM115,9866186,1.4274901944164853,0.9428320153818361
RCC10RGB,3634881,4.1231622503065495,3.32339602114218
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,3.708816188581717
SK-OV-3,56946209,-2.3996417591607235,-3.629091375521928
Daudi,9907093,2.3595872536278977,3.620867456087621
UACC-812,135421197,0.8848266315498433,1.729362675073819
COR-L105,11707110,-2.3960237918310967,0.46509998910929085
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,1.9017537677290495
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.563587989092634
BICR 22,5287620,-2.2777736835755076,-1.9681898653408538
HEL,135398738,1.3240045179008624,3.0363714955385546
SK-CO-1,3825829,3.015639513793665,4.093819212155652
BFTC-909,135398516,3.047749913114312,2.1321611953601187
Granta-519,252682,6.242071482699392,6.440326707769637
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,1.7164514004232354
SU-DHL-1,241158,1.6235055790866513,3.3297086417640402
PaTu 8988t,8515,4.36808886077581,3.9838284344726644
NCI-H1568,44489675,3.7863062268563064,3.8821639417734515
MDST8,135875424,6.383148165610491,3.837454730302613
IA-LM,24771867,1.1290385026114922,1.57167577010321
PaTu 8902,12001922,1.8953174279693872,2.0270950300864605
HCC1500,8515,5.3989297102528715,3.838214247748885
MDST8,4259181,0.8851574645315519,0.333475382586681
SK-OV-3,16038120,1.745962946040546,1.0047651653500167
SK-CO-1,25126798,3.6561952188996503,3.8611195404582217
HCC1500,4261,0.9221319619811188,1.6597259612768567
WM115,613753,3.1291419252746877,3.318150934697205
IGROV-1,6505803,-0.2382223795960626,-0.558838185656558
KU-19-19,49766530,0.1366302187334878,-0.4284263905461588
BICR 22,11494412,0.8036857209518554,1.397286413479348
HCC1500,11955716,2.281516197797272,-1.6513515383350497
MOLP-8,71680916,4.479993680298279,4.383963514102238
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.220168153377264
BICR 22,15983966,-4.391384426150851,-2.2381512034919755
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,3.356585177234591
RERF-LC-MS,9866186,0.0636323256725951,0.6764061478371595
IGROV-1,54613361,1.0826132998561049,0.178982376647644
K-562,4259181,-0.7813149193344907,0.06812398969129183
SW48,6438330,1.214777505056659,1.8200490134402711
LS180,54618305,4.3130332958468385,4.28097814278934
K-562,5746,1.9738407973257048,1.0152761946493114
COR-L95,3081361,3.577896308939448,2.457637177354868
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.7338726659834822
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,1.1076453224862055
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.412283748492656
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,0.2216868971514785
K-562,53495165,-1.204911447319433,-0.3985647412126386
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,0.9426784351837916
HCC15,3676137,4.952150033317278,4.561482281709578
PaTu 8988t,46398810,3.220252132938068,2.4757870131928392
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.5890510013757458
BFTC-909,9927531,5.31835549136936,4.592749185889432
Panc 02.03,16722836,2.9028860212849565,1.807147073687832
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-0.8334456523238676
Granta-519,3011155,5.044202810550695,2.7585627499371954
IGROV-1,3825829,4.144093606877803,3.945122673162209
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,-0.43702501143168176
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,0.3498263933129347
WM115,11238147,1.7518250261640556,2.7148906347863853
HEL,6610355,4.700351008256091,4.183615215670489
COR-L105,10410894,5.46795970795096,3.265372054541556
K-562,135421197,2.032823128578147,1.619166523495791
HuP-T3,25105715,3.756943800954468,3.4509218093085767
BICR 22,11717001,4.533318725499836,4.1186342826449485
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.2864479011621044
BICR 22,176870,3.0604023761484154,2.7009082830186277
COR-L105,9823820,3.977631180290917,3.919617136780035
P31/FUJ,66577038,3.0536576112540916,2.955687600908774
HuP-T3,11612883,3.639610964764467,2.8829774648165323
PaTu 8988t,12001922,2.536714978511883,1.97172607266443
P31/FUJ,24771867,-2.604308550432203,1.6368784316427634
P31/FUJ,3634881,2.159990781463395,3.076759452311896
SW1271,11640390,3.706316930576478,3.5440781279998586
Granta-519,984333,0.7513060576966085,-0.3244332792046898
COR-L95,46398810,2.3153378536205036,2.545565668204843
NCI-H2452,4259181,1.4154165902225178,0.34280166577225357
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-2.9948804914674794
RERF-LC-MS,3503,1.2198018250646854,2.3544579943083948
BFTC-909,168313047,1.967772312792883,2.315865077378133
NCI-H1568,49766530,-3.205306991379519,-0.8659334135750069
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,1.1251549516143284
IGROV-1,44491742,4.406671418311328,4.177950360373246
SaOS-2,54596490,5.687426160237218,4.6768682969782915
Granta-519,46843906,0.846372381562089,2.688824456822653
SK-OV-3,46398810,2.6339706660379205,2.5713661393698266
WM115,25154868,2.4497388117539773,4.346899614628069
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-1.9352844936900524
BICR 31,123631,1.818021308876907,2.6305255042897313
HuP-T3,60750,3.212181181151216,-2.8883708885143373
WM115,71304818,2.065667497969779,2.5682080685665682
SU-DHL-1,11964036,1.0253922980362349,1.0556485784132388
SW1271,9444,4.046685913234064,3.943207004286788
IA-LM,1716436,3.827820678542469,2.9737328893925588
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,1.8468871608092061
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,2.706813992398334
SW48,44137675,1.8984167228990951,3.143390285984793
IGROV-1,11364421,-2.1205062036040982,-1.4621832850738123
PaTu 8902,3465537,3.540732953494624,2.4063053150942895
HCC1500,54618771,1.4039271563223086,0.965426080627208
NCI-H1568,23725625,5.336887169251221,5.139321284950605
BICR 31,9936388,2.7244047649519074,-1.6750328459987545
IGROV-1,49850262,4.068828647042517,3.556780217637412
HCC15,5280436,4.320878094694944,3.5696350522182456
COR-L95,46215462,1.6156782364555438,1.7365826156139772
SW948,25022340,4.946878477600784,2.704510831918536
P31/FUJ,3025944,3.8644283212627895,4.191953898940705
SK-CO-1,5978,-3.732613512446313,-1.6247620276785824
LS411N,19582717,5.192972758226466,3.928836885567758
SaOS-2,26596,-1.8442798913702467,-1.3664638575351649
MOLM-13,6610216,4.131122051839403,4.181660550963367
KU-19-19,3025944,4.41555498235696,4.136919093554349
HCC15,11497983,1.686538707374479,3.8549370604003173
HCC1500,216468,3.3608861469702735,3.3253650948824953
NCI-H2452,56649450,2.972344092085675,3.424678565459167
SK-OV-3,25262965,0.4953902890441227,-1.1795290542668895
HCC15,10184653,1.3258142209068642,1.5589569190197436
SU-DHL-1,3825829,2.249840075454991,3.598088667687135
WM115,49867926,3.8689880289876446,4.259254817547845
K-562,285033,-3.792012978388577,-2.4202025603732658
Granta-519,53495165,-2.785106410212646,-0.5235519516740694
SU-DHL-1,5335621,3.5965276677583846,4.570379181607577
NCI-H1568,1566236,1.6523344134899465,2.2536699683656236
HCC15,25195348,3.62058364960133,3.3506557682639913
LCLC-97TM1,7326481,3.961997196958484,2.910700494510147
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,0.9525771280482934
LS411N,9887053,4.348393626170801,3.6335024673796323
LS180,208908,2.3350670945107783,1.890777026494899
IA-LM,54454,3.681506421747591,2.4255866858840904
RKN,4378219,1.9905206425028277,2.5418734180550713
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.538183614490649
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,2.9133575189029046
IGROV-1,216345,3.498629789107092,3.8761286525031426
SW948,5282054,2.5738720751419746,3.6777935309233896
PaTu 8902,66577038,3.2739824602509304,2.91982172109466
COR-L105,1566236,2.352597865521479,2.503126981722718
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,2.9773591132673856
MOLM-13,46191454,-2.5774836063329905,0.8815850344144195
HCC15,72734382,4.010055800269774,4.564618115739479
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.5444085972816566
SaOS-2,53232,1.3253237607162072,2.852587206479884
KU-19-19,9936388,2.972521935644637,-1.3894838313692899
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.4608779408295347
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.208839800288363
SU-DHL-6,445643,2.4790626422724107,3.9806486271456265
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,4.139395027265992
HCC1500,208908,1.6399748300125228,1.9574264949319087
P31/FUJ,4917,2.744589019426067,3.035691134475314
HuP-T3,241158,3.8412641522091144,4.024572395927352
SaOS-2,46224516,2.521923040225463,2.29250206996099
LS180,54618771,0.643112685351952,0.7724686014506742
Daudi,23725625,2.2816125857144978,4.550148219434256
Panc 02.03,25227462,-1.0518848939229315,0.1558964504343269
WM115,462382,0.0353255606914336,0.6574864704358024
SaOS-2,135875424,3.0421388786055727,3.6817064461546
Granta-519,10113978,3.360346958971763,2.7135324031028487
SU-DHL-1,51037431,2.2415500634191763,2.5703157702810544
SW1271,135440466,1.7072517695379112,2.1931944346183276
BICR 31,208908,2.9880095911503983,1.9254315120378356
NCI-H1568,11719255,3.5544275615483087,3.1220834317669715
SU-DHL-1,4259181,-1.4222017445817885,-0.2344091399155652
NCI-H1568,135984461,4.216726883570129,3.873835954846214
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,1.182891263761668
K-562,25195348,2.6278567451650394,3.186642252792181
SW948,6918638,-0.8188756331889222,0.3663494064414049
UACC-812,216345,3.8515167014354152,3.7980700475340967
PaTu 8988t,446155,5.325372031764619,2.556369173172344
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,3.3728501628203746
NCI-H1568,54618771,0.8004506686595156,1.0852141798321597
HCC15,9823820,3.975711917882334,3.913846453356556
RCC10RGB,9935249,3.9754060705766943,2.8202038621540813
SK-OV-3,3854666,3.321518045263264,2.000627302387348
Daudi,135928012,2.6114481479622516,3.965388126623889
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,2.772062397629453
HCC1500,44491742,3.6723474636183537,4.301641665560915
K-562,54626689,4.3954029102592145,4.540081586219014
SW948,11152667,-0.307089718187717,-0.7521068860407811
NCI-H1568,984333,0.7198134332239758,0.6958763812420883
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,3.288123362592238
IGROV-1,44507138,2.359177395411688,2.850632343909478
COR-L105,44566777,0.9614143121394376,0.8640370590421618
HCC1500,25126798,3.9309577641895137,3.905080867333417
LS411N,5470400,-0.4509258648896809,-1.2268069967182043
PaTu 8902,11427553,3.388107623793881,2.5929638542201854
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,2.048900209274832
LS411N,11364421,-0.88941081068058,-2.0203411430483587
Panc 02.03,6918638,1.5939476449475074,0.5165728451149999
IA-LM,73707398,1.4255919606814562,1.4769123428742879
Granta-519,54613361,-0.5306815642640709,-0.5678142851119553
IGROV-1,176870,1.8349827429681411,3.0686769916755163
SK-OV-3,24821094,3.4952627197751744,2.643743747627206
SaOS-2,5566,3.2892304449964125,3.0961153771575756
BFTC-909,44486219,4.380685277356905,4.297065257556076
SW1271,52947716,2.875834451056303,-0.6925835830912367
LS180,20959075,-3.038194424999374,-3.0618001794704406
BICR 22,2708,5.160276397343071,4.797978150096181
LS411N,24856436,0.7977520405714393,0.6926231843780846
RKO,3062316,2.656751778030552,1.2949233481169955
IGROV-1,2841722,3.834853118277962,4.291494412702934
SW948,9967941,3.223093544556301,3.756891309866827
WM115,5291,3.6779708977342263,3.5477009894418257
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,2.8666068352921807
NCI-H2452,11152667,-1.2581393219211725,-0.2802323335298899
SK-HEP-1,54454,2.662573207119838,2.6369582847863255
PaTu 8902,46398810,2.87785673961289,2.593732683305261
MOLM-13,4096211,0.3628379797080729,1.4347723065255573
SaOS-2,31703,-1.4545352226195103,-1.3013786090582626
NCI-H2452,89928392,1.3829077368930702,1.78078593362389
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,0.5715091662344848
SU-DHL-1,216468,2.865615091111303,2.742215905002892
BFTC-909,5335621,5.263558209813896,4.537644898564029
IGROV-1,984333,0.6618578113050116,0.7115935227043696
SaOS-2,53393127,5.00574224434263,4.076793948674114
LS180,26596,-1.3053249122689552,-1.4679733246186861
PaTu 8902,216239,3.2515461693373946,2.216793053287309
RERF-LC-MS,216239,1.5111459083459036,2.241695448966051
IGROV-1,327653,3.667792542405671,3.232538324158233
MDST8,25062766,1.7641764997703038,2.0482420988613246
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.19224711445269868
SW948,9911830,2.1163810502856344,2.5425156994639777
SW948,25262965,-4.786935998048743,-1.795626150110006
Granta-519,17755052,3.698735089058188,1.2677117214614988
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,2.6734047714768145
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,0.6093269963817182
BICR 31,65628,4.368112552275168,4.390211172182334
LS411N,1716436,3.6051806229528394,2.885530933236528
HEL,31703,-1.5815868160580933,-1.684923523540174
ALL-SIL,46191454,0.8221974593607395,0.4394600193898039
IGROV-1,46843906,3.392503571349757,3.0017990367376997
MDST8,52912189,0.1558018738717314,1.9354090485972906
SK-HEP-1,73707398,1.730256970360003,1.544974286406991
NCI-H2452,969516,2.821538204226011,2.8536721206279334
Daudi,9825149,1.5190393381512124,1.8598763081164105
HEL,49766530,-2.395534265113236,-1.2143164539994167
SU-DHL-1,445643,3.1136870030048116,3.74846300079727
Granta-519,25102847,2.235988678650905,2.2502121207207892
SU-DHL-1,8515,3.677486404661737,3.7068874576889472
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,3.127391441968563
NCI-H1568,73707398,1.0000031751048108,1.305173729738451
RKN,44607531,3.612700906890815,1.5400941604669203
RKO,448949,2.722052887717566,2.0031713614734126
SaOS-2,123631,3.143555798261004,2.34511697060818
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-3.2892269487414074
HCC15,445455,6.40486213649735,4.50976006601268
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,3.712064261904664
MOLM-13,16720766,-3.0154852550238473,0.027492158514745117
SU-DHL-1,52912189,2.819399061651446,1.233831592157495
IGROV-1,6918328,-0.5330006254346346,-0.07538236634536082
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-0.48949396712337623
Granta-519,168312962,2.8455100129937447,0.9315428585989793
RCC10RGB,24748573,3.544482176439233,2.3753280878509493
NCI-H1568,71576739,4.4464222538448075,3.6236569595066443
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.5712890964627638
MOLP-8,3025944,3.977744021049233,4.050302519649673
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.3349230083023114
SW48,3025944,3.8378875325919513,4.006094110047878
P31/FUJ,5460769,2.718083541162644,2.5068753438435905
PaTu 8902,56946209,-3.5225671286307585,-4.041082946314458
IGROV-1,11964036,-0.1609353030421705,1.1976984568521432
HCC1500,327653,2.623652361439541,3.160959644404032
BICR 22,11640390,3.3009766271386014,3.1833395499795274
IGROV-1,400769,-0.5589612210030486,-0.3761225714588028
HuP-T3,24821094,3.9398095537443023,3.2472730866532147
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.711602574976343
RKN,54618771,1.93479648501244,1.365586768254015
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,4.381314729552744
PaTu 8988t,73707398,1.170719580837983,1.558561422684334
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.0499281078716276
Panc 02.03,10231331,3.962628244123872,2.231573372760748
HCC1500,387447,-5.435802195710178,-4.449481074798643
K-562,25150857,2.2256112733235978,2.0271857322266666
COR-L95,135398516,3.161482452438301,1.9443477769230668
MOLP-8,46191454,-2.2442719810217984,1.2569655680001328
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,1.3062637985838554
BICR 22,4259181,0.3497439952553443,0.3642712654145994
SU-DHL-1,49836020,5.336381428124731,3.224923584817081
P31/FUJ,246676,3.344572915959865,4.353953857832111
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,0.8211258739713042
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.5634384803225665
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.3253611677389836
SK-CO-1,135875424,3.678629656731489,3.838387752668166
SW948,3552672,1.903682389315955,2.599001339841203
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,4.374382335967745
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,0.757177083597313
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,3.4312725434277853
P31/FUJ,6610355,3.438139996915945,4.311303961872706
NCI-H1568,446155,2.3736727750277455,2.8604593591403127
HCC15,107985,-2.9906891972859415,-3.5036755683885703
Daudi,6918328,-3.006382851838594,-0.9600460627804445
Daudi,25161177,4.237474374185298,3.7617757440176938
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.3127516124457628
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,3.222727576350607
HCC1500,374536,2.8802619944250765,1.802109093986596
SU-DHL-1,400769,-1.357151076144479,-0.9177890981808997
MOLP-8,16725315,4.20287759788283,4.0747439581479314
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-1.6688386316264434
MDST8,24753719,4.799692184779076,4.165743656080014
Panc 02.03,25195348,3.9334722209588735,3.0607474942345907
IA-LM,5328940,2.67230513268953,1.5426599185138534
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-4.091144898417399
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,1.862069839122187
Granta-519,676352,1.633141874861156,1.836896238243218
HCC15,49793307,-2.657858659953827,-2.2449334939916907
K-562,16065773,1.923835638804153,2.178546464300987
RERF-LC-MS,23582824,0.1470987082457378,0.9845847012880792
SW948,9907093,4.923675844906718,4.250190531102011
HuP-T3,374536,4.193584653265312,2.343460751040622
WM115,11396600,2.8854117577089378,3.5293612523166593
IGROV-1,16722836,0.856484234547582,1.5270775788619475
LS411N,89183176,4.7846004508379085,3.507389416239283
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,2.056233558995808
HCC15,6917907,-3.7751611818797897,-4.585284560965565
NCI-H1568,637858,1.7833024505225796,2.0103727190395286
PaTu 8902,5329102,2.5341846500240246,1.812118775802366
Daudi,54765302,2.540510911033338,3.886744390130486
RERF-LC-MS,100016,6.56071523320666,6.182160192621837
NCI-H1568,387447,-3.95080818095812,-3.8848651463651906
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,1.9582298135311154
SaOS-2,11612883,2.0316436721768087,2.6397474958101452
SK-OV-3,135411,1.6318689765112546,0.6372929525775153
IGROV-1,208908,2.822483792004996,2.1427632223799025
RKN,51037431,2.467401650082352,3.153452814277052
MOLM-13,3025944,3.8428716966726992,4.043426273066972
PaTu 8902,135421197,2.3024316473658004,2.1110708237976605
MDST8,969516,2.598297465814476,2.7112411938019356
MOLM-13,60750,-4.5529472050787545,-3.1446851232430055
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,1.5909686843170832
IGROV-1,9915743,-0.4757488934941289,0.8124971217875847
BICR 31,56946209,-4.213875977630207,-3.980084829046561
MDST8,124202324,2.333625526818204,2.339029436838319
BFTC-909,46907787,2.3649992203474515,2.0801841520313586
Daudi,12003241,-4.903510386182724,-1.8495038168419395
PaTu 8902,969516,4.108056616445131,2.8496277711864275
RKO,24951314,1.467797052763695,0.9720002385134704
SW48,439501,-2.266376314928653,-2.312404234479358
IGROV-1,5311281,3.3250623444804206,2.449151739096051
BFTC-909,9825149,2.463033939289578,2.167594900965183
LS180,2858523,3.002923184305197,2.9681826930112596
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,0.8835047921752396
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,1.0987700001028033
PaTu 8902,10074640,3.6154267469790304,3.310714723152434
LS180,135421197,1.2375553911833763,1.7415369094101314
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.163692552639707
HuP-T3,4259181,1.3598984416642497,0.4245546026696316
MOLM-13,9840324,5.573129737038137,5.630373621641186
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-2.5054213508601206
RCC10RGB,7251185,2.312506998895348,2.643210926935989
LCLC-97TM1,23725625,2.954034200595367,5.062853989689796
RKO,24797083,0.8657042008278414,1.2296773203028741
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,3.281617354221609
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,3.3986905524578415
ALL-SIL,24951314,0.1921049921473096,0.7997068479284273
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,2.78270252748528
K-562,16725315,4.409558206085648,4.040831087703096
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.2979891768759075
SU-DHL-1,9915743,1.482861419138649,0.8699718608481745
SW1271,4917,2.7806051488376293,2.9990530221169673
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,2.477117337203275
COR-L95,3062316,3.2830028596837217,1.1265235646655005
MDST8,10074640,3.541716125988611,3.14995861699526
IGROV-1,44185566,2.2104732991243248,2.390906995602848
SU-DHL-6,57519531,1.2127003418717253,2.33500472321151
SK-CO-1,241158,4.831010946536929,3.6909112868322445
SW948,46843906,2.6248020109336023,2.6819536454261357
RERF-LC-MS,6610216,4.063402980130349,4.2085969052497765
RERF-LC-MS,46843906,4.323049782377064,2.808352605480314
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,3.1362508125510455
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.8372265552567928
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.527374848958142
HCC15,24180719,4.303391195547382,3.7303888362670112
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.391670534839471
MOLP-8,6505803,0.6382990348001342,-0.6699632835609903
Daudi,5278396,2.816567405543214,3.199813709860423
RKO,66577038,3.1469091340303637,2.7798155965976257
MOLP-8,54143018,0.5860183196437395,-0.04452658796932397
SaOS-2,24856436,0.4386880001360848,0.5992847767098372
BICR 31,9866186,1.254760755448308,0.7285724510905418
RCC10RGB,11257553,3.6405008146732434,1.3365593212741986
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.5055501481672902
RKO,57330099,4.8516025997257275,4.188691019700256
P31/FUJ,54649500,4.423311343715707,3.66851632063427
SW948,10302451,4.082058519290096,3.079434077666939
WM115,2746,3.2273654457979957,2.978450887334855
KU-19-19,654092,0.6096416345891582,-0.27684841884583233
PaTu 8988t,10296883,3.999790485906541,3.912777713589082
BICR 22,54143018,1.1733542553992964,0.5719616362769443
MDST8,71466445,2.0942740576673593,3.490667820382486
PaTu 8902,36462,3.471634301287976,1.8460700274141604
LS411N,44632017,5.0127460000138,1.0966395180930455
COR-L95,9911830,2.1813921058815553,2.488642435824643
ALL-SIL,9911830,-2.857836139869332,2.1796244215724783
WM115,3465537,1.2344570371137795,2.3778591491090686
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.3926049742382551
SU-DHL-1,54454,0.0220955119836291,2.5519885172406225
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.767552840977136
MOLP-8,24821094,3.654707766369703,2.5232258963911627
MOLP-8,6852167,0.8455390099609336,2.232970839315832
Panc 02.03,11222830,1.865607722872823,1.6977242810756519
MDST8,2746,2.514425635914287,2.982365320025914
Granta-519,1716436,2.7310795448836904,2.784826746467237
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,2.723128962328175
RERF-LC-MS,11625818,4.251014876931036,4.396160972025166
P31/FUJ,4378219,1.2412027933720209,2.1795766241316636
HCC15,3062316,2.729530034687651,1.0215141857418633
LS180,9903786,2.2166672873522857,2.439895573020465
PaTu 8902,16065773,3.37985868216597,2.4433428058515916
LS411N,9911830,3.118029057589745,2.239180370106295
LCLC-97TM1,6438330,3.0238187505324885,2.237764884626576
KU-19-19,25062766,2.9321374053838807,2.0377758801039816
HCC1500,10074640,2.968051262406446,3.1561879973532645
P31/FUJ,6505803,0.2535639265329721,-0.6979595930043564
NCI-H2452,387447,-3.2957708741809975,-4.1591872275000625
MOLM-13,11228183,-2.7074565632423546,1.4106025906101847
SU-DHL-6,5566,0.7122829809928822,2.8680550760060517
COR-L95,24785538,1.0654849938174582,1.4303720217182552
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.7244186124730022
WM115,4578,4.221194502857287,4.461654564967354
COR-L105,4578,4.590840204947243,4.458646727053263
K-562,374536,0.780579010414565,1.7591259411430753
COR-L105,60700,0.1425021915553204,-0.3739900480234579
K-562,46926350,-4.162486097405079,-4.325074000693771
SW1573,4705,3.887877577681455,3.166111670480143
LCLC-97TM1,637858,1.4157632634757724,1.8826625803416621
WM115,46926350,-4.284670953339827,-3.8716254026996726
RERF-LC-MS,15547703,2.8085711207925015,3.1531939970898732
NCI-H1568,11497983,3.872384435522252,3.6339172229871664
MDST8,4788,5.889593740712007,5.566588994614352
IGROV-1,8515,2.1861539315976053,3.8254779482156724
RKN,24772860,-0.333409077824626,-1.907728615218413
PaTu 8988t,322968,4.849886698333752,3.7384942808884465
RERF-LC-MS,16720766,0.5604118097796991,0.5309022918627592
SW948,6505803,-1.4287073835677784,-0.7777682570620605
BICR 22,462382,1.3729135623232431,0.577503890844213
LS180,322968,4.435040308321651,3.3777673284712346
SaOS-2,11152667,-0.1732170298835725,-0.5070207343003686
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,1.316519948313262
HCC1500,227681,1.895909952215359,3.3599582537868655
SU-DHL-1,57330099,3.736750567984075,4.151870690131425
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,1.9708405989247582
COR-L95,11977753,-0.4790698517891548,-1.617071763805451
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.48230481988938
SW1573,11427553,4.057369297610019,2.641804271098248
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,2.6601246704617396
LS180,12001922,1.7594619366424422,1.8314324008256762
SaOS-2,12001922,2.1147367002170494,1.9150925906897576
SU-DHL-1,3543504,3.7817510655567625,4.046318905700915
BICR 31,24901704,3.914024172074534,3.1579909789215588
MOLM-13,5287620,-2.884996470216499,-2.2634874595149976
BICR 31,25102847,2.842271629600241,2.3537224140692343
COR-L95,10113978,3.7452762075447104,2.979146756462373
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,0.815525822264178
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,0.9491947289157717
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-1.7434483040189759
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,2.2106130840948275
COR-L105,168312962,3.0410731046381065,1.6358072771830512
LCLC-97TM1,10322450,3.85878970197106,3.876499182714974
HCC1500,25161177,4.357780519617112,4.104982160140561
SK-CO-1,9967941,1.837567054996146,3.75229626827494
COR-L95,5311,1.4789786210040632,1.2937323095091486
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,4.051310557703953
LCLC-97TM1,72193861,0.688846554638978,1.6835201467779932
SW48,4096211,0.1208358665406906,1.805489288638045
LS411N,135875424,4.300305751936665,3.5551504911450933
SK-CO-1,42642645,0.466262192383588,0.9446149191165208
IGROV-1,1566236,2.765820903157784,2.2264806130110735
HCC15,10410894,4.508285516741203,3.2354626623884304
IGROV-1,6450551,2.579641476451469,2.5263184406986277
IGROV-1,452548,0.0422661560146271,0.3237728568329916
COR-L95,216345,3.729430833860697,3.96489154972766
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-2.590221818008899
LS180,2945648,3.723684880750219,2.892423951658174
RKO,9936388,0.8183869926163714,-3.9819095023565443
HuP-T3,10231331,2.6811135289001236,2.0171542843171553
PaTu 8902,44493528,4.360494725244959,4.291389937421076
Panc 02.03,45279963,4.323488067826322,3.8751608906405157
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.153124415982458
BFTC-909,44507138,2.8704731321552734,2.4885899268257545
ALL-SIL,49766530,-2.347000417785464,-0.7183758375542495
SU-DHL-1,6918289,4.3249644726818275,1.8104752928054106
NCI-H2452,54626689,4.879011133008654,4.686478971810088
HCC1500,4917,1.9149154714535184,3.147075245116333
LCLC-97TM1,15547703,3.011827246330581,3.0764281171257166
MOLM-13,71304818,2.1544936448447873,2.1689274974237716
SU-DHL-1,4917,2.4666047815714154,2.9878318489050053
NCI-H2452,56946209,-3.558178980562316,-3.447183020720979
RKN,1750826,-6.055252220387113,-1.8583034666388039
RKO,25105715,3.388469834531371,3.3123290564415644
RCC10RGB,46191454,4.887818963424851,2.0569294963742495
LS411N,3815108,3.549037613932863,2.7033699064515715
HEL,56946209,-4.040477533762366,-4.4858508903512115
BICR 22,122327,5.571410232221064,4.572402986387047
BFTC-909,969516,2.723005004244225,2.7822626270493
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.0467956098682285
RKO,24856436,0.2423564692967549,0.19961165320152227
SU-DHL-6,5746,-1.2123840023346684,0.5283232009836404
SU-DHL-1,135411,-2.10627226052293,0.44112232572693943
SK-OV-3,1716436,3.636442167288748,2.8267269414888005
IGROV-1,44543605,3.88270235241076,4.129234415487786
K-562,6914657,-3.91828110768511,-4.2498904712605645
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.8168168966379699
NCI-H2452,25262965,-3.6663688304344695,-1.2521172592448233
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,0.9481372777235094
MOLM-13,11404337,-1.791363376051536,-0.7463815931282444
RKO,36462,3.4370564574699185,1.5367250645329966
IGROV-1,446155,3.750396425244744,2.5845493070064545
COR-L95,72734382,4.117898969233179,4.254304283274997
K-562,11396600,3.7562155275673415,2.8285773071456153
LCLC-97TM1,4705,3.0319662392534057,2.9939539924204737
Daudi,2130404,3.4806417402967993,3.1039801257516957
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,1.2367214093601666
MDST8,327653,3.1544218347658375,3.255812857283226
SK-CO-1,11656518,0.968890652064466,1.5649557549636401
K-562,5311281,3.9022564066083967,2.393984703390127
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,0.6658202361251125
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,3.466437633534929
RKO,445091,4.342692134156949,4.040358897134944
MOLM-13,9935249,2.7939558009041283,2.2203148343905275
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.8898465174562566
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.472123785065915
SU-DHL-1,124202324,2.3695119203399906,2.144306339699786
COR-L105,9884685,2.6443959528770167,0.4232127085379338
BICR 31,10113978,4.990782635230478,3.209301110828804
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,1.372695991805875
MOLP-8,6610355,3.5622833697709178,3.9666570895176614
LCLC-97TM1,2749,2.4194398786749067,1.9322580762080153
Daudi,5311,0.1794409230409946,0.9663293386990276
HuP-T3,2113511,6.036487802507154,5.4515717557897485
P31/FUJ,452548,-2.598049093653093,-0.2572701113226417
SaOS-2,16065773,3.691866894593861,2.3289533211296756
RERF-LC-MS,65064,5.274588293813746,4.720172313725381
HuP-T3,89928392,1.747135585577409,1.6388678897366142
P31/FUJ,56963564,-0.6738396792941169,0.38531767627032104
LS180,5746,0.8609008276830991,0.9679842255224824
BICR 22,11707110,-2.2145574606059912,0.41013753670063285
Daudi,9952709,2.2307089742515713,2.8048744030376778
SW48,3543504,4.30466926238752,4.00389965224594
SW48,11427553,0.5193301330840923,2.3372311484484625
WM115,56649450,1.7070260970326938,3.391755645179515
IGROV-1,89928392,1.4824233552493276,1.47877937518568
SW1271,72376,-1.909620961604672,-1.4280391989734806
SaOS-2,5278396,3.8495121754699686,3.491395079273634
K-562,42642645,-0.9952706094252596,1.0021292862247295
Panc 02.03,446155,2.721578883226381,2.6836971121137623
RERF-LC-MS,44462760,4.251912039026111,3.7424734542867815
BFTC-909,3503,3.411270469206907,2.357610017692035
MOLM-13,104842,-5.846939346357726,-3.9315596012161627
K-562,11656518,1.1460195934444493,1.3530746287027364
HCC15,76446078,6.244123044550032,3.8944564455868886
COR-L95,6438330,1.555078701387849,1.9963665775999815
COR-L95,9926054,2.0133423062539726,1.8833256883750744
BICR 31,462382,1.217928478873545,0.7309073592722533
UACC-812,46199207,3.606176782545976,3.263753160989988
SW1271,16725315,3.214819296898604,4.347463819882761
BICR 22,3385,1.594485383262216,3.861040965731029
HEL,11234052,1.6482548628813194,3.642537285275748
SW1271,49793307,-1.6735159246770874,-2.633217039207836
HEL,3025944,4.107185950107739,4.127216850128857
SK-CO-1,1641662,2.678789461404506,3.509353183225012
RKN,71680916,6.446363106372924,4.688277707378886
IA-LM,25183872,-0.4633226224219731,-0.4264717638970048
IGROV-1,6918837,-2.9804518885508635,-2.810842419641798
HEL,252682,5.808471376099282,6.497396655621169
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,-0.4443307668322833
MOLM-13,374536,0.9670025892080272,1.894126051111314
NCI-H2452,168313047,2.588327036215806,2.374192577324593
Granta-519,4917,3.021022166883331,2.914900641059818
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,1.5764326373144208
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,0.6603744144796818
BICR 31,262093,3.397835562493394,3.028330092975575
LS411N,12003241,-0.0946051023392001,-1.2007923496237713
HCC1500,5282054,2.2651950194203323,3.654227446025415
HCC15,322968,4.854333863324092,3.9660931298041144
RCC10RGB,9936388,2.3235560801623465,-0.9454783667778989
NCI-H2452,46199207,3.026577128215497,3.294307102817293
Granta-519,9444,3.3091580955395146,3.475947819435867
IGROV-1,53392493,2.352084848618059,2.50449956743469
COR-L95,151289,3.0372683791028705,0.7794847624825549
NCI-H1568,216468,4.700562763036761,3.2280941515274093
WM115,25195348,4.859937697346287,2.9648764771229708
SaOS-2,2858523,3.094677154220442,3.0267336848171085
SW1271,421610,4.471416490511734,2.9812091187244016
BICR 31,637858,2.611871003184785,1.8336497332692474
SW948,11175137,1.686043515242534,2.6754130793865403
MDST8,11625818,2.7981930885976705,4.5472038817339735
Panc 02.03,11609586,3.3931905350155915,3.0768231554233147
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.953063776456994
PaTu 8902,9825149,2.767587999144615,2.056217269553959
HCC1500,6918837,-4.362896894201754,-3.1704240332236058
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,1.9019028394266195
SaOS-2,5282054,3.07206551989859,3.5698621580584824
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.293290660801916
SK-CO-1,72376,-3.2194985981528808,-1.7502172688667827
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.4105904764949435
WM115,10302451,3.6553280898048905,3.0124860075948505
Granta-519,613000,2.2510291651452143,2.547777946229785
SaOS-2,11222830,1.0878926350484104,1.5076328211301238
IA-LM,54678924,1.6007306497128662,2.345371136081648
HEL,119607,4.922739390517752,4.893945402363688
HCC1500,6918328,-0.2689126411143879,-0.11895932358274003
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,1.959052371200723
LS180,3062316,2.327440880417239,0.927209547733491
LCLC-97TM1,11317348,1.7152030009838672,2.609231520180691
SaOS-2,6918736,-1.8799034133096575,-1.686953246856158
SaOS-2,12003241,-0.699813042979073,-1.3191386837073182
LS180,10113978,3.7861477365363383,2.9327950820471798
SW48,54618359,4.4319552735559,1.7539659372800704
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.8725804222624244
HEL,387447,-4.961191552031455,-4.689537383529135
RKN,6610216,4.220445612403551,4.3046610981234945
P31/FUJ,656346,-0.3707458386499477,0.9039579729395514
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,1.0388813197082936
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-0.6918790946517892
MOLP-8,9952709,2.638563783306324,2.753904434732347
SaOS-2,11455910,0.8777485884783317,1.1771824079893918
K-562,10184653,1.719293175029272,1.2934189139891197
Granta-519,4259181,-0.7648884727300508,-0.07101726925317935
BICR 22,4521392,3.4098909359208625,4.327894894683055
HCC15,2874250,4.519421691404506,4.649758467944213
SaOS-2,6918638,1.2055090485954645,0.46318673006940664
MOLM-13,9868037,0.9756233042827712,2.540402441187695
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,1.9052640006782426
MOLP-8,16659841,2.203571056365997,3.3313467357232667
LS411N,656346,4.206497662771029,0.7445072390789143
RKO,5460769,5.660789679983863,2.3269833374924427
BICR 31,6610355,4.797647038745592,4.502893346584207
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,1.949249092608681
RKO,11964036,1.8153618806471208,1.133375673494853
NCI-H2452,7326481,3.286880233884326,2.9463863088654576
RCC10RGB,44491742,5.1484686760969645,4.324209738882428
IGROV-1,50905018,6.092412272559071,3.9893354927786437
BICR 31,9884685,0.303781088019613,0.8858638682353467
Panc 02.03,3081361,3.1546648300373357,2.462006031590864
BFTC-909,25126798,3.8219929141120166,3.8976672816057136
MOLM-13,66890843,1.9738756301734208,2.112883793656501
HCC1500,24180125,3.164669305988548,3.043992055078257
SK-HEP-1,53392493,3.66906541895257,2.653684791898464
RERF-LC-MS,2945648,2.437954541344266,2.8714255437299046
HEL,25150857,2.447529551071105,2.193734771276921
BICR 22,65064,5.333446499438452,4.936470965511328
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.2832243035130295
P31/FUJ,123631,2.0303759233077017,2.378882616071455
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-0.943578526130429
IGROV-1,11175137,1.8411496230681277,2.542441264162934
KU-19-19,44241473,5.030815161961597,4.678136461798271
SW48,72193861,-0.4534629909928462,1.3894328257260502
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.376413779671577
MOLM-13,5311281,1.6146001182421037,1.8123472599117738
HCC1500,9915743,1.9340540182592263,0.8703457677487527
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.10077578723621768
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.9972904103755749
LS180,4096211,2.1975503712063604,1.7826280182467686
NCI-H2452,66577038,3.355972963473848,3.012777141638099
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.6555081203656639
HCC15,11175137,3.485795641541794,2.586529448711245
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-0.8976198286640726
HuP-T3,2945648,2.5475895191101197,2.880804450764081
Panc 02.03,6450551,4.166761052507323,2.7677875629153914
K-562,2708,5.362475494708341,4.727593737586443
RKN,219104,3.4277527780329096,3.7951229584736073
RKO,16722836,2.0172870973895085,1.5225165370223916
UACC-812,439501,-1.4243957864326813,-2.291358610489684
MOLP-8,11222830,0.9410853080031706,1.3204340445104814
WM115,1239801,4.563824386797348,3.904872409937605
Daudi,11717001,4.763561920962392,3.9758803105086895
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.537808067350835
COR-L95,16736978,-0.5228132160938015,1.526478946265058
IGROV-1,11213558,0.52356811652227,1.587279389834452
MDST8,44202524,1.4033794041893788,2.1806807987277783
SU-DHL-6,10113978,2.1190356124222194,3.0093937718294526
SK-HEP-1,4917,3.764636353681369,2.9376350821319246
HCC15,452548,-2.1001752731425727,0.04213973008244674
SW48,46191454,-0.9829938197758128,1.0297202193506367
MOLM-13,4521392,4.5803067712490115,4.004674745003326
HuP-T3,25062766,2.4453672011464023,1.9450640881332961
COR-L105,107985,-4.244896937866387,-3.833887764805567
SU-DHL-1,89928392,0.4021872915525221,1.1092278376019236
BICR 22,55508,4.44611517999926,3.2610662259132006
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.8248243292380573
MOLM-13,675434,3.665195693175508,4.171556547219214
SK-HEP-1,6610216,4.694225049802747,4.28760251850485
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.1970517898789799
SU-DHL-1,49766530,-4.824875359994143,-1.0113040936538191
HEL,12001922,1.658840092002429,1.73261088839931
HCC15,46398810,2.6134237903958093,2.5160088783976127
NCI-H1568,3136844,4.658915015928919,4.224450930659086
NCI-H2452,24821094,3.1123469452418537,2.9739854143031494
LS180,3543504,4.376890558116308,4.235356944230695
ALL-SIL,9927531,4.600523700119875,4.5201399878733755
BICR 31,11167602,4.451308398956488,2.3897953034934436
SW1271,16219061,4.25548468975063,3.1057753403133184
PaTu 8988t,448949,1.751499890417066,2.0542308559965656
WM115,2858523,2.9957579985597467,2.960711987433696
RCC10RGB,11364421,1.2845393833467151,-1.5581403865634895
SK-CO-1,984333,1.8899562330111348,1.1156481382094625
COR-L105,72376,-1.002534224494363,-1.7984857049727359
NCI-H1568,168312962,2.190321562510239,2.1129583862450185
SaOS-2,2746,3.4161371679978436,3.067315668491574
Panc 02.03,51039095,3.661030142872421,2.812185883885216
SK-CO-1,65628,3.554197618459022,4.389838849542015
COR-L105,16725315,5.297524124299076,4.213673855397481
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.9075228096802976
RCC10RGB,46224516,2.231293839634299,2.504540352151384
RKN,9956119,4.4432647969313,3.7401981266071784
RKN,16065773,2.958619348149216,2.454005888308785
WM115,17755052,0.4002517605741686,1.4018799962885133
WM115,168313200,2.1363369230808593,2.968034448553457
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.4638559782259557
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,0.7910557805829029
LCLC-97TM1,9903786,1.8016114643921617,2.643929586223317
SaOS-2,49867926,4.146129188416838,4.262213583162305
RKO,25126798,4.002843113400742,3.591696019941967
ALL-SIL,219104,1.1543769867483644,2.670119279858143
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,1.8290864638674753
SK-OV-3,3062316,0.5292744016150154,1.1206439799644559
SK-OV-3,11178236,-2.424602318267421,-2.833639588080353
LS180,9887053,3.1718141126704618,3.762569108983253
BFTC-909,25183872,0.7872065650622051,-0.5872956285021869
NCI-H1568,2945648,2.136721092573253,2.886067613569994
RKO,1716436,3.795795915163565,2.789474722106326
SW948,65064,5.291153994733523,4.9920452635088255
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,4.6048353257836405
SK-CO-1,16115403,-4.417233339728943,-3.9505204546579433
SaOS-2,400769,-0.6660591873157414,-0.6322028787037555
SW1271,2733526,3.2893803459487594,3.867803931957476
BICR 31,4521392,4.267019749412992,4.303374069181403
P31/FUJ,25154868,4.728907139536709,4.442276829598303
HEL,676352,2.4086189638079643,1.974784367739595
PaTu 8902,BRD-K27188169,4.434214541500356,3.4839298415759536
KU-19-19,44607531,3.044914521934579,1.477429264790827
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.842493617223683
SK-CO-1,72193861,-0.1340038294528125,1.4655558432437585
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,2.7660337619961797
WM115,135423438,3.926483426744841,2.4427543890798997
RERF-LC-MS,135875424,2.839581382146162,3.794787945914
PaTu 8988t,46926350,-4.145321949318386,-4.0383605187428655
Daudi,23582824,-0.638376916275564,0.6250009477715242
Panc 02.03,168313200,4.226618217059218,2.7206245856658846
NCI-H1568,11175137,2.3278621292073067,2.7237936406275143
COR-L105,11152667,-0.3968124554752262,-0.24218563790826342
IA-LM,5281672,4.428935042775787,4.416233372041645
IGROV-1,3062316,-2.2361832227909075,0.8973583415730638
SU-DHL-1,5281672,4.30860315799997,4.2347923293588785
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,4.909780120112897
BICR 31,11625818,3.9395546041344858,4.385824579870625
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.523816723908956
NCI-H1568,445643,3.6093957886383814,3.997789294517005
NCI-H1568,4477,0.3996701755478256,0.4376530033654835
RKO,36314,-4.63858923378885,-0.7029153934891602
Daudi,675434,3.694219652985114,4.318422890878129
MDST8,60750,-4.217127024403589,-2.677439334575467
WM115,9903786,3.894434750277636,3.0005729337453264
RCC10RGB,5282054,3.6705963985990993,3.9044250696676857
HCC1500,262093,2.85046563878574,2.8393582610607093
BFTC-909,4259181,-0.0277162117211437,0.21443545657298307
COR-L95,252682,6.347695054422412,6.408950411625244
LS180,9911463,3.681535048080384,3.439176391266681
SK-HEP-1,1566236,1.7725788045776691,2.4451683606576196
LCLC-97TM1,6918736,-2.1743152466595626,-1.6745399732761437
SW948,10231331,-0.4116197219649379,1.35526572860886
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.1575555598717764
KU-19-19,52912189,3.155674258646967,1.9525693672090076
PaTu 8988t,44185566,3.1955818251601493,2.44855930614134
ALL-SIL,31703,-2.84181702758724,-2.464361504560189
MOLP-8,67156097,-2.505693621695456,-1.8160069445291744
P31/FUJ,12003241,-0.93015536828776,-0.8327713953173422
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.610947030379492
HuP-T3,72376,-1.771653200109272,-2.018554074113132
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.923907302483796
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,0.804529761516954
SK-CO-1,54649381,3.727346200170898,3.8009762756512093
BICR 31,4578,4.306546690441069,4.302580835494201
HEL,24856436,0.2549549224561803,0.21653486526100374
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,2.2833941052507774
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,2.123322843338103
NCI-H1568,568763,0.1547040002068053,0.27405937346126785
SaOS-2,10184653,1.5674189620168135,1.3953420306788873
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,2.452216792331042
SK-CO-1,10127622,-1.7782095442547816,3.105068178837961
RKO,6450551,2.9764230599456782,2.303852203223199
RCC10RGB,11222830,2.1708629162803654,1.660860581957136
MOLM-13,439501,-2.531564352317227,-2.559080538963699
KU-19-19,5328940,2.592216165266187,1.717153434731438
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.297574580415609
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-0.9643218081336333
LS411N,46224516,2.772468105753273,2.5505384239473603
COR-L95,3465537,1.5360689669151406,2.411876082184249
NCI-H2452,650361,3.725817753027947,3.8113673960407435
MOLP-8,135423438,1.7176055832456645,1.9790664487848613
Daudi,15953870,2.3174310256528017,3.2898621005087914
HEL,25062766,1.0860006913119025,1.8139198176784008
LS411N,9866186,0.9541786681011424,0.7488936579544374
NCI-H2452,72193861,1.1802568558602904,1.7052695785585315
SW1573,104842,-2.57352069349058,-2.4613811017808382
SW48,1750826,1.3136286655933227,-1.7581445021643671
HCC15,25262965,-1.0400697166295236,-1.34045175691033
SW948,156414,1.6424995325300082,1.3388241496826034
HEL,49793307,-3.822273429090704,-3.642100871209379
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.5934037845038944
KU-19-19,15983966,3.017543110767297,-0.8817379737088409
Granta-519,445643,4.101892829369416,3.710008804684024
WM115,44462760,-6.607584862322745,3.1869218772071433
COR-L95,16722836,1.6737270586986386,1.5301459404220368
HuP-T3,19582717,-4.617931701404403,4.148770487335306
MOLP-8,135984461,3.690365922940533,3.357278610991092
WM115,25105715,3.143290836206988,3.4460544716935018
SU-DHL-1,6610355,4.337111630655639,4.182650853046986
P31/FUJ,107970,2.0437014771117425,2.2528891095629837
BICR 31,9903786,2.10396775229317,2.9855125910764833
HCC15,119607,5.6213928119464285,5.381368648118746
K-562,53392493,1.9280012389180945,2.4580465373207994
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.7715769178815357
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.740977986819478
SaOS-2,6184667,2.75971928345779,2.97139231210922
HCC1500,49867930,4.391361036771465,4.806338521593275
HCC1500,156422,3.756088196252004,3.9573698638859853
LS180,2729026,2.858515315971793,2.596342887560299
UACC-812,9926054,1.7122964049751828,1.8736809655256155
BFTC-909,2945648,3.347829093032643,2.8575843048000773
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,1.9425003294197554
COR-L95,10427712,3.3507411292398315,4.1822737384372894
HCC1500,73707371,6.057238887548947,4.7996111954946405
SU-DHL-1,5566,2.363543718324467,2.993475935569017
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.5297477106032278
SW1271,44137675,2.993655891868926,3.545119231813317
PaTu 8988t,10385095,1.1295524511895831,1.4787725949595494
IGROV-1,107970,2.287061680908213,2.406603443888824
LCLC-97TM1,3081361,3.200154540210029,2.170940761131899
MDST8,24797083,1.659668465713326,1.3923465628187452
MOLM-13,100016,3.967621300341963,5.676724447484824
SW48,6914657,-5.582748420606011,-4.394364660013529
RKN,54454,2.1815674244706407,2.4056176921375907
SW1271,54686904,4.077781574312711,3.7431846840773875
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,-0.5187967286634916
LCLC-97TM1,11152667,-1.9849905525936635,-0.39968315047979425
RKO,6610355,5.147293026177706,4.114290495781209
HuP-T3,11234052,4.425621489915021,4.219940374290964
BICR 31,11485656,2.9684140094972387,2.4080949113864643
HCC15,445643,3.643779771767104,4.017701543533348
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.8919593167908636
Granta-519,6918878,0.9437787040623058,2.188874165861809
SU-DHL-1,16720766,-1.7997333167058054,-0.025051384786257107
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.62544369013852
RKO,11626560,1.596896929931414,1.5828228951544658
IGROV-1,44589607,3.0909001492794377,2.4665898493036873
HEL,168313047,1.7739787927154282,2.167557272996182
IGROV-1,11964036,-0.1609353030421705,1.1976984568521432
SK-HEP-1,969516,2.3030983588134917,2.903367430291269
LS411N,68056272,3.648680202626129,3.421638660737941
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.4014067866820394
HEL,2749,1.5352641298417238,1.4462238181387865
MOLM-13,135398516,0.1807695197937267,1.8958240296044846
Daudi,176870,1.9898427065198672,2.9137630392734355
HEL,10427712,4.076538081897971,3.9474225719399203
SW948,24772860,-2.2115718578693495,-1.87313815089587
Granta-519,2729026,1.8472912754822493,2.2498349500263823
COR-L95,5394,4.313147278509764,3.9273103583891267
LS411N,46907787,0.8939335106347707,1.7710683627995334
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.289432097494208
KU-19-19,11485656,2.7576201496249264,2.4265461611311427
IGROV-1,2858523,3.196384505087132,3.087821644642696
SW948,702558,5.163408425848839,4.9153613394522715
RERF-LC-MS,72734382,4.885789692793362,4.378804483365699
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,0.9191746249855136
RERF-LC-MS,11964036,1.6707185338079893,1.1648643837824482
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.495378921749624
SW48,3038522,2.575519148977434,2.926568606001386
IGROV-1,11364421,-2.1205062036040982,-1.4621832850738123
Daudi,24753719,1.7041863717102288,3.6041487729676915
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,3.8430547724306248
SW1271,73707438,3.2742940196229022,3.986700489914209
MOLM-13,44487061,4.373293273870424,3.5411221893762748
SaOS-2,568763,0.7449819257203903,0.3561553045540348
SaOS-2,168313200,1.7182390433527042,2.851578962777738
K-562,15547703,3.09098547046412,3.060875572683725
BICR 22,24785538,-0.3286106781648999,1.351359518654611
IGROV-1,9936388,2.10108466287406,-2.8558141039656237
BICR 22,4477,1.559722374810713,0.47845595819941783
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.6555833471248622
BICR 22,16038120,1.2563245393113998,1.098237985764026
PaTu 8988t,56649450,4.324867884259214,3.2103994021659092
PaTu 8988t,135411,1.3050507330755643,0.7527143008875214
NCI-H2452,12001922,2.2907278374018296,1.940995794270107
RKO,44185566,2.4837284923488063,2.148876622563249
K-562,9826308,0.1842141800186153,-0.0006370313343876258
RCC10RGB,5311281,4.058856975975892,2.4039698418239563
WM115,5460769,2.9023963298546507,2.4531866929795267
HCC15,119182,0.1055567812373319,-1.0378844207822424
BICR 22,44607531,1.5270609291983028,1.1367463311118398
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-1.1030562348463098
NCI-H1568,25262965,-4.225307409424958,-1.2607934818422253
SW948,5328940,1.2304763256018572,1.641422614509144
IA-LM,10296883,4.25848729020474,3.6251785759280644
LCLC-97TM1,11964036,0.9095700511944136,1.073706920259772
SK-OV-3,10074640,3.759507235638381,3.113448493241295
BFTC-909,25062766,1.7422044094415416,2.0415779928518303
MOLM-13,44202524,0.8413416322030352,1.3933569709022717
P31/FUJ,44137675,3.225768708166513,3.2388918436769303
PaTu 8902,42642645,2.254917267204718,1.1718918682052477
RKO,53232,4.485666667988006,2.747200857869532
MDST8,51039095,3.753808380930837,2.5081202258523425
ALL-SIL,25150857,1.7729123360103365,2.031963208440026
KU-19-19,136227924,3.1447471190609217,2.8053182463017254
BICR 22,9911830,2.5765146499323497,2.6182882995112062
SW48,26596,-2.356334812614481,-1.8385383301388065
WM115,8515,4.149615392892544,3.8797206244106355
SaOS-2,3025986,-1.3703894596366477,-0.9486851597031076
LS411N,6623618,2.410312404439064,2.2735758363385075
RKO,2749,1.3580925102381314,1.7389072473891343
SW1271,9915743,1.6128868969613257,0.8755051547444133
SaOS-2,44589607,3.1014372869468736,2.6987417333322186
BICR 31,9908783,4.390198834476992,4.916057084337245
RERF-LC-MS,1641662,3.403538628142178,3.380244312053559
SW948,168313200,2.3052543991742933,3.135915389425418
BFTC-909,16720766,-0.0189955240044846,0.5272749614324936
HCC1500,46843906,3.5664723036358703,3.0847151367685495
BFTC-909,5291,3.495280995080932,3.8011067090580544
PaTu 8902,5287620,-1.817962379422155,-2.1730061461660233
Granta-519,24772860,-2.616849709254195,-2.555167058945457
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,2.836648583291748
MOLM-13,2858523,2.990787770243497,2.9415290562185787
MOLP-8,73707398,-1.5200522985211378,0.7243894842922899
WM115,4788,5.364989483250021,5.44808425261035
KU-19-19,11717001,1.9129980214779312,4.148188041733306
PaTu 8988t,3854666,2.839522644305469,2.338194011984707
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,0.6574115161829284
RKN,11222830,1.5707482267531538,1.461031197996818
SK-HEP-1,5978,1.689065603838291,-1.587552149666258
LS180,374536,-1.6764778169414856,1.9884841030928766
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,0.9341604937993793
RCC10RGB,46199207,3.760684270246491,3.2225027330230436
SW1271,49836020,-1.4027167140646708,1.989773124672097
BFTC-909,2130404,3.366307483642889,3.3389145749538525
SW1271,3384730,3.1846503121443144,3.1838127552582343
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.165004210211743
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.8365336462569775
SaOS-2,285033,-3.099559966451384,-2.461832394565148
LS180,71466578,4.68838045718991,3.7285568372750113
LCLC-97TM1,2126,5.523539990092585,4.53105880322899
NCI-H1568,9936388,-8.53108348301746,-0.7726847833332035
Panc 02.03,6505803,-1.93196111296706,-0.7545572759073009
BICR 22,9926054,1.8271931211135617,1.8023745076137498
SW1573,54618164,4.339091959582753,4.018223182925197
COR-L95,9907093,4.309721999642839,4.014944498125953
LCLC-97TM1,9911830,3.2250615193472085,2.558994132048056
K-562,151289,0.3703020531314545,0.7827292548102527
HCC1500,24821094,2.4557115965701257,3.1324954593345584
ALL-SIL,11222830,0.8263932665864424,1.2678387499144304
ALL-SIL,44490293,5.541636788423512,2.590546065750022
BFTC-909,15547703,3.647732910564925,3.341520251850793
PaTu 8988t,11175137,3.61207596874577,2.7000586429536697
COR-L95,44566777,1.612039010223373,0.8309523676480195
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.3841030672815946
SW48,9444,3.3118033011757806,3.9028005118147773
COR-L105,52947716,1.1539739817838972,-0.38996250327713033
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,2.107131815869956
SW1573,16013152,3.6979705228045354,4.14425356599252
SW1573,17759555,4.342323370433329,3.674503609861197
SW1271,11609586,3.768986685585146,3.0125203531402764
K-562,3552672,6.190745251508109,2.605715797450965
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,1.1541543583178617
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,2.972820173832367
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,4.368060244209474
IGROV-1,57519531,2.639098862164858,2.641909888858197
IGROV-1,1716436,3.2816872421007375,3.0132178865750086
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.427238648471825
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.5539178201113485
IGROV-1,2828334,6.070696247039626,6.086803939934271
SW1271,53495165,2.774319130141937,0.8748844879834752
SW948,67291369,3.8063591597957593,2.589134645142167
Daudi,11507802,0.3815953316544085,1.183405507855654
RERF-LC-MS,2708,5.106155932743474,4.595972935605021
SW1573,52912189,3.9296893768173065,1.8004732745753824
SU-DHL-1,25154868,3.5324679540942165,4.266079136003055
BICR 31,24772860,-2.497965982707089,-2.2874816189085654
K-562,11719255,4.077642177046201,3.0657931411508716
WM115,5470400,-1.5377493662522326,-0.1427817583224263
KU-19-19,44589607,3.6813877406069246,2.856322500417928
LS180,11626560,1.7567799331145733,1.4697015190262621
Daudi,11427553,0.4642664556868584,2.2163273590946924
HCC1500,44607531,1.3781074542184104,1.5023152930422936
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.37201801384568567
PaTu 8902,4259181,0.9791956381618654,0.22602285180160492
SaOS-2,216345,4.363902597199754,3.6818389427256766
BFTC-909,100016,5.8134150302243865,6.288108398940973
BICR 22,56963564,0.2615280103832354,0.25922608600822783
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.341559784011934
LS180,613753,3.1711720082363337,3.1438057124038994
BICR 22,3825829,4.259881935728516,3.7843644486864765
P31/FUJ,25262965,-1.897985536240049,-1.7325496468645276
RKO,15953870,3.3462063589818034,3.1151439072168476
ALL-SIL,26596,-3.0181503922951674,-1.7586978074158517
SW1271,4788,5.888244914590778,5.584545625391676
COR-L105,25150857,2.68968810352953,2.346407686648038
RKO,24753719,3.882573791668401,3.8997192696036143
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.2711373744319094
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,3.414501602284939
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,3.1978124395602263
PaTu 8902,613753,4.768885644214674,3.044921654874232
PaTu 8902,44589607,3.762990171329796,2.7973463995951153
MOLP-8,176870,4.692998654081846,2.772831378032163
MOLP-8,216468,0.300035377459394,1.6272579062962544
NCI-H1568,1641662,3.419317894706959,3.493966552652287
HCC1500,11626560,1.5792444837322512,1.8888753213933904
HCC1500,3689413,-1.6712109221216571,-0.25423161984982656
RKN,984333,1.094463938199557,0.8219290183850306
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.820871937081744
COR-L105,4788,5.897633886873905,5.590699630058088
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,2.848092140303296
PaTu 8988t,136227924,2.49705731140334,2.7786571808977487
LCLC-97TM1,3634881,2.947438100526324,3.2182811433241603
RCC10RGB,53392493,3.4706572822964072,2.7437754915847155
Panc 02.03,10385095,1.3097039910351371,1.2963749083416527
RERF-LC-MS,445455,4.41080153827665,4.596652144926565
PaTu 8988t,6918638,2.256433939948275,0.4306553721405924
KU-19-19,24951314,1.2793314486163916,1.2492468417567233
MDST8,25183872,-0.5549651899708961,-0.975423878515584
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.206138440545571
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.5344583391295816
COR-L95,9908783,4.358103020890871,4.901789961306183
COR-L105,3552672,2.0991572824292435,2.9790006774480453
SK-CO-1,5566,2.706069596509063,2.912599829259887
RERF-LC-MS,969516,2.2498421794663095,2.7678849672681873
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.7088225523269815
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,2.075176288397597
NCI-H2452,452548,0.0358025934468,0.063076701248928
Daudi,409805,3.686040208403983,4.321422288035336
BFTC-909,5287620,-2.871557478653834,-2.054361677251164
UACC-812,25183872,-0.2383295665292847,-0.6470117733004257
SW48,36462,-1.5563073788110886,1.5081793935921493
SK-CO-1,327653,3.1822308576162692,3.1281185969648906
MOLP-8,11507802,0.9747707839930404,0.8011996463806024
SW48,55508,1.9258231187784565,3.0487004052457762
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,1.9775466116218579
COR-L105,16065773,2.993283969068687,2.1993020121908655
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,0.07760252968025581
LS180,451668,4.827094473942733,1.7938472532276362
IGROV-1,36462,2.313632721410001,2.369055593014206
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,3.3992997192931256
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,1.339220150938778
MDST8,11719255,3.580824685094748,3.110714519048143
BICR 22,135984461,4.376718251500639,3.673489424922772
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.3079514663348677
Granta-519,2871966,-2.0442685638601947,0.0418860703974879
Panc 02.03,136227924,3.0839082623333387,2.79895387028906
IA-LM,10074640,3.892343788144062,2.9972927102725784
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.8279892865964746
BICR 22,10231331,2.1949493731732095,1.76906275530807
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.4691884901569963
NCI-H2452,10127622,4.466077980380041,3.617593968314428
PaTu 8902,11178236,-2.9840755573739943,-3.0676212109667342
MDST8,6918837,-2.3764765121755,-2.583063834636637
HCC15,1716436,2.8917896521916537,3.060139702827941
Daudi,5351362,0.314899635949887,1.311206886169238
IGROV-1,1750826,-3.124548162001242,-1.6039134597869682
SW1271,24779724,6.290779023739936,4.393340224719498
SW948,216468,0.513065020542466,2.917156247399226
HCC15,5738263,4.375256926251463,3.4360355222692043
Granta-519,25183872,-2.24080905771406,-0.9574180343330689
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,1.2664147901010154
SaOS-2,46926350,-4.2820912559124995,-3.8374198210260873
COR-L105,49766530,-0.5480688242609842,-0.42502265075237033
HEL,2874250,-2.245656223692803,4.446406576669116
K-562,45279963,2.402740503794971,3.6507295983495807
SW1271,441298,2.7117876410913073,2.529243065321534
Daudi,46215462,1.1016280052611975,1.5797784516616846
BFTC-909,9915743,2.0959000942543025,0.6642943523075912
Granta-519,55508,1.5366901224911111,2.5628156474287955
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,1.2135608150294188
SU-DHL-1,445455,4.339452591135178,4.454518254373709
Granta-519,11222830,0.944926764715042,1.4124230954093369
SK-HEP-1,135421197,3.339831791709741,2.0232183083558968
COR-L105,11719255,5.177770829400177,3.1793471926353774
SaOS-2,49793307,-3.0698778362667807,-2.847179290639633
SU-DHL-1,54618771,0.3433661921186922,0.8571556819919606
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.5192678388056768
IGROV-1,54618164,4.2184521751950115,4.069941595301567
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.570384916905329
HCC15,4259181,-0.5021574884501439,0.38509789114960974
PaTu 8902,5311,1.4468060231693458,1.4035775590367408
SaOS-2,11609586,3.464015551213678,2.835060617427958
BFTC-909,26596,-1.7437210940555867,-1.4011518229963098
RKO,3385,4.410917651107157,3.4642567948161385
SW48,5282054,3.4229655251352984,3.4637984213033706
HEL,3025986,1.4059985389197358,-0.9358598172422288
HCC15,2749,2.6993987110059456,2.040958362504793
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.112305749496527
MOLM-13,2733526,3.3430267495988693,3.5212854672918503
HCC1500,71466380,5.203984730888507,4.516275478220484
SK-HEP-1,104842,-1.0887000355540395,-2.335680403868658
SW948,5566,3.1149649258053107,2.9776622319476864
Daudi,11234052,2.508646185471885,3.512177992444009
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-0.7334061436633661
SW48,208908,0.7661322887377208,2.2071546673162095
SW48,24978538,0.0148337391131729,0.9127773452874675
P31/FUJ,9926054,1.2698752833949425,1.8259175558201761
Daudi,5287620,-2.5355659158885167,-2.2447865173968036
BICR 31,53325874,4.467091056736401,4.45450924232962
LS411N,400769,-0.3072623933562745,-0.7645214249951008
HCC15,7326481,6.13295321500094,3.1710823133368264
LS180,6610216,4.524725364990245,4.1780847022878635
BICR 31,11609586,2.804864928293696,2.796780427170687
NCI-H1568,5351362,0.9370615420718584,1.3868045463721839
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.6257922459107603
HCC1500,26596,-0.8174609850015592,-1.5507957368807876
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,0.404034637648114
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.725586821428849
BICR 31,5311281,1.899563489561116,2.2475918652518017
HuP-T3,11964036,1.9148977928601396,1.37260919820947
HuP-T3,6918328,0.6989696425214073,-0.05712366036898429
IA-LM,56963564,0.8197284064300991,0.44267606055211073
K-562,25227462,-1.535473545694956,-0.3267267968427411
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.1384669077026355
P31/FUJ,6438330,0.60015264799364,1.9768673492076219
NCI-H1568,54143018,1.7330311939537375,0.5077358237706214
MOLM-13,10184653,-1.0304513474260102,1.1542733341481854
COR-L105,3081361,0.7591954413754667,2.452593619133823
SW48,3465537,3.829258919586145,2.380463403665974
SK-CO-1,135398516,1.0451560562277196,2.3039826213354497
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,2.3395846240816467
BICR 31,11222830,2.7999268343872603,1.586270409835173
P31/FUJ,1750826,-3.787471607079622,-2.0469522942454286
MOLM-13,124202324,0.9453642044256088,1.833856617815023
LS180,445091,4.461419397707798,4.1181970904902165
K-562,4578,4.401657334703153,4.126362812370862
BFTC-909,31703,-0.9928331583982526,-0.8171249868117505
Daudi,54618164,3.154466747848232,3.593243110819604
HCC1500,375860,0.1348683063529126,-0.238190609441323
MOLM-13,3385,-0.0516453787728095,3.0486138943237076
Daudi,123631,1.6174763425926726,2.1485957950236396
SW1573,6610355,4.129027118562099,4.477255613434091
K-562,44589607,2.662527895237601,2.682605315313477
SW948,24964624,1.7910099631647045,2.292960056444242
LS180,387447,-4.2321913932512185,-4.258515151828025
SW1271,445091,4.3767610709371025,4.3164645770163075
LS411N,5328940,2.1913370268343324,1.60682486289488
ALL-SIL,46199207,2.4207183231317826,2.906175481368211
BFTC-909,644241,3.062866082016443,2.199607646580049
SK-CO-1,5738263,3.1381077819263954,3.1519951663751704
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,4.685388358562176
PaTu 8902,3385,6.504553614083827,3.83099718958797
SW1271,5328940,1.739297434861375,1.7762045547447363
Daudi,444795,4.05018196872557,3.9445105670467155
SaOS-2,9887053,4.468769125876902,3.6418564870990804
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.7688784560668
MOLP-8,9936388,3.4211096692910052,-3.991114823528768
SaOS-2,5746,3.648398890023908,1.1042779292357785
PaTu 8988t,135875424,4.8815767191826325,3.7339467255514465
SaOS-2,25195348,4.111342507306749,2.8889664730072195
NCI-H1568,135398738,4.732110826035958,4.295499040300502
RKO,5329102,2.192208184281935,1.8269375634514489
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.628540497610543
WM115,11612883,3.668907379861532,2.6998682790593636
HCC1500,24785538,2.8337652504333817,1.2296821384505203
ALL-SIL,3854666,-1.067048731148745,1.5681548973021848
WM115,11494412,2.975341542339242,1.9494388387141364
Granta-519,9884685,-0.5481626961732873,0.16633254772439293
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,2.052786121103164
KU-19-19,5287620,-2.913600334543538,-1.812906498480805
HCC1500,25227462,-1.134185511373382,0.7205999544858532
SK-OV-3,9936388,2.038842599711319,-1.7166936678062574
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,4.805960420196292
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,1.7204407355814693
COR-L95,9840324,5.902997789616562,5.724652572626628
SK-OV-3,159324,5.082712026660022,2.808153421696174
COR-L105,5426,4.419968019169297,3.6836719522175962
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.4744422666235035
HuP-T3,44491742,4.372770131484514,4.2242835292652865
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-2.3975063114330517
MOLM-13,5978,-4.923441638627742,-2.573098382121523
KU-19-19,9911463,4.338553857034003,3.890990708133665
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.3646375572874048
MDST8,9956119,3.20428794924567,3.621875015040337
IGROV-1,44137675,1.8406125640672395,3.4041600139288954
NCI-H1568,24771867,2.7621066837370156,2.571719765210978
SW1573,3503,1.662872296112478,2.2726586835043405
ALL-SIL,54143018,-1.6646130342073118,-0.2854787168821276
KU-19-19,9903786,4.470072542277405,2.9307033200228965
Granta-519,67291369,2.669151289874282,1.91148553703705
HuP-T3,126941,-4.07371973001698,-2.371532814038967
IGROV-1,11175137,1.8411496230681277,2.542441264162934
LCLC-97TM1,3543504,4.4040963352609825,4.207442983191026
PaTu 8988t,10184653,1.9115764380070437,1.5341390541921107
BICR 31,10184653,-1.3652350776002238,0.8307700098548675
PaTu 8988t,4917,3.9515789700022728,3.183734329987153
LS411N,9967941,4.95978669187673,3.3212440722380676
SW948,6918837,-5.2716912634433815,-3.0722770849266436
Granta-519,19582717,3.2223711893143796,3.648178426938116
HuP-T3,753704,5.56041062328625,4.802116403136341
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,2.3278761338438336
HuP-T3,44819697,0.7007171788005963,-0.43236502866610543
Daudi,49766530,-5.535187194073846,-1.194574815810751
RKO,168313047,1.9322709085928884,1.7566157718336384
HEL,451668,-1.9900462993769088,0.7513808958228617
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.896756654051844
ALL-SIL,637858,0.2842777242368783,1.4994045244347884
SW48,375860,-0.9823609780883206,-0.3992040995698696
Granta-519,426756,3.1337304970475865,4.076415713316293
LS411N,3038522,4.360410119835835,3.0961869148142904
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.641064269719136
NCI-H2452,11626560,1.8431584922948163,1.8497063157785922
SW48,135398516,1.3232406127849534,1.8995960780647336
SW48,5329102,0.4162536894409948,1.7237295297691977
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,3.7314148399022473
BICR 22,11427553,3.133254296040306,2.6854056790669056
NCI-H2452,72376,-3.519434001557919,-1.9074372702453408
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,2.811676074509589
K-562,135984461,3.2548026411837787,3.7346337766159525
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.088461438253352
Daudi,73707398,-0.7942959168982594,1.005491789488653
NCI-H2452,46398810,2.3683678826725387,2.54123097268382
PaTu 8902,5738263,4.741832860910815,3.598660305450607
MOLP-8,10322450,4.082153801594249,3.656001127759845
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.034280764610459
SW48,5287620,-2.9796019172473747,-1.9295453463618144
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,0.8823206120038302
MOLP-8,56963564,0.2564931281605764,-0.05467841429046149
Granta-519,375860,-0.9367901929922506,-0.43714993147604164
SK-CO-1,656346,-0.6691405855346803,0.7398711312745684
RCC10RGB,44607531,1.912198544747903,1.6627942150521762
RKO,9823820,5.913042612438718,3.6219649425719336
SW1271,25262965,-0.6695626057691765,-0.8548728709873176
SaOS-2,2742550,4.001711578380083,3.920521927128047
SW948,44491742,3.910317363967626,4.342150705230865
K-562,25105715,3.3934107563871088,3.184902917785365
K-562,3689413,1.0071697658281389,-0.2710467012270096
NCI-H1568,9911830,1.3917537385715242,2.426289359614975
IGROV-1,42642645,0.3750175292659389,0.8498432951002328
MOLP-8,53392493,1.8438027475223988,2.1537470043883986
BICR 22,4788,5.9489186959823845,5.563459336586682
IGROV-1,5287620,-1.5394168430569777,-1.5363638014259582
IGROV-1,446155,3.750396425244744,2.5845493070064545
LS180,15983966,-3.417830365026362,-1.8845263175921068
MDST8,5566,3.234550965497495,2.9672916739926514
K-562,644241,-4.86229706466587,1.8955608251639964
SU-DHL-1,135421197,1.1384736779813156,1.5034170371320548
KU-19-19,44507138,1.5611189443326865,2.539277191126756
Panc 02.03,5281321,1.7682996743542674,-1.2538641806126043
SW948,44607531,1.464462944366021,1.422497710630189
KU-19-19,54649381,3.8760376098429616,3.961396734662616
Daudi,25062766,1.1734245449662122,1.8476001493571175
IGROV-1,56946209,-4.416985130578084,-3.843788117956923
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.5169426243655972
NCI-H2452,11238147,5.37150149846425,2.8495068839017206
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.273174527666883
HEL,3689413,-2.191477482826257,-0.5458771824392248
WM115,285033,-0.1832916587196474,-1.933741799637289
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.617038336446509
SU-DHL-1,426756,3.3694285311129777,4.497384554006647
WM115,135999136,1.8466122948256136,3.544703383219422
IA-LM,45279963,4.638115534107364,3.4983243567591655
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.3827831822747563
SW948,4917,3.7157271581620166,3.068537191299219
Granta-519,119182,-4.107570420442856,-1.6557600223747893
MDST8,56946209,-2.145438357732055,-3.7767718145887295
HuP-T3,9927531,4.952379772704904,4.808733997261229
RCC10RGB,72967,3.7162805539485775,3.5702064879130693
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,2.978605280917058
COR-L105,25126798,3.974391104898093,3.8016796758943574
IGROV-1,676352,2.310492141650647,2.1386164399714302
MOLM-13,11640390,3.605079146985929,2.9902287129216325
SW1271,10302451,1.5832525718610488,3.1054441219431363
HEL,123631,2.2046071754004553,2.2338888312547365
Daudi,9887053,0.4273795924431001,3.0917553353184446
HCC15,53232,1.2438342439906054,2.8770748494433276
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,1.963218617152885
MOLP-8,107970,1.7976582890286323,2.151127749336709
COR-L105,12003241,-1.8759508779616432,-1.0003376180151133
SW948,11222830,1.2602033369542562,1.5380706242676843
LS411N,60750,3.4958773713368725,-2.4245433070496407
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,3.452742087060973
COR-L95,11152667,-1.0192155235937173,-0.4190879085722942
RCC10RGB,136227924,3.611686331312014,3.051452568034638
Granta-519,46398810,1.929291860170987,2.1766941362112897
SW1271,135999136,4.614562085611917,3.7554116641636277
IGROV-1,53232,2.4872106086763393,2.990012180447371
SW1271,5329102,1.7502689549650896,2.0637517410073656
Granta-519,136227924,1.3333863896282263,2.4815649237857893
HCC15,11213558,1.313690011959325,1.6637056438474178
BICR 22,54619267,3.924840101579574,3.8635986538130136
MDST8,9907093,2.778674083883115,4.2284043625066206
P31/FUJ,11175137,-0.7372235608093404,2.545395591940129
MDST8,36314,1.6029219233562175,-1.092486273911628
PaTu 8902,2746,3.932313359375791,3.0153938365367616
P31/FUJ,3543504,4.167476980253382,4.257693907880463
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,1.9865376416117666
HCC1500,2749,1.6972528944159595,1.9228548159062084
HCC1500,2858523,2.9580940168196372,3.0632395482558
P31/FUJ,241158,2.9181679480161997,3.5915573534663325
IGROV-1,44202524,1.8303703172382677,2.2287791475746492
COR-L95,24856436,0.3013384579313291,0.6343148666062993
Daudi,15983966,-4.480185591931726,-2.6526773994527666
MDST8,9903786,2.958137426904596,2.898406069062249
SU-DHL-1,57519531,0.9649766396601452,2.281040240164794
IGROV-1,25262965,-3.18785020602057,-1.0243735748856255
MOLM-13,135411,-0.7080955458923358,0.19814538733416487
HCC15,24901704,2.315976175325417,3.253546282449331
SW1573,656346,0.5263129478884733,0.5365358343263751
SW1573,11238147,3.4967804964098517,2.773911999732474
MOLM-13,6918837,-5.322581124261525,-3.790566573718701
MOLM-13,444795,-0.8871401586886155,3.928747083472627
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.867424959417341
SW948,44486219,4.202726475674803,4.228828612324592
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,2.988144018507211
SK-HEP-1,4259181,0.3926762831937545,0.2568644396595782
MOLM-13,11152667,-8.249378694414048,-1.2051901019265805
HCC15,46199207,3.454904957256138,3.292478556770517
COR-L95,BRD-K55473186,4.076833088818027,4.0285343882931475
SK-HEP-1,11612883,3.763210558313423,2.92293307407476
SW48,54619267,2.8192087316830587,3.8625405245759925
COR-L95,448949,2.666065821382702,2.014771483300229
SW1271,31703,-2.541706035799043,-0.6356580606035345
SW48,374536,2.9137455711630365,1.7670669489732307
HuP-T3,25183872,-1.5149537087973208,-0.5412563629761723
BICR 31,71466578,6.11729815776394,4.736999097143672
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.4230135118705405
SW48,135440466,-0.9616456131279733,2.005239431680715
Granta-519,322968,2.3569390760499234,2.8219197280179777
RCC10RGB,25227462,3.0929907596871646,0.15763097685651023
P31/FUJ,6917907,-6.201167718101803,-5.477484839311496
PaTu 8988t,49793307,-2.0749757720441164,-2.5455091873687845
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,0.7302236282742678
Granta-519,12001922,1.093482575381039,1.5296084577328422
SaOS-2,54649381,4.670802712896813,3.972942929473147
BICR 31,11213558,1.307666782243681,1.6828433080154444
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,1.9997164162202155
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.585268591041011
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.5135268735112849
SW1573,216468,2.7570678542174294,2.941634191465448
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.7438995693135606
LCLC-97TM1,441298,2.906797889353979,2.5537926585232316
LS180,24753719,4.21554861148433,4.080263597281304
ALL-SIL,65064,2.797289094590348,4.407966707065145
BICR 22,67291369,2.228219380635809,2.3714538116109725
RERF-LC-MS,168313200,3.896073258981905,2.7042041725080845
SK-HEP-1,9444,4.343802313850578,4.117347261073423
PaTu 8988t,5328940,1.37213408852796,1.6035512745853533
BICR 22,5311,1.9321946929787237,1.3519307279774124
BICR 31,219104,4.339385963743166,3.7142860807009908
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,1.1281525146175748
ALL-SIL,4477,0.1906678465210559,0.4348307612020586
K-562,25154868,2.7747166739598264,4.289014765774513
SK-HEP-1,16065773,3.000790971898234,2.4551326622895577
PaTu 8902,11364421,1.1100050491651887,-1.9752577852449722
NCI-H1568,3081361,2.134244125445247,2.500636376693928
HCC1500,11640390,3.4842141291887234,3.4192965466658847
BFTC-909,11626560,2.2197507332783735,1.9505991299535421
SW948,107970,1.650733689507072,2.3075093695315947
RKN,15983966,-2.847635435689191,-1.0333178275633315
P31/FUJ,11455910,0.7543092217738059,0.9606822187806254
MDST8,71466380,4.4925072325945825,4.301256698679419
HuP-T3,44185566,3.047929926499308,2.6202554270596794
WM115,24772860,-3.130789858430774,-1.7872461300286062
COR-L95,327653,2.664763845896721,3.083710776489321
BICR 31,46398810,2.284799792972812,2.7231756988036926
MDST8,46199207,3.2831338438462545,3.275154336020718
P31/FUJ,54143018,-1.089453758548118,0.3584057894839342
RKN,119607,5.106543735080002,5.269840237636338
COR-L105,5746,2.3338049438674933,1.2692544651790438
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,-0.541077601279495
MOLM-13,5738263,2.9100103684660237,2.9897972882546107
RERF-LC-MS,216345,4.25766275770173,4.05665116200136
P31/FUJ,10322450,3.023071845081992,3.9003482689815483
BICR 22,16065773,3.2562595111068933,2.292584375813865
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.196908959717537
RCC10RGB,2858523,3.1824977664847833,3.0435157428987933
HEL,3634881,2.3660153954756,2.8123238698732775
BICR 31,4705,2.7587837218207194,2.942077209171491
Daudi,16736978,-0.1290294552432643,1.1506508314438095
HCC1500,409805,3.5957056987066407,4.72911239727918
COR-L95,11497983,3.7904455836505977,3.4334163109110407
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,3.1286489921853557
HuP-T3,123631,3.4682236131630213,2.7356928463174603
MOLM-13,6918736,-1.7098661921605196,-2.5615178885108514
MOLM-13,46943432,-0.154947866345158,1.527018973691096
HCC1500,219104,2.0821347677363473,3.4077204662894243
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.58488951164587
NCI-H1568,65064,3.2204713254113373,4.956381435320496
SW1271,16720766,0.8044088826386648,0.8223134862334036
Daudi,119607,3.8512151262400978,4.68205276007586
HCC1500,72193861,2.243893882523798,1.7311793810700598
K-562,5328940,0.7651330448756731,1.6245334285922537
SaOS-2,644241,2.5011234622868415,2.1840618007208663
HEL,60700,-1.2821695146150829,-1.0073014354747412
RERF-LC-MS,25227462,0.8140348385016122,-0.2564008077563479
COR-L95,4521392,4.944619543772989,4.312328834975218
KU-19-19,16720766,1.6427063989874335,0.586455593674093
SK-OV-3,3025944,4.375754256809385,4.091321499358951
P31/FUJ,36314,-5.221113398603202,-1.4424833735633904
Panc 02.03,568763,0.7660787595735656,0.29070715988712054
PaTu 8988t,60700,1.4149082605005396,-0.10842723810953231
BFTC-909,421610,2.763760389372973,3.073213649552733
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,2.7090660454704136
RERF-LC-MS,123631,2.7610356359897104,2.7118646531331776
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,2.7243214761694428
RKN,10385095,1.0188882527918253,1.23043103041516
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,2.2831911263463924
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.245855320364346
Daudi,44486219,3.679556481815833,3.9316366212208647
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,1.8906473924032716
P31/FUJ,159324,1.227532336429348,2.8005313036659807
SK-CO-1,6252,-1.3434891204218062,0.5321477732690992
LCLC-97TM1,656346,0.6605690440583806,0.747634273524597
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.3994580326982768
RERF-LC-MS,675434,4.646232548137413,4.423653028436321
KU-19-19,123631,3.236221278135049,2.2815286764914773
MOLM-13,15983966,-4.417403089755366,-2.858132747998714
HuP-T3,4917,3.663340719397695,3.2025394488379244
LS180,44185566,1.7571027497277631,2.1137581246397126
P31/FUJ,11228183,-0.9086595542209992,1.8002773304277073
WM115,9933475,1.7795579913266513,1.8852876219518626
RCC10RGB,445643,3.986839371383198,3.9492361388907664
LS180,11238147,1.5426585727528574,2.4932371670577256
SK-OV-3,6918328,0.3966751205296329,-0.02206988325195591
SU-DHL-1,71466578,4.395132834723917,3.595757427958788
ALL-SIL,135421197,0.8278001934093618,1.7963831844418439
BICR 31,2858523,3.440938149330432,3.010544465384152
NCI-H1568,72734382,4.159676082420196,4.658873836825632
BICR 31,10427712,4.26091650049326,4.241828086155229
K-562,5351362,1.2059406782397044,1.273515550464509
HEL,44589607,2.8579344181758164,2.528307976405426
RERF-LC-MS,89928392,3.2509495975064193,1.3497083860980774
K-562,4705,3.481256778033869,3.22856252348346
SW948,400769,-0.4902020150535968,-0.7186650430297719
RKO,46199207,3.448070090368443,3.050215809271849
HuP-T3,10410894,4.484643398072658,3.234435293402196
BICR 31,969516,3.644181632779252,2.7912726115101276
WM115,54618771,0.9043395114740442,1.6092909006565166
MDST8,2749,2.5181508528519365,2.1290856800493434
SW1271,4378219,1.9495591217614856,2.3132821250952684
RERF-LC-MS,12003241,-0.3897829713203344,-1.0943919248581644
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,3.4357499464256183
PaTu 8902,44620216,3.796821774118314,4.037055932258477
MOLP-8,4378219,3.751203523477959,2.0742584374488455
PaTu 8988t,11152667,-0.7220641758089987,-0.083806892334565
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-0.9953239883454045
SK-OV-3,60700,0.4435128165358443,-0.5179595918631867
LS180,168313047,2.515878081381246,2.1720193612161887
K-562,400769,-0.7978860959413716,-0.5999124453941425
Panc 02.03,126941,-0.7071805078882285,-2.6221893432273804
NCI-H1568,3634881,3.2529386900783024,3.1087651617275975
LCLC-97TM1,24821094,3.5658031163211996,2.9365418542818333
LS411N,11485656,1.6093796612349578,1.8854799753657396
HCC15,16736978,2.153897232237977,1.6204906752446737
LCLC-97TM1,6610355,3.6494140877324273,4.437903785229978
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,2.048202060210491
IGROV-1,9911830,1.9130562323799436,2.416040327768969
LS411N,159324,3.2133975478450005,2.4808172258862173
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.1757409333269555
SaOS-2,322968,3.970591848140582,3.288067048005778
BICR 31,216345,4.54975912567895,4.012324312485032
HEL,3825829,3.033394475732853,3.6540594783986893
COR-L105,46191454,3.4168297701439223,2.0640994907982306
K-562,5113032,4.649240406472478,4.972429632545837
BICR 22,156414,1.4774483319728589,1.3411314950247928
SW1573,135875424,1.8143158468632437,3.9659283772347287
WM115,12003241,-3.303596686294694,-0.7439061812478411
RKN,11640390,3.613472996393559,3.548263721188125
HEL,23725625,2.914554844202699,4.557421729628091
COR-L95,36462,-0.8944975018350346,1.8731974385416084
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,2.9569697226869347
HuP-T3,11977753,3.281021154274905,-1.8226397516687198
SK-HEP-1,400769,0.2777482831309371,-0.35384472155811486
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.3484665672502296
SU-DHL-1,246676,5.693727803678488,4.31717209521084
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,1.8955310286295413
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.0771625045694546
RCC10RGB,44507138,4.147954700367582,2.596246407117724
LS411N,123631,3.048490743589503,2.2131237123911656
MOLM-13,11213558,-2.3442824820578347,1.181105158102593
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,3.0294449159245262
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.4355305044215947
PaTu 8988t,444795,4.288290341819835,4.4507558407227705
SK-CO-1,66577038,1.9378658470267984,3.0219830742847518
SW48,24771867,-3.897611921368264,1.401275867864411
NCI-H2452,9907093,3.826391051371518,4.241808782937291
SW1271,171352865,2.2565348875691624,3.0333458988713056
SU-DHL-1,11152667,-1.9410189761528236,-1.0082740551134373
SK-HEP-1,148124,3.734435411699081,-1.3973948400932767
RERF-LC-MS,107985,-3.0933260647006215,-3.770018332701282
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,2.8929961700275286
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-1.123305262770264
RCC10RGB,10184653,2.2305820416370965,1.575469956513599
LS411N,17755052,2.4732315703899226,1.65940903703415
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,0.5156686227250462
KU-19-19,24753719,4.40371401160258,4.37879771202816
PaTu 8902,72376,-1.694582331183855,-1.9776209346583737
HEL,72376,-3.0304513894944933,-2.334531859477069
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.340276968867708
SW948,9884685,3.1398548031465525,0.4406778395588154
Daudi,24748573,1.578133478161721,1.6151379992091353
COR-L95,4917,3.3160135329409406,3.0315384844003987
SK-CO-1,2708,2.7526164010571152,4.798046190908248
Daudi,5479543,1.606221989903471,3.422071529427578
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,0.869115019617637
MOLP-8,44632017,0.8356757219547752,0.8666809632476723
SW1271,9868037,2.9396003878324857,3.0707395315958776
COR-L95,11455910,1.0154509596480157,0.9445273907642037
IGROV-1,445091,5.8777802446160825,4.304299149345277
IA-LM,107970,1.9308025720075177,2.5101021284209435
BICR 31,15953870,5.115358479555731,3.507426082482
HEL,135984461,1.7610482730169696,3.2462559968687095
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,3.067412850563448
PaTu 8988t,5311,3.6038975682992422,1.4475212709406278
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-1.3219680964122196
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.5859710679771113
SK-CO-1,11228183,0.9546983133897222,2.2454203374849078
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.5934037845038944
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.4172433696995883
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.7014211034124567
BICR 22,42642645,1.569820729256039,0.9547799924849588
RERF-LC-MS,387447,-4.351660250848144,-4.003028424468024
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,1.904049843729486
RKO,676352,2.3070338313311547,2.0174192538098903
HEL,66577038,3.4935326109734217,2.85201237571665
RERF-LC-MS,25062766,1.7296886540377192,1.866718472850331
RKN,52947716,-5.912196482956353,-0.8628208253316545
SW48,56973724,0.919295357428288,2.4601609064045817
LS180,66577038,2.8527700320727725,3.004622704259885
K-562,7251185,2.894408284149289,2.424865880440207
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,-0.07770423642004996
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.9323866726108969
MOLM-13,6918878,-0.6248914400619264,1.567903937648744
IGROV-1,135421197,1.96820638017286,1.8286060568747664
RKN,11404337,0.6786980557761386,-0.281376067303222
SU-DHL-1,6918878,1.5556600104975795,1.9041484230435832
MOLM-13,176870,1.4073018577806429,2.6540907686174156
SaOS-2,44566777,0.9896093397626105,0.7671345815873193
COR-L105,5470400,0.2171168006478052,-0.3506658353977018
LS180,44632017,0.4358481157568056,0.9017273145504227
RCC10RGB,16065773,4.176477311044804,2.4006409196133403
BICR 31,156414,0.5699919561712937,1.1499065109226774
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,-0.7436550107361899
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,0.9661604083317096
Daudi,54596490,4.948926549609605,4.472308729158445
NCI-H2452,11317348,1.7824301660124695,3.1341659947607514
IGROV-1,60700,0.4424479122017752,-0.3353471260625623
IA-LM,135421197,2.370501142960713,2.028377282403148
NCI-H2452,135423438,1.816833708086427,2.616139290253921
NCI-H2452,6918837,-2.3246752526945413,-2.442742023455091
HuP-T3,409805,5.703463345532586,4.984337759231637
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,0.5998623748933527
WM115,3025944,4.015069634557516,4.2475916240920455
BICR 22,10127622,2.812639951672956,3.4796093687084952
RCC10RGB,16741245,4.755009504271123,3.8108714262346997
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,0.5821084945798927
BFTC-909,1641662,3.805506520632872,3.4717177272359994
SK-HEP-1,3136844,5.506062707172487,4.338036595313426
MOLM-13,5335621,3.915836728943439,4.235379011298296
ALL-SIL,6918736,-2.784980550106597,-2.0306049477660606
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,2.321389373403238
SK-OV-3,5311,1.582209129738937,1.4430839613407278
NCI-H1568,4378219,1.8995328874154,2.4239245838539967
PaTu 8988t,135440466,2.5529183901912456,2.2075677103781435
P31/FUJ,208908,3.0114989034455415,2.1518493026739445
MOLM-13,55508,1.530825081139479,2.7418281489624987
ALL-SIL,15983966,-4.919474478826657,-1.561752898673463
ALL-SIL,72193861,-0.8088702984298154,0.9066644915734815
Granta-519,135875424,2.983761714085865,3.5389746512681968
Panc 02.03,25062766,3.7424097220448207,2.2743863181135406
LS411N,5282054,4.11513360382112,3.633830902995556
WM115,9956119,3.8110537513046423,3.4304470552273627
Daudi,10077130,1.7104594990439606,2.7407029991758547
PaTu 8902,54618771,-1.3103145579416535,1.1309477483614219
LS411N,6610355,5.174673905344729,4.343958099452204
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.444541430021103
Daudi,11364421,-5.814557541528941,-3.1794163865800176
SW48,10090485,5.377611493091081,3.974692749637689
RERF-LC-MS,252682,6.464777279315186,6.449119754288052
RERF-LC-MS,25195348,2.310586589861769,3.315792439499013
LS411N,57330099,4.386912904802011,3.9281711173377953
RERF-LC-MS,5351362,3.2669953777859493,1.4157020683999102
SaOS-2,5281321,-2.1045144226453134,-1.2327970679936875
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-0.7981969298730737
HCC1500,15953870,3.698430879415157,3.4756853310793576
BICR 31,107985,-2.559614665868775,-3.514351654238037
SU-DHL-1,5978,-4.006589870739168,-3.1072037921702833
SK-HEP-1,387447,-3.995016034956776,-4.015389662564121
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,2.801787370935977
BICR 22,44491742,3.912327775797625,4.132409823287305
NCI-H2452,10113978,2.1292579793865167,3.277392189293674
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,1.8474914943523664
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,0.9798233260656991
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,1.000343573938381
PaTu 8988t,10074640,3.912219918984309,3.2210782578693458
RKO,25102847,3.0524897378806033,2.0756421951566866
K-562,446155,2.553560117982406,2.9306167240285803
HuP-T3,3062316,-3.5835263694309862,0.993464444709071
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,3.187311125256196
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,2.1852157892004587
COR-L105,9915743,-1.8659407955600968,1.0283679279628912
SU-DHL-1,676352,1.6127382742380425,2.0199678966837387
SK-CO-1,15983966,-2.8914318783251733,-2.0586023584562456
BFTC-909,6450551,3.0302116860685886,2.7631734512695094
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.9154527864663455
LCLC-97TM1,6852167,1.822160840349085,2.8509337928173153
K-562,1716436,3.607306146681396,3.0088411102369874
ALL-SIL,6917907,-6.413711962559719,-5.141314227411913
SW48,44505237,4.455085659285412,2.3020425091752004
MOLP-8,4788,5.509648062033256,5.34871517261106
KU-19-19,49793307,-2.3409308252506777,-2.446713375853415
IGROV-1,46843906,3.392503571349757,3.0017990367376997
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.782919285739722
NCI-H1568,23582824,0.2708211860244319,0.9075234514811505
P31/FUJ,156414,0.8249508749632878,1.2238616961591737
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.708561160671233
Panc 02.03,24951314,2.3006835537528585,1.54317606584663
RERF-LC-MS,46199207,3.61094494328213,3.083089126822968
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-4.35731035283388
IGROV-1,25102847,1.7007012555618253,2.512084867394025
COR-L95,9884685,1.274087436172542,0.21852421043241105
RKO,5738263,3.4166283525852523,3.297316835787169
BICR 31,446155,3.004688823756655,2.539603639263493
MOLP-8,3081361,3.002632255231731,2.0318561784909672
KU-19-19,124202324,2.2262797687523266,2.5837606754891635
COR-L95,241158,4.468160037389037,3.734258087387806
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,3.0486103668221336
SK-OV-3,9926054,2.1800400954819716,2.113341311259379
NCI-H2452,285033,-1.1649166052412432,-1.8090280628555926
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-1.1242080907583611
SaOS-2,3136844,3.967600163436525,4.055210614374564
Granta-519,36462,-1.2340392932323463,1.3755482862190531
Granta-519,24785538,0.1958729752370936,0.7663756792147346
WM115,5566,2.8846390038255127,2.7146769068814733
IGROV-1,31703,-1.792518264692263,-0.5878299217314218
HCC1500,3025986,-0.5847488606379614,-0.9301319542338574
K-562,2828334,5.968313970587813,6.030050091085108
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-1.1127180867120607
LS411N,72193861,2.8187845663214848,1.3767491485248837
SU-DHL-6,11964036,-0.1529025297927845,1.1663353915673826
LS180,6918837,-2.789669873343886,-3.1966148668044467
Granta-519,445455,5.050402748491994,4.396137010846955
LS411N,9926054,1.9376785020428349,1.8759601869213305
MOLM-13,135398738,2.371405234005272,3.0169591100147386
BICR 22,53392493,3.288173891171126,2.5122149891593413
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.5812258617489592
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.550898799891721
MOLP-8,9823820,3.862667538801475,3.428611639605143
SW948,219104,3.4463785749905886,3.73510586800818
Daudi,56649450,2.7731175257265757,2.796094481789794
RKO,446155,4.170579555483674,2.632467950366851
COR-L95,2708,4.088828930735336,4.54502121548618
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,2.5382471479318025
SW948,6610216,4.184431800680971,4.321018464286599
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,0.812264928422196
MDST8,24978538,-1.5034064763640302,1.1159073304079656
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.770370248119908
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,0.6273269275674643
RERF-LC-MS,44607531,1.5104561529736475,1.3918909676897595
MDST8,16065773,2.461320056751215,2.422634841353162
Daudi,11955716,-2.451420398730992,-1.238467245422457
Daudi,44566777,-1.3909109996970672,0.18983919463941112
WM115,53495165,2.3633352174150155,0.2510207926934359
MOLM-13,10077130,2.656845569256352,2.686763484342586
LCLC-97TM1,11364421,-5.841421445385269,-1.034257310148632
MOLM-13,9887053,0.5396890830211841,3.1020605295554957
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.0672903892733525
IGROV-1,46191454,1.3777495915525844,1.5417409034027687
Granta-519,5328940,0.7430401080732436,1.6265237210966321
SW1271,54618305,4.440463475812739,4.306854239911515
COR-L95,23725625,3.551891881441416,4.792471958341142
RCC10RGB,46843906,4.246883034106686,2.9344640080423767
Granta-519,2945648,2.528276278220214,2.602025577372931
Granta-519,11977753,-6.302388202708452,-2.379301958141313
SU-DHL-6,15953870,2.4587311871536315,3.353015834894953
MOLM-13,10322450,2.9930800125873045,3.6348815150619562
LCLC-97TM1,6505803,0.2281876141434561,-0.7087063228324304
WM115,9967941,2.88500943866673,3.580116627650475
K-562,44202524,1.302888790519651,1.9593541262219814
K-562,252682,6.220409267483573,6.433623993248534
HCC15,49867926,4.259454552862098,4.282249931426658
BICR 22,25183872,-0.1596442578279089,-0.8915884756474844
RKO,17755052,3.988455753476612,1.6589814784854608
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,2.8422225120689983
PaTu 8988t,5566,2.9380975134161553,3.0941274891326573
K-562,219104,3.3686951285077273,3.2952573310588025
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,4.342431531942555
WM115,100016,7.477930972064711,6.170996787737531
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,1.9749163893829005
SU-DHL-6,46191454,-0.3846699961999978,0.897284602053129
LS180,124202324,2.088899784140079,1.986646075302724
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,0.9116592671844832
K-562,4261,1.1039684536741017,1.3926699251499621
NCI-H2452,5282054,2.993265650723398,3.8143515140797906
MOLP-8,168312962,1.5743557083321402,1.269363255401982
Granta-519,969516,1.9567849087702365,2.580188462122933
NCI-H1568,25062766,1.9660972036535989,1.9751847856258746
MOLM-13,448949,-0.3738099635599754,1.5766648374125969
SW48,11647372,-0.0986138935854908,0.8942867451889609
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,2.7415298953367437
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.483470265302964
RERF-LC-MS,11977753,-0.575574044510787,-1.8285417341863819
LS180,49793307,-3.6014942577594415,-3.4031986465268913
SW948,3854666,3.050289300885683,2.321439628049797
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.0307211513325534
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,1.6894841621580634
WM115,5278396,3.4301399168519153,3.560819213825353
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,1.8608264827367125
HCC1500,11485656,2.6610961572019103,2.3572386692293033
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,0.10177139767863902
Daudi,2945648,2.1407869976239087,2.4677822689583073
MOLM-13,3689413,-2.8005667715254017,-1.1003935787381562
RKN,3543504,4.234888347098623,4.5432640865098435
IGROV-1,24964624,0.5052308994941754,2.0633374888682865
PaTu 8988t,676352,1.787056590779638,2.1662437368623992
RERF-LC-MS,10385095,0.7812016081678173,1.2237052071988372
WM115,4259181,1.0090630393378868,0.07219059223117846
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-2.0670726829639716
SaOS-2,1239801,5.3522865443092575,3.7856679870698313
Granta-519,44137675,2.975150065736677,2.9857622230157546
Daudi,11455910,-1.173613913103254,0.7288981802179086
UACC-812,11152667,2.562952126743398,-0.3059687868472036
SaOS-2,16219061,3.147835700454569,3.0737386259999813
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,3.103645867039727
SaOS-2,71304818,3.198114510015862,2.466694379393333
IGROV-1,57330099,4.391385744785918,3.8950738031264063
LCLC-97TM1,2729026,2.4668071198749555,2.650465216687976
HCC1500,5281672,4.190998095776345,4.268157133674948
NCI-H1568,9884685,-0.6579514975056241,0.729858855370934
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.5829078590458256
LS411N,107985,-2.091782559178726,-3.5784951944714085
COR-L95,42642645,0.7279572059378924,0.7475710209956711
LS180,5566,2.7460265721966897,2.865755508729923
COR-L95,104842,-6.859012992539376,-3.604267114944235
K-562,702558,5.364922414830515,4.9306069521464035
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.4106176849152339
LCLC-97TM1,9929138,5.774162864206733,5.553791712236009
LS411N,31703,0.7183186901084707,-1.0761581386123589
WM115,23725625,4.964211357698685,4.779709484848558
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.2880064401078384
SaOS-2,24978538,2.44958290959275,1.1183924049125167
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.6544183694824945
PaTu 8902,2858523,3.3217981805434196,3.1879861639801095
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.1767447246936875
SW48,65628,3.988389614478155,4.166440412755897
Granta-519,9903786,1.2937892753152922,2.5020381643381224
IGROV-1,71304818,2.4878074097553378,2.336862131463908
COR-L95,25105715,3.673741872436949,3.465515776821312
HuP-T3,6918837,-1.8626358392084263,-2.640885984082303
PaTu 8988t,72376,-1.956580109455481,-1.7843577669897335
NCI-H2452,46907787,3.091101876271566,2.2310026894770685
SW948,23725625,5.544404993552476,4.935850722195896
K-562,25062766,2.5223735702376753,1.8178569238533597
SaOS-2,753704,5.53840358060444,4.728578649214339
NCI-H2452,56973724,2.8465784993073564,3.229920254428687
Granta-519,71466578,4.383489061930637,3.8867649614949134
SW948,11609586,2.9863433458317714,2.7138289512650577
HEL,71466445,1.5745300131733593,2.5258729803895004
Daudi,5329102,1.2784768117884069,1.7973789819619614
HCC15,409805,6.461768980239098,4.858485097648424
Daudi,2871966,-2.2343916463272873,0.29419986003316245
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,2.953197747746489
RERF-LC-MS,135421197,1.554065103888189,1.7051884363853682
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,3.208460192278467
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,2.143387598598259
PaTu 8988t,25150857,2.5954794764360343,2.4465329795346658
P31/FUJ,11152667,-2.5755274762926095,-0.8201042022507508
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.78420330445083
BICR 31,2828334,6.263113325647995,6.143416247381957
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.5501601039712471
IGROV-1,11507802,1.5049911819213722,1.2593548001627175
Daudi,11485656,1.7254760898020216,2.0398178663215236
Granta-519,11152667,-3.975154363660797,-1.0202837335004495
SW48,11640390,-0.422464249163724,3.4658680161541082
IA-LM,2828334,6.3387056990337705,6.110228650807959
HEL,36462,0.8349109175120154,1.172374273942344
LS411N,4477,1.0450277541726452,0.6246186852805234
NCI-H2452,16219061,3.733701707144141,3.134023983650626
RKO,16741245,1.399079485469943,3.759156727458635
NCI-H1568,445455,4.330931204553833,4.6122628894252236
K-562,15983966,-4.450185495623787,-2.549481011497817
HCC1500,4096211,2.7054358198440345,2.0485314685103244
SU-DHL-1,46191454,-0.3713761809994262,1.0160783022604158
IGROV-1,387447,-3.9508602289798658,-3.960830085793881
NCI-H1568,71751553,3.6437596116554887,4.567183015879848
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.3447081998702033
WM115,46199207,3.650123600055899,3.045342952684463
SaOS-2,71680916,4.865393442781168,4.68661459829422
COR-L95,9823820,4.611798945344124,3.975041878192641
HuP-T3,44589607,2.433680498088492,2.916165392102179
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.0042875232110957
IGROV-1,3634881,2.769147818550815,3.2807591669426643
COR-L105,54626689,5.0742986339862926,4.543152713949535
HEL,176870,2.3693727744318887,2.852078042293278
LCLC-97TM1,9549297,2.332709006301325,2.212408010509888
COR-L105,24180125,3.5925931777332676,2.9969707885577463
MOLP-8,89928392,0.1045876418070581,0.840658089098532
BICR 22,3025986,-2.8899356497226756,-0.9844382564398602
ALL-SIL,400769,-0.758162988868875,-1.2737646192880165
BFTC-909,71466380,5.267829049221599,4.309140915179783
MOLM-13,24951314,-0.2336633009541456,0.6199378105444135
MOLP-8,3038522,2.029025514425164,2.9189107527175384
RKN,16741245,1.555254881894904,3.5639884116873044
COR-L105,71751553,4.255827287979035,4.548855778931292
MOLP-8,60750,-8.573260651984995,-3.655010496144561
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.4830669333599846
BICR 22,24772860,-1.3590035600374548,-2.1507890105445737
LCLC-97TM1,5470400,0.2889153362640624,0.04840848413534516
BICR 31,53232,3.653430995715962,2.710932122361715
BICR 31,8515,4.104799625743522,3.961647438477001
COR-L105,10127622,2.236200578684094,3.303065400375441
NCI-H1568,5328940,0.3466597705312412,1.7424779159741015
MOLP-8,135421197,1.7506124789909805,1.6255324476779784
SW1573,54454,1.176648172779268,2.55970935584963
NCI-H2452,11964036,2.1879069513719087,1.505423274619987
MOLM-13,44493528,3.9608078939228175,4.085671387773243
SK-HEP-1,11396600,5.84824704867975,3.795560495565401
WM115,46215462,1.6800224060395437,1.9268319653537997
Granta-519,23939,5.101725753715152,3.603574797363726
BICR 22,46907787,3.4905986586009843,1.6865898924387497
HEL,10184653,1.0835446596032057,0.8873571263294964
LS411N,9903786,3.6806866285220017,2.662327497507232
SW48,9840324,6.311735261945371,5.70159969125416
HCC15,24753719,5.171121417544096,4.296651466199491
SW948,11507802,1.163064588903486,1.5998162039526698
COR-L105,2733487,7.427108299628283,6.340327426062117
SaOS-2,439501,-2.8243657156627724,-2.3761160542927144
UACC-812,5287969,-2.4803922230812527,-1.6430500212643744
Granta-519,66577038,2.6663435544296346,2.997582019523273
RERF-LC-MS,6918837,-3.051376318733669,-2.549408941767817
NCI-H1568,11152667,-1.392140833696634,-0.4891138172797574
KU-19-19,49850262,4.263742487880845,3.5073919966255023
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,2.069953312152705
SaOS-2,156414,1.509432711545826,1.4519715811495366
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-1.1458932602476382
Granta-519,216468,0.2159572219264565,2.148119021204248
P31/FUJ,3136844,4.357504973194935,4.22439388571096
MOLP-8,6918638,-1.572747132532541,0.19708233221706956
LS411N,445643,4.311506480272609,4.018969108187167
MOLM-13,25126798,1.909946064109967,3.5540615014962618
BICR 22,9927531,5.395078942533075,4.539900604599278
SU-DHL-6,3385,2.96945431954736,3.3385493175840706
SW948,49766530,-0.6875988061214425,-0.4205647397024871
MOLP-8,5287620,-5.023262566828496,-2.198631016875638
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.0114542157011142
SW1271,5746,1.8306286254207629,1.1281702351614513
SU-DHL-1,4788,5.095368657375766,5.4927975937843465
UACC-812,44607531,-0.3950460021726514,1.5910724919225427
SK-CO-1,10074640,3.0297361304753143,3.24578312271364
IGROV-1,65064,4.920352624378345,4.80172601574533
P31/FUJ,9444,3.558733501871851,4.031453860360489
MOLP-8,16722836,0.6223558214261112,1.239213578227821
LCLC-97TM1,11647372,-0.3650454903758569,0.9314960053925294
COR-L95,9911463,4.18924595414168,3.7574080361858244
MOLM-13,3634881,2.324290549736021,2.7839927461669367
IGROV-1,1242560,3.902441161940491,3.5152837013387925
LS411N,702558,5.325144902608101,5.070438688132611
MOLM-13,969516,1.839627080728713,2.5520370718808025
IGROV-1,50905018,6.092412272559071,3.9893354927786437
SaOS-2,5311,1.6246857228566176,1.2683593272691303
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-1.9814042280482236
BICR 31,11178236,-3.7191700347439176,-3.3241576259018957
IGROV-1,16736978,0.1982875499977011,1.656364228852122
HEL,54613361,-1.063581606127445,-0.7071743686604015
LS411N,409805,5.900990799691521,4.988021179407284
RKN,44819697,0.8547407464301948,-0.8592118025480137
SaOS-2,7326481,3.920515261577408,3.0682492657928617
HCC15,135411,0.5020362424433897,0.8601977143051339
SW1271,135875424,3.8663800475620542,3.922853113700664
SW948,5281321,-2.986965028390854,-1.3785907334363925
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,-1.032780331275485
ALL-SIL,16722836,0.4684239096852854,1.0114760630796364
BICR 22,3384730,2.588423009806214,2.2227603490556787
SU-DHL-1,5282054,2.781862093779865,3.3049342448696093
COR-L105,10385095,2.1444085139831643,1.2210680988012776
Panc 02.03,409805,5.9877775932277615,4.848035493297044
RERF-LC-MS,11707110,3.327368501952155,0.5123657625811585
Daudi,46199207,1.9328464692742409,2.962096684953206
SK-HEP-1,9907093,4.5474965014619455,4.148211727181319
NCI-H2452,6918736,-2.096990091914002,-1.2915857887233404
SW948,25062766,2.473025838261029,1.9825017432409202
SW1573,73707398,2.4757839790774123,1.4304521921740314
WM115,19582717,5.070140237856123,3.9586986230720447
LCLC-97TM1,9926054,1.7367616025320842,1.8839634393120843
Granta-519,46907787,0.1510211143130647,1.0639602610331216
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.375368125422202
Daudi,9866186,0.2429325896096028,0.5579211483001696
HCC15,19582717,3.4575202036464665,4.214771420586759
BICR 22,3136844,4.306912771504561,4.149286957944153
PaTu 8988t,15983966,3.5024124287376477,-0.6891836012782967
WM115,24964624,1.5810045411950775,2.367879730129593
Daudi,5335621,3.7832010435602568,4.285284591265989
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.6131258474759096
HCC1500,67156097,1.177976655162538,-1.073873789657658
LS180,6918878,3.4964027843545775,1.8939596351652255
MOLP-8,4096211,1.580191863417666,1.6022225015620517
P31/FUJ,6252,0.489412050489878,0.8292184831754069
RERF-LC-MS,6505803,-0.6931241555509828,-0.9102534600923086
IGROV-1,24821094,1.720998716331183,2.664253236832104
BICR 31,5311,2.2783252682939876,1.5347017022119622
K-562,6438330,2.2742899368871123,1.8204447813038809
HCC15,71466578,3.4480874510133708,4.651137063387122
RKO,5566,3.2270609816668308,2.866377266268019
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,1.680483804526012
Panc 02.03,24785538,2.724480470289088,1.2802959769711575
Granta-519,3025986,-4.58955813375105,-1.2149627810567014
BICR 22,6918837,-3.531862368916405,-2.854483424938629
MDST8,25262965,-2.668035259531665,-1.272894098658591
IA-LM,5329102,2.7310604185474654,2.0832035867388954
SK-HEP-1,3385,5.476337571299632,4.219306593737564
LS180,16722836,2.063998190370722,1.5468827589524095
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-0.77247292088586
LS180,2749,2.025296960861402,1.635010363293604
WM115,25262965,-0.2525217612691299,-1.2493420505900985
PaTu 8988t,5287620,-2.232870102756846,-1.6184633967663484
BICR 22,1641662,3.554805763515046,3.5114916360824693
HEL,11152667,-1.5416892011653274,-1.1507939638085694
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-1.1559906301841933
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,3.5965870752223155
Granta-519,9907093,4.568904425758597,3.893259810103582
HuP-T3,56946209,-4.563482636842077,-4.054886733526791
COR-L95,2126,5.99033959567007,4.544490888549303
WM115,216239,1.6966934324307903,2.2679118056114342
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,3.054290988503033
BICR 31,6918837,-2.993188010662521,-2.7300547916708306
WM115,3676137,5.1484929308777225,4.505194697660814
COR-L105,5113032,4.587192003158758,4.972804139960101
NCI-H2452,23635314,-2.1133256000938596,-1.1813942836232345
RKN,9887053,4.324470541002337,3.800302468233953
RCC10RGB,11427553,3.4421917630858387,3.0577576094689407
SK-HEP-1,3025944,4.243935374614092,4.259296459409565
HEL,613753,3.431831043675297,3.1422725175439994
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.1636171828236315
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,0.894177275719073
WM115,6450551,3.3231751041078086,2.258526505874139
LS180,11178236,-2.7486494175863703,-3.38633191375086
SU-DHL-1,53232,0.8595699071174782,2.6843114399114345
LCLC-97TM1,2742550,3.525188493197443,3.728482606593729
Daudi,1716436,1.8661291896859675,2.801169446200434
SK-OV-3,11964036,1.753508425012185,1.3032413187408032
LS411N,10385095,1.4098978051841675,1.20216519421567
P31/FUJ,54613361,-1.6350280742113157,-0.07940923899778968
SU-DHL-1,638278,2.888532213305057,2.752831071782598
SW48,11228183,0.7765992306729816,1.8619265029189263
Daudi,54596558,3.73872893191344,4.228122225239639
IGROV-1,44543605,3.88270235241076,4.129234415487786
SK-OV-3,16722836,0.9083609759186712,1.6103566423105824
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,2.712337654509912
P31/FUJ,168313047,1.7496121138347704,2.2013953118587617
RCC10RGB,969516,5.025939213907113,2.9448412625833997
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-0.9797374678370577
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,1.9914424020244266
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,2.0124416309610362
LS180,11507802,1.428529607587261,1.248037670204204
SW1271,2746,3.8382249001906814,3.124500111494925
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.8630190263775616
SW48,6918328,-0.3603149144304291,-0.3015764566295529
RKN,11214940,-1.342915177510304,1.6987216081851948
NCI-H1568,24180719,2.911739165396745,3.6936145974004364
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.444099102225196
K-562,11234052,2.2960989815513013,3.9318359896134307
SU-DHL-1,107970,1.234326472603969,2.148792506355785
RERF-LC-MS,5280436,-0.2566098032119844,3.0298668402951865
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.211708765517749
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.4509906575950606
WM115,6184667,1.9705044508079528,2.9344465954103294
P31/FUJ,26596,-2.2448149587984836,-1.4281909087381712
RCC10RGB,216345,4.504390062805713,3.9365052025453475
WM115,3634881,2.5774509186458183,3.037915101875027
COR-L105,5328940,1.3778120925573558,1.5772956057746048
NCI-H2452,135440466,3.051805385291023,2.2542719207256945
P31/FUJ,51039095,1.7212337572708742,2.7839470032439504
Daudi,135398738,3.444692827115736,3.217986286505999
MDST8,753704,4.923832713886697,4.75754254773725
Granta-519,23725625,1.8582588361990624,4.406070826887403
IGROV-1,6438330,2.7487580937365683,2.2146220333292503
BFTC-909,51037431,4.63288955594681,3.190372130385688
LS411N,262093,3.2594677855419456,2.963137286226523
Daudi,12001922,0.8334324910861088,1.4894772466955326
LS411N,10074640,3.3220574057236876,3.0795572987782496
COR-L105,6438330,3.2365890454650867,2.194511522044163
LS180,3689413,1.3392854552239355,-0.28400490915190074
IGROV-1,53495165,1.3981720287668329,0.04433620502010572
RKO,10296883,4.075814636405189,3.5376038432899453
MOLP-8,24951314,0.5243645664323562,0.6359879973202315
IGROV-1,25126798,3.9275606774720817,3.6119106949581776
BFTC-909,5281321,-1.6266730162675118,-1.112982050411819
MOLP-8,123631,3.0356710048833446,2.2437933800966237
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,1.964467530324745
PaTu 8988t,72193861,1.5880501840541692,1.7536279373641688
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,1.545290510964768
MOLP-8,2742550,3.824247044326815,3.493867012118555
BICR 31,10074640,3.67367044204876,2.928113108718755
UACC-812,1750826,-1.5614417963348088,-1.6596153815683419
LS180,9907093,4.718701288752834,3.8685837688969182
BICR 22,25062766,1.615874512669176,1.8939706918801154
NCI-H2452,6852167,1.5258165813873172,3.0738823243542455
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.760711989010965
PaTu 8988t,52912189,2.515835026596807,2.2207150955392514
KU-19-19,9935249,4.318045076797651,3.180468089893432
KU-19-19,57330099,3.159149106170822,4.0787810467430345
SK-OV-3,17755052,2.097752569372091,1.209150887702568
SK-OV-3,73707386,3.7899266428434233,2.9259665572993505
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,0.7143338319337803
SK-HEP-1,216239,1.5998975447874937,2.5040430703961487
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-4.110833486433266
RKO,3689413,3.093382349703003,-0.3213004888751743
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,1.1455167487627522
K-562,44819697,-0.9868024060185686,-0.7361691557838924
LS411N,322968,4.732979049951269,3.2628085627099312
RCC10RGB,3689413,-2.0864832427963336,-0.3241023190936067
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,4.187310234837528
COR-L105,409805,5.8843358134901775,4.957670730770618
ALL-SIL,11404337,-1.8413362349398936,-1.1511964208510939
Granta-519,135398738,2.4818536310203587,3.6399654964728523
IGROV-1,10385095,1.0670946713416192,1.4404906277243188
KU-19-19,5311,0.9327005340349652,1.3896797204560267
MOLP-8,6438330,1.5207659246126146,1.5002921505897873
SW948,5351362,1.282672018702937,1.430877378488421
HuP-T3,54626689,4.821166418142214,4.57530791191347
HuP-T3,16013152,4.473149012747972,4.125238842990627
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,0.516246664215122
RKN,67156097,-0.5718675734992968,-0.9151187465658809
IA-LM,241158,3.7495123409873528,3.815239883524472
LCLC-97TM1,644241,3.02487415997038,2.0955769430691724
NCI-H2452,9823820,3.552631474664052,4.06062071935565
BFTC-909,2749,2.0212973698927184,2.030173469971814
Daudi,9956119,3.1347708383856827,3.4776021340086483
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.6877747233924254
ALL-SIL,136227924,2.439460537978413,2.5999016904933994
HEL,44507138,3.4784823626806296,2.276047053852436
Panc 02.03,3634881,5.203302993958793,3.254258997390919
HCC15,3038522,3.407637609998807,3.077490743656924
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,1.0394329330497885
SU-DHL-1,5311,0.6388765020007606,1.2083244215430866
RKN,16038120,2.2721636156695357,0.9491356626176759
Daudi,6917907,-7.619939635694887,-4.828149546553406
MOLP-8,3385,2.1758430637220334,3.167382034380935
COR-L95,2749,1.0184502693195283,1.9739490233965324
BICR 22,56946209,-6.158851096198738,-4.059725604993025
SU-DHL-6,72193861,0.720057034069739,0.9864269971637101
RCC10RGB,122327,5.581829763733156,4.573933819084588
Daudi,5284329,2.65655795986699,2.9665047241304707
WM115,72376,-0.2019485443349478,-1.8962187016852254
HCC1500,4378219,1.8377088226049565,2.191479437064055
SK-CO-1,246676,3.87632071272349,4.487563871640425
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-2.521037087120546
IGROV-1,57519531,2.639098862164858,2.641909888858197
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,2.020500148565403
MOLM-13,1714884,4.557672503718371,2.939420568631722
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,0.38165442681474593
Granta-519,72193861,-0.9369484536210768,1.0383609233395183
RKO,5311,2.326095881991792,1.0302797881197565
SK-HEP-1,4521392,4.36382839215776,4.32153355471041
COR-L105,3062316,-0.8702764318143076,1.3406296376144915
COR-L95,387447,-4.370301659619954,-4.680741733940133
COR-L105,10231331,1.4114577114599935,1.7789697480704338
SK-CO-1,637858,1.8597515079418403,1.9346665624671529
SW1573,5282054,2.2636648441362417,3.776297498744336
K-562,66577038,2.461713560075674,2.771346286295625
Panc 02.03,984333,0.8671961837803726,0.8039574107441878
HCC1500,9967941,2.192170342398577,3.449427698314631
NCI-H1568,5281672,4.0091617833462125,4.540324405349741
K-562,11640390,3.4084234644631244,3.515642954665513
SW1271,60750,-2.442139934484719,-1.814958857391352
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.4354470642547916
MOLM-13,24889392,-6.717782140097413,4.215728393545355
Granta-519,11364421,-8.40665244505035,-2.148768220983616
LCLC-97TM1,11612883,2.215690343731866,2.600818211647032
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,1.7648865034140464
PaTu 8902,1566236,3.6887913704860535,2.056675439346254
MOLM-13,16741245,4.189200129622084,3.6031498995562496
SW48,6184667,4.015043076320991,2.8278807526728933
RERF-LC-MS,66577038,3.051572744120707,2.8627545450483836
K-562,71304818,1.450074212827562,2.4392611853545203
RCC10RGB,44489675,4.041451654117508,4.146093914928124
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,1.5559036263876573
SW1271,10074640,2.938380325815859,2.905245165503958
RERF-LC-MS,11626560,1.1998891680987491,1.8231912017638512
PaTu 8988t,81146,4.470184859000855,4.704433721787834
HCC15,11178236,-3.9629964965138584,-3.1047460466183674
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-0.862891093813953
HCC15,11317348,1.1767586352696475,2.329115443749015
P31/FUJ,9903786,1.0734919883099745,2.636581400066291
IGROV-1,23582824,0.3287266354391525,0.9912125075873454
Granta-519,3465537,1.1430845598370274,2.2942059259415095
PaTu 8988t,984333,0.9294993195358888,1.0110201761068482
HCC1500,11396600,2.707080690171913,2.8503992081950433
NCI-H1568,6252,-1.964470857288188,0.7190507982757911
NCI-H1568,7251185,1.379011815458227,2.735981532339092
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,1.6894340868514421
LCLC-97TM1,55508,4.820744956173848,3.2399573770127756
PaTu 8902,9903786,4.041497343746548,3.0390805693665084
SW1271,12001922,2.1604198968714754,2.0903379880731294
HEL,6505803,1.212867497705534,-0.6367602136662232
SK-HEP-1,216345,4.108495190728752,4.051569808097892
WM115,4705,2.3860154683324897,3.197908465905818
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,1.389003564632032
COR-L105,126941,-1.5036718028706904,-2.0987438980619526
PaTu 8988t,9926054,1.9241127892750265,2.0709873979627513
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,4.669385322335002
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,0.9145484948389635
SK-HEP-1,374536,4.396616434658188,1.8755648433532068
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.6096381309783006
NCI-H2452,208908,2.397298909776284,2.3454692302867612
SW948,24821094,3.757524617053942,3.0494276191478393
K-562,44491742,3.373435641850853,4.288972309258618
RKO,24180719,5.308193040989237,3.1527745886699123
MOLM-13,56946209,-5.150374128805616,-4.669540691123512
MDST8,54454,0.3151053774213321,2.443961916655686
Daudi,969516,2.18084937908482,2.5917554258290263
COR-L105,44607531,0.2442604090297878,1.2398232723396114
SaOS-2,54619267,4.116373312960232,3.98709724985631
MOLP-8,44607531,1.2227606502433142,1.3483425871899046
ALL-SIL,11427553,-0.6859128537837271,1.9403269441416253
NCI-H1568,11427553,2.9296384487881166,2.895321969721018
SK-HEP-1,6918638,1.490993863020431,0.3575503219971538
K-562,11175137,2.6421325977097663,2.2584365703115385
MOLP-8,25126798,3.554030345273679,3.6725041538996637
MOLP-8,10427712,3.937375048887725,4.030805956107745
BFTC-909,11404337,0.4468911705694049,-0.424413977151014
Daudi,19582717,2.1579117268337975,3.2247749566962205
SW1573,9936388,3.0507391751654698,-1.449751294126037
SW1271,156414,2.097129180606755,0.9579152090747419
Daudi,11213558,0.7122197709980888,1.554807482912809
MOLM-13,135875424,3.721528356214304,3.379692949597908
LS411N,3062316,3.313525141236135,0.4808878586498048
Panc 02.03,6438330,3.381062774421129,2.3990672830570587
MOLP-8,4705,2.7848528520877727,2.8917354751684456
SW48,675434,5.164587034175743,4.2704193813686
NCI-H1568,46215462,1.5662565779678703,1.9216357131705644
BICR 22,23635314,-3.9149935419765423,-1.7511319343979839
NCI-H1568,44607530,0.8979533446197012,1.910913533179214
BFTC-909,89928392,2.1120581393996116,1.6508504784622338
NCI-H2452,8515,2.9816658051225344,4.093852143141503
WM115,252682,5.883677253194902,6.377310417173008
SaOS-2,11507802,0.9759404440699744,1.3072273220687414
NCI-H1568,9935249,0.3822057580098375,3.023116188968416
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,2.2291204949183823
SW1271,65628,4.408026608161547,4.436364532633894
MOLM-13,2742550,3.0943449980031845,3.7287765125981536
HuP-T3,56973724,4.820716068374067,3.2305684102928383
P31/FUJ,5328940,0.1000739186855886,1.5873669757235842
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.697511426007746
KU-19-19,9967941,2.4242338826427794,3.7400141464262435
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,3.8344345061517595
SK-CO-1,5328940,2.280320557186381,1.5261724928560676
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,2.906027668093162
COR-L95,1716436,2.176954941746147,2.985709521234932
MDST8,46398810,3.011862004714757,2.5006585519624402
SK-OV-3,654092,-0.1739817534251795,-0.2906175889008828
SW948,54613361,-2.2535675944820084,-0.09641377708445249
HuP-T3,25154868,5.141210696949765,4.375840862791322
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,3.1645441621907633
RKO,124202324,3.4391315101947386,1.983720150766089
RCC10RGB,9444,4.509247284467684,4.079053432670831
P31/FUJ,135421197,1.0144502005310674,1.7663519704087332
MOLP-8,44487872,4.385798937588512,4.281890383168618
PaTu 8902,448949,2.6032868845304606,2.041914276822128
MOLM-13,11427553,-2.505370137631637,1.69656714291258
IA-LM,60750,4.549488262081028,-1.5772015041286154
MDST8,3825829,4.752817875520721,4.011007562516999
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,0.7747339512152945
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,1.086106571098378
COR-L105,51037431,3.876010066295024,3.1949414104168534
RKO,31703,-1.8438289452025527,-1.2208476216288
HEL,5978,-0.5240559956879017,-2.772172287376726
SW948,168312962,3.6749765666335903,1.6636140479805306
IGROV-1,72734382,4.633226130326536,4.370016445035165
SW48,216468,-0.1130169029097753,2.6497270361944554
HuP-T3,216345,4.480282764347718,4.25150047002924
HCC15,439501,0.3030845703669018,-1.9383351745921944
P31/FUJ,638278,2.9129004591727057,3.1864997703170546
BFTC-909,676352,2.5282943369079818,2.1608043841447584
SK-HEP-1,60750,5.759979022694095,-2.6024123105628747
PaTu 8988t,4788,6.262210396704686,5.569203802687123
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,0.9941165454664042
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-0.9825784966304902
HEL,24951314,0.022330385445513,0.8130276237308719
MOLM-13,46907787,-1.536709398859376,0.5514379230915506
SaOS-2,54626689,4.533352391847383,4.369995329178905
RERF-LC-MS,10410894,3.034247655874134,3.1997389045117353
RERF-LC-MS,9903786,2.6182355767545213,2.848674272567109
IGROV-1,107985,-2.8971910842184516,-3.5201513400982325
WM115,10231331,-3.458943295987183,1.9605149326625326
Daudi,71466578,1.924283792281082,3.142760823509121
KU-19-19,6610216,4.876021689690227,4.326180890254458
COR-L95,6918736,-0.04136223528326,-2.033512136282709
MOLM-13,11625818,3.232701320691832,3.823527963667957
Granta-519,16038120,-0.1772437220791911,0.8339114978908203
BICR 31,46907787,2.190433361645711,1.7797579672929726
Daudi,702558,3.2750017094913657,4.659800280050546
MOLP-8,24856436,-0.8263886484359759,0.19761312049723764
MOLP-8,135440466,1.6989907480456066,1.8040305081291432
SK-HEP-1,46843906,3.844316747572769,3.1121157587452366
RKO,54626689,4.750442055573677,4.574520570273274
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-0.7385499014425037
IGROV-1,11717001,4.394306548697183,3.9122860990174457
Granta-519,5291,3.886616753428741,3.4538858520438662
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,3.0920677365502574
SW1271,262093,2.7991981503454495,2.7843736899306024
Granta-519,1566236,1.1036082649410253,1.8631580386956967
BICR 22,24753719,4.1427183131543615,4.227346966044726
Panc 02.03,9926054,1.881153725115377,1.8637167100827248
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,3.087471119828785
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,2.1569404801549723
LS180,54619267,4.074522434074431,3.811539087682996
SK-OV-3,5281321,-0.7098099698865428,-0.9421175563589932
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,2.165930736845653
SK-CO-1,2729026,2.8886798476744246,2.725002782298909
Granta-519,23582824,0.9303240666722092,0.47376991982943883
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,1.0461236296664713
WM115,24978538,1.155471911978994,1.0592012792190173
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-0.8850828565363598
NCI-H1568,11238147,2.925799577076833,2.8950922388639504
ALL-SIL,135398516,1.5622324093538014,1.2908806166619815
COR-L95,135659046,3.614564650544248,3.6670452627726684
SW1271,1285940,4.280510054640018,3.605221668436414
SW1271,6505803,0.8186340021888412,-0.3827284896208043
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-0.9369468580077975
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.3883458396046746
IGROV-1,11626560,1.7276653519578558,1.779816028949293
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,2.2722137033907903
P31/FUJ,3552672,1.950832295752278,2.7043708105434354
P31/FUJ,67291369,0.7371006748241407,2.5139793348622588
LCLC-97TM1,107970,2.3018486004849907,2.2521731502435203
SK-OV-3,44607531,1.947967745365508,0.9997532879317957
BFTC-909,9936388,1.702123766125507,-1.9039333248125916
ALL-SIL,8515,1.9161675301812888,3.6021124417965122
LCLC-97TM1,25262965,-1.937189863749451,-1.4766777251862877
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.7489575726173199
MDST8,6914657,-1.2463021469195388,-3.728121763871341
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.79382216567653
HCC1500,53392493,1.8683885031226253,2.5678319751954475
MDST8,135411,0.5541309628089411,0.6436307828045856
RERF-LC-MS,1750826,-0.5689233588179538,-1.7760615750338764
LCLC-97TM1,5328940,1.525932870405189,1.451337093389529
NCI-H2452,25195348,3.541594611208225,3.337450946589483
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.49213502563194
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.5711713610005174
SaOS-2,53495165,-0.9847313398251484,-0.07196444739339365
SW948,11626560,1.2721393744446543,1.8959371926916198
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-1.05877534358097
HEL,25183872,-2.1054192111007657,-1.6189355734642716
RCC10RGB,89928392,1.8749323034057075,1.7732393791724559
Panc 02.03,10074640,3.562403354758929,3.2807739949495844
PaTu 8988t,57519531,4.351537289113079,2.8214876929512536
SK-CO-1,5281321,-2.128194299198524,-1.1338628854165516
RERF-LC-MS,5311,1.7201713868016182,1.6107314630900549
HuP-T3,11427553,3.1840600229712037,2.972286305454649
ALL-SIL,4259181,-1.3200126273341632,0.0776188863381104
HCC1500,11214940,3.550811671890936,1.7567999822428615
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,2.003225134289559
HCC1500,25195348,3.452030504957034,3.1281367200627006
SW1271,52912189,0.6284206808713965,2.3925384870612785
MOLP-8,984333,1.0413549547234568,0.4625253090696739
SW948,72734382,3.6940713099503473,4.580355024250812
IGROV-1,46943432,4.105714883822214,2.0035587077774615
BICR 31,25227462,0.4256700478941367,0.061962762818078915
SaOS-2,2126,4.6809882623674905,4.71234537354272
SaOS-2,11427553,2.020035940690151,2.4371326636798485
MOLM-13,6914657,-6.22505002098335,-4.697823283282009
NCI-H1568,24964624,2.125017418877952,2.5143834699250722
HCC1500,11497983,4.502799578122533,3.8541221340706
K-562,23725625,5.2530061405843975,5.0712297813689755
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.712776547355447
RKO,136227924,3.256787131627037,2.695546040812875
IGROV-1,31703,-1.792518264692263,-0.5878299217314218
HEL,6438330,1.7062913765539824,1.6977002179503915
RERF-LC-MS,25126798,3.475546322259903,3.9097393169791776
LCLC-97TM1,409805,4.11204743963536,4.855316058998896
Daudi,2708,2.1654486353587266,3.7703771171985054
SK-HEP-1,6914657,-2.911576812343612,-3.8224396256647144
MOLM-13,36462,-3.0478349617512466,1.0261495964861174
COR-L105,208908,1.1794902635628597,2.3800774996838756
MOLP-8,44491742,4.067907034019371,4.020800606539709
Panc 02.03,89183176,4.957506748320777,4.357583834094946
Daudi,3025986,-1.684737909075286,-1.0419289850582687
PaTu 8902,10302451,3.9687769441396608,3.2175749313526074
PaTu 8988t,9933475,2.2874108911255693,1.8099735844271907
SW1573,5281321,-2.072955292880288,-1.0971869112395032
IA-LM,2733526,5.6911514373146135,3.7158773669689746
Panc 02.03,6918837,-1.2317043962492993,-2.6207579265661134
NCI-H1568,19582717,3.4209569673427342,4.113217517931923
WM115,55508,6.132181701054794,3.0589204651653885
MOLP-8,2871966,-0.632569947519592,0.1393724100174317
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,1.6580090199338036
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,1.0598270077975487
HEL,6918837,-4.248380638359999,-3.3876812467368995
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.21072457018148158
BICR 22,136227924,2.105383482893856,2.8660349873775517
SW48,135875424,3.469184081134181,3.5094686286370025
COR-L95,10127622,5.649647064343883,4.4001831985472055
SU-DHL-1,60750,-4.603947913298721,-3.482751298596008
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.348331190313408
SaOS-2,446155,1.978878402700164,2.606099112934144
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,3.504217096668478
SK-CO-1,11625818,4.187860927408271,4.300479726586917
COR-L95,676352,2.06388279354012,2.0896118046783547
RKO,11719255,3.406006587740275,2.999419793303154
NCI-H1568,135875424,3.0063280878885967,3.8848677327377885
IGROV-1,25195348,3.0698662305180275,3.3152907757705963
RERF-LC-MS,16659841,3.453543705685564,3.8259496916944733
SW948,1641662,3.2658822910658905,3.386687962699358
BFTC-909,5351362,0.3148685714677321,1.517717536368917
COR-L95,24771867,5.320672645408192,2.2301953447335228
NCI-H2452,16725315,3.1677771909290184,4.04650066195574
WM115,9926054,3.0880179510914454,2.0315699513885197
IGROV-1,135875424,3.3275053166921347,3.622043925491482
LS411N,4259181,-1.386635238211632,0.08992009754005599
SK-HEP-1,24821094,3.809459846332286,3.276347150781894
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-1.0753117346426075
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.671287213049647
HCC1500,11364421,1.8102576985092016,-0.7426084834459274
WM115,11647372,-0.748702419415335,1.187076059679509
IGROV-1,374536,0.7022324251593053,1.9531632533523782
K-562,5311,0.9288629076778604,1.114514039963514
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.2328153384892575
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,-0.24581572436956542
Daudi,44607531,0.7322116783883826,1.133654025069871
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.807603776297339
SW1271,448949,2.9810988383972084,2.01610520611783
SU-DHL-1,42642645,0.6641769458510169,0.9850525824018632
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,2.189878158448022
SW48,53232,2.98078944705874,2.9080791480570167
K-562,4096211,1.5585244853649294,1.9237543122664127
LS180,89183176,4.9114720653238315,3.763746077709046
SW1271,10427712,4.007366682408904,4.4732463561522575
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.1573471235634019
SK-OV-3,72193861,3.227068856168802,1.839869239714821
K-562,148198,-4.073315546446919,-3.7515618288061385
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-1.452632518840007
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.6169774717104776
SW948,2729026,3.020599067804879,2.7963487315664834
SaOS-2,3552672,2.445112397338648,2.897601701872227
K-562,6918638,0.0740833242167517,0.31117316791570127
HCC15,67291369,1.6613409933263477,2.7162853809823675
LCLC-97TM1,11396600,3.6456493290211425,3.6913813519180865
HCC15,6438330,2.907250953014235,2.3081908505954614
SW48,123631,-2.3971553119638553,2.425079232849358
RERF-LC-MS,6918638,0.4520678244574614,0.6937261931277152
HCC15,54619238,5.509074276782743,4.567093475042511
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,2.921698506066858
Granta-519,5351362,0.2173676915670352,1.2750082432421272
SW1271,219104,3.9142621703193625,3.8929147036817695
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.0068417200419635
SW948,11497983,1.2110688984787443,3.4462212159187064
Panc 02.03,11404337,1.528571500956484,-0.2662070463393733
SK-OV-3,107985,-2.353051363092625,-3.7614069607074265
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.2955733051437863
HCC1500,56649450,4.199956636233384,2.886720173925829
MDST8,54649381,4.2434412709491385,3.88738570689993
SK-CO-1,24772860,-2.764468608226056,-2.023073903196837
SW1271,2708,3.697662973501111,4.803807277001615
COR-L105,25062766,2.3512127388642865,2.23449648715373
BICR 22,9826308,0.9832071992526458,-0.13485359856181242
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.2366424976935948
KU-19-19,11404337,0.0275069311149896,-0.4904598880537933
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,1.3513538570422154
LS411N,452548,1.178688753001054,-0.3170217571036019
COR-L105,3025986,2.299444367217184,-0.9026813508257352
IGROV-1,25102847,1.7007012555618253,2.512084867394025
PaTu 8988t,24797083,1.3448554408655904,1.5668887350339478
IGROV-1,46398810,2.003787621940583,2.3597249603121315
SaOS-2,2749,2.484303950908632,2.0105854533249468
WM115,7251185,2.999080033015298,2.467056710803174
IA-LM,151289,3.753931026261757,0.9532465576559257
SW48,60168763,3.2354609354554924,2.852762715648095
IGROV-1,168313016,4.807199318661473,4.579265878298484
MDST8,5351362,2.4401541198795726,1.5642433433090013
RKO,5291,3.391339544898264,3.4919834456883283
LCLC-97TM1,23582824,0.7435680585464137,0.718733909106592
BICR 22,16725315,5.207801943730372,4.009150121752352
HCC1500,44632017,4.723480031494906,1.0361239567877056
MOLM-13,219104,1.3929442819191806,2.9370951058909793
SaOS-2,44202524,1.4210473732360835,2.1995263144944177
COR-L105,753704,5.105702577689745,5.07140534573232
BICR 22,216468,1.2752332856392885,2.7058801461318596
RERF-LC-MS,445643,4.345437949323675,3.906675754736236
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,3.210980384130941
HuP-T3,44607531,1.7591062122540748,1.5829041892301625
NCI-H1568,9915743,-0.8427224057935273,0.9754203561653422
ALL-SIL,126941,-2.455728969669062,-3.0608711242330604
IGROV-1,168313047,1.93821625738322,2.3053002345382425
LS180,100016,6.005443229591697,5.898356159703822
SaOS-2,60700,-2.625519230364934,-0.1480371862912567
KU-19-19,9907093,4.38040739031281,4.198960125518657
SaOS-2,9935249,3.097116977919543,2.784297031149761
COR-L95,24821094,3.5692160345671335,3.0816904971497427
Daudi,327653,2.694862581871668,2.914561391472662
SaOS-2,65628,4.208345318362158,4.300384725441636
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.4511322057707503
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,-0.606326046110047
LS411N,24772860,-2.6286287692739587,-2.05596276907112
HCC1500,15983966,1.4595203856942676,-0.8594779310888373
COR-L95,46907787,3.807595772412777,1.5166300346329027
BICR 22,24821094,3.82687279949815,2.52609217193251
RERF-LC-MS,56946209,-3.4945734927118552,-3.8446799923896164
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.7819167582587003
MDST8,49793307,-1.5088082080905487,-2.4304510916609217
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-1.0819463022545426
SW1271,159324,2.241950485620868,3.0496344661186345
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-0.9170320663945316
HCC1500,135398516,0.4161092034804287,2.1429520501220436
Granta-519,46901937,3.6488183223471022,3.366796221188647
RERF-LC-MS,5328940,2.240356815676024,1.4580389434534988
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.602711335485318
Granta-519,400769,-1.7592122365530554,-0.8777190000287832
BICR 22,135421197,2.0438055763788556,1.884669367612035
BICR 31,9967941,4.3746614656618865,3.5757095478833945
Daudi,89928392,0.010222000273875,1.0669921481629994
MOLM-13,151289,-0.2275053531847663,0.6010281163843787
IGROV-1,2874250,4.893662837169153,4.46956150821331
MOLM-13,4261,-0.2853779042398361,0.8034513547787883
MOLP-8,5280436,2.785612173209183,2.9692166417129613
RKN,11427553,3.6372919842764424,2.6790044560935877
LCLC-97TM1,2828334,6.057082646440782,6.109192397110002
Daudi,11640390,2.7767455060282873,3.182110135903928
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,1.8599807735311606
RKN,51039095,3.7797830340785694,2.733999579546966
HuP-T3,46398810,2.968900053185397,2.6493806141205574
SW948,60700,1.1260701186231294,-0.30521153620853225
LCLC-97TM1,168313047,1.50715487575417,2.2396156289435805
Panc 02.03,46174525,6.272327915554807,4.290140293967532
SW948,72193861,0.8788999866892542,1.688887171491623
HCC1500,6918638,0.5709126385335386,0.3774151813359607
RERF-LC-MS,42642645,-0.4358765804877467,0.9665008115105769
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,2.4760572967645516
ALL-SIL,12001922,1.676377280214729,1.8740706800532576
NCI-H2452,441298,2.247705741320954,2.705312023796284
BICR 22,46191454,1.6809351488377804,1.6044319212181235
COR-L95,16013152,4.05038947229277,4.034238943467109
BFTC-909,72376,-1.4314875177558029,-1.9526883206077001
SU-DHL-6,15983966,-6.405792257227171,-1.49237520493028
K-562,11497983,3.839483588328175,3.7759896377650777
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.6248430244412708
IGROV-1,4477,1.1767656777594142,0.5340922072765065
SK-CO-1,9444,4.465837668270579,3.9255568521050734
SU-DHL-1,135999136,4.730243036337901,3.0705347252618758
IGROV-1,54619267,3.9701367924453455,3.937119025281442
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,2.6432845064984276
SW948,31703,0.6983000463207195,-0.5384326519152234
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,0.4028850762396352
SU-DHL-1,BRD-K03911514,2.3803066372148742,3.3519193352060763
HCC1500,46398810,2.5427546617930905,2.7181217909030413
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-1.4285107449219305
WM115,51039095,2.786212621210589,2.4831641029394462
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,1.3276536534061723
HCC1500,24772860,0.2838196702204312,-2.247430140435182
SU-DHL-1,71304818,1.6958772786188914,2.1276243336223204
WM115,16736978,2.885535594388376,1.6723611029437717
NCI-H1568,54618305,4.1006341963066255,4.29310238393742
RCC10RGB,11404337,1.763382313076518,-0.19014810526319015
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,0.7519732084524061
HCC15,17755052,4.876160174226561,1.578264762489732
COR-L95,6610216,4.601423414679649,4.230358528738315
LCLC-97TM1,10296883,3.762301074740285,3.9765448780704684
Granta-519,753704,4.381381177541046,4.618353285090527
COR-L95,3825829,4.2210058836960265,3.894702378605854
HCC15,51039095,2.370618956781999,2.98267640268097
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.8500331513024326
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,2.0256312704500767
K-562,9915743,1.457381054045144,0.9124992090764559
Daudi,644241,1.4114598324864769,2.0844077733168516
COR-L105,6610355,4.615259996363044,4.677804554443656
NCI-H1568,400769,-0.2296701698466811,-0.7164280825177711
PaTu 8902,4096211,3.3878786245174917,2.0732466183214764
IGROV-1,6610355,3.969940996770339,4.15914252645233
NCI-H1568,15547703,3.0519937502167744,3.0183947267017364
BICR 22,11609586,1.2076158919216122,2.8358241685559475
NCI-H1568,6918736,-3.5744965026463893,-1.9492347019893557
Panc 02.03,2729026,3.1511226959620715,2.8886920561747393
RCC10RGB,73707438,4.14323951901879,4.135849058872727
SK-HEP-1,11609586,4.257559552037769,2.8764036209703208
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,1.8645280327773954
WM115,9935249,2.3950107716018465,3.0946097945667876
ALL-SIL,9929138,4.286241964174987,5.098596843145315
SU-DHL-1,452548,-2.7499107831448257,-1.073777234558056
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,0.6517185112304432
COR-L95,262093,1.2094317801688714,2.736518519933278
LCLC-97TM1,4788,5.877974617736734,5.687375481116987
LCLC-97TM1,11455910,0.6647050862050086,1.076594141258826
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-2.0528855550509175
IGROV-1,3025944,3.9702787396819503,4.323847233619722
COR-L105,44486219,4.2268301570583,4.2284988416343285
HEL,6852167,2.7971477189216207,2.266487867155375
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-2.6368151282671004
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-1.3716445329429379
MOLP-8,24753719,3.861578571306771,3.89100886408805
RKN,54649381,4.194319964969153,3.9871805748335203
NCI-H2452,5738263,2.391583749104638,3.435279479492132
RERF-LC-MS,11612883,2.474683430971872,2.7238950660808623
LS180,67156097,-0.3004464994297747,-1.5063287556222378
ALL-SIL,638278,2.4844738615144797,2.7903581361715397
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,1.6821457819413355
WM115,89928392,1.4475546317176564,1.3923618636231254
NCI-H1568,4917,1.9457015565482707,3.123589400718382
Daudi,2746,0.9195319579001202,2.4952366328285907
RERF-LC-MS,136227924,4.560045704487339,2.727304090437875
SK-OV-3,400769,-0.3757443057400228,-0.34793837607381894
Daudi,2742550,2.6022450411597764,3.7020045884501456
SU-DHL-1,1242560,3.2887270842989285,3.4725496857778797
IGROV-1,1750826,-3.124548162001242,-1.6039134597869682
IGROV-1,3025986,-1.046010021597061,-1.045388893274032
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,1.939854547334616
COR-L95,11178236,-1.511835887926392,-3.2269767601193546
MDST8,15953870,3.886262261351445,3.45082573737163
P31/FUJ,71466578,3.434376258750051,4.248247867709252
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.6613640248521093
HCC15,16038120,-0.3287102193479797,1.0475796495470475
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,0.8813125727781513
WM115,44607531,1.8052962391610108,1.3512458121721118
SK-CO-1,322968,3.708989182542924,3.554264494028065
IGROV-1,1716436,3.2816872421007375,3.0132178865750086
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.570867078231123
SK-HEP-1,15953870,5.227718988850451,3.611979014186495
SW1271,10231331,-0.1974856956768426,1.7788967283971433
HuP-T3,168312962,3.781886601468438,1.77213593154241
Granta-519,11238147,3.49055902156802,2.425064051849372
SW1271,54678924,4.1367056407476595,2.345691875643425
Panc 02.03,89928392,1.630028817710481,1.6514776974171033
BICR 31,148198,-3.2373882564770513,-3.2860672874790753
IGROV-1,104842,-1.6690343627553987,-2.3248601124592563
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,3.0595033949579404
HCC1500,10184653,1.0749855490236058,1.225266683438044
HCC15,44202524,2.021204517823952,1.977891291333707
COR-L105,9866186,1.0648092573013754,0.784278077104467
COR-L95,285033,-2.430535969260308,-2.4681575410359025
COR-L95,23635314,-1.8010937940640896,-2.5084324683552595
SaOS-2,11364421,-5.8107581348158,-2.282755789791
BFTC-909,122327,4.590877432942681,4.593116148346751
IGROV-1,54618771,1.2456991772210466,1.3248100124708027
P31/FUJ,675434,4.075878142833804,4.370509617781442
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,1.107240196287748
NCI-H2452,5328940,1.966899609603824,1.7620945653487488
RCC10RGB,72376,3.207429090732714,-1.6878771118242382
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.917072237213464
NCI-H2452,4917,2.7944300449003907,3.1306981429694316
BICR 31,1716436,3.7157300626912617,2.9461642935953147
MOLM-13,1239801,3.478439984806631,3.8625091996361265
HuP-T3,10296883,4.266239948990751,4.055795784303463
PaTu 8988t,107970,2.530920724052233,2.4963713584831946
ALL-SIL,675434,4.0400251875066715,4.305073888286413
PaTu 8988t,16736978,1.6582336139520693,2.03334953559545
LS180,5460769,0.3293841533128088,2.3501206120564317
MDST8,11612883,2.4942536836786635,2.8629467996059255
COR-L95,46191454,2.009346014708409,1.049354855019642
MOLM-13,451668,-3.798095624109847,0.5554051210807835
Daudi,168313016,3.9002026806644734,4.29550769467717
ALL-SIL,135411,-0.5620485907345016,0.25351665538120294
RCC10RGB,46215462,3.684591481140594,1.9028965576068702
KU-19-19,4917,3.607977283390518,3.092065372366083
Panc 02.03,71751553,4.925944110140211,4.61801909118005
HCC1500,5281321,-4.561246998431513,-1.3265524845133945
LS411N,44202524,4.412838675121289,1.8489817549209846
LS411N,637858,2.7012095970179635,1.8481057034073134
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,1.9662112569234145
SK-HEP-1,24797083,1.0035545042427043,1.6431847827265065
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-2.5161258268029845
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.343102265099057
BICR 31,387447,-3.4745770631768553,-4.1129160052822336
SK-CO-1,452548,-1.5551413224098238,0.3184719750834869
SW948,6914657,-4.288216532991124,-4.179794954966892
SK-HEP-1,216468,4.223762462623231,3.277533431260247
ALL-SIL,71466380,3.7861137397034255,4.109242983352752
ALL-SIL,66577038,2.592918053791083,2.642822463464816
K-562,46174525,4.631327159993839,3.9530850017838515
SK-HEP-1,11404337,1.0852289139958715,-0.2830994272001801
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-1.0712904994352102
COR-L105,156414,4.037454349539868,1.3943558168606816
P31/FUJ,5351362,0.932451869978648,1.428060189192954
BICR 22,57519531,2.122776388957543,2.352766030498954
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,1.9595570109600617
SW48,156414,-3.5613148313114293,1.046005078696507
BICR 31,24180719,3.9564262696237096,3.4637374016684714
KU-19-19,11222830,1.7129831318158657,1.6748815655050924
HuP-T3,9911463,3.677427040789425,3.9337921043541915
Granta-519,56649450,2.820913380280981,2.9054778327223976
BICR 31,5328940,1.2878315189706533,1.5171928728416157
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,1.4158236562927302
IGROV-1,19582717,6.764352444432722,3.95616592934019
IGROV-1,24951314,0.9075718706849548,1.4257644735252524
Granta-519,9911830,2.3469616146388033,2.0369022264859833
RKO,3038522,3.342495330103654,2.994337995930359
P31/FUJ,135440466,3.423250795887436,2.296024412144664
IGROV-1,6918878,1.6706182189896102,2.4478017299433605
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.43590539593412075
SW1271,136227924,3.2074421772411372,2.8820610214074356
IGROV-1,16722836,0.856484234547582,1.5270775788619475
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,1.8390740122909122
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.9661813151524855
IGROV-1,168313016,4.807199318661473,4.579265878298484
Panc 02.03,9935249,3.920507280118285,3.0783888819954752
UACC-812,19582717,5.3439559865445245,4.173845139589137
SK-CO-1,54619267,3.100073010472608,3.829353222550567
LCLC-97TM1,56973724,2.3842885859021985,2.95620590688629
P31/FUJ,44185566,1.65624467652309,2.410487465580332
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,2.3070639646847395
LS180,568763,0.2796957344404436,0.32403479167153365
HEL,5281321,0.1504430999261452,-1.6125675423081587
COR-L95,168313200,1.9910859109269063,2.733443945922014
NCI-H2452,100016,6.6405878618594985,6.272793082785625
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,0.9118286986037676
SK-HEP-1,71751553,4.559763777433237,4.586553246238545
COR-L105,6450551,3.13458936271996,2.501138733081559
MOLP-8,227681,1.7901539797099055,2.914407507905841
LCLC-97TM1,24951314,1.6929873886763296,1.3174820154147053
LCLC-97TM1,20959075,-3.5903877814282836,-2.8706778257071734
Panc 02.03,11964036,1.263021853424522,1.3840698558472369
Granta-519,54596558,4.099782953798094,4.053423185961251
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,1.5310330115302484
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-1.5326759527902452
IGROV-1,246676,4.485924799339535,4.348558712878402
HCC15,25126798,3.760529318413009,3.695231464643915
P31/FUJ,67156097,-2.27730723064269,-1.2129560347198882
KU-19-19,4788,5.856744699338042,5.725405044078234
MOLM-13,44507138,0.4726740823031857,2.130602270437758
COR-L95,5281672,3.930459616892441,4.528911690620138
HEL,46191454,2.0114602406157487,1.0539433894180907
SaOS-2,25227462,1.0053365829052552,0.37974813177967887
NCI-H1568,327653,2.9538763640308403,3.289654974224082
MOLM-13,126941,-4.1996343959718665,-3.1801538088969608
SW1573,23582824,0.5044187481506299,0.7275883904504513
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,2.977037781234137
RKN,46199207,3.372714950884571,3.2810437308669678
MOLP-8,2113511,4.489524818659998,5.098923096672934
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,3.142927802249163
MOLM-13,9907093,2.467705892800055,3.6944100545078324
BICR 31,135398516,1.997761003126595,2.0821734769811115
SW1271,216345,3.992520329028928,3.8199286797993484
SW1271,49766530,-1.8216621121390524,-0.5885974981062481
BFTC-909,44819697,-0.8003395289407239,-0.724078288974197
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,2.6888114143055883
COR-L95,24951314,1.2848618182948477,1.2689446462786993
Panc 02.03,11427553,3.85172253134883,2.9127378070004926
RERF-LC-MS,11955716,-2.426679724944883,-1.3210893732603313
LCLC-97TM1,168312962,4.14705930417905,1.8112422291045613
LCLC-97TM1,984333,1.7706091320352773,0.8625433108341322
RERF-LC-MS,3689413,0.4263782886644774,-0.2364401461325653
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.2318669230170185
HEL,72734382,4.138558929268269,3.7771533638083445
Daudi,5281672,3.0556000328651267,4.236294344447407
Granta-519,73707438,4.294812737502366,4.263754815601327
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.9928522363014167
BFTC-909,3465537,1.8561429441463555,2.7375570361304566
MDST8,53232,0.2243602329572143,2.8246059754553
PaTu 8988t,54618164,4.622822732421989,4.150929425448596
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,-0.5751997302758276
BICR 22,241158,4.423333712203234,3.897841096890123
IGROV-1,25150857,3.031865110078871,2.355052572228701
MDST8,2729026,2.783400494590182,2.7592032293151965
IA-LM,56649450,5.159895082661475,2.8533410375110333
RERF-LC-MS,44137675,3.373454428855253,3.3732073782536327
HCC1500,11612883,3.8728122953700113,2.941064916126093
COR-L105,44491742,4.003695029376484,4.283363327961351
SU-DHL-1,17759555,3.5507610454949177,3.3431550684885787
PaTu 8988t,2828334,6.317024230854033,6.065776255761189
PaTu 8988t,168312962,3.961414669504744,1.6179834090393275
NCI-H2452,15953870,1.9726746369071917,3.7160853325950054
LCLC-97TM1,54626689,4.751501808909531,4.608091657682014
PaTu 8902,136227331,5.567107594748722,4.25823850438001
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,3.9824455402136287
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.6709993366207524
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,3.0919870970534253
Daudi,11317348,0.8828508555827204,2.221255432966018
IGROV-1,26596,2.910298792762654,-1.1615437274992408
K-562,2742550,1.8061055262772656,3.7644074878145615
IGROV-1,25062766,2.144848161581278,1.9624754193784983
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-2.243338488507324
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,0.6040448923887759
SW948,123631,3.5700289871060327,2.2317641863071453
COR-L95,168312962,1.6965693753889812,1.553233079100333
IGROV-1,9956119,3.7231415872817024,3.4641646310640812
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.2782789418463962
HCC15,23725625,4.984445415553906,4.824779777344378
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,1.2161629636908522
RKO,2708,5.0364138660049935,4.446708323859762
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,1.8017718903937407
IA-LM,148198,-11.384967135346804,-3.5125949968048578
PaTu 8902,44202524,5.539571067533291,2.3885247786296246
SK-OV-3,10127622,6.3662035368843535,3.9511099362376667
PaTu 8988t,16038120,1.6913300198770496,0.8300311132150706
HCC1500,6610355,5.5539350619643395,4.662364973546948
RKO,9956119,3.3077949428120195,3.536685785407109
MDST8,8515,5.547245054967808,4.019635917158285
HCC1500,5978,-3.1049031694332183,-1.7817214964412178
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-2.1739533067832797
BFTC-909,262093,3.5924629632259792,3.0260408407849577
RKO,23635314,-2.140231911981244,-2.115194451098191
MDST8,11626560,2.2403804115384207,1.8122839145730263
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,1.2024768671452615
COR-L95,44819697,-0.3616253875757693,-1.252923943583003
BICR 22,5351362,1.2051272382141311,1.1584880885026068
K-562,9967941,4.015535149970178,3.597147357626564
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,3.3179521517148047
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,0.795292450868729
UACC-812,25102847,4.053875686762356,2.569692598075264
SK-OV-3,6610355,6.222226160480143,4.538547590539481
IA-LM,11152667,1.0642318645878492,-0.36696642271577323
BFTC-909,6918289,3.427790661189136,2.5256618605051324
Granta-519,11167602,4.36712443545526,2.007337724668805
BICR 22,60700,-0.4008092990404712,-0.4806731899530183
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,4.209119023153209
RERF-LC-MS,241158,4.36087401910034,3.5645769706422845
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,1.219885843417837
HCC1500,24951314,1.2674136228128516,1.3745477154143202
K-562,65064,5.606410384518605,4.792160552315281
PaTu 8988t,6852167,4.186106645973286,3.045734519362209
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,2.4711846977745955
RERF-LC-MS,25154868,3.293982375318642,4.500046089753027
Daudi,11719255,1.9605498566152704,2.9532935419835638
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,2.7900505922487993
P31/FUJ,9907093,4.323796399268767,4.028199286125126
SK-HEP-1,56649450,4.110961369423777,3.380140191638719
SW948,11238147,1.5812364597614252,2.9094281980368897
MOLM-13,60700,-3.6931560077615337,-1.1047544068473742
SK-OV-3,54618164,4.236989567252486,4.019687491654009
WM115,53232,2.2909547616931243,2.9100220339977123
Granta-519,11213558,2.214733921051264,1.2901997477418952
HCC1500,12001922,1.110118640671234,1.9014189054899628
MDST8,12003241,0.3559193403256231,-0.7585958236631002
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,0.6077416139876323
MOLP-8,44819697,-0.0313402586892576,-1.052483051500603
COR-L95,136227924,2.879022500990784,2.814036302282463
Granta-519,135421197,0.2234065586927925,1.3828886473473068
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-2.1771234066864626
SW48,6505803,-3.5264924347891897,-0.47591820897869946
IGROV-1,8515,2.1861539315976053,3.8254779482156724
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.345073594096325
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-0.6078076941479932
MOLM-13,25102847,-4.845176201807707,2.0690193791165035
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,1.3242483293229663
SW1271,53481919,3.611390941951582,3.813473007064605
RERF-LC-MS,24964624,3.0594292113466515,2.3099983626967706
LCLC-97TM1,969516,2.175595213634207,2.6704794427452363
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,1.76982800446388
RKN,49793307,-1.2643121180608,-2.706399652551623
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,3.1615479994109705
SU-DHL-1,15547703,1.7605543364675147,2.756813658136005
COR-L95,11625818,4.182153411947424,4.32284634417266
BICR 22,12003241,-0.4808187565312439,-1.3315524420325169
LCLC-97TM1,124202324,2.4863882679536133,2.5198186542472385
BICR 22,24797083,1.5794716057353129,1.564344075655653
WM115,136227331,3.7917327546536983,4.1284334715264865
MOLP-8,23725625,3.090240324780466,4.779309638530645
NCI-H1568,3552672,1.826953477138791,2.9515025801516823
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,1.725969009176412
IA-LM,51039095,2.817946248906647,2.7804459960495245
K-562,11964036,1.6077176524784418,1.2353907777648
HCC1500,5470400,-1.7385310235308598,-0.29074300437073913
SU-DHL-1,11396600,2.533401176626175,3.3062029381424765
BFTC-909,216345,4.226804426652683,4.215704423005314
Panc 02.03,71304818,4.256945507775637,2.5504307072543204
Panc 02.03,219104,4.2068478561753375,3.8630743777980707
SW948,23582824,0.2041553679799947,1.0153386683938952
NCI-H2452,5287620,-2.107035322199283,-2.0901583630233147
SW1271,15953870,2.918493523161381,3.6213912907123404
IGROV-1,119182,0.2112476135388779,-0.7309402489075728
SW1271,11656518,1.475105479065936,1.8665249543583453
Panc 02.03,49766530,0.9655059796360064,-1.1266809389552763
LS180,89928392,1.7442798189695845,1.2043616182896928
SW1573,53495165,2.229023421141798,-0.2877831838720196
WM115,16659841,5.127619480623103,3.6481437263304537
SW1271,3552672,3.981050843991283,2.6928677208108294
SW948,9926054,1.8406028662949705,1.9350162592023228
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,0.7251625174866034
RCC10RGB,71466445,4.397911896340776,3.878921190802148
WM115,7326481,2.374260909001927,3.053632982763363
SW948,44202524,1.7116279237548724,2.230487435814982
RCC10RGB,46907787,5.224507823938942,1.7899402429918814
LS411N,9936388,1.997277136132151,-2.73110131211423
SW1271,135423438,1.1699634662635283,2.7176695061587424
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.7131363094120755
COR-L105,123631,-0.3749766708664047,2.2373633529461556
MOLM-13,52947716,-3.8827491455655694,-2.1264134884863446
HEL,36314,-3.7348038354216593,-1.8832939175912822
KU-19-19,54454,2.6957608866389866,2.9361009958855244
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,1.5200790038943084
MOLM-13,71680916,4.890723285268907,4.302557859363577
SW1573,65628,4.136448104244246,4.441496877386153
HuP-T3,11178236,-4.0067645508863174,-3.28197423427797
WM115,11364421,-5.628114250516673,-1.5895898390241043
K-562,613753,3.252228295501032,3.1291304634839032
IGROV-1,24771867,1.9944882740161016,1.9129989295946743
ALL-SIL,11152667,-2.075218964097288,-0.8977402371249797
BICR 31,3081361,0.7844567898788304,2.271439362663234
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,2.0659472695520735
RCC10RGB,4788,6.17872638158586,5.654744554834475
Panc 02.03,11626560,2.1710424521283427,1.778241416108338
IA-LM,11175137,3.357915620650256,2.609736058321821
RCC10RGB,11626560,2.6825909392900376,2.124572207052412
SW1573,168313200,1.7327341920391253,2.8801923165970376
Granta-519,2828334,6.191507302277889,5.850132854021203
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,3.0366317499575906
MOLM-13,5460769,1.2989705913507943,2.3589230247201667
SU-DHL-1,216345,3.4378126257341406,3.6450889782270686
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,0.8771673604296244
MDST8,9926054,1.8075400364112937,2.1060038516425656
WM115,676352,1.7628184284101875,1.960283177644463
BFTC-909,55508,3.078625314561866,3.069810413305057
RKO,100016,5.817852214634293,5.912715178907049
MDST8,46943432,3.6174081091701886,2.3554046773792496
SW48,5978,-4.7084088584036525,-2.9010878632985317
ALL-SIL,44491742,3.700418914769662,4.108617454527537
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,0.5156619409852338
SU-DHL-1,11178236,-5.1175240313736845,-3.544844181744539
BICR 31,11955716,-3.162575487986667,-1.2891110404152002
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-2.1422819904691153
MOLP-8,374536,-0.3332412159105151,2.0188317577156183
BICR 31,66577038,3.1838871840280745,3.0290607641750267
MDST8,409805,3.941558883413243,4.807093548167543
K-562,6918878,0.8571724386049573,2.1396635988266217
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,3.232742504051836
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.871080400082318
NCI-H1568,5281321,-2.717480517336961,-1.1343664636854613
LCLC-97TM1,374536,2.574075324433214,2.151539464800386
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-3.0213625772752657
HCC15,66577038,3.417660968254761,2.941434873781448
IA-LM,9911463,2.6703246121465436,3.733399701566331
SW1271,1566236,1.9677070098040983,2.2719196964924664
IGROV-1,11238147,2.1723642292765084,2.5526743472778817
SK-OV-3,11364421,-1.984047807336832,-1.6329141431295673
SU-DHL-1,54613361,-0.1121754666598921,-0.19513865924924714
COR-L105,119182,0.6226208228567816,-0.5085590963920791
WM115,3384730,6.229532895174781,2.570609555665074
COR-L105,9967941,2.071649254258539,3.541316132585099
RKO,72193861,0.7735395045157347,1.3337847336168178
COR-L95,753704,4.781559661696253,4.77341346159819
IGROV-1,49766530,-0.195540678413639,-0.7015483474812002
BFTC-909,8515,4.73152093133166,3.9055721616901242
Granta-519,31703,-4.611611754102639,-1.2475026713203177
SW48,19582717,4.381046957550593,3.8203148331394066
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,1.1547340531653942
HCC15,15547703,3.515422457694346,3.3152099743181584
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-0.7428869071459849
SU-DHL-1,BRD-K58730230,4.384837032763104,3.2230340505566564
HuP-T3,2858523,3.211348955084378,3.01819899497161
LCLC-97TM1,24901704,3.846855123751057,3.345930589004139
NCI-H2452,44607530,1.9759156929339727,1.8082274353849042
HCC15,9936388,-3.3305479025951783,-0.5353009220931993
RKO,46191454,0.9841477576830012,1.0877146945268372
SW1271,3081361,2.248142117307072,2.249152925026229
HEL,100016,4.260371486080393,5.635611091990645
Panc 02.03,327653,3.634511095206161,3.227318175093245
NCI-H2452,25062766,2.439590704022921,2.097645845375885
SaOS-2,44607530,1.05170222821091,1.8061675783624798
HEL,5335621,4.9483155198907225,4.583736811553881
BFTC-909,6852167,2.133526407129769,2.697340801252727
MOLM-13,638278,1.880317910461832,2.874821758646842
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.590293224744039
SK-CO-1,387447,-5.86001644251988,-4.275344447521015
MOLP-8,10113978,2.697897563265303,2.6345734763329642
MOLP-8,216239,2.6519870661660803,2.000325613613033
NCI-H1568,46174525,4.305444868539079,4.3455452419381935
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.580097274884109
LCLC-97TM1,44607530,2.097748917507136,1.692711541549536
SaOS-2,9911463,4.168030006572111,3.827948462271948
Daudi,24889392,0.6157424479011876,3.7996760077140515
PaTu 8902,51039095,3.3801139171258976,2.9288710510287372
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,1.7791417275709471
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.1938743375262832
Daudi,387447,-5.635352264179238,-4.5288392937107
IGROV-1,5702613,4.420745339537274,2.821968350756947
LS180,375860,-0.0541765269880971,-0.17879565229624153
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.5596640406634561
MOLP-8,241158,1.846975252387852,3.1457662227099714
SW948,44819697,-1.5719383449848416,-0.3289222017981567
NCI-H2452,5951923,4.988154330604512,4.519211679315584
MOLM-13,54613361,-1.833470941599732,-0.5047481930941057
SW948,148198,-4.802987893737634,-3.4551535012458867
BFTC-909,4261,3.835594401773327,1.6149357231647254
Daudi,45100481,4.914271492759253,4.013144609275742
MOLM-13,3384730,-1.9717967977442377,2.0616881052207057
IGROV-1,5566,3.174346862827938,2.933444836903223
SU-DHL-1,10302451,2.2731723403274535,3.1250483496986994
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-1.2267584676526468
RKN,24797083,0.944322820476056,1.4729359325721472
SK-HEP-1,148198,-3.434194259121147,-3.402033714452349
SW48,16736978,1.8227831775957584,1.5201009566021728
HCC15,2708,6.122532058448304,4.853816256202628
SW48,5335621,4.0461877603353855,4.533602900089523
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,1.4381888694604528
NCI-H1568,71304818,2.2110745175145876,2.5380428617655126
COR-L105,5311,1.9211659995219237,1.3535013998512773
SK-OV-3,5328940,3.4311724872159903,1.8580920677638029
RCC10RGB,1716436,3.489109378341682,3.166962499940978
MDST8,6918878,1.145593411739036,2.5415483576134155
RKO,11364421,1.233720517884939,-2.285090019624283
P31/FUJ,65064,5.109694638799521,4.867232442231973
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.011973184031756
PaTu 8902,3025944,5.120505038776715,4.315395065499401
Panc 02.03,12001922,2.5444953584324193,2.0866665827127027
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,1.9935825258456248
ALL-SIL,54454,2.130103786841792,2.2312710415963677
Daudi,11238147,1.1945947480643642,2.269656011997633
WM115,148124,-1.9357807696466565,-1.859511512768746
PaTu 8988t,25262965,-2.4539636298097376,-1.1231784909765097
IA-LM,49766530,-3.412847117105243,-0.19407311397239868
Granta-519,44185566,0.7632366174102183,2.1173540047554495
MOLP-8,44607530,1.0628729381864028,1.4425036488740042
K-562,409805,3.7514940654800064,4.6238107960165715
BICR 31,89928392,2.942196417475874,1.6595713173066085
SW48,23725625,4.606874242451815,4.710112332844355
RCC10RGB,16038120,1.536821218292656,1.1826944460870408
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.3916633002331467
RKO,148198,-2.1467795088860875,-3.649979585842666
SK-CO-1,409805,5.790109243945559,4.99354827005514
HuP-T3,7251185,1.9415241444855404,2.636598353999298
LS180,11612883,2.759028826688456,2.3043549734303026
WM115,11507802,3.278245549501506,1.5944375908857515
IA-LM,168313016,4.257474229118996,4.716865782355002
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.1432107090381827
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,1.474964847781343
SW48,10302451,2.1638159560649157,3.4273248631628475
Daudi,65064,2.8809848507042095,4.256642219180008
LS411N,11612883,3.0472980958623705,2.5079789414468108
NCI-H2452,11214940,1.2392722713501154,1.9794997172499693
ALL-SIL,984333,-1.3370961884574026,-0.4284359571424452
P31/FUJ,1641662,2.802136916275355,3.468600709575031
MOLM-13,25183872,-2.142456248879295,-1.4874885399039284
K-562,969516,2.7986550178028216,2.579369534358479
Granta-519,54143018,0.4327684951223574,-0.3143727146866806
SU-DHL-1,44819697,-0.3444138900100821,-0.9487120172950356
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,2.182195549771203
Daudi,9933475,1.2993243126142855,1.4976687292407607
SK-CO-1,10427712,4.208191107568486,4.192064762901384
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,2.7243214761694428
HEL,2841722,4.805306475973069,4.170789510149832
COR-L105,9926054,1.7310748902984938,1.8552744671657357
RCC10RGB,15983966,2.263334704673794,-1.2235567980346895
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,2.135787886370265
IGROV-1,46174525,4.5083762186279595,4.459478612556566
BICR 31,11175137,2.7548462189262817,2.684979503248041
COR-L105,11609586,4.426382611322312,2.821919192752548
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,4.648036522611755
IGROV-1,107985,-2.8971910842184516,-3.5201513400982325
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,2.744617540269831
IA-LM,71466380,4.547922152882383,4.502451941553627
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,0.8203658585578896
K-562,11612883,3.292128537791773,2.748716124292722
HuP-T3,15953870,4.533958601099395,3.5252340640034006
NCI-H1568,219104,4.078417481216408,3.9184139775886764
RKO,65064,4.5178366082525,4.808238477809009
NCI-H1568,9911463,2.564901149372131,3.8868862242860565
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.43268231627126147
ALL-SIL,6852167,2.025737624061405,2.5692863329352247
Daudi,16065773,1.627011760718674,2.3074961568505445
MOLP-8,10410894,2.1334782114390425,2.989203402304186
RERF-LC-MS,73707371,5.9060077591992375,4.7458454128020175
RKN,1566236,1.687441004968786,2.3398686820425474
IGROV-1,439501,-2.1510551928674557,-1.9654080806865135
MOLM-13,57519531,1.2030375936335158,2.0557719389405293
Granta-519,11625818,4.458439944218401,3.8794342054182813
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.5103852296932518
MOLP-8,3689413,-2.303477592076259,-0.6482394542111696
SK-HEP-1,54596558,4.485352352092043,4.563318808442837
SW1271,4705,3.86061099620112,3.2652363686207155
Granta-519,9927531,4.885085469625254,4.482036885986644
SU-DHL-1,11427553,0.3775832797434548,2.5152344496805843
ALL-SIL,15953870,2.429039509996585,3.3425172794113407
COR-L105,4259181,2.2372065992854133,0.2443227202536245
HCC15,17759555,4.480266922784899,3.7678609534469922
COR-L105,10184653,-3.6529884694455608,1.5680338546775314
RKO,72376,-2.4980018930037673,-2.6710672385784
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,3.329779052669196
RKO,613753,3.427719504210608,3.2151460090491177
LCLC-97TM1,10302451,3.3699574981481217,2.944459076540239
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.6253673233860377
MOLP-8,3634881,2.730356562919761,2.917385142115397
SW948,11612883,1.2539645440532456,2.7184583371681748
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.8016226690983297
BFTC-909,10074640,3.0053798884123837,3.138886194921594
LS411N,24901704,3.828527152917887,3.1937120369183587
SW1271,51039095,2.010271277744507,2.696779248786588
K-562,9935249,0.8993678101188762,2.916872134502884
COR-L105,462382,1.111643181026989,0.7593595187410827
Granta-519,10385095,0.7144131323279258,1.0256289416196998
COR-L105,5281321,-2.635307184860664,-1.235957382796433
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,2.8987986879576577
LS180,11234052,4.148077533652898,3.8727358740938147
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,-0.47143415987538395
COR-L95,25154868,4.601001468087818,4.1645603816221755
Daudi,3025944,3.5610963405625267,3.9750887427913706
SW48,24180125,2.6937498240420457,2.846616518635337
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,1.7858166994576987
PaTu 8902,168312962,5.583922762984923,1.7844998277405222
COR-L105,5280436,1.8180108392693488,3.0027396883600215
SU-DHL-1,44507138,1.5242294298964132,2.2334869014009375
MOLM-13,10302451,1.7245492330691454,2.9903710594720154
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-2.4529819362033862
SK-HEP-1,44607531,1.6636821475505756,1.5912620777539885
IA-LM,15983966,2.169762444969255,-1.2751497578588364
IGROV-1,56946209,-4.416985130578084,-3.843788117956923
P31/FUJ,25126798,3.55669651950966,3.78344388762037
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.7454685120917681
BICR 31,15983966,1.7355748159582445,-1.5069175788457208
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.3725689218188837
NCI-H1568,135421197,1.29303587511011,2.0689118720885884
HEL,374536,0.3200488785786777,1.7220707619443751
NCI-H1568,25161177,4.305259269080427,4.211157493454915
Granta-519,24951314,0.3336244464551668,0.9241377845309425
LS180,400769,-0.7559227838025858,-0.9187700018726899
MDST8,44607531,3.32682409463767,1.5894923632984415
WM115,46843906,3.7194943725295992,2.8898275591146056
RKN,24771867,0.8860225124393014,2.5366958653242166
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-0.5912883247964181
MDST8,72734382,4.130038178532864,4.576435042533582
SK-CO-1,1750826,-0.0283504159212216,-1.4934244133762515
MOLP-8,10184653,1.0374255182903005,1.127972430536583
NCI-H1568,46398810,2.1853633940590966,2.6213425095608978
PaTu 8902,6438330,3.32865710338655,2.207565904724315
K-562,60700,0.041873955903415,-0.6919242001103697
KU-19-19,23725625,4.865374475902274,4.770371275211887
BFTC-909,6438330,3.0201113942824436,2.0398310983130132
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,1.2927923651919675
HCC15,65064,4.883028365063005,4.893136201494742
HCC1500,285033,-0.4229420433590342,-1.8207198440430332
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.7955559990215391
LCLC-97TM1,5479543,3.538440111241957,3.2810155194505835
PaTu 8988t,613753,3.3970334474933495,3.133708008883563
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.3773418286357741
SW1271,2949965,2.7362256869687895,2.521133156087472
SaOS-2,4705,3.668938036329027,3.124050241370475
KU-19-19,11364421,2.01242470272022,-1.92504211872064
SW1271,676352,2.2943086949623885,2.1583529535407964
RKN,24856436,1.2279395925477072,0.5292574864280928
SW48,159324,-1.9628962598081805,2.629287354694971
ALL-SIL,568763,-1.7129740739789223,0.40635599404683453
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.547138909111093
WM115,9907093,3.0763750955907883,4.435213532598223
SW948,637858,1.5262532123254355,2.067688986403499
PaTu 8988t,24901704,4.232615528659116,3.1255577726334582
SU-DHL-1,11238147,0.4308170484254632,2.3566272655992297
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.5200293786562704
COR-L105,3634881,3.59150153069964,3.1577405298902352
BICR 31,49766530,2.6564815829329236,-0.8183398805677036
SU-DHL-6,439501,-2.4303946334698057,-2.5969648693168987
SK-CO-1,6438330,2.884853035173295,2.167308714835714
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.6356481204230763
SW948,23635314,-3.685869994463448,-1.9438727425507876
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.33755462046698
RCC10RGB,24753719,5.18895385781671,4.347918003926884
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-0.6101363800868714
HCC15,53481919,4.945944641956239,3.981797234286593
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-1.1045114287228628
BICR 31,11612883,2.9886930364048387,2.6531447675132176
HEL,20959075,-3.3486318540939535,-3.196200791135811
SU-DHL-1,24964624,1.891650824203322,2.3467761430352594
K-562,11609586,2.0906528510972775,2.6703979954614088
KU-19-19,89183176,4.239044338938638,4.290006839476749
MOLM-13,9927531,3.44947203831576,4.60102724221917
COR-L95,10302451,3.773437494355592,3.24181680240229
SW1271,10385095,1.244878723840673,1.398468163020623
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,0.7960045106691568
IGROV-1,17755052,-1.0246415273055465,1.4841664570261066
Daudi,3634881,1.264969339465191,2.813532735900227
MDST8,46224516,2.508010817025431,2.243991946150284
SK-OV-3,65064,5.055886881526936,4.7127345815688795
IA-LM,11364421,2.389092199855664,-1.4817590098640259
P31/FUJ,6918878,-0.2487475841908946,2.383487537613445
SaOS-2,426756,5.396474834861055,4.551776973950509
MOLP-8,25150857,0.9011737742745826,1.8522344006793134
BFTC-909,11167602,2.8757137848929006,2.3540375418901203
RKO,10302451,3.926970734642152,2.9638009992567373
HCC15,6252,2.2097348223357396,0.7110115631113831
PaTu 8988t,135421197,1.788370067257354,1.9564376718550491
SW48,42642645,-1.378549292450493,0.8684095274045346
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.425427261435172
COR-L105,73707398,2.56355231698926,1.4649631234023355
Panc 02.03,3854666,5.373190444337423,2.0248677891679487
WM115,11404337,-2.7813606850874595,-0.2876845594061585
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,2.9737532628679695
K-562,9803433,4.389269041756261,4.676802116388676
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,1.040210753148375
SW48,11152667,-1.5089069748808788,-0.6535650923218833
MOLP-8,BRD-K55473186,4.200306440270822,4.1087532302560215
MOLP-8,3854666,0.8063321236158104,1.3397333546169639
WM115,156422,4.742483160763306,3.8534848917212816
BICR 22,10302451,3.218470138701286,2.9664800603148747
P31/FUJ,3815108,3.712799909664185,2.8267626790062126
SK-CO-1,5280436,3.963354946284049,3.230695661565328
SaOS-2,11625818,4.3669462586555055,4.611307093196533
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,2.0923923934777324
NCI-H1568,24856436,-0.7402646666066086,0.6623805967849328
MOLM-13,19582717,1.836192229041244,3.5348455352746324
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.393776809075853
LS411N,65064,5.143309491248943,4.780805341537218
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,3.695812688900493
SW948,1716436,3.337695569228523,3.0406794429034316
HEL,60750,-4.342121097179363,-2.491955315736594
SW48,5738263,2.8832489904283207,3.222268329996299
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,2.7469399816348528
LS180,135984461,4.839780886141452,3.6007356532881563
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.3819835615962206
SW48,3634881,4.093042888484318,2.981373458355533
WM115,82146,3.7974591517158,3.6853926952623697
MOLP-8,24901704,2.731912612856625,2.9884905216853457
SU-DHL-1,9826308,0.1808938529022712,0.1158764278031263
SK-HEP-1,60700,1.3088528574816594,-0.09896508414840907
SW948,49793307,-5.1176222473357775,-2.785943152092047
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,3.1942928650622826
P31/FUJ,15953870,2.7000087530897776,3.322247761439816
SK-CO-1,24901704,3.265743022928408,3.1883647735858474
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.8870532790781542
Panc 02.03,100016,6.582809568040202,6.018594462202145
RKO,168312962,-2.5117583451491012,1.5961696604536317
RCC10RGB,25126798,4.759098567819552,3.9006640185860224
SW1271,24964624,2.7126751219569147,2.138739490248875
ALL-SIL,9444,2.1167841583667277,3.2815918672115485
SW1271,1641662,3.842487885295187,3.7293021339256605
BICR 22,676352,2.452861704781308,2.1439403233896925
K-562,54596558,4.166105900128149,4.297188914301736
Panc 02.03,9933475,2.3025810529048205,1.9013015691530586
NCI-H2452,374536,-3.751500666928139,2.314458594896532
SW48,9825149,0.0451584979105152,2.051617192687826
MDST8,3634881,2.8722303311625006,3.3099742163099197
SW1573,24180125,4.83914798243841,2.994850382609711
WM115,42642645,1.5932691238490415,0.9518327822742768
SaOS-2,24753719,4.762341084721446,4.33183369640564
SK-CO-1,25062766,1.7088187930933407,2.1632836082782374
Daudi,71466445,1.7957550148901065,2.5929357242533437
K-562,9903786,3.6050720376028105,2.7889366431968985
MDST8,5281321,-0.743993786053836,-0.9229605440955967
WM115,216345,2.152490626678771,3.79140185491863
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.825994690335529
Panc 02.03,44566777,1.8066319547984584,0.665656031099618
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,0.9477309257163335
SW48,1716436,3.2732206570492512,2.5273843439872024
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.1426047187056336
COR-L95,5281321,-5.086788267908354,-1.441622838828679
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.510363189430735
LS180,5287620,-2.159393408078438,-2.1478313247669694
HCC15,24856436,0.7194572205096856,0.9448538109147456
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.203747666196702
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,4.046797726933494
K-562,54613361,-1.429503199294265,-0.009060709446342026
PaTu 8988t,5311281,3.776140248734943,2.5420590082937666
HCC15,10090485,4.457627969814505,3.8321740621177414
LS411N,1242560,3.5784744482633526,3.410381789244826
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,1.227803171977011
MDST8,3854666,1.4298592595361392,1.9332210078580234
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,1.7313112339225543
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-0.9761005805115994
SaOS-2,448949,2.4147534872316916,1.919320138850933
K-562,44607531,1.5533391017282614,1.4438255817413421
RKO,656346,1.2468664563159324,0.5871618193905228
SW1271,54619267,4.215254166837184,3.994262507930942
PaTu 8988t,107985,-3.7439330143768106,-3.5723884259447094
Daudi,107985,-4.311158471957254,-3.6182764951851256
K-562,89928392,1.1726799483120014,1.2568273860294439
BICR 22,2828334,6.182973514514405,6.074570372329176
PaTu 8988t,462382,0.0850922030405946,0.7721065429100241
COR-L95,54619267,4.025082196689936,4.045293270605294
SW48,44486219,4.521255071137468,4.164062703923912
MOLP-8,136227924,1.5113872866650588,2.4684502779996724
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.7636676014556
LS180,176870,3.0513508415646644,2.578957333207334
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,4.9903999162801735
NCI-H2452,60700,-2.076184021255351,-0.15817481644961284
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.4303787494828044
Daudi,2749,-0.7661278600765006,1.3160251109291476
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-1.2341203924989064
HCC15,11364421,-3.377820549130246,-2.012930397424692
ALL-SIL,135984461,1.7193250250744925,3.2478115988641805
HCC1500,1750826,-2.1124887265082255,-1.943025498032955
RKN,53392493,3.005817826052642,2.54548201668693
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,1.2540298499949574
BICR 22,5287969,-2.619429839358568,-1.6837158397125718
BFTC-909,24978538,2.589526114093726,1.3032882492149382
SK-HEP-1,2828334,6.264472809398218,6.119776119980409
Daudi,4705,2.565440722309658,2.96904973992167
HEL,11485656,1.96241131365886,2.059597129654422
BICR 22,23582824,1.0399288647056628,0.7890669185457406
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-2.308396679135383
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-1.083661067230416
MOLP-8,11364421,-5.744944118703229,-2.9967330379568025
COR-L105,374536,-3.312479831607182,2.314915930406548
SK-CO-1,56973724,0.9140094173628892,3.0944494070613824
HCC1500,135440466,3.12374064827048,2.2218631145115095
COR-L105,24978538,1.189273057385404,1.2606239303393663
SK-HEP-1,45279963,4.052806603396004,3.742637693948499
K-562,11317348,0.8853213314815674,2.712249321312038
RKN,6918837,-0.6134153399361431,-2.605450499741885
LCLC-97TM1,285033,-3.3608842191269104,-2.0958422835363955
HCC15,11455910,-0.3399110905288865,1.345083001285269
SK-HEP-1,176870,5.630942733934813,3.5154842862182227
RKN,23635314,-1.997093039658799,-1.9425282323817061
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,3.8066756632612737
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.0672903892733525
SW948,969516,2.384481795832599,2.725447017383973
WM115,24180125,3.7433275341391057,2.9198588130997685
SK-HEP-1,135440466,3.4774178685499324,2.2720966177743924
KU-19-19,11626560,2.7733848967135017,1.878841304534935
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.761209188345557
LCLC-97TM1,44507138,1.7278080476353117,2.5858296739688167
SK-OV-3,25150857,2.8200349544845045,2.3835842101056826
HCC15,44491742,4.47716804785037,4.283251920588919
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,2.8912252689080136
LCLC-97TM1,25150857,2.1625900659079296,2.4360063372496916
P31/FUJ,124202324,0.9428129005296164,2.1521405648071426
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,1.8709712097823634
COR-L95,6505803,0.0712785503404296,-0.3390595594642755
HCC15,24964624,3.0755429715166063,2.6244488166643603
MOLP-8,11647372,0.2904161448795228,0.6733751540937368
BICR 31,11977753,-1.0341786941527915,-1.5440221898601956
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,3.7573580857382956
HuP-T3,5282054,2.779269170716028,3.8115394027790446
SW948,54618771,1.4567685239775812,1.1018408073546944
Granta-519,24797083,0.9051026865971544,1.035962169176185
SW48,73707398,0.6331221198690845,1.218179357340454
BFTC-909,135411,0.8518885281649031,0.8500320937049076
HCC1500,675434,3.977739266447536,4.488132056280681
SK-HEP-1,6918328,0.8938731782790444,-0.052109597382817716
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.371812767028687
LS180,159324,3.258862193159196,2.2397283365584486
HEL,168312962,0.5016152377841688,1.301324566656413
SaOS-2,44607531,1.4975746891341548,1.378130375040564
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,0.4858516077735666
MOLP-8,6610216,4.187822370904977,4.081818825427726
HCC1500,5278396,3.6802956879537856,3.504313131621173
K-562,445643,4.07029800941494,3.90442701930295
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.179191566336672
Panc 02.03,5351362,2.6810485074832,1.3342101604956491
BFTC-909,23725625,7.000464253417552,5.053826810613632
SK-OV-3,8515,5.143916520422132,3.9457850886038184
RKO,24779724,5.847036108864024,4.514852504945471
MOLM-13,65064,3.286890258414819,4.659011414733309
P31/FUJ,9868037,1.2869642230829814,2.913611743867965
MOLP-8,52912189,-0.8757353744499203,0.9280357585028872
HCC15,2113511,6.327015395869061,5.656465545532634
IGROV-1,25183872,-0.4560099928976716,-0.4428265768056655
MOLM-13,44259,-1.8425758706378912,0.4900884529271309
P31/FUJ,9911830,2.020541196825024,2.4244535345000533
NCI-H1568,11455910,-0.0792581795853734,1.3077476272785313
Granta-519,409805,2.9966967612339417,4.126768793938828
IA-LM,7251185,3.003277248553597,2.4606170451524916
LCLC-97TM1,24771867,-3.13973757551719,2.194707238303113
SaOS-2,387447,-3.480142635313653,-4.199994875551827
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,1.8992865612267673
HCC15,71466380,4.492977556176778,4.514287288627635
KU-19-19,11178236,-2.578122805273377,-3.187715893688747
SK-HEP-1,107970,2.7276242080982405,2.3257570362498776
SW948,3503,2.019264798250741,2.268016518402151
MOLM-13,11455910,-0.3133362084586128,0.4734763911297146
COR-L95,216239,1.9606601522489808,2.1006691183538817
MOLM-13,20959075,-3.627453597088981,-3.3169763767069145
SW1573,3543504,3.864321270652805,4.409035323536966
NCI-H2452,16722836,1.367876124233394,1.8904206660232004
LCLC-97TM1,2949965,2.4577774402858203,2.814161455696279
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.3461182456770286
SK-HEP-1,9911463,4.3683168964450125,3.9046020550598812
P31/FUJ,11404337,-0.879305702132212,-0.5349642079631616
RERF-LC-MS,23725625,5.011639185934848,4.665339021885375
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,0.4171452713445747
SW48,126941,-4.535727103151088,-2.6641155844897937
BFTC-909,6184667,3.207156937684644,2.920372065016881
KU-19-19,2945648,2.475372674219151,3.0369770340170907
HuP-T3,387447,-4.787053098216054,-4.314301445613365
Panc 02.03,44493528,4.298055948100647,4.295931659033293
Daudi,4788,4.597613323137637,5.333264675388182
K-562,46907787,1.0881737362577,1.3329288816737594
HCC15,6505803,-2.813846830430111,-0.33146749783569
MOLM-13,3503,1.2246558483585983,1.968876987087618
NCI-H1568,136227924,3.032081072579533,2.974956508809268
RKO,9444,4.448790979485227,4.177259343915075
Daudi,107970,1.216737596928884,2.2463466800965817
Daudi,5311037,3.4563783042396015,3.5994000595498146
SW948,10184653,-0.1197105127119604,1.3404816706407603
HEL,89928392,0.5480178499310975,0.8723696384933625
SK-HEP-1,5566,3.210365271342881,2.959602406966292
NCI-H2452,44493528,4.324080951064212,4.502341556105723
SW948,24753719,4.222068008445673,4.303267623866231
K-562,11717001,4.3318290739670555,3.981100714261034
HCC15,11647372,2.6612404016221824,1.0048938670726073
COR-L95,11214940,4.129361910595318,1.7992275794127028
P31/FUJ,57330099,4.216278217816623,4.364806308194853
COR-L95,24889392,4.336996294263524,4.0972017946167165
ALL-SIL,16725315,3.2612856597636064,3.618624770370866
SU-DHL-1,2749,0.1348057545057474,1.5018558962600728
IGROV-1,6918736,-0.950858733923241,-1.688117902214457
HEL,46398810,0.908204113249262,2.172028814597105
COR-L105,969516,2.680370673187369,2.9010983979887066
MOLP-8,613000,0.7667530859484226,2.1079320337982344
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,0.7615102056954481
SW948,375860,-0.5776308885037049,-0.47760368331501285
Granta-519,6438330,1.446800550416973,1.474852014353989
SaOS-2,3384730,0.9471099210722488,2.1351020823861777
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-1.0494155049515548
SW948,10127622,1.0689347689119728,3.2010866977445027
SK-OV-3,104842,-0.359869843998673,-2.5340219189202786
HCC15,2733526,3.237047771361035,4.012270909964354
ALL-SIL,9884685,1.523019065964201,0.23556128044326305
HCC1500,31703,-0.1591983874970776,-0.7581184437487706
MOLP-8,24785538,-1.5077289265748457,0.9402909911590953
COR-L95,6918328,0.296514622397876,-0.18626076022829546
LS180,24964624,2.8898766327054153,1.9221157978731185
PaTu 8902,2945648,2.947030382730425,2.955463678089495
IA-LM,16038120,1.0865848932778794,1.1924989064417806
Daudi,54619267,3.035333918034676,3.56258633981261
Daudi,5284373,1.725683673378691,2.5168501898854734
SW948,56946209,-4.45606402023299,-4.444131994240164
SU-DHL-1,9956119,2.7884192993685666,3.385001726098876
PaTu 8988t,3689413,2.4784022576221836,0.13812831874682654
WM115,44241473,4.443917717257507,4.4751552322360055
HEL,11507802,0.749942791895586,1.0021968443179556
LS180,25150857,2.6595729662678846,2.216299097532054
ALL-SIL,11964036,0.9057184864624424,1.0471262413206583
SW1271,5351362,2.529410314371741,1.7120304594019127
KU-19-19,151289,4.45756440863607,1.0526256425285883
MDST8,24785538,2.8042557252914597,1.7997093560187951
LCLC-97TM1,11228183,2.6499520646531254,2.374563955873755
NCI-H1568,10127622,5.078058454742808,3.9407357964130285
RKN,676352,2.5860960344205175,2.1026055869265368
WM115,6505803,-4.475953396274594,-0.4085230352813496
MOLM-13,5278396,2.870927952465231,3.283918426219034
SW48,1641662,2.4016053281737544,3.303418833797517
Panc 02.03,5329102,3.1751218779490404,1.986812641865605
P31/FUJ,136227924,2.3905530687579497,2.6926224636797595
LCLC-97TM1,5281321,-1.0764177966981967,-1.213557072305691
SU-DHL-1,23635314,-2.2508595154996844,-2.136139178848318
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.4978106482156353
MOLM-13,44494015,-5.247330257185634,2.596488903363059
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.5388732214564724
HCC1500,46199207,3.053954841618667,3.216567148738439
NCI-H1568,6610355,3.436001375430949,4.52114595076187
HCC15,54618164,4.329878027642837,4.076719879383192
RKN,969516,2.6409066030454804,2.7305625586826925
COR-L105,71680916,4.738410817171978,4.676269216489694
SU-DHL-6,3634881,2.3700422517918653,3.2158446035495554
Daudi,374536,1.069903440531545,2.081735038917637
K-562,322968,4.0833948777840225,3.4649881182259707
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,2.486091713208853
K-562,136227924,2.737847329779252,2.9070405202795224
HCC15,15953870,3.1000423449826275,3.4500835259569373
BICR 22,6505803,-0.8504421983690468,-0.5863507398656129
BICR 31,409805,3.7719372874267982,4.950398401233713
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-1.4403321209530473
KU-19-19,71304818,1.8280747292346609,2.428467540194116
SW1271,6917907,-6.616351101315701,-4.062083262029846
SW48,44589607,2.4172125993075335,2.3823512451008275
KU-19-19,3854666,3.1161318305167995,1.9389242877226385
MOLP-8,11404337,-0.9705317414577028,-0.829623166488892
SK-OV-3,11152667,-0.6824217491873509,-0.17932566943545336
LCLC-97TM1,72199292,1.0139745528188595,0.8444530878285141
SK-OV-3,5566,3.179406871626594,3.0901303668260756
SU-DHL-1,11683005,2.624367478757415,3.2574164530644083
PaTu 8902,71466380,4.078142681912824,4.221929673049823
Daudi,56963564,0.012925039709307,0.11703251790555523
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,0.9848051127926124
SU-DHL-1,25195348,1.1859308431356896,2.9661897844334773
RERF-LC-MS,11494412,1.0302757077826894,1.5168770645126672
IGROV-1,3634881,2.769147818550815,3.2807591669426643
SW48,445643,3.7110082204631545,3.826549761789465
IGROV-1,3854666,2.3355254440561137,1.9310241326835
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-0.8142129306824499
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.205679067419899
PaTu 8902,387447,-3.44390255134181,-4.435467823595631
BICR 22,25150857,2.1797682691439233,2.52292480012293
SK-HEP-1,54618164,4.274964046269975,4.171963894991228
BICR 22,44493528,4.288893884195869,4.324873430994709
NCI-H1568,969516,2.3539842482072353,2.7422684655214646
HEL,52912189,-0.3930066433927971,1.3153526264252837
BICR 31,53392493,3.0187901836288824,2.542650390047783
Panc 02.03,6610216,4.56797737488032,4.215772101785709
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,2.794021662338464
SaOS-2,445643,3.906030165734591,3.921795144088031
SU-DHL-1,9967941,3.123701665105139,3.63741489099168
P31/FUJ,10113978,2.718593007254544,3.0797595686492896
K-562,54618771,1.1969173800987956,0.932860746848635
SW1271,445643,4.255849699563793,4.0074449688177785
SU-DHL-1,16741245,1.9818901112506189,3.7632467237007847
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,0.6118049057240138
SU-DHL-1,9935249,2.376788737359572,2.314971389753793
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-0.9365358253659528
Daudi,11625818,2.088957631704298,3.7068804230359182
IGROV-1,11213558,0.52356811652227,1.587279389834452
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.3805332218357957
SaOS-2,9907093,3.731287417721421,4.097085363770669
COR-L105,54618771,2.0419110046350135,1.0335819086025126
RKO,9935249,5.020114551473781,2.4886020385927448
RCC10RGB,54649381,5.891551456540707,3.7771502857074095
RCC10RGB,11228183,3.0224846047699288,2.2024430534824235
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,1.7265401967896197
ALL-SIL,11683005,2.0727325774258794,3.5765420129902044
RKN,9935249,4.428036529076262,3.1144656682968086
SK-HEP-1,6918837,-2.2229066751457345,-2.3558702569106305
Panc 02.03,36462,3.4500230117265933,2.251225933879304
SU-DHL-1,9866186,-0.7631869517914462,0.5492237603196795
LCLC-97TM1,448949,2.0046135576158637,2.006589317752624
SW1271,2858523,3.03244629786768,2.915829593935139
SaOS-2,46398810,2.449640817433895,2.452932327310207
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,1.2651111893659517
COR-L105,16013152,4.074366111138725,4.043104014068646
SW1271,10127622,0.8769341404821704,3.129516067582207
PaTu 8902,24951314,1.6215809376037376,1.287959927220949
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,1.8188623504351489
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,0.825424411342
Daudi,72199292,0.1565760694605324,0.6300772074527644
PaTu 8902,409805,5.142449436796194,4.93274615474156
BFTC-909,16115403,-3.993091010962378,-3.9567599801377633
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,1.8252425262876608
NCI-H2452,6505803,0.3706171048891257,-0.3645263998248231
K-562,123631,1.7867714727142892,2.4401876867032253
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,2.2273221723529506
SW948,56963564,0.1376223024943695,0.3232318811224617
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-1.2372401546787317
KU-19-19,25183872,1.353604037781074,-0.5255460042694904
K-562,462382,0.6666012292356907,0.5167765980937815
BICR 22,216239,3.622359576149126,2.187264968821406
SW948,72376,-2.235310823117723,-1.7590010906142919
SK-HEP-1,16736978,1.840110323821058,1.7086905859363746
LS411N,135440466,2.8415058675889,2.2900057283909225
BICR 31,2871966,0.8542621552894032,0.5136232081585613
NCI-H2452,5311281,2.597680352332147,2.514042737805868
HEL,25195348,3.2451646073619416,2.8084477273139345
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.8077811747262796
SW48,24856436,-0.3608375787119608,0.2798127362631489
COR-L95,23582824,1.713723586402061,0.728160335206674
NCI-H2452,400769,-0.2625889565980605,-0.39071435376064273
Granta-519,6610355,5.056177796240837,4.08200950172562
RKN,135984461,0.6080422026652917,3.7600420394642886
IGROV-1,9956119,3.7231415872817024,3.4641646310640812
SU-DHL-1,24856436,-0.2626900450765423,0.19637409447898072
BICR 31,9911463,4.617619725588035,3.7509867436340216
BICR 31,2742550,4.742856926113666,3.785693679251683
Daudi,6450551,1.0042642679666238,1.9784093023135498
HEL,57519531,1.593967479342305,2.059812796174051
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.9437721277645805
RKN,216345,4.602972623005823,4.102726354164098
SW48,46224516,2.362473255058207,2.41841486408401
RKN,10184653,1.939164173873933,1.57391656525352
MOLP-8,31703,-3.4249459011432912,-1.7592275436465112
HCC15,9911830,1.9028880277746671,2.3954136970044266
P31/FUJ,24180125,3.650250525491935,2.926226818443498
HCC1500,11427553,3.400784702269924,2.984369833073674
WM115,4378219,1.986798403927216,2.719315463807795
MOLM-13,445643,3.334033231716822,3.784092675180871
HuP-T3,135440466,1.565116417651368,2.281946322984322
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.426670037761651
SaOS-2,5284616,3.138246393599145,1.9527836455681427
LCLC-97TM1,156422,4.251965697410575,4.045695438104904
Granta-519,71680916,3.9040498639791226,4.325088800397186
SU-DHL-1,16725315,3.3729799888412257,3.866563314361066
P31/FUJ,20959075,-3.3972839651855207,-3.2359590609592237
K-562,16720766,1.059873963232806,0.5652906257862612
WM115,9915743,2.6223908273409515,0.9168231433287941
COR-L105,11238147,3.8255779395664065,2.9301988320589487
HCC15,6918878,1.2461206152093485,3.0610873428501204
SK-OV-3,11427553,3.3243369937323877,2.696282743403165
RKN,6918736,-2.1202784612128416,-1.7327585778112589
NCI-H1568,10385095,0.5241849666466598,1.4535625331362863
LS180,6623618,2.712323731600185,2.143280462706652
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,2.1122269844589714
COR-L95,5287620,-3.7742892062529183,-2.188389866975255
Daudi,11977753,-5.803293235753203,-2.151971329278078
NCI-H1568,375860,-0.3746562160702436,-0.09970440632382743
Daudi,1242560,2.7879344365615633,3.2481008429485474
RKN,2729026,3.0549768432694377,2.711446424229597
SU-DHL-1,56963564,-1.155496663147979,0.07940177531599482
SK-HEP-1,42642645,1.5394057036271682,0.7349234119806457
COR-L105,9935249,3.5389604716579175,3.0204584906799203
SK-CO-1,107970,2.4721550322855843,2.3496885594068346
RKO,5113032,5.90165838842917,4.788311500601081
SW1573,135411,2.599466343128946,0.7666174198374546
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.134817768380043
RCC10RGB,6610355,5.214940260192328,4.523841203419716
BICR 31,5287620,-1.513974949921974,-2.1391113935780828
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.29886547623117
RERF-LC-MS,72376,-2.3536044208150644,-2.0479603751466646
UACC-812,7326481,2.606201441290427,2.862718893867627
MOLP-8,11717001,3.6554432811683824,3.8454683399915957
P31/FUJ,1317464,4.709019850634407,3.2953215716457565
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.61619178603719
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.464240478143962
SaOS-2,44507138,2.054017263478066,2.6507128447729214
IGROV-1,445091,5.8777802446160825,4.304299149345277
RERF-LC-MS,54613361,-1.445874788963763,0.04533916249105165
RERF-LC-MS,72193861,1.0218744083195843,1.130780370499883
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,0.9000663804065769
HEL,56963564,-0.4081404928481738,-0.044043851920373474
PaTu 8902,136227924,3.2072125986231117,2.720079061149052
SW1271,25183872,-0.9123448839798644,-0.49031793123353845
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,0.5780358862800277
IGROV-1,25154868,4.833387840688245,4.328626247282122
LS180,107970,2.4480125060803077,2.2795751069829944
RERF-LC-MS,9840324,5.508232790936476,5.816691981986266
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.019946532058338
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.651973737416259
COR-L95,60700,-2.695152938475503,-0.44743417791798534
HCC15,24785538,0.0662714662573936,1.4631398783909455
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.0954849263297946
ALL-SIL,73707398,-0.324762560862376,0.8941623031898891
HuP-T3,23725625,5.187021863055133,5.003594563030212
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,2.7090660454704136
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,3.6648773210991896
MDST8,6505803,-0.0816923181525763,-0.3437843205437007
SK-OV-3,5351362,2.7626479495985765,1.6555481508170593
IGROV-1,36462,2.313632721410001,2.369055593014206
BICR 22,54618305,4.315554591509874,4.266336098304281
MDST8,5311281,0.3396864368094036,2.4207310122920918
MDST8,9866186,0.4787443726889831,1.1645682460211184
COR-L105,9840324,5.89386509883338,5.892240496572218
SU-DHL-6,9887053,3.723065049771557,3.3731640931565647
SU-DHL-1,10113978,2.4232665022526154,2.7415710922234395
K-562,6610216,3.734328570580528,4.155583089158887
MOLM-13,9936388,-7.059788369591511,-4.574189245441607
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.2554042113807262
WM115,135659046,3.4373276092449667,3.724218797761099
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.6627954345252034
RCC10RGB,2708,5.228545547030361,5.111526961030335
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,0.26232705561840736
HuP-T3,969516,2.913535439683091,2.7748558166179573
P31/FUJ,135398744,5.7727848933678,6.361113383123293
SaOS-2,168312962,3.518591614256865,2.0348860495423047
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-3.023579418773258
Panc 02.03,11364421,0.2085573081853932,-1.1927769207223817
SU-DHL-1,3385,0.1709309619587451,3.5019208338214103
COR-L105,3854666,3.5309487733662923,2.053545426265881
K-562,3025986,-1.372296763308674,-0.7697372565224879
PaTu 8902,25183872,-0.4459453921876214,-1.1666159201049242
BICR 22,25022340,5.75714905141274,2.2942089912021375
SK-CO-1,71466445,5.862416915369376,3.5441641811523654
HEL,159324,1.7687894675630291,2.4823998376643397
P31/FUJ,135411,-0.6620772647112111,0.5375378995225557
K-562,11455910,-0.068399521398108,0.8896733531630813
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-1.0835036170255363
SaOS-2,135421197,3.6760992974277817,1.8043195276795803
RKO,54678924,1.753529637740366,1.93047349390579
LS180,9926054,2.059729849775666,1.8963140410289836
PaTu 8902,3081361,4.091517551590367,2.3823629387617866
HCC15,54618305,4.644823264977023,4.444624489694624
SK-CO-1,135421197,1.070123520764916,1.8004605825447977
MOLP-8,5282054,2.3704039128819603,3.3920396666171855
Granta-519,2874250,5.483813332492178,4.150421342784472
SW948,15547703,2.460178853059974,3.0395242103345326
RKN,11175137,3.1657803092866224,2.7009226842857856
HCC1500,15547703,2.6330912213710693,3.052981155441642
PaTu 8988t,3503,2.8268609009838706,2.390035681060948
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,0.31862965343008964
NCI-H2452,409805,5.262030999116563,4.827426344235681
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,4.9035357964678346
K-562,107985,-3.1543528536618175,-3.761143640183562
RCC10RGB,6918837,-1.099435459858538,-2.237897181328039
HuP-T3,2746,4.662800576379415,3.347449533130903
Granta-519,135928012,3.1328015926823065,3.9956564127612695
HEL,2733487,3.1527152778808794,5.779391100486196
RCC10RGB,11175137,3.603105896683611,2.7636687225988066
RKO,51039095,3.7257826703811014,2.415363691548011
WM115,3689413,-0.1044392328624619,-0.43662011324740013
SaOS-2,25154868,5.397428200613107,4.44787430479943
RKO,25195348,3.4491832635970585,3.1103948772129315
BFTC-909,49850262,4.237463012213885,3.397683875774591
SW48,168313047,2.500888470511616,1.956234561930041
WM115,444795,4.375682835505768,4.074100859121637
IGROV-1,5738263,4.037832478240785,3.3077405372778084
MOLM-13,24748573,1.5626639761830592,1.8445975646204738
UACC-812,6917907,-5.293133909322777,-5.38408448337317
IGROV-1,168313200,3.9938362637732983,2.9768773872240852
PaTu 8988t,262093,3.2462588578894587,3.0345692093196623
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,1.6618055680341213
WM115,3543504,4.159835009416132,4.125541535070234
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,2.362041704437024
SU-DHL-1,9903786,2.5464454731205777,2.506140196760221
ALL-SIL,6438330,0.5772640537372373,1.8182534701519333
SK-HEP-1,322968,4.726859452680793,4.137483027072367
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,3.110745308177528
WM115,2874250,4.6839306454467975,3.853369193538104
HEL,327653,2.969363674974165,2.9217642415880767
SU-DHL-1,11625818,3.655247454502854,4.017963962820973
UACC-812,49766530,0.2629782697340875,-0.47308150906021235
SU-DHL-1,3815108,2.229733806447586,2.559643155448905
IA-LM,71466445,4.189377103287156,3.5688608927447296
HuP-T3,1716436,3.1901993610711092,3.1659419985185173
SW948,44566777,0.0218128389697893,0.5729051041181196
SaOS-2,24821094,3.1556587771151117,2.7369332413089893
Panc 02.03,135875424,4.996461687769912,3.999693216407443
COR-L95,3136844,6.4544258549997675,4.168775420376917
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,1.4615802217664446
LCLC-97TM1,3385,2.7516430893834696,4.001214197080561
K-562,135875424,2.7247406179323055,3.8269144233320778
LS411N,5329102,2.797825403975713,2.027031526347466
MDST8,24964624,1.7196440159479949,2.555066771902209
KU-19-19,10090485,5.355458016675434,4.260080805020895
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,1.2576325852901997
RKO,89183176,-5.254565057669901,3.4915482065828574
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,1.1199001684350418
Daudi,24775005,2.5651956502981093,3.6669791208333096
SW948,46215462,1.7533079238953375,1.7267247752149109
BICR 31,6610216,4.499990209090508,4.2600190632348625
ALL-SIL,89928392,-0.8842785165403505,0.9957228137929447
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,3.156089458218305
SaOS-2,9933475,1.7767718055197024,1.929176338665801
LCLC-97TM1,16722836,1.3652485758433368,1.4613685382874684
LCLC-97TM1,49793307,-2.6941720612695814,-2.996656488752791
SW48,10127622,-3.686333454689576,3.1536442222129106
Daudi,451668,-1.5751627659840317,0.9852142037443382
NCI-H1568,135398516,0.1447365774963497,1.989857945923918
MOLP-8,11178236,-5.22072808334844,-3.715914965480531
NCI-H1568,46907787,2.5747387573296425,2.2593293009313906
PaTu 8988t,6914657,-5.535111189097384,-3.671083042831027
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,0.5587799375251238
SW948,3025986,-0.0730103520402185,-0.8134831074044567
IGROV-1,11612883,1.8715405446213529,2.5913339505441297
RCC10RGB,3081361,3.5981013353753464,2.3863635699360195
MOLM-13,73707398,-1.293008226929777,0.5672081427815304
RCC10RGB,9915743,0.9759946846108524,0.5872259382375951
HCC1500,24771867,4.066345817331682,2.8300222365315433
K-562,44137675,5.346911467461658,3.527855276237533
BICR 22,89183176,4.4276408454646,4.0898862583543965
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.5187680688658353
BFTC-909,54619267,3.991913685478571,4.067899246713792
RKO,71304818,0.9175289508752972,2.3385133553217843
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,1.8294444010792201
BICR 31,25161177,4.144120396566418,4.1935139996758775
SK-CO-1,6918328,0.4731277879927994,-0.08131594661568368
RERF-LC-MS,6914657,-3.1593675222943896,-3.9299773974735985
NCI-H1568,44185566,2.743919877007031,2.679842906189543
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-0.921935010026572
COR-L95,6852167,3.112371536345172,2.93916697055301
P31/FUJ,5113032,4.875284905433655,4.839094693532149
BFTC-909,24180125,2.699370118217823,3.0999097921382326
SU-DHL-1,6252,0.3334498529847555,0.38854062519225663
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-1.2589629709783199
LCLC-97TM1,322968,2.924684365208183,3.5296234751952618
Daudi,60750,-4.624244800464318,-2.904332020285046
NCI-H1568,3385,5.30334090203815,3.760019229552978
COR-L95,5978,-2.5997235685562026,-2.5352409811332937
Daudi,24856436,-0.3602858360333429,-0.00012540468841439666
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,1.20767225755273
MOLM-13,445455,3.1473640199222386,4.146301344975878
SW1573,135421197,1.3915330004591782,1.7864696569571707
HCC1500,16065773,1.504426355167742,2.40738784659427
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,3.040963960068055
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.6670138510558334
Daudi,9826308,0.3207715704810925,0.05437348035714385
RKN,17759555,4.047966260499275,3.8496782267979115
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,1.2122406578258096
PaTu 8902,9911463,4.390925153080421,3.6850867820486464
LS180,54613361,-0.777399447336216,-0.23862227991073687
COR-L95,11396600,3.695258257335492,3.48948450673757
SU-DHL-1,9911463,3.067527187401269,3.5506158134585406
COR-L95,4477,0.8356196347588036,0.4199066265656656
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,4.155607415824254
COR-L105,12001922,2.476912212032941,1.9362087062779827
NCI-H1568,25154868,2.392234118098981,4.313340098003617
P31/FUJ,24964624,0.604485461730223,2.3452566554439658
RKN,11507802,1.1392194525963166,1.4543085194057723
Granta-519,2746,3.996696473436098,2.6085864315885683
BICR 22,6918736,-3.590209831667407,-1.6711992940897433
IGROV-1,135423438,0.764137689665023,2.163866642700267
SaOS-2,5460769,2.263492155098724,2.583261007747221
MDST8,3025944,3.984610722170807,4.28799199239976
HuP-T3,9935249,3.692881062494191,3.1337552806770366
BICR 31,54618164,5.999146696375086,4.141943894915338
MOLM-13,3552672,1.8354180523958712,2.6551497409741653
ALL-SIL,24889392,1.2675997647257198,3.939893695092291
P31/FUJ,5470400,3.6840145170482383,-0.1136135955643376
RCC10RGB,68056272,3.770230744947895,3.6202038491278894
K-562,135440466,2.878154323162211,2.3419037706890005
KU-19-19,16038120,2.2784541929956563,0.9662915758356826
IGROV-1,969516,2.460805405371151,2.6569211525654355
RCC10RGB,54596490,4.957303932772775,4.505651268441295
SW48,54618771,0.2213541125267267,1.2168188271734648
SK-CO-1,56963564,-1.3743653333208103,0.3189493056870083
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,3.024034955964741
SaOS-2,4096211,1.593922478920674,1.8428132110306987
WM115,11317348,4.689716075377342,2.5543069729251213
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.7911943305804051
LS411N,387447,-3.952629374311597,-4.053792832704619
SK-CO-1,11396600,4.255124433433546,3.692471977777245
RKO,2828334,5.934464187728916,6.044931322913485
NCI-H2452,6184667,2.981030320075281,3.0688063958168006
MDST8,119182,-3.087899770061731,-0.720196961866748
NCI-H1568,5282054,2.3545727551586744,3.7429196904701962
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,2.838701933378267
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,1.7008738571708386
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.3539263268664937
MOLM-13,5311,-0.2452037316548625,0.7365528424616027
Panc 02.03,119607,6.223236877281167,5.308696863997523
P31/FUJ,5566,2.621678413077409,2.8561280526631943
RKN,5311281,3.300248210659573,2.3480818018816683
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,2.3765524541925895
K-562,11152667,-1.0937594737206502,-0.9261585565903411
WM115,241158,3.4880777915567496,3.6256038597996176
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,2.945136107380569
SW948,11707110,-5.12001559624384,-0.15790722514719607
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,-0.17129379467013212
RKO,3503,2.683687073265507,2.157156324436481
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,2.3936289559872916
HCC15,3081361,2.87617011057776,2.3048660287073175
SW1573,25102847,2.4268351657646874,2.6973529424232545
SW48,24785538,-2.175303706573729,1.2152731723122108
NCI-H2452,5329102,1.9284891088724192,2.0168414488189845
NCI-H1568,56946209,-4.312547212322036,-3.672275391951701
SU-DHL-1,23939,4.934189555353841,4.067332672281946
IGROV-1,2708,4.438419625543199,4.844061300379173
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,1.4246020843768588
K-562,44489675,3.6585617881709585,3.919587263716417
SaOS-2,23582824,0.6839328831098858,0.690989484487892
WM115,1242560,3.734530534800184,3.5826327200371453
BICR 22,89928392,1.801349914013067,1.5438644511993713
MDST8,375860,-0.0509298762434446,-0.012794242042292745
WM115,387447,-5.543981096917634,-3.764362916722243
PaTu 8988t,46215462,1.6929329300119484,1.9841969571759837
SK-CO-1,25150857,2.4521914239487965,2.292900884643531
RKO,46843906,3.289277038806309,2.227599597291245
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.5083058865459168
SU-DHL-1,3062316,2.138301047480956,0.8270108067939372
LS180,31703,-0.5385699496513472,-0.8519303203825958
NCI-H1568,54619267,3.44714412714971,3.9486350653186797
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,2.446201128682697
SK-HEP-1,5351362,3.433378240202124,1.5960387899732036
Granta-519,119607,5.75770191278477,4.8870978473578734
HCC15,2729026,2.745990777117554,2.7104853250111463
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,1.3253453292690849
MOLP-8,24797083,1.4809895165463562,1.0960810582364753
MDST8,446155,3.7715450651151854,2.6337436817133657
SaOS-2,11317348,2.7618337203443377,2.750266373087752
SW948,67156097,-1.6378764151549952,-0.881620224470847
ALL-SIL,448949,0.3821166271144734,1.6467031173832758
SW948,5287620,-5.231918659547503,-2.2613936313961864
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,3.784527431537814
RKN,159324,4.081844329649501,3.1144656682968086
SU-DHL-1,6917907,-5.829381256855267,-5.365601219681695
BFTC-909,3825829,4.25128930140834,4.018701729320135
SK-CO-1,119607,5.49560679798916,4.901896244741667
LCLC-97TM1,6450551,2.230680139016655,2.608736542667617
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.06859512731107492
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.2196216644008016
HCC1500,54626689,4.657243866783195,4.67243372578942
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,2.946100248961527
IGROV-1,9866186,0.4571266497661056,0.7926754175173568
K-562,24772860,-2.920105669473321,-2.253343405663175
SW1573,9956119,4.0915863238100645,3.63040918153897
BFTC-909,5280436,4.2143472852581025,3.5169487135843798
SK-OV-3,5282054,5.04615494272688,3.4332229109096164
SW1271,24180125,2.511417012575286,3.048792795886559
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-1.2056075382241382
LS180,46398810,2.878388522539818,2.2296590301291945
P31/FUJ,2749,0.384854271149864,1.9118282674974052
NCI-H2452,5281321,-2.0767365956379944,-1.2077703339937726
SaOS-2,9927531,5.410264314347966,4.712227657705008
WM115,156414,1.595819692541897,1.4494762411037931
COR-L95,15983966,3.7167583960216897,-1.3645131471582979
SU-DHL-1,10322450,2.9485372728674473,3.6184140567462846
HuP-T3,66577038,3.287519898796673,3.0518139480541255
Daudi,6505803,0.7229387165377155,-0.4212974487474736
COR-L105,46926350,-4.1614749205792565,-4.284039104350251
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,2.1975997040207993
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,3.9840305094458817
MDST8,24901704,2.355370692316459,3.2559944731329837
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.2485759936697252
NCI-H2452,25126798,3.2665335299764298,3.8546394265107518
ALL-SIL,107985,-3.6188373708521495,-3.584781273208947
P31/FUJ,5738263,2.6277017246063252,3.2510455469425716
HCC1500,2742550,3.2494473825713026,3.863734319250168
LCLC-97TM1,54618771,0.7707104681824843,0.9534947188426712
MDST8,3062316,2.63216781392049,1.1268319389881
K-562,100016,4.034095210213227,6.053529342327862
NCI-H2452,136227924,3.4253193575490695,2.8982605100281438
IGROV-1,3025986,-1.046010021597061,-1.045388893274032
IGROV-1,135875424,3.3275053166921347,3.622043925491482
RCC10RGB,400769,0.8506758933165035,-0.22044787612744976
HCC15,44241473,5.510013950441446,4.584330829830272
SK-CO-1,26596,-2.200264316257102,-1.2299054278891657
HCC15,613000,1.6197134073445976,2.5639139310749113
Granta-519,10427712,3.8202730219655496,3.8365640743458482
HCC15,5479543,3.813478020040636,3.467626145010131
PaTu 8902,135423438,1.708930423466824,2.35883249030561
Panc 02.03,24964624,3.328827283539013,2.4976183215585497
LCLC-97TM1,25154868,4.98783448400422,4.342515705413609
RERF-LC-MS,5113032,4.48589538963195,4.790049149492179
SK-CO-1,168313016,6.229837204453753,4.754974907378344
SW1573,9926054,3.1618263718643513,1.939775835058349
MOLP-8,451668,-1.0880279758209197,1.3685318476999546
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-1.8294755583505675
SW1271,46191454,0.8015154670027128,1.7683738984592174
IGROV-1,156414,1.4212019235656712,1.2584318538722123
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,2.9089285165572267
NCI-H1568,11647372,0.9090690740398496,1.0223430515241483
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,0.8831981794686098
HEL,5394,4.33544579006292,3.508579873848778
Daudi,23635314,-4.750280690911186,-2.288556640348205
SK-OV-3,3543504,4.529917197725731,4.030241185847789
NCI-H1568,51037431,4.33384460889792,3.201090285974354
SU-DHL-1,2708,2.612747958759665,4.26218808043345
SW48,151289,-0.0884278513227002,0.6533830710243287
SW1271,24772860,-2.1080107772753607,-1.5751471400073083
SW1271,675434,4.352597318848774,4.643477637160059
Granta-519,44632017,0.2326960109936577,0.7227651734942636
SaOS-2,11955716,-1.373693500458253,-0.9320836727358749
KU-19-19,159324,4.255883770522122,3.180468089893432
SU-DHL-1,4261,-0.6665613942828803,1.199374551260117
COR-L105,10302451,1.2881684147693646,3.248760355021152
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.7819167582587003
ALL-SIL,4096211,-0.2650943934034739,1.4466709690465092
IGROV-1,216468,0.5330864756407336,2.7110809882601807
Daudi,46907787,-0.707382985228944,0.724906936661497
ALL-SIL,11175137,2.2895463411974597,2.005323603368887
HuP-T3,7326481,3.4338903427833674,2.845233022656783
SK-OV-3,11626560,2.736987670099794,1.9949571853853696
NCI-H1568,5978,-3.194054905017319,-1.8600705601637413
P31/FUJ,25062766,0.5108470478058419,1.806873025492899
LS180,4261,0.8191216854939201,1.339264820393914
HEL,71304818,2.1837189642761645,2.1934852220305605
NCI-H1568,71466445,4.632148673172368,3.7979917113823087
PaTu 8988t,5282054,4.412677005920707,3.654277091369463
SW1573,54686904,4.039437320121271,3.740157286399591
RKO,53392493,2.7606647137416616,2.3715867351790147
PaTu 8902,156422,4.606541116596145,4.090805674848009
COR-L105,54454,1.772071227552003,2.6463618496363663
KU-19-19,9926054,2.3371072555508445,2.0360429070425594
IA-LM,3136844,4.47285753340146,4.282993098187383
Daudi,3854666,0.3283534306514684,1.4587441702153472
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,-0.35988426821631736
SU-DHL-1,72193861,-0.6645199564816581,1.086116338665071
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-0.8964341258950573
SK-CO-1,44202524,0.5946445627983161,2.003340274150685
K-562,1750826,1.7671131923879069,-1.6529051635564869
LCLC-97TM1,3854666,0.8191923722369518,1.9632522993762231
SK-HEP-1,4477,0.3599343153867445,0.6513823317038165
BICR 31,5282054,4.622453961920413,3.8693937261132283
ALL-SIL,3025986,-1.187507928097146,-1.2289862386173729
BFTC-909,3062316,2.03384364484094,1.00745220241066
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,3.947272088574224
Granta-519,444795,4.599812836973149,3.583011365740333
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,1.9935416542824564
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,1.6086984260895878
RKO,1566236,3.4833841973625725,1.897510973507293
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.6554368121237137
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.383003934619008
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,2.1156931699598873
NCI-H1568,8515,2.0721444777555327,3.921691411528513
MOLM-13,24978538,-1.2743594434772367,0.5867758886125252
SW1573,23725625,4.357604161446221,4.816175753035246
HEL,15953870,2.2428109686656295,3.236181051429246
Daudi,52947716,0.9938257746380776,-1.331574623352943
BFTC-909,44259,1.3269924163099676,0.8720104495200345
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,2.587923638103669
SaOS-2,6918328,0.1895131607356872,-0.023282774048175137
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.45286599406356
NCI-H1568,3503,1.1278876480867208,2.3956984720424965
IGROV-1,72376,-2.111352545322758,-2.2017219221481663
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,3.001947549959183
SK-CO-1,654092,0.6285789884023978,-0.4260404602270075
SU-DHL-1,44589607,1.246014317818898,2.513696107775285
PaTu 8988t,3552672,2.097731757890035,3.0786822156948848
HCC15,5282054,3.6050373222028815,3.908871140153189
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.441661447203058
WM115,16013152,3.8161355323039,3.9744833865214395
ALL-SIL,54618305,4.365324809283883,3.9884437547444604
SK-CO-1,25195348,3.743308569883415,3.3062900004493643
BFTC-909,123631,2.8792987518934403,2.3927469921911464
NCI-H2452,25022340,5.0430378131248785,2.740066360117716
BICR 31,11719255,5.311316415457661,3.2508546052960656
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,0.960633637693347
HuP-T3,568763,0.3762081962980199,0.2596949185729164
Panc 02.03,71680916,5.6819891784443595,4.5794163476875696
SK-CO-1,44484440,3.788843022204708,2.953316107627351
HCC1500,60750,4.75355506285403,-2.737113285516992
SK-CO-1,44607531,1.475264767684201,1.4379369912720508
MOLP-8,1317464,4.425962710369034,3.0984908809302216
BFTC-909,107985,-3.700699007813787,-3.4421723013542738
SK-CO-1,3025986,-0.6416687634539443,-0.6822170510911769
BFTC-909,44493528,4.370300807083883,4.251580204118992
SW48,49850262,3.202043440642355,3.2427596325642494
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,0.9973043313465546
MOLM-13,5746,-2.6320399073484633,-0.01934947176794723
NCI-H1568,36462,0.6787379731584755,2.475065120577889
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,0.7013836730863432
LCLC-97TM1,31703,-1.7062756219896058,-0.7179078046984197
BFTC-909,54454,2.6967031082973527,2.5721465484174844
BICR 31,5351362,2.0722735669158876,1.4886619913957244
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-2.7698733053770463
HEL,3543504,3.6690825601144064,4.305534112554658
IGROV-1,11178236,-2.8618715106425725,-3.4209748756598293
SW48,176870,1.305545107688616,3.025939835659683
LCLC-97TM1,3062316,0.5973926668956511,1.1626266084104215
HCC1500,6852167,3.541859976914812,2.9497909917856617
MOLM-13,54626689,4.673711949381485,4.367598130087648
RKO,11175137,2.9264569639519906,2.2857823894558305
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.4674104658910547
BFTC-909,73707398,1.325657316242966,1.4053416738559241
SK-HEP-1,11485656,3.3898088020096324,2.4034429859280313
SW1271,637858,1.8302889918552376,2.048875456179886
P31/FUJ,151289,0.3376751835645198,0.710010334712814
MOLM-13,6918289,0.5846893448973186,1.4088021907255157
RKO,4096211,2.0568907070726397,1.6394713430852008
HCC15,42611257,3.545791426903468,3.5229174523724094
RKO,51037431,1.443783779144223,3.001666019989989
RKN,1716436,3.648262431092988,3.058089891385045
RKO,216345,4.0768365061219525,3.3467539688825316
MOLP-8,54454,2.3030156333842533,2.3219397189463296
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,2.0078046195423553
SW1271,11719255,2.0964009449704335,3.2693660468752883
SK-HEP-1,5328940,3.1706915881362097,1.8264582570761476
HEL,6914657,-6.908409772348001,-4.545635579637158
LCLC-97TM1,6918878,3.384977217975284,2.5819126423403485
HuP-T3,46943432,3.2592232125577665,2.103440302606265
KU-19-19,11152667,0.8748891502312,-0.28285186754155855
MOLP-8,5278396,3.6007551773478093,3.0601817010542702
MOLP-8,71304818,1.8062780808091792,2.1103759047319874
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,1.7466143044508715
SaOS-2,5280436,3.62212536353362,3.267775741204234
IA-LM,71751553,4.579394980470846,4.282522285915687
COR-L95,374536,2.031472802797221,2.138305693049491
HCC1500,1716436,1.6304357372897462,2.85914780275556
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.2585271011001204
SW1271,9967941,4.951865473173475,3.5358895543155895
KU-19-19,6918837,-3.3861016705907203,-2.698707602997349
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,4.23500495346592
RCC10RGB,54626689,5.11978438920743,4.555858632816366
COR-L105,24964624,2.7213287093015848,2.367639266300654
RERF-LC-MS,10184653,1.661334722418144,1.7006590078077262
COR-L105,9907093,4.049740181744662,4.405003006463663
WM115,4917,1.7802954819592542,2.7401066844562605
Daudi,25262965,-3.918146889356354,-2.007859475117871
RKN,9926054,2.8101544562472056,2.0273879429211252
COR-L95,969516,2.641832541585458,2.657474828512851
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,3.1978175258427224
LS180,60700,-0.831384616867798,-0.5271636088218253
HCC1500,25062766,2.7449885477672136,2.022208858291548
COR-L95,11640390,2.478695805138082,3.1887092294777246
HuP-T3,54618164,3.3933985234085755,4.1253519268605805
SaOS-2,25105715,3.6317688538247968,3.3551636095521373
SW1271,5335621,2.365445027841909,4.37488893704425
NCI-H1568,72193861,1.9818580959671683,1.755183240668466
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.5252745732181874
SW1573,10385095,0.5068001344623563,1.4423191726299707
ALL-SIL,2841722,3.706104916487932,3.958801363291719
P31/FUJ,71466445,3.0287439983851225,3.44494143607916
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.3967451947225258
COR-L105,4917,3.658916006838,2.937865716119857
RCC10RGB,9903786,5.708919982977709,2.8868186229209214
HuP-T3,25161177,3.646148401953212,4.077165567807128
K-562,71466445,2.3693775657442373,3.117981066262
K-562,11977753,-1.2336845020581693,-1.807692640924272
LS180,16725315,4.563180557999628,4.00077053501506
NCI-H1568,66577038,1.9593359628641709,3.0989525783431633
SaOS-2,3465537,1.5281169625539155,2.2507754540892644
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,3.5618064932274445
MOLM-13,17755052,0.2343645648969551,1.0504705591654355
RERF-LC-MS,67156097,-1.006688958645714,-0.6058039248632715
SW948,5470400,-3.941225454290086,-0.4325799817450058
HEL,44185566,1.408371464536178,2.096262111921283
RCC10RGB,3503,3.522457107356278,2.423074400918369
BICR 22,9866186,0.6641273098552615,0.6237264410021759
K-562,52947716,-5.609155633475852,-0.9240981612540833
SaOS-2,1641662,3.0320316508312883,3.3808401921423634
SW48,5460769,-0.8804369809799648,2.297009427957319
MOLP-8,11625818,3.354870459420626,3.9689266612915155
KU-19-19,3025986,-0.2897675094370045,-0.870466774484268
K-562,9444,4.095192274458736,3.9328854456304123
IGROV-1,5329102,1.2794664511054334,1.983972772863884
LS411N,11427553,2.839596649209722,2.5417359608633805
SU-DHL-1,10385095,0.4695713178913991,1.077249432866983
SW1573,124202324,3.209850220678193,2.3830010868813347
BFTC-909,2949965,3.0294119536880197,2.8633581604703227
Panc 02.03,44589607,4.606435993835204,2.810846480295372
LS411N,25126798,4.124739072985443,3.7234645183008444
RKN,24785538,4.869460471506453,1.7357513619199796
SU-DHL-1,31703,-2.5255735182995203,-2.23541193904458
KU-19-19,6505803,0.0199416611110358,-0.7749391051086809
MDST8,5281672,5.754114909876849,4.675692122878815
PaTu 8988t,9903786,4.140175125497243,2.917627675458899
SK-CO-1,11717001,2.027201802005241,3.7560606073047755
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,1.674098096665175
HuP-T3,54454,3.567661200928428,2.787028827308875
MOLP-8,262093,0.615798330418347,2.307198732637051
SW1573,6918328,0.8267852089643692,-0.17820064548991407
LCLC-97TM1,73707398,0.638027637531153,1.2059658685971586
SaOS-2,11719255,3.097989779485228,3.1462560178911985
SU-DHL-1,73707386,2.8817783064824773,2.9026602013828136
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.271447314227185
LS180,9915743,2.834892961755663,0.42986027243159897
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.7557240295233554
BICR 22,4578,4.285603675470092,4.385127268930637
SaOS-2,24951314,1.4499530102948022,1.2204847173300022
RKN,6918328,0.5495182279950256,0.1544793734332435
IGROV-1,66577038,3.2148239132520455,2.985333393487731
COR-L105,15547703,4.316721747481802,3.334806012144579
HCC1500,753704,5.032412058463686,4.89365380791877
RKO,44819697,-0.2126149769206573,-0.7280103314756893
HCC1500,16013152,3.952751911590144,4.000394627141526
SW948,89183176,3.757757719513151,4.3741631541017325
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.61482478564075
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,2.336572759994543
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,2.6702926631076167
IA-LM,44819697,3.529669119404179,-0.23205865550969418
PaTu 8988t,148198,-4.283282973565046,-3.6139448916417503
HCC1500,5287969,-0.1960949732639439,-1.6783046586501686
RERF-LC-MS,5460769,5.094680634820597,2.807900650255874
BICR 22,10113978,3.5652875556244923,2.961961209193403
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.1237823233883522
LCLC-97TM1,6184667,3.4160200622822736,2.8289715779155995
SK-OV-3,44507138,1.930427516054787,2.6897405742475753
SW1271,54626689,4.884226988721356,4.572881837709257
COR-L105,25195348,2.918205578273492,3.071617038610123
MOLM-13,49850262,2.0503909100702873,2.994720376792755
LS180,104842,-3.608354535822108,-3.0827285922703447
Granta-519,6184667,3.6411271735359207,2.6649996630489556
IGROV-1,49836020,5.658436828096057,2.341136084725362
HuP-T3,54619267,3.893027602521098,4.063355789339976
SW1271,409805,4.993473873943069,4.81390597814777
NCI-H2452,2749,1.5209092727807076,2.024260130310205
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,0.5773538423306932
SK-OV-3,119607,5.6958068077620405,5.187324207220756
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,-0.0976520872227954
SU-DHL-1,6184667,2.253300303827536,2.5691478689260543
WM115,2871966,2.231269661110087,0.6079533911149538
SK-HEP-1,219104,4.349330089087446,4.0217511271206074
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,2.7511759811952476
SW48,8515,2.6507036204950256,3.4978682460758654
MOLM-13,241158,1.7093626682651633,3.0576025432900353
RCC10RGB,71576739,5.1028364410536735,3.54576914111752
LS411N,54619267,4.196494516067777,3.9171072376293767
Panc 02.03,637858,2.766769284687194,2.171293749983074
P31/FUJ,25150857,2.053516150415863,2.4489159698312584
P31/FUJ,24951314,0.294555023880993,1.1966197035314567
SU-DHL-6,16736978,-0.092754907722646,1.1019784106769144
RKO,151289,1.190219151105647,0.5284366158088964
NCI-H1568,1716436,2.664872339798973,2.9871613556542114
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-0.7889873836906593
LCLC-97TM1,49836020,1.9924259842665932,3.449784668453666
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,1.8221169247244509
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.30077266054613
SW948,11647372,1.3621251009964823,0.9328867718886836
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.7494289921713344
LCLC-97TM1,56963564,-0.6229750501206363,0.28289003303418886
IGROV-1,11427553,2.926316692603687,2.3560158336980375
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.310143779531078
SW48,24951314,0.6660870475429757,1.1090156347625995
RCC10RGB,46398810,2.467266718263722,2.6681218293485602
NCI-H1568,16720766,0.7309820541773976,0.6560011372058813
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,2.8769950424200834
HCC1500,6918878,3.8452122267855544,2.511320703458008
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,1.1923983189682774
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,1.9749021060492113
NCI-H1568,9840324,5.648333485386012,5.876068299144764
SaOS-2,24772860,-2.2454069761524416,-1.8022660680988027
NCI-H1568,12003241,-1.4870303892505918,-0.3708116949439363
IGROV-1,135411,0.626702113064729,0.7389325907411058
SU-DHL-1,123631,2.2104669936854817,2.4725346180318275
BICR 31,676352,2.5344425849235472,2.1225072544429553
WM115,2828334,5.840169576442124,6.158776051980949
BICR 31,16722836,0.993439631718574,1.6500359561815827
LS180,71304818,2.5144465721497573,2.1437844896417895
HCC15,176870,4.3801450304989835,3.3853143301297406
SaOS-2,44137675,2.8908105588075537,3.4970916264720917
SW48,57519531,1.1891467216952898,2.6118844283626372
LCLC-97TM1,46943432,0.977611384475134,1.9670741480730114
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,3.72628965059889
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,-0.7814995673487388
UACC-812,52912189,-0.0403441295384107,1.9442679962161742
HEL,638278,3.1804055556137394,3.0876873445513167
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.3929964661188485
UACC-812,45279963,4.1756281682233185,3.752276891817323
MDST8,12001922,2.1068751805520423,1.748761409833372
HuP-T3,11626560,2.4663043755994094,1.7360932403682663
HCC15,9884685,1.2743229964902805,0.6548289656376589
Daudi,82146,3.751797413920901,3.427174956524952
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.3484665672502296
BICR 22,969516,2.807563254821311,2.8130662526426717
RKO,6917907,-7.36544436443182,-5.3885939160474985
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,4.360257557846248
P31/FUJ,54649381,3.661627004097492,3.9243450413647385
P31/FUJ,15983966,-4.570279214878008,-2.1673804091728646
COR-L105,49793307,-0.7736136433109717,-2.900721863542286
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.3026976477157164
SK-CO-1,57330099,5.774767561552264,3.992916020942002
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-0.9936485613923861
Daudi,36462,-1.782907247885185,0.30164400545212766
SW1271,10077130,5.262255440725952,3.1618501814850823
PaTu 8902,124202324,2.5191853508509823,2.160721268545291
SW1271,4261,2.1417567232825157,1.7066519957773638
SW1271,568763,-0.4148311333850545,0.6025802498149802
IGROV-1,44185566,2.2104732991243248,2.390906995602848
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,1.8786725116016152
RERF-LC-MS,54678924,1.4734481784853186,2.0122089998003885
SW1271,17759555,2.4829827438054104,3.713338009434258
HCC1500,2871966,-1.8945265193529464,0.6038079670658751
RCC10RGB,119607,6.074674808773517,5.2853816530483835
MOLP-8,5566,2.8349074996791295,2.883715156943034
K-562,24901704,1.0460453676907424,2.985095778397518
SK-OV-3,44607530,2.4027946355264507,1.470600890256654
IGROV-1,44589607,3.0909001492794377,2.4665898493036873
SU-DHL-1,44185566,1.07324922266726,2.1345123786979054
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-2.065348672495934
SaOS-2,42642645,-0.01972406793895,0.9588954444600384
SaOS-2,327653,4.165382989627235,3.1081743033585867
RERF-LC-MS,44491742,4.380479941679622,4.18414041753955
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-1.5532565271806564
K-562,3038522,1.918387146447148,2.9323103109807955
HuP-T3,702558,5.633624519144866,5.15397215734296
ALL-SIL,2858523,2.9846374491002376,2.839900880137389
WM115,44589607,3.0632481185375933,2.6596620909631365
LCLC-97TM1,11977753,-2.2409153175434953,-1.7599020210222651
Granta-519,7251185,1.138949301849667,2.025041653684183
MOLM-13,446155,1.5984418257641329,2.47188316268982
SW1271,11455910,0.4702460968788743,1.404690106172503
WM115,10184653,1.7306018843706388,1.453898803598453
SW1271,12003241,-1.4062779923685875,-0.9808960979772969
SU-DHL-1,3038522,3.3518104703058467,2.8316770433241385
RERF-LC-MS,44819697,-0.3406635094896507,-0.6032205380938404
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,2.2230598438413947
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,1.835583897335534
RERF-LC-MS,3825829,3.876424055067748,3.8942252424793846
SU-DHL-1,208908,2.168834483257838,2.103668963911974
COR-L105,4378219,1.9356703916494296,2.8725471815647854
SU-DHL-1,44489675,4.002710700308593,3.9210530761458022
BICR 31,5329102,1.5123342757929257,1.9155230518836541
BICR 22,72193861,1.1787223619968317,1.4668316519244433
SK-CO-1,4259181,-0.2853622975740302,0.4629433548042616
RKN,5278396,4.050807510430523,3.681170639378448
LS411N,3543504,6.407278726964401,4.206654491865671
Granta-519,2749,-0.6711865738648753,1.326061568556667
LCLC-97TM1,11222830,0.9756157307321038,1.4796276142684983
HCC1500,49766530,0.4188049276678212,-0.813176583813355
BICR 31,24821094,2.272776200428542,2.813299417574109
LS411N,15953870,3.79326986504028,3.3830523113444446
KU-19-19,15547703,3.5460273004695364,3.076354143350329
IGROV-1,10410894,3.2660402181528263,3.351431739070601
SK-HEP-1,9936388,2.725726666175631,-0.5120614648140989
SU-DHL-1,68056272,2.8441937668208297,3.3379054434937467
BICR 31,107970,2.625018410874988,2.205656083602594
RCC10RGB,24978538,2.2083570886635258,1.3113368371036944
MOLP-8,42642645,0.4027543307161444,0.55434064349388
IA-LM,6438330,0.5920782597943414,2.438880928415163
HCC1500,25102847,3.871994319987046,2.8125167090228125
SK-CO-1,9903786,1.8148473241522671,2.780700905790561
SK-HEP-1,51037431,1.9503987957256583,3.346813461908985
SU-DHL-6,15547703,1.663295720719241,2.8501099525684026
PaTu 8988t,42642645,1.5127014290808742,1.0520693567858646
Daudi,4578,4.14840859618435,4.199206235691297
HEL,73707398,1.0006953763352662,0.6089014077271884
RERF-LC-MS,3634881,4.923247717838372,3.0792579906204964
HCC15,9907093,4.55737056946543,4.175649618071776
IGROV-1,16725315,4.890680859998698,4.259191289093518
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,1.611287542465589
COR-L105,107970,2.936160881286492,2.4291166571380653
PaTu 8902,11485656,3.4031855994132663,2.2280799865950707
BICR 31,5287969,-2.0848564793948423,-1.5876922830146287
SU-DHL-1,3503,1.2104794697541517,2.200497586524965
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,2.0461246043587975
RCC10RGB,107970,3.009214725762471,2.3792707690020594
KU-19-19,51039095,3.4730458815699743,2.80749641248715
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.299954914918973
IGROV-1,16038120,0.2864038103759729,0.9447411779638588
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.905889955734109
SK-OV-3,1323703,3.751791158325908,2.049739110631842
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,1.3313678341418447
LS180,56946209,-4.291807545115399,-4.428047011418624
BICR 22,16741245,4.124711805224883,3.6356055675069747
Granta-519,11396600,3.399615682634249,2.2196062170134043
LCLC-97TM1,4378219,2.0431586025336332,2.3957448869885116
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.7791778914113063
PaTu 8902,3062316,3.1999770976977966,0.9594638862284639
MOLM-13,9825149,-0.4975121245832732,1.79446083563326
PaTu 8988t,36462,2.8739750906545263,2.3649084381409087
WM115,4261,1.0617223830766982,1.475368121617941
BICR 31,54618771,0.3365869204450262,0.9532763754238432
IGROV-1,6918837,-2.9804518885508635,-2.810842419641798
SK-CO-1,49850262,4.729060483840123,3.5524412987413143
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.334804151937429
SK-CO-1,49793307,-2.625714785229563,-2.849348463910984
ALL-SIL,159324,0.7144692186053382,1.9593953108222018
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.5114195636962624
RERF-LC-MS,24821094,3.899392046553833,3.0286475513669666
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,3.050742972577558
ALL-SIL,54613361,-1.2150310590443698,-0.5077869088852229
MDST8,54618771,1.2096098448968695,1.1668969882774924
MOLP-8,26596,-2.4791577040777812,-2.0047321624395322
RKO,4788,5.372325515812119,5.6179935290768235
P31/FUJ,44589607,2.3901798108348533,2.766076643262262
SK-OV-3,613753,3.56222269809742,3.1432681654479677
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.6126503466630069
SW1573,2858523,3.1892649395611556,3.1328784464390527
LS180,72193861,-0.0461725132802377,1.2167501486099837
RKN,25126798,3.956068538327861,3.9805377280076057
MOLM-13,6917907,-6.412365954060792,-5.511932030008017
WM115,50905018,4.954075896774319,3.947607521809256
HCC1500,54619267,3.954111090910006,3.969077868325528
IGROV-1,6252,1.1284141516966473,0.6356173065619392
Granta-519,49766530,-2.591856607816134,-1.3281895452048884
RKO,400769,-0.364727826621167,-0.7739548609413428
SaOS-2,5113032,4.015669070835574,4.881199718042329
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,0.6586234591856416
BICR 31,400769,0.3553213589698107,-0.4174696472111914
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.8291972914938148
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,0.36347484588968976
RKO,24901704,3.90150667551114,2.825603742898329
K-562,675434,4.134192231732703,4.401432253736204
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,3.115429251402519
IGROV-1,60700,0.4424479122017752,-0.3353471260625623
RERF-LC-MS,439501,-1.3704502050640626,-2.2936453091514863
PaTu 8988t,3081361,3.3861147832051004,2.2828011038114067
PaTu 8988t,11507802,1.1782523393568187,1.779020343526297
RKN,25154868,3.091821445991922,4.308194247393987
SK-HEP-1,3384730,4.617019540739567,2.962097841735174
IGROV-1,135411,0.626702113064729,0.7389325907411058
RKN,44202524,1.6880658914716755,2.035799582011443
MDST8,10127622,1.4568360900186117,3.210798025472241
ALL-SIL,5978,-4.2912860791141725,-3.279784117214123
LCLC-97TM1,25195348,3.14182472834864,2.992381751847555
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.4896596124669852
MOLP-8,2949965,2.304667717892232,2.488718697072762
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.6877747233924254
NCI-H2452,11485656,2.991875358712002,2.2175826707726842
Panc 02.03,2708,5.654354843286421,4.985175527296771
SaOS-2,15953870,3.7774839542606617,3.2881012142598327
LS411N,11238147,4.220683195687341,2.5655142762601115
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,1.890716400613834
COR-L105,11404337,0.9270352493146456,0.12710221357957616
RKO,20959075,-2.9107192765247536,-3.1621435762196173
IGROV-1,452548,0.0422661560146271,0.3237728568329916
SW1271,25062766,1.8071163488926476,2.1928111309089617
SK-OV-3,24180719,3.148638094054939,3.556000311157189
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-1.0888444598410836
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.29873216091722093
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.5626599775548224
NCI-H2452,25150857,3.315566378385427,2.433884166986089
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,3.3632702699021855
LS411N,216239,2.6090534487015953,2.198160076080532
SW948,2828334,6.27053385486612,6.0801140633533866
HEL,25262965,-1.9607005706581808,-1.8191497173297357
SK-HEP-1,46398810,3.2056962377986333,2.7108007761437385
P31/FUJ,46191454,0.7861082656977861,1.1346760200359718
SaOS-2,11404337,-0.7935370479535776,-0.4133277666033282
LS411N,6918878,3.507421995092854,1.9158861953076731
COR-L95,5566,3.0030322186541754,2.9851451825286044
NCI-H1568,2729026,2.4592472427928795,2.753189754024813
Granta-519,5566,3.1418180472473023,2.759323522554592
SW948,15953870,3.980690301912255,3.486135203438265
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,1.9283586187998114
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-1.1891081349990669
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,1.4879606319604328
PaTu 8988t,4096211,4.042256121680771,2.15003443546501
HCC15,638278,3.5096393014384346,3.155324426645308
LS411N,44185566,2.59688005994845,2.213985667192595
WM115,15547703,2.53174585982074,3.2190196032606724
RERF-LC-MS,46907787,3.883745984979501,1.9825195826630173
RERF-LC-MS,49793307,-1.4864117200972382,-2.554755259430155
LS411N,6918837,-3.511331359252859,-3.03081157256367
HEL,2729026,2.9938268289747394,2.5145859917122313
SU-DHL-1,9911830,2.4926956672938543,2.5228564963592452
RKO,6505803,-0.9276151073099124,-0.8711120620050654
HEL,5351362,1.012542471793317,1.189448788920564
SW48,448949,2.118847083295334,1.7252927101936866
LS411N,3854666,3.592971008902542,2.0418662358253012
Daudi,55283,2.1333092426313143,2.5101519656839817
WM115,568763,0.4176363376103466,0.4128463632040999
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,-0.08717050798301472
K-562,54143018,0.8143265967368298,0.2650832168146251
WM115,6914657,-1.139050920215431,-3.6594297010456858
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,0.6735387298457526
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,2.8176584392347883
Daudi,57519531,1.0816397392331083,2.165389380323365
MDST8,9840324,7.1320098113776185,5.851263371656072
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,1.810650087842794
NCI-H2452,67156097,-0.4931697978204585,-0.22782851141885804
ALL-SIL,11507802,-0.6218585688390301,1.2126888017318627
MOLM-13,9926054,0.378361077880871,1.7642909680619172
LCLC-97TM1,676352,2.332754642745106,2.114406407553488
SW48,6450551,-0.0066484474606689,2.1652892534011765
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.36303396313420777
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,2.9481459290743417
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,2.7487857821357737
KU-19-19,46191454,1.4474607873871597,1.453879489425367
BICR 31,135440466,1.3506373291640237,2.143028500743894
SW948,44632017,0.8619787858061628,1.1803190337150598
NCI-H2452,159324,4.677055932941875,3.2284739018159248
WM115,60700,0.0008203329731028,-0.33824852998620053
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,1.7331250433149725
RKN,9936388,2.306220468641662,-1.1165351181466279
MOLM-13,2945648,3.0282797197343374,2.6399400609588803
P31/FUJ,135875424,3.622681212031297,3.8396817246199118
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-1.2230857514999762
BFTC-909,24964624,2.4776408698208003,2.527370014784273
HCC1500,3825829,4.205963950909598,3.9957641177713494
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,1.8860770736488741
SU-DHL-1,135984461,1.9491307161872016,3.1102713781938496
NCI-H1568,409805,3.8387714265583592,4.923782790191495
COR-L95,2945648,2.3261820103406183,2.9168849574295086
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,2.6139047755781006
IGROV-1,5746,1.9055212643377857,1.172553297962277
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,3.390362498795026
HCC1500,104842,-2.1208898309536073,-2.798647735396821
IGROV-1,148198,-2.659972993252853,-3.38623078278233
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.4307138992413116
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,1.5468833111443012
IA-LM,5746,4.310443233142937,1.1568036720898478
WM115,10427712,3.357641117907952,4.513147197933309
WM115,31703,-1.493876478932265,-1.1305895298874131
K-562,10296883,3.719487542859837,3.6050517548844563
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,0.8019387810964744
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,3.0554712727280497
IGROV-1,10184653,0.79276129336756,1.2925935376690696
K-562,5287969,-0.8630520858269013,-2.0659348426599506
MOLP-8,148198,-4.437033387624053,-3.780574743850349
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-0.8423261235036729
BICR 31,24951314,2.26082148142024,1.4795085195543125
COR-L95,9887053,2.0711365362831193,3.6024912674208127
SK-CO-1,2841722,4.495379043063509,4.370382523804168
COR-L95,54618164,3.8157010413732406,4.011735208052194
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.262079874399904
SaOS-2,25262965,1.6840235781335875,-1.7982393717558391
MDST8,25150857,2.921484336528134,2.2124122263983783
SK-HEP-1,984333,0.8474815446030621,0.5538340743878476
COR-L105,5311037,4.270584574919318,4.088111715004512
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,1.704136646060604
LCLC-97TM1,3825829,3.858617243526108,3.939094421089953
SK-OV-3,24951314,1.413681041410239,1.314312626970579
NCI-H2452,9903786,2.1501841215173396,2.8569875568771796
PaTu 8902,56963564,4.5637436248697565,0.13330880537468895
SaOS-2,262093,2.7398792490382244,2.799017851736157
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.645420720140745
BICR 31,3854666,2.26793763186435,2.1200412357013914
SK-OV-3,15953870,4.452396287203901,3.7401555309542176
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.1461797234284
BICR 31,24785538,2.8976650742045127,1.3702343976518123
HuP-T3,9903786,4.0743016574038915,2.727326825510379
Granta-519,11175137,2.0306520437568767,1.975167648593399
Granta-519,25105715,3.663648488967505,3.2655762242029795
NCI-H1568,49867930,4.553956635433513,4.674080237420547
HCC1500,16038120,1.5738549040879308,1.2191965823401323
LCLC-97TM1,227681,3.759896348853487,3.268216674596908
BFTC-909,49867926,6.076136735210805,4.257999267070391
ALL-SIL,5278396,3.0589186731365814,3.270259880746158
HCC15,2742550,3.2685764522673972,4.0191808953846335
RERF-LC-MS,44486219,4.018485879154908,4.200177823864131
RERF-LC-MS,462382,0.9319597157341816,0.5517005484839324
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.9201100585323854
SW1573,3854666,2.927116287337192,2.178603601631787
Daudi,9935249,-0.0031627785077317,1.8503064573899832
MOLM-13,10231331,1.9024628033326092,0.861569618786844
SaOS-2,6918837,-2.9214939411920593,-2.764689254244256
HCC1500,11507802,0.960722132601806,1.6337720036450734
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.4330016289315157
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.4880677129879105
LS180,9911830,2.83226076921101,2.402120086492721
RERF-LC-MS,11222830,1.7620759794741472,1.493110175971434
MOLP-8,6252,-2.041702184925406,0.6667213404345754
SW1271,5978,4.916909360273371,-1.6026826506588592
MOLM-13,5479543,2.5400848053862264,3.1168189068940277
NCI-H2452,11612883,2.7546488169018963,2.809066283702681
NCI-H1568,44493528,4.1542795967274175,4.272265046144494
RKN,46398810,3.1612721401313792,2.6077067269682805
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.237825705564008
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,0.154088639360688
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-0.9507255332001197
SW1573,31703,0.7694714266266048,-0.9896901888290555
BFTC-909,11238147,5.503103761619835,2.8459329758337395
SK-HEP-1,637858,2.866868896175592,2.1271725625557263
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,2.0147819143455696
KU-19-19,2828334,6.071698785304069,6.09490607613859
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,1.3995002077704661
RERF-LC-MS,2828334,5.9123201087220325,6.048839100207566
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,3.398667117229796
PaTu 8902,54649381,5.340946431274584,3.82153011562664
RCC10RGB,11214940,1.429625683961422,2.018398684852366
NCI-H1568,25195348,2.211268152441431,3.034959275823541
COR-L95,10184653,1.5221413196357014,1.1002860657236813
BFTC-909,3634881,3.6308731463535704,3.126511819230942
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.770370248119908
SaOS-2,24785538,-0.4134197784310965,1.4723225663746493
RERF-LC-MS,4705,3.292681011259135,3.2578276460782907
MOLP-8,10127622,1.9499981558353492,3.339905670124629
Daudi,11626560,0.3779689739853294,1.5158146212890085
MDST8,168312962,1.677679532849221,1.7458112692646088
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.0348724004806638
MOLM-13,10113978,0.7724135376915046,2.7346168164979603
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,2.390806004370894
HCC1500,216239,1.4805608336728902,2.251592358272816
RKN,5281321,-0.4803497212669658,-1.1724469614323911
PaTu 8902,11175137,3.538788964844938,2.6759424930069087
Daudi,10113978,1.6179427120332186,2.6229053303647056
K-562,26596,-3.6076758496321832,-1.4646108837577887
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.44701734138249266
Daudi,5291,1.8632614405000685,3.477029935968369
NCI-H1568,2874250,4.364133169191667,4.592144615595783
LS411N,984333,1.2324204412799928,0.6062163616567072
PaTu 8902,11222830,2.39915227633331,1.6251138255842925
MOLP-8,54678924,1.6307832002497362,1.5817362796341436
COR-L95,49793307,-5.549400502924621,-3.3320180258911294
HCC1500,45279963,3.5713917460093434,3.7204761775824933
WM115,54765302,3.574934655958074,4.13628508064699
SaOS-2,136227924,4.496792726095474,2.878251460856204
NCI-H2452,107970,2.3345640718356364,2.2721551385965157
LS411N,16720766,1.2713952174238143,0.5265043301793821
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,1.1999445457015534
MOLM-13,216239,-5.069803023561943,1.8399116087541934
RERF-LC-MS,44241473,4.536869636330491,4.7440995578216185
LCLC-97TM1,10074640,3.2021543880531156,3.1521633853976003
Panc 02.03,10296883,4.297264305827386,3.878174375628404
IA-LM,3689413,-4.432004355370191,0.17216109723717982
RKO,375860,-0.2095842697906711,-0.07615417986574922
HuP-T3,676352,1.9029965224961456,2.2008313814200817
SW1271,5470400,4.349220092525355,-0.12616752562087094
NCI-H2452,656346,1.056906556032961,1.084178557304578
BICR 31,56649450,1.7574149169243078,3.3909918820862748
RERF-LC-MS,24785538,0.8057743011820994,1.4508111573996358
SaOS-2,9825149,0.8893885919981879,2.4163147111462866
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.6085229287929828
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,2.6980835924198825
SK-CO-1,638278,3.4780853527987854,3.0751544488523512
WM115,4096211,3.685037910266886,2.016570277566261
RKO,126941,-5.081226966265268,-2.918664297635958
RERF-LC-MS,54618771,0.9955970244631366,1.0634298776807876
Daudi,50905018,3.9297282000687312,3.8381546438299865
WM115,11609586,3.058244435077658,2.7226368674299586
BICR 31,9926054,1.721382648019371,1.9485352121747612
RKO,24821094,3.7157598247146977,2.8650751721784116
IGROV-1,135440466,0.9791523710816318,2.2914830981632557
NCI-H1568,44202524,1.0522971592210668,2.026717575668278
HuP-T3,9933475,3.0776536859408807,2.162062242638202
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.211993388616873
BICR 22,11612883,2.729453217725868,2.5838051652772043
MDST8,25154868,3.4078840547236333,4.362097252585863
WM115,12001922,1.1273981641266086,1.8581586804561103
SW48,2742550,3.28553671385033,3.4697779254745007
WM115,445091,3.8598878691820886,4.330051622851277
RKN,135875424,3.6230459419726526,3.6383149056822264
BFTC-909,2708,5.254338200716292,5.0269491998894456
SaOS-2,2871966,1.7918423486815835,0.44201701267252147
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.1527369381133252
HCC15,44632017,0.3758817607479284,1.297001636091566
COR-L95,2729026,2.664378744829576,2.6482385935999297
SaOS-2,1566236,1.7620742085681662,2.332985549161373
BICR 22,11955716,-1.4294009955010087,-1.2796387670061316
BICR 31,2729026,2.966794528433677,2.637931612210538
COR-L95,119182,-1.6347192148686482,-1.1998979340409581
LS180,5328940,1.742567210928755,1.363407440198482
Panc 02.03,46398810,3.420081587494409,2.6280984641856513
RCC10RGB,60700,3.171193268028763,0.06473867928980365
SU-DHL-6,451668,-1.4332734905345434,1.7522350161781557
Granta-519,16219061,2.116318709414125,2.6328424403428428
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,1.079237800940483
HEL,53232,2.5038982548529747,2.7679662759838037
RKO,44507138,3.480554434186059,2.2268200045949373
NCI-H2452,3081361,2.98247650375621,2.416744685851449
RERF-LC-MS,44202524,1.2785968032229695,1.9150626380808031
RERF-LC-MS,16722836,2.4162442447682193,1.6938541747549
HCC15,637858,3.032734575357801,1.8893238683557108
IGROV-1,11396600,3.99372654279783,3.5690589960856185
BICR 22,44202524,1.658152527320416,2.2160515493458304
MOLP-8,54618771,0.2679151571300236,0.7801374740617228
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-0.9332390668957221
LCLC-97TM1,54678924,1.535359034662644,2.0734631260406
BFTC-909,49793307,-2.946331542038894,-2.813198389220475
KU-19-19,5738263,3.812580710038467,3.3310363136546437
PaTu 8988t,24821094,3.93253598055128,2.9469270976642448
LS180,148198,-2.644013472885731,-3.7558901559753632
HEL,409805,5.92709656224454,4.445431328099136
RKO,11612883,3.106052261550285,2.489290163244429
SW1271,122327,4.37632222345113,4.635793973578567
MOLM-13,44241473,6.124350775268443,4.428539191385399
HuP-T3,2126,5.715410620657667,4.710054023037705
K-562,5291,-1.1872539047134878,3.667990743998411
RKN,5282054,3.624299707956654,3.719608708285303
BICR 22,613000,2.6534426018316277,2.3345364162762605
HCC15,49850262,3.6300454046422774,3.4879484795095292
SW948,613000,2.5939391420023212,2.4807259550111054
COR-L95,135440466,3.0574476104836914,2.262585603440469
SK-HEP-1,262093,3.158620019748703,3.063311751089837
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.807375936595108
MOLM-13,123631,1.0914116119684203,2.2552941696834448
BICR 31,4378219,2.049792351388142,2.6096362280172163
LS411N,16722836,1.825979837410603,1.5096786561403528
SU-DHL-1,10074640,2.3568880289385654,2.837051408455506
ALL-SIL,6918328,-1.7903684912223865,-1.2986137444925643
SU-DHL-6,3384730,1.0298608560692932,2.123297112542372
SU-DHL-6,11485656,1.7981230616770194,1.996695495028974
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,1.6795327561706876
NCI-H1568,176870,1.641159934282528,3.024436687287446
HEL,5280436,3.9989145330348896,2.8070037287075693
BFTC-909,5328940,1.2290524134113243,1.82935554870012
SK-CO-1,151289,0.7492352886663923,0.9438006286919864
RERF-LC-MS,104842,-3.024577047260716,-2.466534174874679
PaTu 8988t,46843906,4.444995617536364,2.9459536490351614
BICR 22,24856436,-0.0251718817877118,0.4127675982721159
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,2.0318740572336416
IA-LM,67156097,4.3159050642226,0.25367636315843545
HuP-T3,6438330,2.3942211080747837,2.2559005561989602
HCC1500,10296883,3.843895309810077,3.541870484688055
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,0.7143905844999421
SK-CO-1,56946209,-3.7989193199280016,-4.200704440749763
Granta-519,148198,-4.763660659469611,-3.784876804573021
HEL,4917,2.9031193377759603,3.1101264326012124
RCC10RGB,66577038,3.312011612499516,3.068417921499482
Panc 02.03,3689413,0.2165954212360822,-0.22348284056978673
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.6319763238609173
SW48,241158,3.5185545260205364,3.321263662301084
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.0851916142294578
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.3755688425577732
K-562,11167602,1.4540526159902811,2.165341654734653
HEL,9911830,3.2406370139452134,2.08064441052197
SW948,25150857,2.687963392787196,2.388030473105061
WM115,44137675,0.4260207876885596,3.3888623939289624
SaOS-2,4917,3.064827494863108,3.0470838233968345
SaOS-2,3503,1.987605483793098,2.3926399815742445
LCLC-97TM1,9840324,5.858053248657865,5.82904315446005
RKN,11178236,-3.061903912386503,-3.352213374188702
COR-L95,46843906,2.16387123849571,2.6365879797460137
K-562,46191454,1.7723208241237427,1.43942959232011
LCLC-97TM1,5746,2.627938158922912,1.0817942595770087
RERF-LC-MS,613753,3.34976336152667,3.1015504003234975
HCC1500,9823820,4.617789125102065,4.062749892518039
PaTu 8902,49793307,-1.5016152541437175,-2.5504874518574714
LS411N,24964624,2.837560916730962,2.2410524342257294
Granta-519,42642645,-0.7384711962533689,0.7777009834230306
Daudi,156414,0.7854974484116999,0.831498949179359
HCC1500,9840324,5.570797833564005,5.704985116392496
HuP-T3,6914657,-2.995276103152913,-4.1081279409563765
SW48,11178236,-2.976969958039468,-3.826149904301186
Granta-519,11214940,1.149911870185247,1.57700828832751
Granta-519,72734382,4.317814968690637,4.066754478295804
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.6692529801466423
SK-HEP-1,15983966,0.8278271069258164,-0.7314809547557515
BICR 22,6610355,3.5129220888937622,4.252627355185513
HCC1500,44489675,3.6836892776405854,3.9141750729613665
IA-LM,3634881,3.385658224323674,3.1796747586481438
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,0.9602565477169223
COR-L95,4788,5.892645370038274,5.5481239853438025
NCI-H1568,11717001,4.19629869858104,4.126210066299828
RKO,46224516,2.430810450928805,2.3550729322939477
LS411N,6505803,-0.6536233604701492,-0.6466134774420843
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.402069490223488
HCC1500,16725315,3.090868252599208,4.295033513196586
Panc 02.03,5287620,-2.132468814908427,-2.1035830638037445
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,-0.237664799078767
LS411N,5351362,1.130738510814583,1.5186131967667709
IA-LM,168312962,3.008218706470952,1.9724856904244528
SW48,9887053,1.6385742110161594,3.7503969871357157
HCC15,2945648,3.8992008266513305,3.0704161267255508
WM115,10385095,0.3137764342063494,1.2540027078716003
SW48,11213558,0.38171338020492,1.7991966739003735
IGROV-1,9911830,1.9130562323799436,2.416040327768969
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-1.7707023243895508
LCLC-97TM1,5284616,3.038958191933125,2.65312380541348
SW948,5311,0.5245292911924586,1.3497440389277844
PaTu 8902,2949965,3.498586647815041,2.7022717241661276
PaTu 8988t,53232,5.050646647161413,2.7642478971043145
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.3042382502616002
P31/FUJ,2729026,1.895106624580685,2.770391332248132
SW48,568763,-0.0201118962331156,0.21202619887613244
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.090069651345156
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-2.962403702241985
SK-CO-1,54454,2.352526453014332,2.7696928322722174
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,2.224215485812153
SW948,151289,0.9927868711009586,0.8052319291422175
RCC10RGB,676352,2.417271143726191,2.259840665624564
LCLC-97TM1,15953870,3.316413299321368,3.303926916141739
HCC1500,252682,6.335850466863892,6.496578665798756
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-1.0135161799532937
SW1271,702558,5.67814751001827,4.806954628860509
HEL,3503,1.2339935625044716,2.2533641500128194
SW948,6918328,0.2458443826474451,-0.10249594414239933
ALL-SIL,124202324,0.3755400921280209,1.942739655238038
SW1573,2729026,2.4001203305493397,2.729583217228243
SW948,57330099,4.403961221202979,4.103752884623236
UACC-812,42642645,2.375397400257474,1.1470405300034578
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-1.445982930925497
PaTu 8902,984333,1.3011106079808883,0.6825624189431986
P31/FUJ,135398516,1.7387657861081838,1.6596943570039995
WM115,46224516,3.0669076127990276,2.4379264989561324
SW1271,24771867,3.777194428597206,2.1890457159154617
HEL,73707438,4.0836720937600175,4.179689187635911
MOLM-13,16038120,-1.7825288578452578,0.481529488306463
IGROV-1,10427712,3.944243047938238,4.323529603139886
LS180,3815108,3.93048377981505,2.6548325015538374
HCC15,1750826,-0.4775912601104041,-1.5528606603823298
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.124150777772284
P31/FUJ,42642645,-1.1469220315427042,0.9012100982130745
HEL,1750826,-3.7677259179114047,-2.268386987035655
NCI-H1568,25183872,-0.3156837582718859,-0.691271224371046
SW48,54143018,-1.2192841502688678,0.6778685042098769
SaOS-2,441298,1.6833347099113902,2.8060763904639363
SU-DHL-1,119607,3.7964753700545546,4.911036725542942
LS180,654092,0.275565618798522,-0.39875731986112145
RKO,6918736,-1.762610939534952,-2.019944784037813
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-2.771981580633321
SK-OV-3,168312962,4.003119281373622,1.6631546451550334
PaTu 8988t,3062316,1.6786738127042626,0.49974696466576113
P31/FUJ,5746,-1.0128835373821496,0.9394158292560895
ALL-SIL,46943432,1.7359798293614472,1.3220408201263552
IGROV-1,119607,5.004384040905396,4.862864783836668
LS180,135440466,2.758543039731734,1.8028953952436257
HEL,15983966,-4.130179752932702,-2.4227046125611595
SW948,11228183,2.319596035574442,2.113086252253628
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.4692722306835462
NCI-H2452,219104,4.089454197150707,3.8180319425114932
LCLC-97TM1,24856436,-0.9719468010392746,0.4649925118837767
WM115,1716436,2.084402062067542,2.7362258568613864
WM115,54596558,3.929397107249587,4.386172907486191
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.465774437261281
SW48,2828334,6.103861625006206,6.063265427434269
Granta-519,5335621,4.386788840750005,4.524396948626847
NCI-H2452,25105715,3.487348959516136,3.405799751162624
LS411N,11152667,-0.1489697958567156,-0.6500567452157511
HCC1500,4259181,0.9827468065480526,0.257773883344491
SW1271,1716436,3.164329770032204,3.0761837220243815
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.7234292637889085
KU-19-19,637858,2.3404288739792314,1.7331957638299342
SK-OV-3,3081361,2.5908903164469317,2.321203381224764
BICR 22,10322450,4.612637955736889,3.9159349651049604
ALL-SIL,44819697,-2.9345943950607136,-0.8427886748644035
LS180,4259181,0.5796574720850999,0.1902590202145763
IGROV-1,6918328,-0.5330006254346346,-0.07538236634536082
RERF-LC-MS,11178236,-5.98494163410248,-3.1542099468134803
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-1.1667315119635295
IGROV-1,11485656,1.900409616013456,2.099946220068879
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-1.1670192822071082
BICR 31,16065773,3.973194001978765,2.47566329739449
IGROV-1,6252,1.1284141516966473,0.6356173065619392
SaOS-2,135398516,5.990406168261382,1.8647883340055293
RCC10RGB,11485656,3.364959979667133,2.436869126936511
NCI-H1568,46926350,-5.085925204635643,-3.9708367389404158
LCLC-97TM1,123631,2.4246211789463445,2.4995485362498417
BFTC-909,44185566,2.75887016136311,2.69448310316549
BFTC-909,124202324,2.9321657702899295,2.503902631958207
LS411N,4917,3.429074291339912,3.0378264666557016
BICR 22,135440466,2.8663984884678513,2.214611516574347
HCC1500,10127622,5.201205269222406,4.323006331961519
WM115,24748573,1.2650334763374356,2.3819627809573385
LS180,17755052,1.7669119525953814,1.1700606532464306
HEL,5278396,2.941082820113368,3.271288633797903
K-562,6917907,-5.621792844351372,-5.6767890903035205
WM115,11175137,1.8074191527620995,2.7054169261053715
ALL-SIL,6610216,3.679901693613009,4.029299889886705
IGROV-1,3815108,1.915722485757852,2.7573634377634972
IGROV-1,44491742,4.406671418311328,4.177950360373246
NCI-H2452,11647372,3.7610160121318055,1.4566987328374776
Granta-519,25262965,-5.6090339200635375,-2.220680981507529
HuP-T3,5287969,-2.0305885584054693,-1.9952902558460108
Panc 02.03,4578,4.394890119629889,4.4392291490100035
PaTu 8902,46199207,3.581196343990194,3.096461659588158
MOLP-8,5329102,1.1360795478534944,1.6583789339616888
SW1573,24797083,0.9725439959134782,1.4090536260831052
COR-L105,11507802,4.378208095645504,1.9694003748047555
SK-HEP-1,10385095,2.0924930980552148,1.5290485738280837
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.561635317757848
MOLM-13,54618164,3.841266236609366,3.8187517490362484
SW1573,5287620,-0.7347028317725576,-1.9949500901425543
Panc 02.03,24821094,4.183998590604807,3.1121776852742453
NCI-H2452,11977753,-3.0535753971711617,-1.3441634980937331
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,2.8944980520209356
K-562,5278396,3.2143611477277325,3.382564944423054
MDST8,46907787,1.4338285439483007,2.5018611141227867
MOLM-13,16219061,2.363003680724254,2.51446607383484
IGROV-1,3854666,2.3355254440561137,1.9310241326835
LS180,11175137,3.0855574956004506,2.2888483469309864
PaTu 8902,24180125,3.5735575491444505,3.0503221047074205
Granta-519,135440466,3.2501433765769097,1.9414354535442966
Granta-519,3634881,2.8250958488191533,3.173033513346813
BFTC-909,24785538,3.0409365635840433,1.5576730136669394
Daudi,9903786,1.3988461789185107,2.4231233355087998
IGROV-1,126941,-2.246216453812328,-2.350553410885426
HuP-T3,327653,2.4979616286385573,3.19657253331187
KU-19-19,24785538,4.6207321752497545,1.5059346951233261
PaTu 8902,11238147,5.651020754323713,2.845099116971673
P31/FUJ,24772860,-2.926152167827307,-2.231307416900522
SW48,969516,2.6010409472277303,2.7326745945114768
NCI-H2452,11656518,-0.3763326461825258,1.7318986945255026
LS180,156422,4.137124258725139,3.8363211814026714
K-562,16038120,0.8140588279430221,0.9603293176207596
HEL,9956119,2.2634866876643924,3.4309388178393037
MOLP-8,16013152,3.9032026583920656,3.7360937500097253
SaOS-2,7251185,2.1177882155213488,2.361904017066302
SW1271,16722836,1.1489272284540188,1.8312296120952465
SW1573,1750826,-4.895155026964416,-1.3856093211595784
COR-L105,6918878,5.053406021852451,2.701940601762309
HuP-T3,44566777,1.596285673654969,0.5468445247270796
RCC10RGB,11167602,3.5267453541831695,2.707212727926578
KU-19-19,3689413,0.155027117273248,0.07780308112493102
LS180,262093,3.1953995116592826,2.8023698766466287
HEL,168313016,4.358661125075543,4.35917900197088
LS411N,448949,2.5849168666236273,1.954983351887715
RERF-LC-MS,11507802,1.168612691302407,1.0275971420654613
RKN,3025986,-0.1432368238740909,-0.870340172707094
LS411N,5566,3.1552423609786153,2.8417518798096575
MOLM-13,168312962,1.173226591058953,1.0487363947549762
KU-19-19,16741245,1.8623441782077492,3.777334839433401
BICR 31,5746,2.9612823230829592,0.897078951040442
RERF-LC-MS,448949,1.7883798522328354,2.0902269994391647
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,1.894488862444513
K-562,135411,0.731253239019591,0.3412051381225008
WM115,3825829,3.803690072721518,4.169556381595203
PaTu 8988t,1566236,2.792784501487116,2.5341730590674656
SK-HEP-1,25102847,3.375423501622406,2.471500099623515
RCC10RGB,4378219,3.5112219508307017,2.5727758453961225
IGROV-1,46907787,2.182756719431072,1.9218123634855302
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.3540877477003583
COR-L105,9903786,2.948812050867326,2.6641325768225204
SK-HEP-1,5287969,-1.6185163943497696,-1.6744722430841634
LS411N,66577038,3.114674219164565,2.8981700977738365
LS180,11152667,-1.0678137233062412,-0.8409928836308903
SW1573,10322450,3.835483834832597,3.9185663653534215
ALL-SIL,4369359,5.632204520937589,3.3421152986374487
P31/FUJ,6918289,5.395091759648689,2.1887775402245393
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,3.080541126681482
BICR 22,54626689,4.975060177279609,4.457764422392925
RKO,11455910,0.1271196393609195,1.018475058020878
NCI-H1568,2749,1.8950065449811435,1.9291112653618763
SK-HEP-1,2858523,3.173409588420467,3.116387507514275
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,1.466742471724336
NCI-H1568,16736978,1.0202421307584555,1.6120844439904902
NCI-H1568,11640390,2.883529605834316,3.585400745219924
SaOS-2,375860,-0.2844076074043694,-0.2923704209027161
Granta-519,9549297,1.4990763156673828,2.0487278765109234
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-1.8059911781425058
MDST8,9915743,3.1722151191536607,0.7887001994832591
HCC1500,7251185,1.592161448601532,2.396670654190226
PaTu 8902,654092,0.4014878659730266,-0.4506966746952792
HCC15,36462,0.276886424919507,2.1145989470391475
HEL,11222830,1.7664464656365049,1.2444208463513307
LCLC-97TM1,6918328,0.5489211755624944,-0.12356044761616859
SW1271,11427553,2.280233400826346,2.7421312544682475
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.5600952877924132
SW1271,216239,2.3992651597700805,2.549101430203209
LS411N,52912189,2.124177170278397,1.5419977315809157
RKO,262093,2.7220373961576834,2.8476256825889847
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,3.039049235307056
SU-DHL-1,24180125,2.3898229933344193,2.7450442199715694
P31/FUJ,10231331,0.360402840185862,1.990264003337049
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,0.9998597486198767
HCC1500,4705,3.1720127097688073,3.1665342540361543
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.86690769402458
ALL-SIL,49793307,-3.5976005593324607,-3.3727515856256884
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,2.5151671049297937
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.3710280074230594
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,4.744457865580509
ALL-SIL,44489675,3.868517697091687,3.9270202110146117
COR-L95,9825149,1.4009706639997015,2.0729723137893123
SK-CO-1,25102847,2.4259034566713087,2.4725721981988253
COR-L95,36314,-2.5383774872687743,-2.3010008110484472
IGROV-1,1641662,3.5854177848263675,3.5281859689438635
BICR 31,16720766,0.8786813091838682,0.5951892043144899
BICR 22,51037431,2.6213243445689254,3.2373972345353486
BICR 22,2742550,3.9616050819266326,3.815079874178959
Panc 02.03,46843906,3.852893526574364,2.9949094605037
NCI-H2452,2708,3.4614923437122704,4.850634301651217
RCC10RGB,15547703,6.556615668020641,3.4919897803335407
RCC10RGB,5311,2.218274000934613,1.604489240381493
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,2.4814350388506856
LCLC-97TM1,24964624,2.5877637900313384,2.244757849388156
KU-19-19,107985,-2.420790531142743,-3.6637758080576823
PaTu 8902,67156097,4.866613623772486,-0.7235014475592753
KU-19-19,676352,2.681008284282423,2.075273946737664
NCI-H1568,67291369,4.628091486396258,2.46889868293869
BFTC-909,54143018,0.6300785047889099,0.46044396106856483
BICR 22,5329102,1.9183442886017033,1.8826901162625704
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,1.2102180795812887
SU-DHL-1,1641662,2.0867851207635044,3.07667336096786
SU-DHL-1,54143018,-1.2287450259829942,-0.11746615777428915
WM115,3552672,1.460151745141153,2.6663062175815053
Granta-519,6505803,0.3707466177802866,-0.6609448610954631
BFTC-909,2733526,3.41724914482818,3.8297482450747573
COR-L105,445643,5.447871607768224,3.8710281263019373
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.444467923280398
COR-L95,135421197,1.4504202802892363,1.8664232010529807
BICR 22,4096211,1.2113689067872688,1.9200086528833227
Daudi,241158,1.9180708700138325,3.0532319397706194
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-2.9398716416970405
COR-L105,44543605,3.798835657012519,4.285575502165328
NCI-H2452,1641662,5.47511848960003,3.5903740203409438
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.238925840678319
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.35672987539270395
MOLM-13,44489367,5.70063080501961,4.487560988493126
MDST8,9936388,-2.5080849755955485,-0.5366000551536639
Panc 02.03,5311281,4.827416145020449,2.477950179344325
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,1.5079077562296115
Panc 02.03,71466380,5.929652601038649,4.3821452855195755
BICR 22,148198,-3.168643556299537,-3.3664328480811765
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.744038278767512
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.065601106225925
MOLP-8,36462,-1.3356090090333852,1.2176893869892709
RKO,168313200,3.1169425006108455,2.71113751170526
SK-HEP-1,24951314,2.4991128927954063,1.3612305198061758
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,-0.4962377134078927
COR-L105,71304818,2.509036292239667,2.4952466980781525
LS180,11485656,2.0322073649322716,2.0152865216197
SW1271,44185566,2.531281599529394,2.544056919358159
P31/FUJ,49836020,4.674155414221834,3.3197109166748078
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,2.6463653598762233
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,2.769441618168239
RERF-LC-MS,9933475,2.253072026550434,1.9446003859499934
SK-CO-1,24964624,3.1718881088721735,2.3608327799368203
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,1.619060031107935
LCLC-97TM1,54619267,4.094508182091097,4.021894055078195
SW1271,53232,2.609582991635379,2.953017155102829
COR-L95,5282054,2.7623794331923293,3.5145459489214774
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,0.7445752460171943
ALL-SIL,2749,0.4174204822378836,1.4658419056634187
MOLP-8,11455910,0.4759456923848041,0.6476300597033656
SK-OV-3,5329102,2.1848030817162427,1.9305613561873645
IGROV-1,5978,-1.5618214380165825,-1.409970807085074
BICR 22,135411,0.5903998872112299,0.5599314418299425
NCI-H1568,6610216,3.52063980115584,4.249680683047467
SK-CO-1,176870,3.965368978694832,2.9673794078823423
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.2675168159205383
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-0.9187291468517129
IA-LM,9936388,2.150111055311291,-0.8557529841067992
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.5927062884017285
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.659161603503658
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,1.1276112745764946
P31/FUJ,11214940,0.6332731592867608,1.8253159543903679
WM115,421610,3.513747492259629,3.125082261874549
SaOS-2,227681,4.210698048028356,3.3121658675875536
BICR 22,25102847,3.5270600092516444,2.599790986412732
BFTC-909,46199207,3.2760821272908753,3.175424305140949
IA-LM,25154868,2.8804249714329537,4.178559918094757
SaOS-2,5738263,2.656867973667437,3.2404523117650093
BICR 22,5738263,3.828959854789421,3.2320753712977623
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7644504953766773
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.6589059876566292
Daudi,24771867,-1.2539165255857252,0.8353652370577597
Daudi,446155,1.8075236258569949,2.6020454748037225
LCLC-97TM1,56946209,-4.83981355951691,-4.257218831714498
BFTC-909,702558,5.601571619782522,5.08177612837614
LCLC-97TM1,24797083,1.6672233423539589,1.3228137759633256
IA-LM,2945648,2.6647419367463794,2.596085350098039
LS180,11717001,4.39666521822979,3.8694096589842952
LS411N,42642645,1.4293896003043414,0.5884393216426117
SaOS-2,16038120,-0.4228492368909831,1.0988444964651667
HCC15,387447,-3.5284625014182556,-3.6627847308010284
K-562,24785538,3.0712560410264436,1.3937558561080727
PaTu 8902,6918289,3.1585202712855196,2.501081700270461
BICR 31,11404337,-0.6318210319309021,-0.5694477269857932
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,1.1330086695710349
LCLC-97TM1,5460769,-2.8089441547625067,2.5503869465379134
IA-LM,25150857,2.846024040084871,2.242859244769457
HCC15,56973724,1.575466068691269,3.201448471361694
ALL-SIL,3384730,0.9130815120154347,1.8520487022564565
Daudi,426756,2.2442144831253383,4.014774625652851
NCI-H2452,6918328,0.3371182351616307,0.08109463540044047
SW1271,11364421,-1.228057709924225,-2.047550103846708
HCC1500,9911830,2.253316240952314,2.587908888066756
COR-L95,60750,-4.239654973449372,-2.5938223187971534
COR-L105,675434,4.897128449999278,4.585902842490039
RKN,5978,-1.5379865785523688,-2.258903171228492
BICR 31,1641662,4.3069637553272715,3.4590880588993156
SW48,5281321,-2.141746406212142,-1.5084577606359175
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-1.6790346072995865
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,0.9242688139921809
K-562,12003241,-5.632155645383806,-1.0463193637479906
IGROV-1,11455910,-0.2792640061206097,0.9550249751381678
COR-L95,10410894,3.9632969340699735,3.1771779893432917
SW48,5351362,1.0988845715277948,1.338649902973384
HuP-T3,9907093,4.467626530245781,4.204144246756506
IGROV-1,16065773,3.3717508464278585,2.4362071390253006
Panc 02.03,439501,0.4668648826805023,-2.3573098335983733
COR-L105,11427553,3.315123926488956,2.804280827861876
IGROV-1,119607,5.004384040905396,4.862864783836668
BICR 31,151289,1.9519908762907336,0.9371689437124684
SK-CO-1,60700,-2.5556595153787915,-0.298427927009078
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.150701244528428
BICR 31,3825829,4.543850483279072,4.018598066828286
SK-CO-1,65064,5.377201033407044,4.883721535707482
HuP-T3,613753,3.2946831222357233,3.164151809903497
SK-HEP-1,89928392,1.6602086186634375,1.8898501891427455
NCI-H2452,5291,3.747673065274588,3.7613144757953028
NCI-H2452,24964624,2.8171716992687967,2.48065837853828
SU-DHL-1,654092,-1.6609972231677514,-0.5094383970440124
LCLC-97TM1,327653,3.202975625508304,3.158914615083684
LCLC-97TM1,11507802,1.3666879232460134,1.6106194539733105
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,0.6773438409485207
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,3.444635373329736
SK-CO-1,11222830,1.7982943188317977,1.5281454045512723
WM115,24951314,1.781657055553587,1.2987034025354895
WM115,135421197,2.9135607351561883,2.1033423283146884
LCLC-97TM1,136227331,4.3740550996774745,4.132022300851179
BICR 22,24951314,1.8959621159637303,1.0886017284121576
HCC15,15983966,-4.250826265389746,-1.384814781219697
Daudi,24964624,0.5895170730703193,1.9899912240539939
SaOS-2,11257553,0.2323229130258903,1.2488645419117799
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-0.9707554079167838
RKN,46191454,2.1430961760764897,1.499342815986934
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,0.3557223799155505
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,2.961247467021416
BICR 22,10410894,2.962619033825151,3.1123351132552517
NCI-H2452,168312962,2.634597095527088,2.125316033141984
MOLM-13,452548,-4.1979459883625045,-1.2923274667085471
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-0.8367139101869155
SW1573,44185566,2.872643000979188,2.5047093946209844
SK-CO-1,5470400,-5.490738264790885,-0.4525248988337422
BICR 22,9933475,1.970614134756263,1.9307441160436343
BICR 31,24753719,4.233476426959058,4.125729587166446
HuP-T3,4261,3.8165819220848767,1.6467333007787892
COR-L105,7251185,3.034502689275401,2.393380550115347
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,1.415408978990759
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,2.035164567837696
SK-OV-3,49793307,0.1269396758315965,-1.9102463671544976
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,1.1574007476102444
KU-19-19,216345,3.688803948438149,3.7837869652274185
LS411N,638278,3.5631537252490917,2.989727166854296
SK-CO-1,374536,2.850215581982446,2.1660243844410507
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.8323645292919166
P31/FUJ,11178236,-2.454576103037029,-3.308895753991041
SW948,439501,-2.1692174321648174,-2.1658009545425845
NCI-H2452,9911830,3.1691750432917645,2.8726580944999296
IGROV-1,9911463,4.195269991960018,3.763435061912179
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,0.9829137785245835
KU-19-19,46199207,3.5920417522591723,3.1726374240152797
IA-LM,25102847,3.5065737869109017,2.542324203050688
SaOS-2,10385095,0.9171223668306429,1.101316440284221
SK-HEP-1,285033,-0.6546577384402199,-1.813297920699399
WM115,1566236,3.8332358430398847,2.4673665206685453
LS180,3025986,-0.3657173630682503,-0.9680541976850912
HCC1500,11625818,4.269459310239442,4.442178581338476
HCC15,44259,1.006506996100477,1.1072656860920411
RERF-LC-MS,285033,-2.0574538896256587,-1.9731617689082324
IGROV-1,241158,3.288496474515495,3.854946685728569
BFTC-909,6917907,-4.2174557642594035,-5.335297233908181
BICR 22,375860,-0.6251605141105395,-0.26452389616414973
BICR 22,119607,5.438520616053313,4.963940640440139
RERF-LC-MS,676352,1.6328584527608256,2.0390690511929535
HCC15,6918289,2.816502870816243,2.5779775152208417
RKN,241158,3.8611150596916577,3.8888935163413922
COR-L95,3634881,3.005165393659793,3.0703232725507466
IGROV-1,11626560,1.7276653519578558,1.779816028949293
LS180,3385,1.8718372753364907,3.4499243176930996
SU-DHL-1,56946209,-5.3778659012875325,-4.481977619694766
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,3.93441004232291
NCI-H2452,448949,2.771204919609998,2.1848737603774886
SW1573,5113032,6.532830278238065,4.956400691883614
SK-OV-3,11485656,3.3782074628341894,2.334445248291094
BICR 22,81146,6.036644504914818,4.707423132528259
P31/FUJ,76446078,4.256026108364254,3.736318399403908
Daudi,2113511,3.606563716227827,5.1990650782654
HuP-T3,5328940,2.3682781464336147,1.7255685906601261
RKO,6852167,3.601912647929868,2.5863297657361004
SK-HEP-1,1750826,-4.478019715406424,-1.4583621776216527
SU-DHL-1,25102847,1.7846654255237482,2.4847476919801466
KU-19-19,2749,1.0704171129437314,1.9107346615941898
COR-L105,136227924,2.729950058152846,2.736008282304049
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,1.829153988619997
RKO,25154868,3.654559992823761,4.102879845703822
HCC15,5113032,5.023051877119823,4.819141904317351
LCLC-97TM1,3815108,3.2576294300862867,2.868391026208592
SU-DHL-1,6610216,4.061950863639378,4.159391568628003
LS411N,136227924,3.1900427132689724,2.7544369606718693
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,3.42680887854031
KU-19-19,51037431,1.6044173216619535,3.25971442212696
MOLM-13,637858,0.5048034575879493,1.2671864348422153
SW948,5329102,1.476566645762777,1.9682392795743624
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,4.746262459452348
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,1.8110015857047
SW1573,1566236,3.3872191513469025,2.435091179231738
IGROV-1,46174525,4.5083762186279595,4.459478612556566
SW948,9956119,4.230492181635778,3.761893323758938
SaOS-2,100016,6.565789067704999,6.097979262963006
WM115,11152667,0.9737214532192616,-0.5588781444757348
HCC1500,439501,-1.4156205398968564,-2.1457369167343243
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.721614638378232
NCI-H2452,49793307,-1.217787389832333,-2.189288312611659
BICR 22,208908,1.938925459708866,1.8220005166431539
KU-19-19,675434,4.307992798559183,4.655209633738831
SU-DHL-6,168312962,-0.817402334599034,0.8534363314517723
RKO,4705,3.750134101835121,2.950988390532982
MOLM-13,72193861,-0.3301410770598842,0.7879428818460681
SU-DHL-6,11497983,-4.838706392617486,2.2828795256649754
IA-LM,6610355,7.432350505906943,4.5859710046551445
SU-DHL-1,100016,4.0163007651424945,5.775655652203625
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-1.1653064157755242
BICR 31,11717001,4.942461846011657,3.941440234921294
MDST8,452548,1.517979290481689,0.25854582458592346
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,3.2086368449491545
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,2.1447527664974926
HCC15,216239,2.699139377969599,2.2570174988551046
SW948,54143018,1.1269042701713536,0.20154083686034296
PaTu 8988t,2871966,0.7913795837456433,0.6490199077033858
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,4.114631273878665
MOLP-8,702558,5.64086941386953,4.732428890456828
SK-CO-1,9926054,2.0008566323964576,1.9558182407319091
NCI-H1568,208908,1.6425276108518176,2.208841411802436
BICR 31,11364421,0.6668909809197356,-2.2078161306016124
RKO,6438330,2.4839059464581785,1.9214195381440913
HCC1500,11717001,5.16685929391629,4.031775205309041
NCI-H2452,5335621,2.361346054519045,4.683412097409397
SK-HEP-1,168313200,3.8713243832650335,2.9899314038092224
MOLP-8,5281321,-3.090542457479921,-1.9113641651868838
LS411N,5287620,-2.7795044954925423,-2.2423221338838233
BFTC-909,42611257,4.384387627976705,3.589083997491798
MDST8,135421197,2.23565927197073,2.1784646489961044
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,1.087291595168922
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,1.8652034458306606
SU-DHL-1,136227924,2.1802521862386395,2.7062547783495376
HEL,9929138,6.278460484472286,5.189599182979728
BICR 22,100016,6.157225392196351,5.896289952545228
BFTC-909,6610216,4.898578232775107,4.284930298533677
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.168248342804749
P31/FUJ,2708,3.1798246734444535,4.445060058260073
SK-HEP-1,11222830,2.864448489509693,1.5885925001102432
SW948,6450551,1.190778779915613,2.472903556776634
P31/FUJ,3503,1.1912257572322915,2.2495384770759146
SU-DHL-6,11214940,-0.480666123434414,1.4485111741609926
Granta-519,3101542,4.848909880356854,2.9105139369917454
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,0.8930402975803191
SK-OV-3,54613361,2.1799599530092597,0.27064105144521944
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.6400866684407482
PaTu 8902,9866186,4.760639543290191,0.8641503886882488
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,2.9201881298630843
MOLP-8,445455,4.348825488954634,4.31844210908738
LS180,327653,3.1909584751660973,3.0424444658310166
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,0.9922485518979383
WM115,24889392,3.868386170167097,4.116613444827102
SK-CO-1,54618771,-0.118181134306818,1.0722354288208689
SaOS-2,9868037,3.691858985861763,2.940210236391589
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,0.8410898163747159
HCC15,10385095,2.335943691067567,1.305751007313628
MOLP-8,2874250,4.289349020932475,4.633986643593372
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,3.1178782463925376
SU-DHL-1,44137675,2.905771721153928,3.368802991055515
SW948,16038120,-0.173493225813213,1.1343494975990531
SW1271,387447,-4.431171658059158,-4.0306656883422
HCC15,71304818,2.608087345638841,2.4132451089862332
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-0.8432813417696754
SW48,44259,-0.1330653223053438,0.3697041289161565
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.732267469579268
BFTC-909,216239,2.6603594422751136,2.2725306842920885
MDST8,9825149,2.535214047656483,2.0398407417739732
BICR 22,11625818,4.758067302616356,4.138078368437851
LS411N,6852167,3.3651093558735035,2.6022363695810413
BICR 31,7251185,3.1852875333924415,2.7804324641174434
ALL-SIL,25195348,0.8279476297727174,2.5408821127600643
SaOS-2,73707438,3.8840228628110336,4.379180102609536
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,1.969866829894151
BFTC-909,17755052,1.7621152527207813,1.7319174839614333
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.6379034464372153
SK-CO-1,3815108,2.810447278858876,2.7708136233110086
COR-L95,3025944,4.2211844332657344,4.147899621321711
RERF-LC-MS,9825149,2.3136516136403595,2.0712009016320967
KU-19-19,72376,-1.7461965003174784,-1.955926234977361
K-562,568763,0.3044566284292496,0.40330196372587934
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.386048429079787
Granta-519,6917907,-6.07944377191165,-5.458053016533969
SK-OV-3,4788,6.178998906779571,5.4884449663772035
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.0091984120742357
RERF-LC-MS,6852167,1.8897499878184068,2.7567605103597415
RCC10RGB,2746,4.042085650474663,3.4855107337956643
SaOS-2,54143018,-0.9786223984268784,0.3523346088718315
HCC15,451668,4.7728580097586635,2.6486536680568524
RKN,135999136,4.319110081529012,3.8098471645956886
ALL-SIL,11228183,-1.4217334963731665,1.0100938395524681
RKO,568763,0.6942409100068829,0.24301347060761416
SK-CO-1,71304818,2.179260281615582,2.5786190265531688
SaOS-2,151289,0.9278405880660672,0.8109741607184426
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-1.1013443060147325
MDST8,241158,1.799926141571129,3.6710396987012706
BICR 22,11214940,1.8032425349242045,1.632939974568633
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.3294173390029553
LS411N,9825149,1.7370452341191267,2.108228397306206
K-562,72193861,0.1570904811456113,1.3185542599666573
RKN,89928392,1.2442310560485252,1.7477832343895148
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.501127299414142
RERF-LC-MS,44493528,4.358183394704722,4.471122063213072
COR-L105,5738263,4.054674337055045,3.392708599572119
P31/FUJ,5280436,3.1830796623136832,3.3581274636333562
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,0.050096889355720965
LCLC-97TM1,135398516,2.1563049020997593,2.069145487176966
COR-L95,25102847,2.826830714185171,2.4027709381829023
BICR 31,11427553,1.8414471938085448,2.8514314169225456
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,0.9926806806961983
IGROV-1,15547703,3.339928221860449,3.1692887990679335
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.5194553919897242
LS411N,6918328,-0.170211770014818,-0.4904954337274327
Daudi,3136844,3.4483363469146098,4.038789162133356
MOLP-8,10302451,3.559537910744256,2.9558101709672946
LCLC-97TM1,24772860,-2.203105978452304,-2.007466245912115
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.0543835102653183
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,1.7722819148492226
SW1271,119182,-0.4023310904747799,-0.3319383934634472
RERF-LC-MS,135398516,2.452363199699896,1.916004202160087
SK-CO-1,44495899,4.504236306700641,2.9639846600447255
IGROV-1,10127622,3.2581804056600165,3.2083391583756207
SK-CO-1,44491742,5.1736211152382285,4.305889643844219
MOLM-13,4477,0.1750371811238646,0.6194413529787098
WM115,25183872,-1.8696572442850008,-0.8968465639165192
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,0.8646345392286671
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.0678512509944715
HCC1500,5335621,4.362965892261437,4.537632879655131
P31/FUJ,1716436,3.053886593694114,2.957497414208894
Daudi,9915743,0.3665260221427978,0.6207738369008563
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,2.3880680114253665
SK-CO-1,5311281,1.7217135985324663,2.614451251398401
IGROV-1,3503,2.453392942972796,2.432633710958026
SW948,17755052,0.6738246482480579,1.8188490221728164
Granta-519,5329102,1.3717145166802862,1.7186399902058977
HCC15,25183872,1.7330298559310635,-0.3126330250470216
IGROV-1,23635314,-0.611739968448912,-1.2960857453434245
HuP-T3,46174525,5.4457837824532245,4.306397802629105
IGROV-1,46199207,3.293579955374855,3.0659044279290173
NCI-H1568,11656518,0.902462789439692,1.7119897894688523
SW1573,12001922,2.294011710402099,1.9126105948074785
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,1.426502800126884
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,2.218114134328395
SW948,2871966,1.833559506117821,0.5535173459540604
RKO,42642645,1.3055497818976145,0.5725572087967004
NCI-H2452,6450551,2.947106204512916,2.5937316889644735
P31/FUJ,10302451,4.186780329312711,2.9375359241502172
P31/FUJ,6918837,-4.676526715032863,-3.139301133116672
HuP-T3,3552672,1.4793505278318,2.6460926905526416
BFTC-909,25105715,3.3944682152224455,3.3710685507276095
HEL,44197249,3.8651368484410056,3.399195228848159
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.5500422989574412
BICR 31,46215462,1.6669957894505008,1.8538255976857219
HuP-T3,9866186,1.729562359157257,0.6035735107187835
HuP-T3,11717001,4.25253085122872,4.264103712312262
NCI-H1568,54618164,3.652866089784218,4.052497589873948
WM115,441298,3.225500618866892,2.5573520498771924
LS411N,71304818,3.0616651991102697,2.4033189195352964
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,1.691685190274773
SK-HEP-1,10184653,3.249474772070569,1.4406256602387253
BICR 31,12003241,-1.4237270953299652,-0.99589308853831
RERF-LC-MS,25150857,3.1332692975488934,2.303758736414029
COR-L95,24964624,2.1587115359420994,2.438532634546969
SU-DHL-1,44241473,4.633491620971472,4.630465760045736
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.3851288776368975
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,-0.22838402198776375
MOLP-8,6918878,0.495059053850733,1.446969101667721
RCC10RGB,448949,3.406339167429426,2.128071807932005
HCC1500,148124,1.3380754252474834,-2.534730859920607
HCC1500,5280436,1.8565158203383687,3.2989388818089975
IGROV-1,10302451,0.4135234554742116,2.8377535734831274
Granta-519,285033,-4.09305161448312,-2.5208547897553264
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,-0.059546609800127756
Granta-519,71304818,1.7993370678919798,1.9877161065019948
NCI-H2452,3689413,1.184555113675537,0.040801180641415385
IGROV-1,2708,4.438419625543199,4.844061300379173
SW1271,49850262,4.063818012025616,3.2747250151380602
LS180,6918736,-2.1262365465987907,-1.8757648169050367
PaTu 8902,10127622,6.3250626499292295,3.4996547797664137
SW1271,57519531,1.4534695216386555,2.5141131073837464
HCC15,57519531,1.9577451103636032,2.4535970457187535
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,1.7468878350458683
SW48,44185566,0.7812235367324193,2.181119512512281
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,0.5900865304806627
KU-19-19,241158,4.34083218708613,3.9952934745704107
NCI-H1568,11404337,-0.63897934294681,-0.506355362466284
Granta-519,219104,2.15431657191886,2.74827543487862
SK-CO-1,5746,-2.8271360432483035,0.8471728678344338
WM115,6918837,-2.450050091846588,-2.6955785392347393
SK-CO-1,11152667,-1.1935109806009474,-0.5259343723902434
SW1271,9825149,2.2012182796133084,2.451929850746903
SaOS-2,208908,2.5337103611164893,2.186887866801536
SW48,5470400,-1.7303817372543355,-0.7558278271798048
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,1.637866735681661
SW48,15547703,3.0370188863847414,3.0743156556967453
SW948,46907787,2.3709287142369555,1.9568005120428862
Daudi,5113032,4.739966647777949,4.593766542060651
SaOS-2,135984461,4.8186429168984475,3.610608459565047
MDST8,168313047,3.800021027786958,2.294898065619106
RCC10RGB,11964036,2.4986740771219673,1.3423409252716498
SW1271,24785538,1.505278847517323,1.5074866303846488
BFTC-909,3676137,5.055523871435828,4.48685656212319
SW48,9868037,2.459515994210572,2.9545025532604603
KU-19-19,10231331,0.2937024112037242,1.8954609991602263
ALL-SIL,54619267,3.6744484896003713,3.476779045585189
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,3.8419853142808824
RCC10RGB,24951314,2.138755705452886,1.6567121764364763
SU-DHL-6,26596,-1.882707371112463,-1.3677679634596183
COR-L105,46843906,1.9821208299636863,2.7355896167731775
RERF-LC-MS,4477,-0.1141702320643991,0.6426413751671438
MOLM-13,49766530,-2.4914272268054107,-1.6166988294803921
SK-CO-1,4917,2.9299888563447163,2.9989513822237126
Daudi,72734382,3.17690285998388,3.953412447333911
LCLC-97TM1,11625818,5.063433550011292,4.312726804950517
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,0.739952147469848
ALL-SIL,451668,-1.1904263441284522,0.22359013158952123
SK-CO-1,219104,3.537047767593632,3.700727360954555
NCI-H2452,65064,5.258935158123576,4.917715245261047
BICR 31,25062766,2.0025728701089904,2.041461349316346
LCLC-97TM1,4261,1.8883571230172835,1.7367517150052212
BFTC-909,54618164,4.281231487810877,4.075285635459911
NCI-H2452,16736978,0.9447398024439234,1.9494461813007846
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,3.7215763863977065
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,3.350115142247967
WM115,6917907,-5.049795628811172,-4.308966348706723
HuP-T3,5746,1.6464242063318688,1.1147377848381022
MOLP-8,327653,2.384727852533787,2.9164375360128254
SW48,72376,-3.1415011638088144,-2.6946799617660613
SK-HEP-1,23582824,1.0257570544783106,0.794034393381466
K-562,12001922,1.1213264373636214,1.8688614507024746
WM115,10410894,3.2188686198907743,2.921465033418908
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.1237823233883522
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,3.2784615316592607
KU-19-19,44819697,-2.543386759740491,-0.27897361097370044
LS180,46199207,2.9384583216685023,3.201494970731072
LS411N,56946209,-3.80128700519076,-4.238187591514899
LCLC-97TM1,6918289,3.014261251605047,2.6516215955616236
KU-19-19,107970,3.004209688555129,2.4188960367711627
MOLP-8,72376,-3.958595065171294,-2.792786143835414
IGROV-1,5291,3.6852809555447985,3.669786132924403
Granta-519,46191454,0.5060764897707477,0.7341020671393939
COR-L105,24901704,3.8942422617258714,3.3508193111629225
NCI-H2452,24797083,2.030715286150645,1.63550581451819
NCI-H2452,124202324,3.032884210730814,2.536673336506654
LCLC-97TM1,4259181,-0.2611730486969081,0.21756891062482475
KU-19-19,73707440,5.592820593626321,4.425591637323141
RKN,5460769,5.79272629497122,2.761904485435064
RKO,10184653,1.6814092199651305,0.8845973506081165
PaTu 8988t,24180125,3.300808715406375,3.1634471681127856
COR-L105,2858523,3.082532365215724,2.9599609225131105
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,1.8770466584148207
LCLC-97TM1,16065773,3.044024356255971,2.293973363388301
MOLM-13,16115403,-5.622868208190141,-4.371318321814945
Daudi,104842,-7.567274671559235,-3.252131263231321
PaTu 8988t,3825829,4.270364787448243,4.0674853543658935
HuP-T3,227681,2.514870644267688,3.3500587682210066
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.4246774581081223
COR-L105,11964036,1.2117851204645589,1.3671889817761673
SW1271,135659046,3.922158232881772,3.6285672015932646
IGROV-1,4917,2.985904350427039,3.168962749631079
HCC15,9826308,1.2579647962340863,0.5559232266109249
SK-OV-3,46199207,3.479599233509405,3.1379577532031093
KU-19-19,2729026,3.069520174525383,2.5948335491163914
COR-L105,25102847,1.810865395215699,2.2426098072953646
SW1573,9935249,2.8664920450292852,2.684161833778278
COR-L95,1714884,3.7968274989469992,2.9340613809864133
PaTu 8988t,7251185,3.286029674356028,2.4806081670267606
SK-CO-1,24856436,0.7128954142297991,0.5732676485978803
HCC1500,5738263,2.955373895930653,3.3781020937703397
SU-DHL-1,6914657,-4.020831804674196,-4.531397098898287
SW48,638278,3.16751315896482,3.0072396252520917
LCLC-97TM1,135421197,1.517750954289076,1.6405223299181906
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,-0.33022315547222036
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,3.4880874266476116
NCI-H1568,6914657,-5.120590256929669,-3.9104987785231247
NCI-H2452,3676137,5.703513737309888,4.427815039831551
PaTu 8988t,11238147,3.9795465318298526,2.718939993873451
RCC10RGB,5113032,2.807854627845623,4.8699702894818095
IA-LM,44607531,1.5934898700442923,1.0465904910456898
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,4.276394136947909
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-2.6011086239488024
RKN,3815108,2.827407220517517,2.911009898508742
IGROV-1,448949,2.098499309472767,2.219392189237119
BICR 31,5426,4.483861121335425,3.6181557532681747
SK-OV-3,322968,3.987773865251791,3.794011358194891
BFTC-909,15953870,3.192835350037467,3.584475857237896
BFTC-909,4378219,4.497242068417329,2.4545108822887145
COR-L95,54143018,1.379812266453913,0.08438530084178104
SU-DHL-1,11612883,2.467580560997241,2.507957155921963
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,0.37449093906129277
LS180,5978,-1.0800938866172374,-1.618112614085747
NCI-H1568,44566777,1.438409258191859,0.7103343668680299
BICR 31,42642645,1.5553576315566706,0.7070028870063241
MOLM-13,654092,-2.113392174262404,-0.9165912170586394
LS411N,124202324,2.3656166654970137,1.9388053698634955
SU-DHL-1,5329102,0.4187283879213827,1.7340511636097073
Daudi,51037431,1.7669670215364446,2.9607887794944387
RERF-LC-MS,45279963,3.7797867340420215,3.653627125388939
IGROV-1,49850262,4.068828647042517,3.556780217637412
BICR 31,12001922,2.662375748901725,1.9442588653758919
IGROV-1,49793307,-2.5291790820063538,-2.652582070373802
PaTu 8902,2828334,6.440933390339598,6.0498755210191355
SU-DHL-1,24951314,0.6018835624310062,1.1093477005489085
MDST8,676352,2.6149374435458643,1.9306725397659557
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.208360877166778
MOLP-8,44185566,2.3020252385384747,2.0108562118976185
RKN,44137675,5.459450119186335,3.5544756522242524
SU-DHL-1,216239,2.4334915471860064,1.9935641386381775
RCC10RGB,5328940,2.5920229504771264,1.6999369154512454
MOLP-8,5351362,0.578803181676615,1.0361274742179711
KU-19-19,4521392,6.281175440463305,4.427923278125692
HuP-T3,219104,4.090562015064086,3.9042292701061085
BICR 22,16722836,2.37465920140225,1.6029116299472077
Granta-519,54678924,3.4908303220152512,1.6086091468735222
SW948,5738263,3.889172676108031,3.27009582263421
SW1271,9549297,2.1335240165820606,2.6883457041452625
MOLM-13,5280436,3.611781786093365,2.8397854664914983
BICR 22,3062316,1.4778056821676904,1.0194958649345127
HCC1500,46191454,2.281809335685502,1.4443620885622659
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.588782122228888
SW48,9549297,0.4487326680785643,2.126690089030104
SK-OV-3,46843906,3.785109660734252,3.0869991823956764
NCI-H2452,5351362,1.571040634520482,1.621435188878999
RKO,56946209,-3.445993729976747,-4.25663856776303
SaOS-2,56649450,2.657103116813459,3.0886347326831394
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-1.3395917918728026
LS411N,23725625,5.218761480016774,4.788327888706618
RERF-LC-MS,4578,4.625372786711685,4.34226552445417
MOLM-13,11507802,1.0337656748409854,0.8008807316422284
SW48,65064,5.106206142410259,4.756868358366149
HCC15,2828334,6.579413009448801,6.1527352921901866
SaOS-2,4378219,3.572923749570723,2.452685793478572
BFTC-909,23939,4.493588141952023,4.08145771361057
RCC10RGB,439501,-2.548266242367821,-2.0338843431894484
SW1271,3815108,3.2377532103389832,2.6075340721264935
P31/FUJ,5287620,-2.889875327880449,-2.244344745905283
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,2.163425313269515
LS411N,5281321,2.872375461605106,-1.4388994592380486
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.162146597382476
MOLM-13,16736978,-0.7178102164081313,1.086318806565494
HuP-T3,24964624,2.5347495437600753,2.4975752165649006
SW1271,3038522,2.6397404309625574,2.982614711129935
SK-OV-3,6852167,3.0870556066687076,2.843074541545152
PaTu 8902,25262965,1.559985123462204,-1.8070844321567905
PaTu 8988t,89928392,1.7442497788257625,1.633418580703468
RCC10RGB,5494449,5.764110819730859,2.8212365560372272
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,1.6570021816104137
Daudi,5282054,2.334684985175564,3.0804037031551967
SW1573,9866186,2.2605214925080035,0.9403705095283946
SK-HEP-1,16013152,4.2454363352103925,4.279465872799917
IGROV-1,11647372,-0.6595372928368528,1.2241370433829772
RKO,60700,-0.2024014556335324,-1.085948236725316
SaOS-2,66577038,3.461550546017496,2.9507594439946825
BICR 22,6918638,0.0558003797401064,0.23525348352686482
NCI-H1568,6918878,3.5715267618547832,2.936137651963955
RKN,17755052,4.615024850417848,1.8556607741307456
RKO,10385095,1.2981289243482117,1.2229257776403109
NCI-H1568,25227462,1.3523005990409367,0.37958007512048875
IGROV-1,168313200,3.9938362637732983,2.9768773872240852
LS180,52912189,2.5201251776162454,1.2193038443879292
SK-OV-3,446155,4.068831864004445,2.5872555659445386
SaOS-2,2729026,3.0079080963172573,2.5005679279300823
COR-L105,24785538,1.9787344511962284,1.5533364303260426
WM115,9549297,1.875565618317202,2.4016287671330256
COR-L95,53392493,1.7864953470488698,2.31628585780891
SaOS-2,219104,3.933074432676362,3.6649213397590414
WM115,3854666,2.6196721416111024,1.9288077883728285
PaTu 8902,11626560,1.9806688551606229,1.7799076598355574
P31/FUJ,24901704,1.8625310117446785,3.120275280818483
IGROV-1,9911463,4.195269991960018,3.763435061912179
LCLC-97TM1,216468,0.7418366776466117,3.08059266283354
MOLP-8,387447,-5.214034261316855,-4.7845862962205885
RCC10RGB,16722836,2.017391543442539,1.9055672458878137
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,1.0619118076243184
SW48,5311281,1.5627745937535438,2.2632905240685086
MOLM-13,11497983,-4.003769607545663,0.4007589265936691
KU-19-19,2858523,2.990442019675252,3.088593556085136
COR-L95,11626560,1.5180153972734145,1.8414345923211213
WM115,123631,1.7981952102566006,2.485533710603187
RERF-LC-MS,2874250,4.628157945253743,4.651677083527966
MOLP-8,65064,3.020382379730844,4.564151406116724
RERF-LC-MS,3854666,0.8294073497518095,1.5036842361224476
HCC15,3689413,0.3467742153458734,0.07273866077121982
HCC15,25150857,2.8177810894811786,2.531962753734124
LCLC-97TM1,46174525,4.403281113181967,4.211466499434671
SK-HEP-1,31703,0.3185055118054912,-0.6378294346758644
BICR 22,123631,2.0553358195001383,2.0301060960694643
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.4808734580952234
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,1.039551967817851
COR-L105,11213558,1.6245415685033464,1.729726241695822
COR-L105,3689413,-2.1605707630353708,0.15497819712202893
MOLP-8,4917,1.932746630984224,2.9828486090201234
HEL,11238147,1.9261110470981635,2.4641761935152497
HCC15,46907787,1.7788170946404287,1.8599495346005728
HCC1500,3062316,2.994925150114549,1.2715069671395967
MOLP-8,9935249,-5.983061984872936,2.181760320641849
IA-LM,135398516,1.3190430503048431,2.062086257037688
NCI-H1568,6917907,-6.013699668749745,-4.786019168716796
PaTu 8988t,25062766,2.121196656552597,2.0016691853503508
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.6417589141943045
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,1.667222646927447
HCC15,3825829,3.261310602619802,4.146928562591055
SaOS-2,36314,-6.649536011740597,-2.0005235764210925
BFTC-909,54613361,0.5481358040879688,0.1527905695688575
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.7885650078805767
KU-19-19,135999136,4.912207411852192,4.066653942589687
HCC15,126941,-2.714458984381298,-2.61051925288171
K-562,387447,-4.172741798582805,-4.517827877071164
BFTC-909,400769,-0.3884900564724624,-0.5687947564691735
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,2.131675413562084
K-562,19582717,3.29667086675107,3.665165454533552
LS180,676352,2.815097827506973,2.0016188030899333
SK-CO-1,5278396,2.886619996042885,3.587903356211372
SW1271,654092,-0.6724961197062129,-0.18341903770212484
BICR 31,984333,1.688597902845401,0.7077119019190147
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,1.6830077879549454
PaTu 8902,6918328,0.0837665640709721,-0.3505275328198977
KU-19-19,25126798,3.8528221502524262,3.6085650400840747
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,1.9341766317208537
K-562,984333,1.160515473081413,0.3679667517223426
BICR 22,4261,1.6582900308021409,1.6223758473670853
P31/FUJ,24753719,3.279397605233023,3.9638060052044866
RKO,89928392,1.6264666324972337,1.1518189296953834
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-2.080240856727558
MOLP-8,2746,0.9128995235322724,2.4004317554803647
PaTu 8988t,44589607,3.069724280166482,2.8380814959921126
Daudi,55508,3.074140286884227,2.970926003634001
IGROV-1,53232,2.4872106086763393,2.990012180447371
HCC1500,11178236,-0.8618797474299623,-3.3230116467280313
SW1573,11228183,1.3544411199442492,2.259513642378768
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-3.7832514724688764
HCC15,151289,0.5818248951012718,0.9768650978294474
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.9002242036320889
LCLC-97TM1,9956119,3.701469228999412,3.6835227873596654
LS180,65064,5.333283055182179,4.752083719876932
Panc 02.03,1566236,1.9322803720882225,2.2585635159997093
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.4582886621273277
COR-L105,5311281,2.5909348271223833,2.548580130526438
COR-L105,4261,1.037866526492344,1.624782804987928
MOLM-13,6505803,-3.0527041000310255,-0.7710734414769307
SaOS-2,24797083,1.1743557883271736,1.3681090784099574
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.5053195884125565
PaTu 8988t,44819697,-1.4855632158782932,-0.020849205335129795
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,1.0619118076243184
MOLM-13,136227924,1.704251401840426,2.51737909183325
K-562,11955716,-2.44804051648688,-1.418104949208713
PaTu 8988t,119607,6.161307312166748,5.301102474139067
COR-L95,71466380,4.385390307812106,4.3572895294555245
SW48,400769,-1.161678790289576,-0.7636285731178739
SK-HEP-1,54618771,0.9570801540222316,1.192825629446135
Daudi,10410894,2.7348964142664096,3.027435976448246
P31/FUJ,8515,2.4023085754769133,3.846227167867129
MOLP-8,12001922,1.340541943266141,1.7058842671321366
SaOS-2,24180125,2.5037581025896896,2.9506182387205877
LCLC-97TM1,11497983,-3.4928977535107872,3.7035421811824487
KU-19-19,54618771,0.4920305765445359,1.3759043421456352
BFTC-909,9826308,0.9467806471528852,0.14808221953927808
HEL,6252,-2.3526628041976547,0.07229743589105883
PaTu 8902,1750826,3.002378182351502,-1.6290807268933158
HEL,375860,-0.4243086466742362,-0.4977908725747217
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.7968840184032753
LCLC-97TM1,44137675,2.6535109564984403,3.4857319507544777
BFTC-909,4096211,2.208598833058293,2.08334540766855
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.816450009523865
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,1.8349229485101244
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,1.9938666313117859
SK-CO-1,10231331,-0.7210930575000714,1.7648521473583643
RERF-LC-MS,9908783,5.63449812951243,4.924740748437181
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,1.5138294426317154
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.1940245788143213
SaOS-2,54618795,3.185724709117328,1.154477702680134
PaTu 8988t,637858,2.5993481939897314,2.0435395014351725
HEL,984333,-1.1600295079037413,-0.058681361847308836
HCC15,2841722,4.4106331963661285,4.389361097878041
SW948,676352,1.6772543111300298,2.1525295537931983
BICR 31,24964624,2.1782924417506235,2.5126096277866283
MDST8,984333,1.6302493723588198,0.5511613876306417
SaOS-2,25102847,2.0054521503393956,2.50895222373053
NCI-H1568,11396600,3.496587037401377,3.791388612748113
SU-DHL-1,25126798,1.813712960287442,3.5335010669085114
MOLM-13,445091,4.269392983422825,3.970715148105208
IA-LM,6918328,0.468629569752011,0.07143225240960618
RKO,16038120,2.1201165412688385,0.7697798964924795
Daudi,3689413,-4.376822515219121,-1.059791985743518
LS411N,1750826,2.0365622567800985,-1.4410809476346023
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,1.2704857440973458
LS411N,11640390,3.2208706785393972,3.179339071908742
SK-OV-3,2729026,2.529477515357917,2.4694347927201354
BICR 22,1317464,3.72634745746102,3.4537196082001618
PaTu 8988t,6917907,-5.027469783550181,-4.321516103738914
BICR 22,168313200,4.032164885313491,2.739330010206256
WM115,24180719,-0.1236916700903925,3.165371371108955
WM115,2708,4.839353437835411,4.815326483907813
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.9461477296921923
SW948,135398516,1.5329637117305952,2.3301549489695885
SK-HEP-1,15547703,3.182423809990023,3.3849437921925833
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.329828107495738
SW1271,400769,-0.393739366900267,-0.23101588141770427
COR-L95,11657048,4.451680892653422,4.209112830285105
KU-19-19,5470400,0.4514058362673593,-0.21921598978781262
SU-DHL-1,46199207,2.2603615990150803,2.8569641527566465
LCLC-97TM1,452548,-0.620032222833134,-0.212112128157555
COR-L105,216345,3.681753487249753,3.7270897186837977
SK-CO-1,6918736,-2.135863333000623,-1.72091985604869
SK-CO-1,5351362,1.1244803572081656,1.409174681770263
Granta-519,451668,1.0102660805443675,0.5719466955827701
RCC10RGB,71751553,5.18764953581067,4.514765290200208
SW948,44137675,3.8395253943289553,3.5032582782596737
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,0.8770561658188281
LS411N,654092,0.6196619744838121,-0.395841925134989
HCC15,11222830,1.5967166138936082,1.7773931266396878
RERF-LC-MS,54143018,1.1379926617289184,0.2413392672463213
HuP-T3,107970,2.2315719384591133,2.343687282785271
MOLP-8,462382,0.932516774133838,0.19650516541799462
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,4.356592362653563
COR-L105,448949,1.923777772079977,2.1027551733971404
SU-DHL-6,5311,0.0847535344452709,0.8657937666038237
COR-L105,65064,5.250674314711081,5.03462112308058
RKO,9908783,5.5436232623995805,4.674787300532157
BICR 22,1566236,3.7080344976190434,2.0821864212881303
SK-OV-3,2708,5.531711784720637,4.701832480928569
RERF-LC-MS,148198,-3.5927713028936834,-3.7557392560353593
K-562,10127622,4.587499993681003,3.9488495137170383
MDST8,3543504,4.366917593553272,4.350318112338353
NCI-H2452,675434,4.57874791360699,4.500913790839038
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,3.0257272666494015
K-562,73707398,1.1020172598138147,1.0091104233621055
BICR 22,11178236,-2.3138277354389176,-3.306862383390982
KU-19-19,53232,3.650570649303299,2.805698984300757
COR-L105,2126,5.6436039579971045,4.788616994194985
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,0.04941524751476334
WM115,984333,1.7219326558446977,0.2917391011723408
Daudi,6918878,-0.3078198284611306,1.1671769318777385
HCC15,16725315,4.804384009366738,4.172098814583678
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.7301582622684711
ALL-SIL,56946209,-4.755076906810128,-4.355124322009633
P31/FUJ,25195348,1.3039046822632598,3.155782135088489
NCI-H1568,4261,1.7177455985107426,1.84377275263141
BICR 22,11238147,2.160553784520482,2.687880793744179
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,0.8932510772915279
LCLC-97TM1,25126798,4.007107372760091,3.843353033876182
PaTu 8988t,11612883,3.2937262662044424,3.029653164875162
SW48,44507138,1.5733509414979852,2.233647054570224
SU-DHL-1,66577038,2.452346655400699,2.9053083924328034
ALL-SIL,60168763,4.204461937910143,2.7641211441138194
Daudi,25227462,-5.495402710114509,-1.5548657986457044
LCLC-97TM1,613000,2.0466318432711708,2.146155368984036
LS411N,2828334,6.327786282136184,6.019216374881818
IGROV-1,9866186,0.4571266497661056,0.7926754175173568
SU-DHL-6,72376,-4.568822946856545,-2.5359409552550405
P31/FUJ,984333,-0.8646677641211812,0.380113586046196
COR-L95,123631,2.8240072692867915,2.5337787963561866
IGROV-1,11497983,4.37450324471555,3.0085038410221445
BFTC-909,5281672,4.401358042981416,4.509397333624796
PaTu 8902,44607530,2.9609228636650826,1.978221509229766
HuP-T3,5566,3.0002994658008935,3.064193012260524
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.6372945978194366
IGROV-1,2729026,2.3541792737160296,2.5809861990613907
COR-L95,11222830,1.53452681839189,1.4563844118149336
LCLC-97TM1,66577038,1.6013450181273698,3.089909738363389
IGROV-1,24772860,-3.2892316801587835,-1.7234643803312069
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-0.9907784531559143
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.5554280194161945
NCI-H1568,54678924,1.274078635657008,2.249214903861099
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,1.0604221684021689
RCC10RGB,9908783,5.908182650801537,4.71688658783036
IA-LM,66577038,3.3956332242260765,2.8785896849583423
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,1.550600219218167
COR-L95,9935249,2.976260244275784,2.6393403020613833
SU-DHL-6,9868037,3.231553190440303,2.6238262467476385
RCC10RGB,11640390,5.2605770793622275,3.751640743388922
Daudi,285033,-6.062056136351362,-3.207579079579118
BICR 22,11626560,2.057582050988773,2.0316836537055627
NCI-H1568,60750,-4.838669884752028,-2.6182222762510934
MOLM-13,2708,1.6215518677504634,3.785801341316285
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.7442306009204802
K-562,10385095,0.5975872383647969,1.0429435200123671
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,1.9865104294917628
ALL-SIL,9887053,2.3955838154567703,3.19740222769897
RERF-LC-MS,151289,1.06337646711186,0.8160954175941432
LCLC-97TM1,71466445,2.7974721848465025,3.6425721411985403
RKO,15983966,1.976330033309676,-1.9781249961693828
SU-DHL-6,54143018,-0.9166021499884252,0.03981769612814541
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.7905088850334785
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,2.595153627473249
IGROV-1,49793307,-2.5291790820063538,-2.652582070373802
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,1.7824775552407368
SW48,9866186,-0.0602537260044697,0.5594892393090748
ALL-SIL,24753719,3.3195109491118635,3.610593038765819
PaTu 8988t,409805,3.676693079768219,4.944043531314217
BICR 22,11175137,1.6412636442827269,2.3634422275821145
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.0582347350891512
MOLP-8,9887053,1.3364969406129874,3.210972122234236
Daudi,81146,4.468898659357518,4.161683629370717
NCI-H2452,6438330,4.066979701794873,2.4392990960095777
SU-DHL-6,73707438,4.161722925172636,4.226521009532488
SU-DHL-1,9825149,2.3972801394012415,2.0214086555328015
LCLC-97TM1,1242560,3.1698209685240832,3.368142916567299
RKO,44632017,0.9673312213076444,1.0561233484120236
ALL-SIL,10184653,0.3156525087572682,0.8378069230647885
MOLM-13,15953870,2.45012914744678,3.330329169206309
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-2.94727106056949
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,3.059496481277392
Daudi,9908783,4.64363842559646,4.488896830091616
BICR 22,2746,3.5358057095338404,3.074348390230507
SK-OV-3,9903786,2.611217845094376,2.832185279575282
Granta-519,446155,3.3236756015859266,2.2872321927435366
HuP-T3,46843906,1.6260119885378777,3.1034541144741974
RCC10RGB,25102847,4.4790627708666255,2.6158674634589563
SW1573,119607,3.675967979424282,5.221607700630739
NCI-H2452,36462,2.3648017756260327,2.303520516463306
RKO,9926054,1.883626680074333,1.8667111388345123
UACC-812,11396600,4.679415745859403,3.839005149333547
LCLC-97TM1,67291369,2.1623476689900527,2.4720564926666317
SaOS-2,9926054,1.5065280757428428,2.0189711241739077
SW1271,11485656,2.5257448561020053,2.42475950062593
SU-DHL-1,65628,3.0805404655500843,4.084860228932751
RERF-LC-MS,24889392,5.73600211591012,4.002065352238334
IGROV-1,16720766,-0.0562020789376145,0.647908670034544
SaOS-2,53392493,1.7453499080757628,2.405238510354678
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,0.8848532495633991
LCLC-97TM1,71466578,4.4967812415195025,4.503961171799116
MOLM-13,135440466,-1.1165614244178856,1.7054332867789463
IA-LM,1566236,2.064855820915055,2.6788618686410346
SW948,3825829,4.076553662425885,4.018375121971228
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.244272858779983
WM115,322968,4.566671406107956,3.693115516678018
RKN,637858,2.0099352926359533,1.9866500726313832
COR-L105,135398516,1.4567379833558207,2.0601950803950837
LS411N,15547703,3.407600768992332,3.1464322763938934
SW948,6918878,-0.2941800388813576,2.4176029401887558
SK-OV-3,31703,-0.6007067740148971,-0.45445937099650985
BICR 31,16038120,0.7865824758597759,1.0093002533347548
SW1271,46943432,0.8939870827443378,2.3614983046636664
Daudi,67291369,0.2775886597323658,1.7173692942960284
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-1.3629008837045307
BICR 31,11455910,2.0785566961581186,1.4057915342830065
MOLM-13,25150857,2.0975264071969075,2.0237394058259492
COR-L105,46174525,5.553907170062061,4.483403511855942
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,1.9445928618370893
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,2.091858884910789
IGROV-1,135398516,1.9751898057484376,1.9417865908267244
PaTu 8902,3689413,3.662647678116459,0.28902719109290176
Daudi,31703,-5.42156315939604,-2.516773731201293
IGROV-1,24785538,1.106246320450551,1.416587249654369
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.4213888084769154
PaTu 8902,676352,2.5672836386659625,2.1168631689108928
MOLM-13,426756,3.5583078181784504,3.9616213767059576
WM115,64971,1.594754361798162,2.766641069489002
SW1271,4521392,3.9428497415690713,4.460019184287566
HCC1500,19582717,3.689290387765622,4.171117797029539
BICR 22,71680916,5.5411632888305755,4.704493551064973
IA-LM,462382,0.6444148679919928,0.5266245001013438
P31/FUJ,24856436,-2.072993507389728,0.19187447082875303
LS180,135411,0.2951252953722391,0.5402245700602868
MOLM-13,72376,-3.7215877343251456,-3.138502316918104
RKO,6610216,3.958403220086871,3.981195364784891
RKN,452548,0.7515073582009456,0.18508714761096798
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,1.096366639417449
SaOS-2,3038522,3.0360203721983257,2.844587705740688
SK-HEP-1,409805,5.808157500863876,4.967145019452312
BFTC-909,44137675,3.23817368119839,3.6205384555097
SW1573,25183872,-2.56928333929943,-0.8613543010869433
HCC1500,23582824,1.5666293035108128,0.895913139326292
MOLM-13,11612883,-1.8374573083034769,2.257943005045443
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,0.8934363395330912
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,4.091620471056576
KU-19-19,135421197,1.2163789616721166,1.951272686113823
SK-HEP-1,49766530,-2.8567737760804324,-0.39876693270327357
Daudi,46843906,1.1534141628569738,2.05916960717685
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,3.733818515731834
IA-LM,11494412,5.732457488131999,1.7528709066336818
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.7899449536268294
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,2.628290944069292
Granta-519,46943432,2.0409318821812477,1.4844983097724225
MOLP-8,46174525,3.423634821116614,3.9859996446875217
RCC10RGB,19582717,5.580606305911862,4.246084962733544
NCI-H1568,71680916,4.3779497666633915,4.6320131489593095
SW948,3689413,-2.2648112033429824,-0.28852366310906524
RCC10RGB,252682,6.528801566934436,6.628145244155981
Daudi,135875424,2.734623655159311,3.3833706740420104
K-562,4788,4.09681667300412,5.635600843480099
BFTC-909,66577038,2.856590203747272,3.018133571638836
BICR 22,56649450,1.894872176339528,2.9206653818355743
LCLC-97TM1,23635314,-2.2617116518456792,-2.193597705048988
SaOS-2,16013152,4.240825830990255,4.0197443000102355
MOLP-8,5738263,2.3540234006064424,2.9141235710218534
IGROV-1,3552672,2.134472496867482,2.4552023691890343
BFTC-909,6505803,-2.7076869289136147,-0.5237732112746596
NCI-H2452,9952709,3.912471204941481,3.0033737782917007
SW48,4477,0.2937974315698831,0.43234204231556406
IGROV-1,10113978,2.874171865860951,3.2991809111972397
Daudi,3465537,3.6729414318228697,2.2524518146982477
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.5850128155544779
WM115,60750,-0.3155979924811316,-1.9792475285413753
LCLC-97TM1,3552672,1.9872160910848609,2.6565057974118162
P31/FUJ,16720766,-1.2973124396101832,0.4732563723506225
PaTu 8988t,16722836,1.7927006401716397,1.51781165085173
RCC10RGB,24785538,4.443576486987547,1.5564355243878376
LCLC-97TM1,54454,2.264936650655555,2.5635925959994394
BFTC-909,44202524,2.4582417316930916,1.9751669895174544
NCI-H2452,9956119,4.089312834038711,3.7027457072993535
LCLC-97TM1,44589607,2.470818031732135,2.788048866456229
K-562,9911463,2.5078915917546336,3.754900910976063
RKO,12003241,-0.2410566552434749,-1.1009661906382013
SK-CO-1,9887053,2.665990529661509,3.78407118255193
HEL,9444,3.6260707724362113,3.7034087877052957
RERF-LC-MS,54618164,3.9158352593779377,3.9957052558297943
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,3.2809652660389004
MOLM-13,400769,-1.4398892181534526,-0.9758850441153791
RKO,54454,4.6965621210229225,2.6071175527018657
HEL,3815108,1.7280464955300685,2.641309324970118
HuP-T3,400769,-0.02490432142157,-0.40349288689194135
COR-L105,439501,-1.395093001857319,-2.262034266830019
P31/FUJ,11717001,4.27266863837082,4.062182931925442
WM115,44566777,1.1755609042254629,0.7857128585961634
Daudi,9823820,1.816535221490948,3.439880045601307
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,4.192115806877358
SaOS-2,11178236,-4.192404287761835,-3.3959849372497217
RKO,107970,2.3673735748138265,2.0310484709039796
Granta-519,3384730,1.8851059301538475,2.1509273973505465
Daudi,3081361,1.2348545680767924,1.7460230964530954
COR-L105,11656518,2.8708923278875846,1.7034101988225863
SK-HEP-1,4261,2.0689452694586596,1.67496937035385
IA-LM,4261,0.3595729013120086,1.7244836203621425
SW1271,5282054,4.135247135343962,3.6431897350035434
NCI-H1568,44491742,3.692908194165655,4.309614966911577
K-562,10074640,1.329135681779355,3.108708047178759
IGROV-1,9908783,5.873270433212515,4.726498786883154
MDST8,24951314,1.0921901869172437,1.294538622578829
ALL-SIL,3081361,0.1962192778787347,1.3300917726179793
SaOS-2,4578,4.61303870633514,4.370114753519497
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,0.016431856018817498
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,1.7969246622381356
IA-LM,25227462,1.9658589227885097,-0.15160079001881027
MOLP-8,71466578,1.6771539715617054,2.796050120786027
HCC1500,11977753,-0.4307765862265268,-1.958926439636598
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,2.7113978852722385
BFTC-909,568763,0.745825262149274,0.34156374250986
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,3.9961906846231017
RCC10RGB,613753,3.3201179844199498,3.126957719942884
BICR 22,421610,1.881248812005912,3.135190785631033
COR-L95,55508,1.7090560645840305,3.1995116281325835
SaOS-2,2945648,3.259308629519986,3.115868532349533
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,1.4967146670240845
RKO,409805,3.580644131410829,4.696078798833704
COR-L95,53495165,-2.3377393798516395,-0.5843016852561822
SK-HEP-1,25154868,3.1824362497542182,4.3245750093613955
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-0.7318275821754152
SaOS-2,5978,-3.9287237947590494,-2.1331596563549944
COR-L105,4096211,2.67395928769434,1.8579334831590026
LS180,15953870,3.325208983942858,3.229019862252014
Daudi,66577038,1.2731684674623205,2.7466413900876474
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,2.7517422722459073
RKO,6918328,0.803085247134139,-0.620705524219562
SW48,4259181,-1.8199657809061969,0.07411322062609246
SK-CO-1,44185566,2.2410285456889176,2.494855240377533
K-562,5978,-3.1400031562505393,-2.33975416200364
SaOS-2,613000,1.0847199338514617,2.473148186909679
LCLC-97TM1,9826308,0.172966057550933,0.15416722566604388
Granta-519,5311,0.5114694341413046,0.9796908292016624
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.6343957799873774
SW1573,4788,4.2029613497215195,5.617169969051308
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,3.264100547119797
WM115,2729026,3.0250773642114175,2.6847708949464417
IGROV-1,23725625,5.712368491237602,4.864744910243981
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,4.066519130253544
SK-OV-3,24964624,2.562140083880341,2.4515137784220036
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,2.4545419058773352
MDST8,5278396,3.853168516309647,3.5716647755678497
RKO,119607,4.75876667689532,4.95280509052324
MDST8,65064,4.754326425577863,4.554208113448395
MOLP-8,54596558,5.109397009340411,4.305167525465979
WM115,9911830,1.4636751787761997,2.189412391520424
SK-HEP-1,44486219,4.3977685724309215,4.426128706106582
BFTC-909,15983966,-4.834157449814871,-1.563345096678026
SU-DHL-1,24901704,2.0463171426909086,2.994273281515541
NCI-H1568,3025944,3.938114410703908,4.268233831705823
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,3.044620206773543
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.6406371899703402
RCC10RGB,16725315,5.2458056955252275,4.336274847795427
RKO,53495165,0.8925500623489324,-0.4854921384890115
HCC1500,71304818,1.489157695167493,2.474732321959864
COR-L95,135398738,4.3251787986630195,3.9043200535482345
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,2.502211368289701
SaOS-2,56949517,5.721423210410403,4.4430441200663155
ALL-SIL,644241,-6.056766449232899,1.4474927003596338
MOLM-13,42642645,-6.876168570605093,0.19946924929537585
RCC10RGB,51039095,3.636696049778912,2.827920842318768
ALL-SIL,60700,-4.240130526526249,-1.126798091915508
PaTu 8902,15547703,4.581249636071297,3.185554209836173
BFTC-909,11609586,2.9417391320909134,2.812077489154896
SW48,11455910,-0.1633281652990052,1.1163454260107306
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,1.860910318765332
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,0.8423437398122444
MDST8,11364421,1.2673702676732186,-1.3315632573025409
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.500678909136366
IGROV-1,23939,4.412541857664819,3.8817220343543295
HCC15,11626560,0.3588759938830249,1.8684055022963333
MOLP-8,1750826,-2.6273703880538166,-2.3123641854209978
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,1.9394349867118055
SaOS-2,3634881,3.4478485283346454,3.1660968221217614
KU-19-19,65064,5.4276979548790285,4.635775193459339
SK-OV-3,53392493,2.9853646548342767,2.590755646024619
BFTC-909,44607531,1.7004331217528663,1.565751704089095
RKO,9915743,2.8851858618766957,0.5503036964038579
WM115,969516,2.5733075045080405,2.7951533567745264
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,0.4517182504950535
HCC15,1641662,2.7903081608832743,3.6413495898668753
PaTu 8988t,24856436,-1.0780184146975675,0.6123862486974448
BICR 22,151289,1.1052603945032196,0.8775959259057307
RKN,10302451,3.971829298943927,3.1695375356614868
Daudi,9840324,5.326423492349393,5.837182945705588
Granta-519,24978538,-1.4483375486726318,0.41101550357514655
IA-LM,969516,4.593397144463051,2.97700558127525
LS411N,16741245,4.421981695824733,3.7909298424874796
SaOS-2,241158,3.6917409878316136,3.7188138237427126
HCC1500,49846579,-4.075833194843517,0.7366848210834814
LS411N,11626560,1.8283516183370416,1.65582487421501
NCI-H1568,2746,2.7741418395417163,3.2134266298109475
PaTu 8988t,375860,0.0559535091713014,0.15198304159406673
BICR 22,613753,3.418897622092284,3.094605835233183
ALL-SIL,52912189,0.8155728349845486,1.159069007922014
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,2.999151712871288
BICR 22,3634881,3.8771660288779457,3.1898036997519954
RKO,3543504,4.836700902585943,4.19638628032483
Granta-519,6918837,-5.331886820340028,-3.653147899767264
SW48,56963564,-0.9893979738252238,0.15799247552379272
Daudi,4259181,-0.0890599021012781,-0.3082543036162827
Granta-519,7326481,2.8185757173328927,2.7612151294010103
SK-OV-3,4096211,3.632564776557465,2.0515384410673136
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,3.0283891046417977
SK-OV-3,24856436,1.946601057004947,0.4510504657108833
Daudi,613753,2.7401651571031618,3.105844527109004
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-1.7184134151881472
BFTC-909,452548,0.7682850038212578,0.13150283114453876
P31/FUJ,409805,3.653161003579303,4.637999602811339
IGROV-1,11404337,-0.7659238947812715,-0.1186730586349198
SU-DHL-1,24753719,3.670729792524347,3.795006295125116
BICR 22,24901704,3.9299918475898408,3.3053620001085933
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,3.8917314108648067
NCI-H1568,135411,0.4069452326541798,0.7469935210089411
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-0.8189560919136176
K-562,126941,-4.461586339574126,-3.131152096435965
Panc 02.03,2113511,6.868929428825361,5.473919179859074
NCI-H2452,44241473,5.273016525632626,4.5961613808923385
RERF-LC-MS,135984461,4.284403636339015,3.7215098362131145
KU-19-19,5329102,2.6076401407195355,2.0843151147144408
SaOS-2,49867930,4.412008076102657,4.710741562496039
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,2.047088943337384
IGROV-1,54618771,1.2456991772210466,1.3248100124708027
BICR 22,7251185,3.2802016727508105,2.5902813426646274
WM115,11178236,-3.130587173648645,-3.0432423659892396
BICR 31,168312962,4.404506435623785,1.3524346135030632
BICR 31,135421197,2.236076370585341,1.8769624204591233
K-562,72734382,4.39493075447737,4.156720990263445
Daudi,4521392,3.754955104648716,4.007353601892062
NCI-H1568,9903786,2.4011050725962115,2.8664080293747998
Panc 02.03,1242560,3.876690059869664,3.5644076603172623
SaOS-2,24771867,1.911103494547597,2.555667884640929
NCI-H1568,46224516,1.8217130718981496,2.5648730545961964
HuP-T3,637858,1.096014734488476,1.9569173878952413
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.1933805095963996
HCC15,9825149,1.99442718669858,2.349338216870598
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,3.766730520378133
LS180,9967941,3.3265068520356227,3.207114728925083
BICR 22,15953870,4.283514914534557,3.1709018216471083
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.602030605252146
P31/FUJ,49766530,-2.577046245506879,-1.0373898249868883
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,3.2847683842327826
IGROV-1,5470400,-0.2457809435208252,-0.1298670157043169
K-562,3025944,3.938999685525622,4.22034279927929
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,3.6188345640259483
Panc 02.03,1641662,3.717230762709902,3.5487652782610453
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.378846382176863
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.7648631505126321
SK-CO-1,613753,3.569116813952151,3.1838920903928534
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-1.283008998824028
LS411N,73707398,1.3643081745247092,1.0391974582622525
RKN,60700,0.8209474049972991,-0.24989579022917827
P31/FUJ,52912189,-0.0654684439378525,1.2455456801632203
Granta-519,49793307,-5.0235824363471675,-3.366645665136738
LS180,439501,-1.9142457865624176,-1.9678342474805113
BICR 22,19582717,3.5857042125142247,4.012151316787927
P31/FUJ,11612883,1.4537759753270971,2.7739742587996346
RCC10RGB,135423438,4.4299924289236055,2.1250913942580834
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,1.938445341999696
IGROV-1,24797083,1.5319862293819655,1.4051753602706483
WM115,11657048,4.298694485616108,3.8680719643829757
SaOS-2,5328940,1.8581375817896455,1.515331256490834
K-562,11427553,0.716330793964625,2.384733232032012
BFTC-909,60700,0.4554202898414442,-0.5061909208515878
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.3463698644513973
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,1.040631973584308
HEL,656346,0.4971755704716853,0.6146508480548133
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,2.6935420836271384
SK-HEP-1,25126798,3.9918710327668503,3.95688770123108
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,0.5299102524338933
HCC1500,568763,-0.919346546730658,0.3834079479779383
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,2.3648570481263023
NCI-H2452,71466578,5.120149615089657,4.556516789657007
COR-L105,2871966,0.4959639880090196,0.4664060011141573
SW948,5746,1.511438037719251,1.3864041690525692
WM115,10172275,3.759074377781229,3.7125233928264656
PaTu 8988t,11964036,2.992263460840089,1.379734171927344
SW948,16219061,3.499504842183279,3.375407921127681
LCLC-97TM1,53495165,-0.6427926162361222,-0.3400538982027628
UACC-812,3081361,1.9829916627298712,2.3759829237242123
SaOS-2,5287969,-1.655987163162804,-1.8838734475972194
IGROV-1,25183872,-0.4560099928976716,-0.4428265768056655
IGROV-1,44607530,1.2936443589937894,1.60438315651456
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,4.8713392727408875
SK-HEP-1,57519531,4.12625544642691,2.6011182338930188
BICR 22,119182,-2.736639797021525,-0.8899939098685157
PaTu 8902,4521392,4.129468839379376,4.3234853355391
LCLC-97TM1,60700,-0.7670870439402468,-0.47663322611222353
ALL-SIL,44607531,0.7892287314343482,1.0478921862859072
SW48,16720766,-1.213948450866439,0.1924746542381233
LCLC-97TM1,9911463,3.937478558519083,3.698017789856248
SW1271,6918289,2.985913038733717,2.2489219175357253
SK-HEP-1,25183872,-0.6604608842788147,-0.367608606923095
P31/FUJ,5311281,0.8046363155731003,2.3232721159912493
MOLM-13,107970,2.204740997332017,1.9878005527988483
PaTu 8902,44607531,2.4953979740561136,1.5752663938066545
BFTC-909,5978,-2.385180460490498,-1.5262042812101206
IGROV-1,9926054,1.8111808945519428,2.027874043958518
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,0.45236877760427946
SaOS-2,44632017,0.980304929421305,1.2321742009237895
WM115,23582824,-1.5173797182891284,0.7629013545339202
RKO,5746,2.147448518007633,0.7816671135884173
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-4.120378042278144
COR-L95,11234052,4.796206825131301,4.148192124600113
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-0.8996272024976156
MOLM-13,46199207,1.8343479247638497,3.1707489811778835
SK-CO-1,216345,2.2578794962248403,3.660307280015607
LS180,24951314,1.284825385865239,0.8309359426065869
SW1573,71680916,4.0865163925225385,4.565471063355976
LS180,11427553,3.214146965067504,2.2307784851203873
HuP-T3,17755052,3.4304742988115366,1.8919165623593097
IGROV-1,44607530,1.2936443589937894,1.60438315651456
HCC1500,11964036,2.769497384705972,1.1994764245898621
LS180,446155,1.950458971830876,2.48035747642799
SK-OV-3,10385095,3.0219456492917485,1.308683072360604
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.0468910287980426
LS180,23635314,-2.728761007932067,-2.389241668241104
ALL-SIL,25262965,-0.0785584741633136,-1.9097801193563244
MOLM-13,9956119,3.465056755214706,3.541485601797615
Panc 02.03,54619267,4.6873070757127335,4.050097370220398
MDST8,45100481,5.670163105184411,3.9788225824458556
P31/FUJ,11427553,0.2126015278922564,2.499079931965539
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.3370038199581924
SW1271,123631,1.9601206845091983,2.5017864627720696
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.255795294805622
SW1573,11626560,2.096503053081923,1.9867173092646275
COR-L105,11717001,4.401406695561914,4.057122817564071
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.5625242870906384
IGROV-1,135984461,4.285945029851472,3.690144212864764
HuP-T3,16725315,3.145396972494799,4.217013179867663
SK-OV-3,5278396,4.0115131897954175,3.546972320173935
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.001643530523069
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,1.8275480357309255
HCC1500,7326481,2.1911838281348897,2.8581488036119476
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,-0.33213791195211984
RKO,11485656,2.16906736756012,1.9558670539522842
HCC1500,17755052,3.708779056995352,1.6792688081293545
RKN,16720766,0.5941206863048918,0.5808085819745291
SK-OV-3,49766530,0.1985460846164677,0.4015199705085625
NCI-H1568,11178236,-4.756412327662482,-3.2282894217398
K-562,613000,2.5009117496842292,2.2486010745519813
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-0.6762711935641014
Daudi,49867930,3.141108082189553,4.674610165548183
P31/FUJ,451668,0.4769801026955246,1.5404960523363784
SU-DHL-6,2708,3.434249932793118,3.9679693698017173
RKN,11497983,4.544575984994342,3.7686651245815725
IGROV-1,23582824,0.3287266354391525,0.9912125075873454
HCC15,2858523,2.7763462118547833,3.0804762937365524
RERF-LC-MS,3025986,-0.71270364092759,-0.746010835866766
LS180,984333,1.4840791700280882,0.5606361607345535
COR-L95,24901704,3.9540534266274183,3.258413355845855
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,1.6159600858186973
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,1.5188040352413534
COR-L95,409805,3.71634228772174,4.723302046739701
PaTu 8902,9823820,4.420414335239228,3.9316460055150753
Granta-519,24821094,2.4908648032560183,2.8755740770241016
SU-DHL-1,26596,-2.3613305357908625,-1.8748349416419055
RKN,285033,-0.0275118271199953,-1.9938476025619243
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.9154860349080383
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.609413207136235
NCI-H2452,9936388,2.1806204942966803,-1.1380272907998985
LS411N,54618771,1.0517408544895162,0.8270563531655205
RKN,72193861,2.3331130274465313,1.5857106645610433
MDST8,46843906,2.4704071908178844,2.9709522690468835
HCC15,11485656,2.480533785053976,2.496702636865153
MDST8,11977753,-2.9914432786855305,-1.0367569428394292
PaTu 8902,168313047,2.1566405666580963,2.2310586148355376
MOLP-8,135928012,3.056644501758044,4.074894945218395
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.219825775738214
MOLP-8,10074640,3.1436066614625173,2.9660326228388856
HCC15,12001922,1.9087360775911748,1.9129187996324624
LCLC-97TM1,3025986,-2.553955076787079,-0.827522793155779
BFTC-909,2842253,5.585220688564769,5.0603471238286435
RKO,216239,1.9979551619375524,2.081524120220109
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,3.840502899808916
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,1.8149648181070617
Granta-519,135398516,2.1425852334349575,1.7555101524648882
KU-19-19,10385095,1.1563887024661463,1.316402036191009
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-0.5146717602415789
SU-DHL-1,9803433,4.734138876460479,4.686147175954805
HCC15,135999136,4.472611779685761,3.9157680265198094
SW48,11238147,3.1100916590750045,2.512952217764705
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.5162093733519364
BICR 22,409805,3.8456212820768214,4.9186521376963235
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,1.4714316236097864
P31/FUJ,24785538,-0.2737810661065927,1.3697198701186275
Panc 02.03,176870,4.923826321280428,3.0960045040964674
RCC10RGB,322968,3.1449149812629877,3.8863647386082523
HCC15,107970,2.678547076190946,2.3416510370561903
SW1271,71304818,2.7682192858067385,2.446793518416823
LS180,3634881,3.5372782333734696,3.0555529420420733
COR-L105,11214940,1.6414587299435788,2.2430730457798047
SW1271,5287620,-1.7165830209074355,-1.5715395327911847
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,1.5255168634590113
COR-L95,49766530,-0.268325836176492,-0.8108709896335866
P31/FUJ,6450551,0.3392586382091512,2.314568446844115
PaTu 8902,5566,3.0665407385312182,3.120840776521504
SW1271,6610216,4.395476769861187,4.265738322526061
IA-LM,4477,0.1872236957364025,0.6417086314462582
BICR 31,6917907,-2.0849244140580683,-5.541425396396456
Daudi,56949517,3.615784656128556,4.219812197976906
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.8652232912177455
Granta-519,156414,1.3767921664113123,1.0199946810724356
SW1573,60700,0.5293530759970745,-0.503611206810378
PaTu 8902,11404337,0.5155229173062875,-0.36559582102476434
BICR 22,52947716,-3.710960782083666,-1.3908336947071265
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.4183910024720578
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.154360775448874
SW48,216239,2.7420558854204105,2.2149247429858963
HCC15,136227924,3.0147456858017923,2.929168581786616
MDST8,400769,0.2052239388954162,-0.394498096287125
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.2437494300834921
RCC10RGB,4917,3.4531775579708044,3.1615065562711897
RERF-LC-MS,73707398,2.0319367406190483,1.2322554405559383
LS180,4917,2.9590600733191272,3.0433741499677245
Granta-519,46926350,-4.5411361861126,-4.327508456880142
BICR 22,1716436,3.778329286476686,3.102625938611693
LCLC-97TM1,55283,2.725406070596606,2.7519318406157214
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,2.152476512303319
RKN,168312962,-2.199105388969794,1.8247455471677834
MOLM-13,54619267,3.3881439662249657,3.7999292344793525
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,-0.4897582388377306
COR-L95,1239801,5.40725658561935,3.912763201692042
IGROV-1,10184653,0.79276129336756,1.2925935376690696
HCC1500,16741245,3.4170657459529865,4.009399829843906
LS411N,44491742,5.693616041532359,4.250996580687153
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,3.7201319705826688
Granta-519,24753719,3.151565571990212,3.896874397092588
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,1.6806527203074566
RKO,107985,-4.24085601271806,-3.6857592936506958
HEL,322968,3.0393820993226535,3.3128294866839707
Granta-519,46224516,0.9242838162777752,2.277122675366438
LCLC-97TM1,9823820,4.2474508710721315,3.8885403826561635
MOLP-8,23582824,0.4015956903029024,0.7880352263330183
NCI-H2452,60750,1.245026450810127,-1.9515400916721466
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,1.9151401954203278
COR-L95,54596558,4.049100773357865,4.3032373398737
SW948,135398738,3.916695667859345,4.019921801453992
SK-CO-1,9936388,-6.4137542305703015,-1.6598649324334023
Daudi,60700,-3.752408099295295,-0.9575440915181562
COR-L105,11612883,3.356288934915157,2.8300997154316976
PaTu 8988t,10302451,4.044762571435361,2.9918453066542776
SK-CO-1,44507138,1.8454813707467936,2.383065034960493
COR-L95,44486219,4.398500193784116,4.230084849840818
LS180,1242560,3.670855291471482,3.568084148196044
PaTu 8988t,25102847,3.84691315859083,2.505152388632268
SU-DHL-1,1750826,-3.9186889861650713,-2.3690967708584405
IGROV-1,4261,1.934016649932683,1.5999524534659593
IGROV-1,9903786,1.7387584479757865,2.7155260484885404
IGROV-1,9935249,3.330117761231163,2.5644209066975203
COR-L95,446155,4.383849487789403,2.513015076245878
COR-L95,9967941,2.195306027237361,3.5762453181565133
BICR 31,49793307,-0.900639036765476,-2.90702086058911
Daudi,52912189,-0.5619081020202099,1.0362241101773189
MOLP-8,9911463,4.2009596294807245,3.5229479162195205
LS180,44589607,3.154958497437342,2.724260770215078
Daudi,24821094,0.7293316215174883,2.7676229530504326
RKN,12003241,-0.3350096455718494,-0.8989771427136413
LS411N,148198,-2.2204558676981576,-3.5022417574398883
RERF-LC-MS,446155,1.000000375050646,2.6855756392695596
MOLM-13,10127622,2.24693559354045,2.7806645386665974
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,2.5489011786330433
P31/FUJ,72734382,3.508076038929844,4.399389391862974
SU-DHL-1,568763,-0.4525318049600722,0.13894653516414582
SaOS-2,11977753,-0.3684170228919589,-1.8012670798749326
SaOS-2,969516,2.4754458532868067,2.744945404159953
SU-DHL-1,54619238,4.649416356939895,4.608064351859751
SK-OV-3,6623618,3.404966669354166,2.3691054382729333
WM115,9952709,2.366340614566085,3.186733846578881
Panc 02.03,10184653,2.526680989613479,1.3479363317362407
SW1271,3634881,2.897813479014186,3.2228445445996523
P31/FUJ,72376,-3.3088434861533704,-2.4594624938409964
P31/FUJ,46907787,-0.8407426122417735,1.2161764635624728
IA-LM,5351362,3.020488284300014,1.6818757270605245
NCI-H2452,676352,2.443862996701222,2.0960635210327676
SU-DHL-1,56973724,1.0008411647005613,2.2803948876305964
PaTu 8902,1716436,3.3992265902353425,2.9683681734286553
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.1411734509581795
MOLM-13,11717001,3.6418982852877457,3.5939887886884314
MOLP-8,613753,2.6774354597179,3.0279440545445055
IGROV-1,44137675,1.8406125640672395,3.4041600139288954
P31/FUJ,6914657,-6.361388893160888,-4.263514374141161
LS180,60750,-4.478139976515186,-2.076778064994566
SW1271,3062316,-1.9256219632112692,0.9883869773128059
RCC10RGB,219104,3.453227771477981,3.8104609023851053
HuP-T3,6917907,-1.7519392074642692,-5.180855662231886
SU-DHL-1,11656518,1.4392799669460994,1.0697371012453658
MDST8,54626689,6.955475194588027,4.233258364317151
SW48,10410894,3.4061289364485794,2.8234030645563384
HEL,72193861,0.4910118925931417,0.8379711189927739
Panc 02.03,65064,5.367712415574159,5.093526949111643
BFTC-909,984333,1.0937084793466407,0.8563002966061783
IGROV-1,426756,6.142776526139055,4.14194468858204
RKN,11152667,0.0617927102225113,-0.5271858248601796
BICR 22,3025944,4.210034761741456,4.151546308036005
SU-DHL-1,11640390,4.597120644825806,3.406406338495208
RKO,44589607,3.597229089573096,2.4634683154134662
IGROV-1,56963564,1.8260986108097368,0.31249781201577376
Daudi,24180719,3.437659555986817,3.4702926959817773
BICR 31,45279963,4.353781648061694,3.5050191759154297
KU-19-19,445455,4.442962740031222,4.666694291950484
Panc 02.03,5281672,4.500820026656837,4.453976647219
Granta-519,675434,3.9057117034292976,4.349350517238466
WM115,46398810,3.009678027858605,2.51628259223681
BICR 31,119607,5.814089022953436,5.253164272923729
IGROV-1,23635314,-0.611739968448912,-1.2960857453434245
HEL,44819697,-3.010940469478465,-0.919250367636378
ALL-SIL,5282054,2.788902246408387,2.9228659756018156
WM115,5328940,2.031963430852867,1.7130421043477904
BICR 22,11455910,2.0554057071158303,0.941680497214207
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.0704568858839476
P31/FUJ,4259181,-1.476581151251805,0.208763829474695
MOLP-8,54619267,3.766514987830834,3.7065678609551855
P31/FUJ,44489367,5.126164790260484,4.639901821409808
RKN,11625818,5.974552631000589,4.5090645694505085
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.6557621158673946
BICR 31,5470400,2.045329114611378,-0.44169912076396955
LCLC-97TM1,5738263,3.894572665100205,3.1748158241809974
SW48,2729026,2.3283979545053155,2.541106661143188
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,1.9892897777930887
COR-L105,11167602,4.878993593502554,2.556754765459049
HCC15,9549297,1.5760835884765407,2.4092720847269233
HuP-T3,448949,2.1685596620814565,2.0514057749906423
Granta-519,9915743,0.9460784198503543,0.8005152139920934
MOLP-8,51039095,1.4019996450160122,2.4640839389190985
COR-L105,56649450,3.0558986692826595,3.1506977053879
WM115,16038120,1.6321211746217177,1.0843045140837495
K-562,31703,-1.219746708928784,-1.3043629484069683
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,1.89484435368578
SU-DHL-1,11609586,1.5538406664396571,2.5821295268970745
BICR 31,3025944,4.108701914406302,4.304528000475956
SW48,66577038,3.1598846844687545,2.741416560021164
Daudi,24180125,1.1000611971852634,2.4423664531572205
SK-CO-1,6184667,4.676967004326267,2.8784494068383215
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-1.8456344935608804
SU-DHL-1,67291369,2.039504043535649,1.8379975568976346
IGROV-1,3815108,1.915722485757852,2.7573634377634972
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,4.816461433969186
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.3327392446699546
LCLC-97TM1,68056272,3.7652459105524585,3.6232658539576357
NCI-H1568,9926054,1.8156743035592564,2.0659371931659196
SU-DHL-1,2113511,3.6581551041454823,5.092944916086497
HCC15,3503,1.8764785687467953,2.265665916322053
SaOS-2,3062316,2.2990980703822115,1.193895307634289
K-562,16736978,2.075477087199636,1.4651083831727914
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,3.124190790072126
RKN,135440466,3.1815161125023033,2.319643249917016
SK-CO-1,89928392,1.2451759556756246,1.5776596607816362
NCI-H1568,54596558,4.146513733670967,4.375611626460621
LCLC-97TM1,4477,1.1810793422928998,0.5398673082988676
LS180,16741245,4.152630132762677,3.779674377120791
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.3751244914868965
BFTC-909,159324,4.114702101808939,3.2180743622548884
PaTu 8988t,2113511,6.37119394515457,5.379667081739568
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.5109731452194926
IGROV-1,5291,3.6852809555447985,3.669786132924403
PaTu 8902,16038120,1.215016097060631,1.007107805522079
ALL-SIL,10302451,-1.1728976190372558,2.7427561611053255
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,2.3762901069218354
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,0.8648499197671413
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.425427261435172
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,0.575800883810981
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.395111629305666
SW948,7326481,3.486606738365962,3.054083617694989
HCC15,44507138,1.6295786006094204,2.5997524783814274
RERF-LC-MS,16725315,4.583339442818838,4.165291973546978
P31/FUJ,148198,-3.664233852608881,-3.4230806846203525
HEL,49850262,3.2265871136708997,3.103440886463899
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.7575451386209036
BFTC-909,60750,-1.7298046099952136,-2.32312839925598
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-1.47765096838246
NCI-H1568,675434,4.067969537829177,4.532582389680608
COR-L95,19582717,3.635233206850296,4.05662888447745
COR-L95,148198,-4.800055382400855,-3.4795243794044017
BICR 22,44819697,0.2156040754176,-1.1045649402108706
SK-OV-3,46224516,3.444215787907748,2.697393065987322
HCC15,5281672,5.6563329698974965,4.4501370074204
HEL,6918328,-0.4966077251990671,-0.5073539617619712
NCI-H1568,24785538,0.5698046292147018,1.8910321174112306
RKN,23582824,1.7370647325872666,0.8813234547951899
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-0.574979685491947
SU-DHL-1,322968,2.585334286015635,3.292147806927878
BICR 31,24797083,1.8361324304615187,1.2806567156109225
SK-HEP-1,3062316,3.432714145613195,0.924658085578611
PaTu 8902,2729026,2.7803221257085884,2.7372583640211654
SK-OV-3,11609586,4.251063762376387,2.6433427151986684
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.366579495147403
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,1.3954102916650521
Granta-519,44607530,1.7224857333943702,1.39457777281939
NCI-H1568,15953870,3.42403550557497,3.326704991257196
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.377505002667778
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.6175742183595
MOLP-8,252682,6.161004481234046,6.353890451103018
SW1573,126941,-1.0305779796426808,-2.847814409141451
BICR 31,9927531,5.661036072082279,4.669603279763362
RCC10RGB,441298,3.7731685554529384,2.564391585333833
MOLM-13,387447,-5.119095777855545,-4.70640439431108
Granta-519,216345,1.0997896286755158,3.1970715861552836
LCLC-97TM1,107985,-4.222636663811031,-3.6502421048919005
LS180,3384730,2.894746509752001,2.384644130476389
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-2.796807738421326
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,3.30566057962185
KU-19-19,44493528,4.383684457454455,4.267044873724451
LS411N,53232,4.5193815700089655,2.6360759783983867
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,2.0828158560751096
LS411N,6438330,3.3380693145982816,2.3141148272358247
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,1.9203250187922418
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,2.219589835693836
BFTC-909,16725315,4.495652912061774,4.3002566124843735
RKN,124202324,3.704376342602573,2.753731638771747
LCLC-97TM1,10127622,3.458194652659875,3.864831133445759
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,3.07310747863155
SaOS-2,5494449,1.7356769079300427,2.4636329409959044
HEL,702558,3.166026376934585,4.508880106786775
KU-19-19,11612883,2.975593545287462,2.859908387326609
BICR 31,6914657,-2.1990076047646703,-4.09315979270855
PaTu 8988t,2858523,3.414247843041017,3.038262050316206
SW48,9911830,1.5953282800372102,2.2093135090339953
Daudi,11178236,-7.583909031047052,-3.786261131650359
Granta-519,44819697,-1.094231558387569,-0.9285811753265202
MDST8,2828334,6.077771510152207,6.168567246732889
RKN,9911463,4.114615883902867,3.846220868836042
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,0.9738520541998337
SaOS-2,9903786,2.3206358959344264,2.5426376177356875
RKO,44607530,2.6096687798301677,1.5686085062736796
SK-CO-1,11455910,1.152685438196598,1.2738267879665057
SK-OV-3,25183872,-0.070614613180641,-0.4767365867621639
WM115,25227462,1.5125525407178182,0.05603326196242968
HCC15,2126,5.047391044285817,4.602225138437828
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,4.257476088789398
HuP-T3,11238147,3.6375005285241033,2.7288964279878765
SU-DHL-1,168313047,2.0629090722275945,2.107243282807242
BICR 22,5335621,5.24838502551373,4.424138477801286
SK-OV-3,135398516,2.140261030425796,2.0576005399180333
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,3.006958769628123
RKO,11214940,1.6564081526645635,1.8536732076739355
SW948,9935249,-1.8483271913214137,2.8466412826830907
NCI-H1568,2871966,-1.5477941874243064,0.663137794563412
WM115,54626689,3.4845925362433,4.439447258990026
IGROV-1,46398810,2.003787621940583,2.3597249603121315
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.5775270551144452
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,3.087671777604679
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,2.894500275925468
BFTC-909,3025944,6.464154930724253,4.200460408739563
BFTC-909,10113978,3.8739618499623094,3.2266862632488538
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-3.2243060405693793
BFTC-909,24748573,2.672786285704278,2.244994858027173
MDST8,23582824,0.3553467044538872,0.9341049468144544
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,0.9549858072760816
SW948,53392493,1.921137473015096,2.6909770927874876
LCLC-97TM1,5287620,-2.537847801025228,-2.2007054402636994
HCC1500,3552672,1.623977684405255,2.7805761403556484
SW1271,2113511,4.856200971437617,5.411446645528839
RKO,11238147,3.3996395604326977,2.412608931073289
MDST8,56963564,1.9609696235744132,0.649165778573642
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,0.6549749486027031
MDST8,73707398,0.930898424190815,1.6103705879919812
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.5132459490190522
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,2.135878751690359
HCC1500,107970,1.6380228058856745,2.2732376387512163
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,3.0610160506634707
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.6298924697664585
MDST8,11222830,1.739834123793711,1.6683626944395384
MOLM-13,11364421,-4.614262921489179,-2.955232192942529
MDST8,89928392,1.3331112546959425,1.6473836958036592
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-0.6503333703876331
RERF-LC-MS,148124,-5.592640359076286,-2.1743967769350814
PaTu 8988t,219104,4.30352428274638,3.717990092241024
SaOS-2,16659841,3.6368059645085737,3.728148643894537
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.481745395628324
ALL-SIL,25183872,-1.1896517316661384,-2.1274734232044232
HuP-T3,3503,2.6961085729175465,2.1622713108421108
SaOS-2,148124,-5.379251304292956,-2.6839902030720224
SW48,25102847,1.5289459974072863,2.4168276148610284
PaTu 8902,6852167,4.282216220168943,2.6524204863199383
ALL-SIL,11396600,2.960335319566646,2.906892989174275
LS411N,54649381,4.0879656113234315,3.610305541849881
LCLC-97TM1,56649450,1.9268896253969057,2.9745754569211145
Panc 02.03,42642645,1.4849485241267697,1.1312675456809922
PaTu 8902,5328940,2.100447742300893,1.5237004840297623
Daudi,10127622,5.05479511248997,3.378109745176171
SaOS-2,15983966,-4.612114381732812,-2.1407311067649575
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,2.836612389760349
MOLP-8,11214940,2.188017762346292,1.5283029001381467
SW48,44607531,-0.0703962424187993,1.6028966141627723
IA-LM,637858,2.795809218533269,1.9751093299167974
LS180,119182,-2.2864715680735603,-1.1526067797013637
SK-CO-1,135411,-1.9906675184189948,0.7129115173870805
SW1271,15983966,-1.9627382742922743,-0.6364063933554349
LCLC-97TM1,11485656,2.4293249862604913,2.2048716413809744
Daudi,135984461,3.9990978127252728,3.350383831076472
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,1.249600306456566
SW1271,24180719,4.447587763279296,3.447216891202014
RERF-LC-MS,4917,3.617944790726347,3.102480557235066
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.512014939999339
COR-L105,44185566,3.03526972595121,2.599047739644773
MOLP-8,8515,3.727464051425151,3.561964045060065
Daudi,11656518,1.0836561052202376,0.9482597197839698
MDST8,10302451,4.267643132743765,3.141850037938657
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,2.417815903239037
MOLP-8,135398738,4.11621412508813,3.210748560741399
RCC10RGB,568763,0.4218853975706897,0.38418602997627177
SW1271,285033,0.340737243750418,-1.6241481812639356
Granta-519,67156097,-3.3327998752636483,-1.6029681674806404
WM115,11964036,0.4423113132234746,1.4244101713154464
SK-CO-1,156414,0.1991331726980137,1.419587279249499
BICR 22,568763,1.1340411223212885,0.3336954722959937
P31/FUJ,176870,1.9707243184949097,3.369744337161789
SW1271,24748573,2.5868513601661336,2.4933502609732336
MOLP-8,72199292,1.2541603744267094,0.6084985250652609
RKO,5282054,3.8735499096789856,3.4800127754854686
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,2.7878108325445727
HCC1500,16722836,2.402902940836366,1.7693273011805621
Panc 02.03,46199207,3.8452319744534886,3.1784759381363386
PaTu 8988t,71304818,2.8353343090304257,2.4536104743723426
IGROV-1,241158,3.288496474515495,3.854946685728569
Daudi,71751553,3.830487233171358,3.864254396305514
COR-L95,46174525,3.763282126483136,4.1172323339306915
NCI-H2452,2126,4.762499509878762,4.703071485212907
HCC15,11228183,0.6025691709173914,2.183078194034103
HCC1500,11404337,-1.1638452247583002,-0.20047996724557493
PaTu 8988t,16725315,5.4103858057829095,3.9894800846343514
MDST8,4378219,1.9480435949418269,2.3171996297272415
IGROV-1,5351362,1.961059142684053,1.4223567390252714
HuP-T3,44489675,3.6946366435409352,4.052056938819427
SW1271,4259181,0.7411137136724786,0.4566353322678144
RKO,5978,-3.7617282032773582,-2.0097777753017003
MOLM-13,11485656,-3.968420003132376,1.8754848471680734
K-562,24821094,1.908113699718487,3.1293764941326057
SW1573,89183176,3.862510153781557,4.156954487713911
K-562,24180719,3.2747438118023533,3.438446720554876
LS411N,4788,5.997281207159956,5.534318795595567
IGROV-1,66577038,3.2148239132520455,2.985333393487731
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,3.93340457595827
Daudi,9549297,1.403366421117492,1.9831516414037023
UACC-812,11427553,3.574449796486334,2.910277348592325
MOLM-13,52912189,-1.0667663091505395,0.9817605300515092
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.2161375275085902
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,2.854982254319018
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,1.763994436472793
IGROV-1,24821094,1.720998716331183,2.664253236832104
Granta-519,11427553,-0.9723301484726812,2.1410412860983596
MOLM-13,208908,2.7636340376000317,1.9666379723380456
IGROV-1,9915743,-0.4757488934941289,0.8124971217875847
Panc 02.03,241158,4.402915180139186,3.8755077192822953
IGROV-1,24748573,-1.0654275876710166,2.1319879380060365
COR-L105,5287969,-1.8496230723467,-1.636355309149988
MOLP-8,10296883,2.725727750190508,3.2375039471072866
SW948,241158,4.5321951743877005,3.6147950541082805
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.3128654467951053
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,0.8307551414893847
SU-DHL-6,10302451,3.370117636140473,2.838283630581758
IGROV-1,9936388,2.10108466287406,-2.8558141039656237
HCC15,72376,-1.512462057486854,-1.8186905852294364
COR-L95,6450551,2.8920154707175776,2.4644594050580584
NCI-H1568,5738263,3.2402226460817323,3.204809081548207
RKO,54619267,4.028311361432676,3.7178445416341193
RERF-LC-MS,4261,2.068565192175152,1.4651554038818995
K-562,73707371,5.645446798773975,4.632260989387303
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,2.9386452350381256
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,0.748695249437897
WM115,122327,3.780637240577924,4.754421885662762
WM115,25150857,2.4679229997528394,2.2722627369723414
SK-CO-1,11178236,-3.2010052407962215,-2.9329590638938465
RKN,753704,4.966407297087677,4.849751172641364
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.4349685354302983
SW1271,227681,3.2917347097405725,3.3243848124829807
MDST8,568763,0.1407924711645573,0.5189926209583328
BICR 31,5566,3.2898773587253096,3.0182501449577264
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,3.8488827741295535
RERF-LC-MS,6450551,1.967154760545028,2.2163066337869997
IGROV-1,2874250,4.893662837169153,4.46956150821331
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.8781521421459706
HCC15,56946209,-3.385198311974778,-3.8250248497616757
BFTC-909,136227924,2.3418993883842134,2.933324020297676
Granta-519,1750826,-3.7858867937492984,-2.648651790657813
P31/FUJ,11625818,3.2136174191857174,4.243132840913206
COR-L105,10322450,4.112392966182136,4.130845150320527
HCC1500,5566,2.905130044911903,3.060895539588032
SW48,51039095,1.7096770563148074,2.3986503167215663
SW1271,8515,5.208985199998064,3.80510214887894
KU-19-19,73707398,1.7453733414385195,1.3548354278224912
K-562,11707110,1.6681367726124623,0.21084346854637573
COR-L95,16065773,1.8842547212847705,2.3727072655598196
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-3.335107786142534
IA-LM,11178236,-6.720771550362321,-3.1036189717385185
MOLP-8,54596490,4.413151323823571,4.435612450507689
ALL-SIL,44202524,-0.4119558263455749,1.9707959764664549
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,2.86018453863473
MDST8,6918328,-0.3527629143091293,-0.14146624000302346
BICR 31,104842,-0.0442586507462943,-2.973354121224076
BICR 31,6852167,2.001013365002547,2.84458885124109
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,0.9638201915496218
IA-LM,24821094,3.0699000024292293,2.7015773240065926
IGROV-1,73707398,0.8848064516600974,1.1347722612781994
SaOS-2,46191454,1.8159544721998524,1.6078804769077908
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.4941703831886328
LS411N,25150857,2.959758413524705,2.2305639804844235
HuP-T3,11175137,3.603877049706456,2.763535909704741
LS411N,135984461,5.061110843141604,3.7961590693988576
IGROV-1,4261,1.934016649932683,1.5999524534659593
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.524306008902341
HCC1500,9952709,2.298703589628035,2.783508549706553
SK-OV-3,176870,3.5610869734905255,2.8719895361309913
PaTu 8902,9952709,4.3707417693645745,3.0725894909109748
P31/FUJ,56973724,0.796880831995934,2.4995797177086283
RKO,2729026,2.3662843020346753,2.5301059948440145
RKO,387447,-4.452540898932811,-4.564599003438307
SK-CO-1,135398738,3.5773200936681584,4.1708649267908955
BFTC-909,3552672,4.498195948808332,2.939766160321201
Panc 02.03,7251185,3.0530850004567767,2.774563557759034
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,0.23961878829172328
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,1.904724689320515
Panc 02.03,53392493,3.617637281515077,2.6787314445157824
LCLC-97TM1,446155,3.780165105352184,2.8052728496051373
BICR 31,23725625,6.004496967521932,4.829289878669407
RCC10RGB,11612883,4.41570881394896,2.8022089923381133
WM115,5280436,2.216411919293008,3.1677632043078625
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,1.266977481766554
NCI-H1568,10184653,1.3826991243685076,1.2613503653854905
LS180,10427712,4.740953715848998,4.211757147365661
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,1.0130203178473374
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.2779755766186405
HuP-T3,12003241,-0.2833744856936582,-0.6518769542586657
Daudi,9884685,-1.7998414591903729,0.2837308607419647
SK-CO-1,44259,0.6005082969424771,0.8229294453997322
MDST8,10231331,0.2022855962524302,1.670992408641976
SK-CO-1,4261,0.7789911540114764,1.7324722394286811
P31/FUJ,10074640,2.9862675466657764,3.092055929898404
SK-CO-1,12001922,1.782153173177779,1.8621031882079435
SaOS-2,16720766,-1.9505026731708328,0.7599395409465359
RCC10RGB,216239,3.3222265979679375,2.557648290818761
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.9736873007270833
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,0.8540316516541894
COR-L105,72734382,5.425179503032161,4.68435754526553
LS180,11640390,3.36619781023128,3.05234669831725
K-562,25262965,-1.232298297425116,-1.808894249402873
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.897715098970005
LCLC-97TM1,135411,0.5874500365845237,0.690530095411881
SU-DHL-1,46398810,1.696894130738712,2.352839474824946
P31/FUJ,6610216,4.336076332167018,4.148644346891401
BICR 22,5291,3.723640910280853,3.4997718852382578
HEL,44632017,1.0842639602191189,1.0698631305041233
Granta-519,4261,1.1412453306659267,1.0262381028432737
Granta-519,56963564,-0.5609340564012296,0.2218722792864987
MDST8,53392493,2.9375507482716334,2.547918067122035
LS411N,44819697,-0.923326266781905,-0.7796201737806205
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,3.565603650365984
NCI-H1568,5291,3.770643134542437,3.681069536080681
BFTC-909,11612883,3.5324782187628827,2.8614490607514056
RCC10RGB,11955716,4.4260489213830425,-1.2616137673555623
SW1271,11626560,1.376954486231794,1.8694022209906493
SW48,46943432,0.8743166493146273,1.841484449247379
HEL,3062316,2.2727573444408633,0.8678972099943121
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,2.5540557705916176
RCC10RGB,5329102,2.357265375302505,2.0692298436171983
ALL-SIL,9866186,-0.4181259896802407,0.35057342351846266
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,2.0335140631170017
HEL,23635314,-2.6594801266287154,-2.1564417787290036
Daudi,10074640,1.7373836938395748,2.984246621632725
RKO,26596,-1.341584325458414,-1.369345282021884
WM115,11167602,1.5239005360441813,2.4416550632742595
IGROV-1,2746,2.8413672686351212,3.2466845131775206
Daudi,24978538,2.467871482925033,0.39555182295847224
RKO,2858523,3.1569923390566332,3.084599627505055
LS411N,15983966,2.6804451752833978,-2.2040975504038047
SK-OV-3,452548,0.7579906967862455,0.1732456360036456
MOLP-8,25262965,-4.805551534468427,-2.0675173318764872
LCLC-97TM1,46215462,1.4949685345148778,1.838126782017385
BICR 22,439501,-2.4052901035443,-2.31724067109665
SW48,10184653,-2.0074491437034094,1.2243544273231435
P31/FUJ,168313016,4.690131242833582,4.690700892160154
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,3.3035285541262702
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,1.7209412217757265
LS411N,54613361,3.867376577775082,-0.26826262079345164
COR-L105,24772860,-1.435746068442861,-1.9309086674802205
K-562,11222830,1.892206265748428,1.402493628657854
Daudi,10385095,0.347773175212431,1.002875405096614
HCC1500,44137675,4.199849963716895,3.400146652150915
SW1573,11404337,-1.3449252751203844,-0.3909839128720622
SK-HEP-1,46191454,1.8876467264614776,1.5375271014778509
P31/FUJ,135999136,4.068676884464422,3.942831567544448
RCC10RGB,25150857,2.370598483016253,2.4989718297868664
NCI-H2452,57330099,4.302779847582817,4.185077695138932
IGROV-1,10127622,3.2581804056600165,3.2083391583756207
COR-L105,5282054,3.9571885951378505,3.7983705901044864
LCLC-97TM1,53481919,3.8027519676947232,3.7816278304607294
NCI-H2452,3025986,-0.5496531660815697,-0.7487389932771983
WM115,11955716,-2.4505472507691013,-0.8132575322247118
BFTC-909,637858,2.264716830291231,1.9595772965515241
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.6257619424072576
Daudi,1641662,2.995591169153073,3.091689903763482
MOLP-8,446155,0.367312642153156,2.3453229780306706
RERF-LC-MS,135999136,4.400683337930441,3.5059380822437594
WM115,5738263,3.851280366828244,3.319064562431789
MOLM-13,65628,2.9573007313246924,3.7711865138828373
HEL,9936388,-3.337900467930123,-2.9260812830872585
SW48,104842,-4.777281812432541,-3.2511321729830813
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.5078439612685791
Granta-519,11626560,0.2073830225530282,1.6112408769100959
SK-CO-1,969516,2.7975557975376035,2.720407362815431
SW948,11640390,3.051257470103826,3.4993181626663326
HCC15,10302451,3.767869991537956,3.1657927934745898
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,1.8096703024134422
PaTu 8988t,46943432,6.478561461465468,1.7809184708964483
K-562,208908,1.7214906675478436,2.0484032087159325
NCI-H1568,11612883,2.467781963295413,2.8945264548894225
LCLC-97TM1,9884685,-0.6945268748645868,0.3882416998991504
Granta-519,6918328,-2.2526378564537355,-0.721029248521808
Granta-519,5470400,-3.2597420844446163,-0.25059466311135015
LS180,10231331,0.7625893939503741,1.9267414991369842
SW1271,46199207,3.134892747913181,3.2540181600406832
HEL,11404337,-0.835651629585067,-0.8406748982027217
Daudi,216345,1.872370108624604,3.3630587841438513
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,0.8716717061755384
RKN,54613361,0.2026815444056028,-0.042308013328918086
LS180,452548,0.7544699085550369,0.13299823503060465
RKN,44493528,4.408823872302737,4.371148916898062
SK-HEP-1,11238147,2.1467729161342524,2.9417260953926063
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-1.613393926287619
COR-L95,11364421,1.7062947816433405,-2.1985856406173245
KU-19-19,452548,1.4010535434747853,0.09770206449382111
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.3466988946290535
IGROV-1,44819697,-0.8326420176056434,-1.060023184298978
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.9884882776162645
RERF-LC-MS,2729026,3.1361811776879644,2.6646170977098484
RKN,4788,5.902938799554125,5.6266088971071255
K-562,216239,1.6121414929675577,2.175278657987931
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.6246866096664676
IGROV-1,2746,2.8413672686351212,3.2466845131775206
IGROV-1,637858,1.814476597989254,1.9923886767217271
HuP-T3,11214940,1.8541641961456377,1.788784663408899
IGROV-1,46907787,2.182756719431072,1.9218123634855302
P31/FUJ,445643,6.117258311867223,4.007112053560286
Granta-519,3854666,0.1662242620713641,1.6235616255245537
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,1.6571820077081683
LCLC-97TM1,135440466,1.105929023295497,2.132261438484978
RERF-LC-MS,56649450,3.38813984116235,3.354408987298233
SK-CO-1,11612883,2.4661452350243493,2.781697592530129
SK-HEP-1,44137675,4.549525792934436,3.503000643489606
HCC15,72193870,4.3690783386047025,2.928260045209748
HCC1500,2746,2.6069735713089006,2.875586619603265
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,1.329023669714578
Daudi,11222830,0.8543881776084605,1.2976671302790193
WM115,2749,6.3303951951253445,2.1981238439296713
K-562,9840324,5.675524269237515,5.783050497148866
MDST8,10113978,3.624916965791189,2.928467088392417
NCI-H2452,44507138,2.753685109279225,2.574360582357232
MOLM-13,5282054,3.1361279245897857,3.2555572735787757
BICR 31,9911830,2.2138272662609064,2.4873120169968597
HEL,6917907,-5.38656193144065,-5.392172247652677
IGROV-1,2858523,3.196384505087132,3.087821644642696
MOLP-8,322968,-1.2094679469942695,3.10308607502168
BICR 22,3503,2.960513829073252,2.246404342410149
ALL-SIL,10113978,1.6173510565910796,3.0167673590979467
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,1.9247728515127065
RERF-LC-MS,119182,-0.645974794966856,-1.0770330070689402
LS411N,4261,1.591263829932159,1.330075744673487
SW948,4096211,1.12279899109382,1.925545459957941
K-562,11485656,1.7795111963017332,2.225307741618362
MOLM-13,53232,2.182263698942312,2.676186336807557
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.6864157862072632
IGROV-1,3689413,-0.3633634632064185,-0.10664326968183895
RCC10RGB,12001922,2.277970650057297,2.065861088154572
RERF-LC-MS,246676,4.480243243269967,4.435369905337722
HCC15,374536,0.7951987879889547,2.1542449175564626
MOLP-8,11977753,-4.876868381891939,-2.242605883927227
Panc 02.03,2874250,4.438896474206821,4.617778743900935
COR-L95,613753,3.031049367391043,3.134065113295301
SW1573,9840324,5.095993559480237,5.798016834425869
SW48,24901704,1.780712261537264,3.2776946156006317
BICR 22,6918328,0.5113628660513942,-0.03263765624860529
Daudi,54613361,-0.5183638298018372,-0.3263487304069199
LCLC-97TM1,25102847,2.141917897082315,2.515183736356838
HuP-T3,3081361,3.872954779649628,2.442957058116919
LS180,969516,2.6818241036299275,2.573835168382501
SW1271,2945648,2.4921907486938646,2.6812462256420986
BICR 31,25126798,3.691910729857057,3.833418821827863
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-1.5481704042204945
Daudi,262093,0.7533038243356376,2.5103529818905392
RKN,20959075,-2.033811748726601,-2.8085447426246173
KU-19-19,702558,5.449368171937104,5.0752202657817715
SaOS-2,2842253,6.143936300195383,5.14801358146761
RERF-LC-MS,26596,-1.2372341703529914,-1.66760752250733
PaTu 8988t,5329102,3.3339986936080717,2.0647748148375418
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.536358888990751
SaOS-2,73707398,0.8491853151273433,1.2125089208682749
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,1.1861869199677506
SaOS-2,984333,4.259432573695519,0.7277471559739572
LCLC-97TM1,53232,3.007779101776312,2.93799478904848
KU-19-19,3503,3.0769201112014803,2.439465440884987
WM115,57330099,5.984461482923693,4.253955843843052
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.5406192624612745
LCLC-97TM1,44491742,4.237702230509644,4.21806839557441
SK-CO-1,9915743,2.0474134916136184,0.6687460473418022
HCC15,73707398,1.6988346513711203,1.370416650358508
HCC15,4477,-0.3802251277588812,0.740116081868669
BICR 22,26596,-1.8883514509946957,-1.6413509690382
SaOS-2,445091,4.479630914494518,4.190862074189658
HCC1500,3503,2.0705498046235817,2.420523390670119
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.976815304855531
RCC10RGB,71304818,3.488257335656729,2.6510774940226365
RKO,241158,4.5302703569847305,3.53547367594249
SW1271,168313016,5.582938604018868,4.510739809884722
SW948,10385095,1.3660359707166476,1.299922022482615
RERF-LC-MS,3543504,3.1700226881436193,4.024139808768494
LS180,5311,1.1738972820475675,1.0698214594727877
RERF-LC-MS,5291,3.9873816513243785,3.6435572825487395
RCC10RGB,53481919,4.9196370953200805,3.761427233310761
Daudi,44241473,5.233980827552566,4.642370605789486
Panc 02.03,10127622,3.4148938287456776,3.8711623251417233
BICR 31,49836020,4.313223650735915,3.0465619754557305
Daudi,54618305,3.9105424608095847,3.8460318240168023
SK-HEP-1,5746,3.319924463812582,1.331205676146397
ALL-SIL,67156097,-2.3407546390754037,-0.9937390118982755
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.6113704714128374
P31/FUJ,613753,2.9305719806169432,3.130047726222139
PaTu 8988t,1641662,3.634680635371761,3.521355417616501
SU-DHL-1,15953870,1.992339234699044,3.242460922521324
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,0.6270964426565694
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,1.3471998862300871
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,1.2599446764734643
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,2.585175695718545
SK-CO-1,11364421,1.7180407971266538,-1.5305239106637536
COR-L105,16722836,1.79329711252707,1.7364418921237756
IGROV-1,439501,-2.1510551928674557,-1.9654080806865135
ALL-SIL,50905018,3.9646846974495418,3.7422887092347166
SW48,25126798,2.5731969050098993,3.510240833303233
PaTu 8988t,10113978,4.3652834043747335,3.1994929683235838
SK-OV-3,12003241,-1.2313805329375749,-0.6464137107698303
Daudi,1317464,3.6966432302020817,3.357246104471434
WM115,5978,4.185238310426041,-2.0440242682910728
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.7922891607036617
ALL-SIL,24785538,-0.5874123218373029,1.0769998220079515
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,0.6862747473098446
IGROV-1,9967941,2.9735049794712545,3.478110615316944
SK-HEP-1,11977753,-1.1270659898133608,-1.2371394721910491
COR-L105,676352,1.9469411585028615,2.110952455641635
MDST8,11485656,2.867381561993162,2.427171199764951
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,2.9854989936036476
SW48,6918736,-2.164113269607571,-1.5720832407782417
SK-HEP-1,445455,4.37046727572682,4.622339357672555
Daudi,4096211,1.4831417361144643,1.5588151135363753
LCLC-97TM1,16038120,-0.9192372639718316,0.9099130152192919
BFTC-909,3384730,4.46542670181497,2.8006093215845875
K-562,36462,1.3855340321895664,1.8275832205951155
SK-HEP-1,5329102,2.506246240472525,2.1246413469799013
WM115,25161177,2.874219730459086,3.921549412894129
HCC1500,119607,4.730010050453825,5.110007608934514
IGROV-1,24964624,0.5052308994941754,2.0633374888682865
HCC15,421610,3.960173561996767,3.1155862632543134
ALL-SIL,4788,4.920956242868583,5.013651013763591
IGROV-1,49766530,-0.195540678413639,-0.7015483474812002
SK-HEP-1,11175137,3.0126176485486114,2.822948589568239
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,2.504638547651025
K-562,54678924,1.7343444538293111,1.9217278260234127
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.552363170803285
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.538099193665038
COR-L105,6505803,1.059348129706536,-0.26975553048886686
P31/FUJ,25183872,-2.108478877482417,-0.7720024089266652
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,0.9877260488966025
NCI-H1568,9444,4.259676436179719,4.083634989388768
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.44066153475406
KU-19-19,19582717,2.992815973528006,4.137885359634022
RKN,36462,2.460575122343829,2.2111553902169994
P31/FUJ,3062316,2.2346133515561415,1.1268868356476638
MOLM-13,36314,-7.769941141611737,-2.3427225675699304
HEL,44484440,3.2564839193688524,2.993449842081513
RERF-LC-MS,168313016,4.277512101574917,4.7419840155628386
HCC1500,637858,1.1010846881251866,1.8979879261807915
COR-L105,11178236,-3.064044900311784,-3.566756841170333
IGROV-1,44202524,1.8303703172382677,2.2287791475746492
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.5876160070555684
MOLP-8,11175137,1.914718066408171,2.0354845720706334
LCLC-97TM1,1641662,3.5570250788057187,3.412869266622634
SK-HEP-1,46199207,3.772137058295689,3.2157117394266193
SW1573,6917907,-6.296104468024424,-5.539421015461777
HEL,89183176,1.9576500820122449,3.065587087806016
SU-DHL-6,49793307,-4.306431914357451,-3.6063099263472504
K-562,6918837,-4.262812875828109,-3.3189935644505284
Daudi,44493528,3.680262260756896,4.180443417409785
RERF-LC-MS,5311281,3.366561586065275,2.25483954076452
IGROV-1,675434,4.336225379212549,4.4946930849708995
NCI-H1568,216345,3.8344110950672823,4.018529240891878
SU-DHL-1,9926054,1.6936537424309908,1.8148918119845983
Panc 02.03,9911830,3.8856260346392903,2.547123637503096
HCC1500,2729026,1.749867272011919,2.74390363734795
ALL-SIL,42642645,-2.33031271995146,0.44997219099325486
Daudi,9911463,2.4252044126403915,3.4206720785680047
NCI-H1568,45279963,3.534456091536717,3.458750364693791
RKO,135999136,6.045591123054076,3.4483313299784295
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.4773965550611794
SW948,9903786,1.6902329933335576,2.6265831802159694
RCC10RGB,9956119,4.44093701823858,3.806512013530168
SW1271,25154868,5.0403607075499375,4.1468174221542355
K-562,65628,4.517417686157834,4.2729609174687395
SU-DHL-1,613753,2.797885663964736,3.1449695755083815
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.5089989660874782
HCC1500,44566777,0.0909506116020526,0.49614759352694404
NCI-H1568,54454,3.61375646412465,2.7235546407204456
SW948,44507138,2.949706410080911,2.6388315241767106
SK-CO-1,17759555,4.047587343089958,3.576176609585878
HEL,568763,0.2288469977463405,0.34401551118172774
BFTC-909,3815108,3.5118939741133075,2.981952632227937
ALL-SIL,24901704,-0.1489296834412312,2.7297229506369765
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.3663387971287932
KU-19-19,24772860,-1.0696999794461075,-1.9515960037161975
MOLP-8,9866186,-0.5209158528959533,0.32744469626475564
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,1.3824875856053518
HuP-T3,71304818,3.5647709327393287,2.5656008835321735
MOLM-13,11683005,2.7238157220539345,3.0711218568053242
HEL,54618771,0.7283869495698151,0.4916274464490783
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,2.8037758965591486
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,2.138031234306471
NCI-H1568,25150857,2.4294918673251416,2.5077603150232877
RKN,6438330,1.1013294242613172,1.9272769141263313
HCC15,644241,2.326085716096255,1.8289042096216468
LS180,2708,3.937371430907984,4.783816478277511
LS180,51037431,3.4786862718788747,3.2198533311446544
K-562,16741245,3.9224206604880583,3.7042903099764444
RERF-LC-MS,44185566,3.014427147988128,2.497462422114474
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,0.6783809304048363
RKN,5566,3.4992110401170944,3.0396533184469066
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.4321381726943099
MOLP-8,216345,2.155670358283386,3.1698912884768475
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,2.0748747579435816
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,0.4555289091413231
PaTu 8902,46224516,2.4477060426075723,2.5818589344203713
RCC10RGB,241158,4.984223152954295,3.883354905009051
HCC15,11612883,1.9950389922708311,2.7301707705058247
HCC15,969516,3.14053560758236,2.8745310105734796
LS180,9866186,-0.1716689837079009,0.5103179858744371
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,1.5997551990909986
RCC10RGB,24964624,2.93015987785669,2.5942993595811616
MDST8,216345,3.5638732818875094,3.7004601827152124
RCC10RGB,10302451,3.839480938635774,3.0649009289723352
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,5.9885618095352955
WM115,44491742,3.78432787650886,3.9077908046019187
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,2.9917078381398103
KU-19-19,262093,2.7281718696395303,2.862018152890788
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,2.9434878860286777
COR-L105,1242560,3.3237423881291233,3.784038951728543
MDST8,16736978,0.980275670291684,1.3643051959118397
NCI-H1568,16722836,1.2045551605263336,1.8217591975534098
WM115,5282054,2.577591804396212,3.6185719485317884
IGROV-1,25195348,3.0698662305180275,3.3152907757705963
PaTu 8902,148198,-2.774580136562139,-3.3635069518122633
HEL,26596,-1.8679385890512872,-2.0353335203036953
Daudi,25126798,3.548189682848153,3.6196335444115344
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,3.1219057520136495
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.8757874430682822
PaTu 8988t,56946209,-4.946927234389905,-3.8311224557256747
SK-CO-1,2945648,3.4071568821077993,2.7576247982448945
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.5803571068095598
BFTC-909,3136844,3.2427360302120403,4.193947567521023
IA-LM,71304818,3.3887828048220094,2.502573332311456
NCI-H2452,122327,4.606448802646307,4.807922284851184
LS180,12003241,-0.6460664270988897,-0.6833284628111191
SK-HEP-1,16741245,3.65273757252914,3.9128282310795517
RCC10RGB,6918638,2.235907203261483,0.6797700842601497
WM115,16065773,1.4979025411384967,2.532728196821726
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.1543312444591223
Daudi,54678924,0.8831010429483725,1.3958136054407126
MOLP-8,9903786,1.299688823902182,2.1125031522096878
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.510927553145061
WM115,219104,4.514482202684108,3.531301007495915
Daudi,25150857,0.8259987709661276,1.9098902710287853
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,3.630628871648776
BICR 22,25262965,-4.220207088048826,-1.5413936221922437
BICR 22,25126798,3.759096897040898,3.767105047897238
HCC15,11717001,5.339668805105819,4.199018106360179
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,0.9941467185993499
BICR 31,6918328,1.2499033439512497,-0.29153590959387565
COR-L95,25150857,1.208080540357677,2.340474413474931
ALL-SIL,104842,-6.679847729141338,-3.4064390865100878
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,2.5930018427935004
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,1.4500490459825974
IGROV-1,11612883,1.8715405446213529,2.5913339505441297
HEL,9926054,1.596813412273358,1.6846884302364176
HCC15,11404337,-0.219975280966356,-0.38119175135366445
LS411N,168313047,3.2811764574410893,2.2342932072894306
HuP-T3,168313200,4.289513738947004,2.968165160218896
RKO,216468,3.08027711257304,2.4778945619480215
HCC15,5566,3.133848096057735,3.034111315128593
SaOS-2,2130404,2.752105467907615,3.1801666554949923
PaTu 8902,6623618,2.257974787323956,2.1561863544803717
Granta-519,45279963,2.8131243875516097,3.4018039248346588
BICR 31,6918638,1.4401869695378149,0.5345248704657977
IGROV-1,2729026,2.3541792737160296,2.5809861990613907
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,3.0858278306799156
PaTu 8988t,126941,-4.347732149803542,-2.150378520882384
BICR 31,44607531,1.4420456412349776,1.527795115773752
RKO,227681,3.9032876810461814,2.894463225928853
Granta-519,5278396,3.331153353007608,3.3892781452061977
MOLM-13,11214940,0.2452206847669268,1.3962150613889657
Granta-519,6914657,-5.464946920891912,-4.51930234343146
SW1271,72199292,4.741032264194907,1.2244393658694288
LCLC-97TM1,3676137,5.47833794075875,4.511665180391455
BICR 31,6505803,0.2507928346620714,-0.5713115999517187
NCI-H2452,9927531,4.529523169776047,4.819474269108627
HEL,107970,2.2652057864285893,2.11675182683836
P31/FUJ,73707398,-0.9687174770786582,1.0162782459403379
SK-CO-1,3634881,3.2176217097393867,3.364457009266163
ALL-SIL,71680916,4.0231197218666015,4.106872405719395
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.641671673182801
NCI-H2452,54678924,3.78052585603054,2.1064979538653987
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-2.9435980751872113
RKN,9840324,5.059199694090175,5.866518671788721
LS411N,25195348,3.7393125277208608,3.110779979426852
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,2.916629045311289
BICR 31,11497983,4.106423080888053,4.163043323021746
RKN,3825829,4.2934517576030276,4.143074851326986
Panc 02.03,104842,-1.6275579890051994,-2.801086467878408
SK-HEP-1,4378219,1.9889575503272792,2.656832747684045
NCI-H1568,11609586,2.169671625299293,2.8453578787595997
NCI-H2452,24772860,-2.067021978185303,-1.9009204661742485
HCC1500,2828334,6.090675120485649,6.0208352226199064
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-1.1922458249716468
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,1.9331425960839608
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.6725631178173823
SK-CO-1,426756,3.753929508081783,4.344430052594526
SaOS-2,46215462,2.3169135098646483,1.7130321373685455
IGROV-1,216468,0.5330864756407336,2.7110809882601807
RERF-LC-MS,25262965,-1.1343637554659964,-1.519097356943467
NCI-H1568,53392493,1.829675716879907,2.829612525949721
WM115,6438330,2.009543324889134,2.380012683866131
P31/FUJ,9908783,6.361014450142155,4.901223187535509
HCC1500,5291,3.388112901698238,3.740668005856579
HCC1500,216345,2.2086555393223293,3.843059773327677
SK-CO-1,16722836,1.1930735523198912,1.5335368192498249
MDST8,2858523,3.149165485885388,3.081021753061433
IA-LM,44486219,4.346993548383093,4.344665316633457
P31/FUJ,10427712,4.089067276268696,4.139127422727244
K-562,24771867,1.7261535062160185,2.1381289480330135
SW948,2742550,2.6149964231270166,3.809945248019194
COR-L95,2113511,4.880906118348224,5.214161021350992
BFTC-909,82146,3.493415453952883,3.7161050129704787
BICR 31,4261,2.904745052497421,1.7590020799383856
BFTC-909,119607,6.015893315993201,5.2987437928872785
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,1.6827057884528867
Granta-519,262093,1.5974758737964725,2.6314567700198164
COR-L105,4521392,4.261553030698096,4.378560581507444
HuP-T3,52912189,2.4400429797195065,2.1114494031761213
HCC15,168313016,4.627209757330862,4.692227949295097
MDST8,15983966,1.9809932367095728,-0.5663668388683311
Granta-519,9866186,-0.14818829969678,0.0729196328549246
SK-HEP-1,462382,1.018219313736715,0.5103352652727255
Daudi,7251185,0.6493905196982933,2.0394561026746882
HEL,3385,2.274300648457042,3.1510774042595147
NCI-H2452,44185566,2.4757676958398824,2.663397551533251
SW1573,9884685,-1.2788581073527363,0.5514140660737477
RKN,6505803,1.4092626649390017,-0.3786368441302077
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,2.991283553872216
RERF-LC-MS,11427553,2.91041132641442,2.714922746643463
SW948,107985,-3.1361927230844255,-3.771686510591
IGROV-1,24951314,0.9075718706849548,1.4257644735252524
IGROV-1,753704,6.461140333581179,4.74992720439229
LCLC-97TM1,54143018,-1.232378656007133,0.11346959817017149
SU-DHL-1,16038120,-4.191759239414132,0.39949900380561415
SK-HEP-1,65064,5.472205201006758,4.927540778685351
COR-L105,2733526,5.6711261994322,4.0125418021050105
HuP-T3,56649450,4.499318873015619,3.375278295643182
SW48,16741245,3.865069024996995,4.046688706845832
HCC15,89183176,3.7013914070621903,4.54527298444302
SU-DHL-1,135928012,2.7237506411412427,4.205242375342926
HCC1500,24901704,3.772063812557438,3.4332367558166585
K-562,6505803,-1.797722788015983,-0.49756430114642664
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-3.323041788103632
ALL-SIL,9936388,-6.364749169872344,-2.361718281432679
P31/FUJ,5284616,2.141886646431612,2.126434982816073
RKN,654092,-2.299209260296745,-0.21109145225654471
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.6921256250129173
Panc 02.03,462382,1.1832417961450334,0.6559874175408396
P31/FUJ,11609586,2.709581392176905,2.881037874601378
COR-L105,322968,4.452130073523545,3.802528196216242
RKO,135398516,4.318914396092429,1.978847565139215
Panc 02.03,44185566,3.1312758482446976,2.6750166571248584
NCI-H1568,72376,-1.5373297187690371,-1.778404384404153
Daudi,11494412,-0.3802447608890573,1.2378610481114685
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,3.141607907925193
SW1271,2126,5.27764055734565,4.412517909601617
RERF-LC-MS,10296883,4.230661493555322,3.8293726604774916
SK-CO-1,53232,1.9491581074450712,2.8730375532620904
HCC1500,11222830,1.0956735100670385,1.5976832149443456
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,1.1542922620084306
LCLC-97TM1,16219061,3.747043694071086,3.0706540767182053
HCC15,3543504,4.297283358198234,4.3970899218382336
SW1271,6918837,-1.9255423784418917,-2.6885516950893087
SaOS-2,53301938,5.583232766578932,2.542169563281725
UACC-812,9866186,1.6792636289805696,0.9347884103098303
RKO,5278396,3.510721289362286,3.1654821155946076
K-562,16722836,1.308803334400655,1.5616791380228776
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,2.748288002618931
P31/FUJ,9935249,2.700947453739227,2.8005313036659807
IGROV-1,5351362,1.961059142684053,1.4223567390252714
IGROV-1,44819697,-0.8326420176056434,-1.060023184298978
HCC1500,5746,0.8617369744590151,1.406891338929994
BICR 31,15547703,3.2095649219178006,3.1436251709498517
P31/FUJ,72193861,-0.3659416399435479,1.1656366707026853
PaTu 8902,24964624,3.11499425545507,2.553858039252451
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,0.8501082901361875
SK-OV-3,24901704,3.989938255280614,3.145752439157241
LCLC-97TM1,2113511,6.012866888022406,5.433583211448304
SaOS-2,3081361,3.085781742119062,2.3184779331178644
IGROV-1,15983966,1.7101486625531308,-1.263194751983571
MDST8,6852167,1.3374988720553735,2.638246745830955
MOLM-13,67291369,-0.0488061328139809,1.7124060312362313
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,0.6674947305220142
MOLP-8,9926054,1.7939353525170396,1.8262284203355739
SU-DHL-1,168312962,-2.257405592485961,1.470316219726313
LCLC-97TM1,219104,3.650486733954163,3.82228392621261
HuP-T3,984333,1.5721860041126483,0.8626727068661517
Panc 02.03,4477,0.984097917718396,0.603554966332894
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,2.7247554482500056
IGROV-1,9929138,6.483056540257463,5.230881630661155
SaOS-2,11175137,1.9690729540796783,2.5658108152269246
LCLC-97TM1,9915743,-0.0836077976930932,0.47728793945657216
PaTu 8988t,9907093,4.39010034793255,4.2300582031679355
LS180,73707398,1.191690395470446,0.9119358400260286
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.6946179983843463
Daudi,11960529,3.700971671461623,3.8491428411432644
RKO,4259181,-0.4049041326260317,0.2188950918581224
MOLM-13,31703,-4.683228669920675,-2.066551856710146
SW1271,4477,0.3648589081307944,0.6400106574534279
HuP-T3,216239,2.9976543037230665,2.3607690303928175
HCC15,9903786,1.5576741113339283,2.729080832959819
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,1.2487913557156423
Daudi,1239801,3.0112900662314717,3.7195216432414067
PaTu 8988t,25126798,4.088623680113087,3.845549992193234
RKN,227681,3.7901732699912585,3.227909132273893
K-562,216468,1.7844503846326911,2.3846251627723065
NCI-H1568,11234052,4.07711650557102,4.17601063621292
RERF-LC-MS,17755052,1.8057357372617977,1.780379880228382
HEL,135999136,1.6019096984193502,2.9399605931546353
HEL,9887053,3.0781159437380974,3.4679438494477215
RKO,11625818,4.5581118700811105,3.9064262743611504
HuP-T3,322968,2.6241189840020787,3.7391807509433566
BFTC-909,11317348,4.568727931072339,2.9014984086014546
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,4.022314382876295
MDST8,1716436,1.1500764778734351,2.9658950106579347
ALL-SIL,16741245,1.8101156107911176,3.3612440769076617
Granta-519,16722836,1.0937584859115594,1.211563975943785
PaTu 8902,10385095,2.391345219233966,1.439856212546313
WM115,3038522,1.9104775831242309,3.007387390813305
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,3.4037646717872634
RKO,11497983,5.954072388877685,3.247123977088376
BICR 31,46174525,4.37434163277974,4.018026714183793
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.3867877536365918
PaTu 8902,73707398,2.5949502925816397,1.112752857009569
MOLP-8,1641662,3.485304007232308,2.9004135424425828
HuP-T3,11640390,3.629059315953643,3.4691913739923432
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,3.719790160577249
LS411N,49850262,4.021647044836445,3.182528297921854
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,3.0465283151990956
SW1573,24951314,1.273840217876839,1.1948857461584617
RKO,441298,2.3183923582018107,2.1928627162489143
COR-L95,5335621,4.389010810876702,4.4618506714916215
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,2.5291362967789808
MOLM-13,24785538,0.0261170120397283,0.9437323599927496
Granta-519,374536,-1.3755413186728007,1.5657823875832924
HuP-T3,9911830,2.533690069517969,2.541038032187367
HCC15,11640390,4.25082988279064,3.5047240813990426
Daudi,375860,-0.7416229308895455,-0.4415635051596357
BFTC-909,16722836,1.424017650466323,1.6614042531254523
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.4750962642373115
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,1.84582908382406
LS411N,46398810,3.253541487295017,2.300965538040016
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.896030847110773
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,2.2544109806396038
BICR 31,136227924,2.8140968842668923,2.9422746574701226
SK-CO-1,24753719,4.51149350773187,4.270493687915926
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.3644930308727574
SW1271,57330099,4.656552081384507,4.232222102508837
ALL-SIL,60750,-4.149254188873004,-2.7136548707949286
MDST8,42642645,1.1052716804296012,1.0774074432956726
ALL-SIL,25062766,1.575972356073685,1.9367120774223119
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.850036804684925
SW948,11455910,0.6774609071475187,1.2083935325629922
SK-CO-1,11485656,2.076616779710352,2.2132778706802263
P31/FUJ,387447,-5.269499156732966,-4.480733743846755
SaOS-2,54765302,6.138432086002101,4.024774061947291
KU-19-19,3384730,2.4463371108200995,2.703068467106905
SW48,56946209,-4.8342224094221455,-4.294535311013651
RERF-LC-MS,71304818,2.1402027844306986,2.6224388308515283
SaOS-2,5351362,1.054118918695375,1.3005376321720459
SW1271,60700,-2.0966401571631805,-0.28688629214959266
SK-OV-3,12001922,2.3689117655248197,2.1126611004581037
BICR 22,11222830,2.7513096778080293,1.4704380310686123
HEL,637858,1.821308587756956,1.3365486492794088
LS411N,11609586,3.7769222068832384,2.48020604540086
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,1.9829172307025817
SW1573,53392493,3.256582971351183,2.783893951640516
IGROV-1,71466380,4.863636874274779,4.2768788912304165
SK-HEP-1,119607,5.888068080296772,5.197579728628665
K-562,5329102,1.5928854941533903,1.8919581729726445
RERF-LC-MS,24901704,2.6292316786888295,3.124750442713146
RKO,54649381,4.449908747747005,3.598347606693758
KU-19-19,6438330,3.038685724131264,1.8527044737237972
RERF-LC-MS,6917907,-5.461995819879327,-5.254853040061119
Daudi,6852167,0.8630196090584432,2.51427998895102
RKN,2708,5.19327789915259,4.896579627398687
SK-CO-1,51039095,2.6345691844177006,2.7981888523871943
HEL,9935249,3.1121102066484827,2.4823998376643397
Daudi,6184667,1.7615544136572183,2.778375198225866
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.3294176770472332
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.5561844180101874
LCLC-97TM1,5978,-5.540378308178224,-2.1446203431925723
SaOS-2,135999136,4.306712196094447,3.736805180400558
IGROV-1,5311,1.0068816368200209,1.4323314085774574
PaTu 8902,10184653,3.3664490630517023,1.287383843047609
IGROV-1,54678924,1.4704159748793169,2.0682258847883856
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,-0.27217683768206163
IGROV-1,16720766,-0.0562020789376145,0.647908670034544
RCC10RGB,31703,2.24368059098483,-0.9969634512249815
SW48,4261,1.3708847234833408,1.2837460997879109
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-0.48096385701117333
Granta-519,11494412,-1.422706675432074,1.0118176927738756
BFTC-909,10302451,3.622269240471498,3.224041009793334
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,-0.09026670305818736
SU-DHL-1,11497983,5.985793176782232,3.0136633194136793
HEL,44486219,4.241945120616936,4.101066684370735
HuP-T3,9926054,1.9266750805140576,1.9248323218838725
Granta-519,5281672,3.715092894597705,4.121007502905478
NCI-H2452,568763,0.2251625503779925,0.5257763310567647
Daudi,15547703,2.9729250708388815,2.709511560618844
RERF-LC-MS,1566236,3.687566928717542,2.3153317970195064
SW48,3689413,2.066117060158584,-0.005142957002378517
RKN,11396600,3.670395083293249,3.8056182007140897
COR-L95,25227462,1.0954609187473372,0.15487272829558613
P31/FUJ,11497983,-3.9754433923569295,3.9451795377872414
COR-L105,11977753,-3.381629820862821,-1.2530972581481254
SaOS-2,10302451,5.268852772808677,3.290287082523543
WM115,25126798,4.207732195436686,3.870388039111434
HEL,6918736,-2.4872933380365483,-2.0241384776070066
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,2.6397232021660613
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.1883613380861338
BICR 31,11626560,1.5769037831027732,1.6922667570353744
SaOS-2,53481919,3.9662352208904,3.800742806667184
NCI-H2452,4378219,4.095695943124218,2.5604071976940137
RKO,135440466,3.093117295091816,2.2430132266599565
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,1.560701097696892
IGROV-1,4521392,5.131794979216607,4.332884797788121
WM115,6610355,3.646348527159068,4.148583700265253
IA-LM,46199207,3.643614442277753,3.090267839023775
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,1.0844284540245328
RERF-LC-MS,4259181,-1.273108977623296,0.1758878632538616
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,4.067043444227732
LCLC-97TM1,9866186,0.636434294421894,0.8044238594008941
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,3.827411404421874
BICR 31,285033,-1.6333817403557132,-1.6652783279037444
SW1573,24821094,3.391149888356164,3.4206272067198196
RERF-LC-MS,984333,0.876742343627688,0.7490183512453626
SW1573,2828334,5.538488922798482,6.10111726930383
BFTC-909,11214940,1.666026285351028,1.9580385678807624
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-2.2299143376781645
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.2064260066261268
MOLM-13,16722836,-1.8349401857846608,1.2996898831401098
MOLP-8,135398516,0.6877200142840878,1.8986694327643157
NCI-H1568,56649450,2.3390116545362956,3.2286076202431895
COR-L105,5329102,2.9490674090485007,2.091870364680422
BICR 22,104842,-5.460039616101889,-2.7034126069816735
ALL-SIL,44507138,0.0905903694215729,2.137873999752988
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,1.8550900884199748
Daudi,252682,5.82526834825694,6.353136547356138
SK-CO-1,24785538,-2.301834394825824,1.2280045070195105
HCC15,4788,6.208189927463216,5.672791204594239
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.712668538883171
SK-HEP-1,5282054,5.2464488654660935,3.8961667243635696
K-562,2729026,2.90327889883348,2.68069806833563
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-3.9341698692289024
IGROV-1,135398744,6.402844237905131,6.51936572083013
Panc 02.03,44819697,-0.6097657869730747,-0.8516039743233534
COR-L95,6252,1.2572884944075156,0.308616150761308
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.2793168411548965
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.5029644015440792
RKO,135411,0.3039750611139232,0.6766266404447556
SW1271,5284616,3.4240840801047825,2.195213038416701
Daudi,9803433,4.921870042846492,4.458792958506788
HuP-T3,1566236,2.433067651410228,2.3036768190516064
NCI-H1568,11364421,1.3511041801335055,-1.4369285709210013
SaOS-2,54678924,2.353285364311993,2.118319358999391
NCI-H1568,6438330,1.052967118553252,2.110702871133852
SaOS-2,56946209,-2.927880316628738,-4.071146602993074
MDST8,71304818,3.102141708789901,2.4700485958252334
MDST8,16722836,1.8236379945665244,1.7477104159485497
COR-L95,5460769,3.3963309413836815,2.615853613300229
SW1573,5328940,2.8151731448483424,1.7221908657515195
P31/FUJ,44486219,4.066329818545256,4.240307842576381
SK-CO-1,44819697,-0.0659450585917303,-0.26605094974033155
NCI-H1568,3689413,-2.0602171008804935,-0.16664525333625196
SW48,4788,5.795432827385499,5.450012532057534
IGROV-1,11625818,2.877471533668122,4.1878056176764265
HEL,5282054,3.8014373831294073,3.1677277293209563
Granta-519,2858523,3.0573334835342725,2.8861210477598562
Granta-519,2708,2.6467102550113357,4.005225239889678
SaOS-2,10074640,3.1546787022314264,3.1132663419297204
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,-0.4508924968008612
NCI-H1568,462382,0.4864277786958156,0.34109556409058983
PaTu 8902,6450551,4.419968438595772,2.6553504474245266
NCI-H1568,89183176,4.755399227223714,3.941545106593718
SK-HEP-1,89183176,6.199387598364303,3.829151762298662
COR-L95,3689413,-1.01311028513846,-0.8061649744600351
SW48,322968,2.620984302451229,3.3547283205942477
NCI-H1568,2113511,4.994259934049027,5.420032624839333
RERF-LC-MS,10074640,3.277461458690314,3.054260783581089
P31/FUJ,11485656,1.9746673234827223,2.228587482636001
NCI-H2452,24978538,1.4440845227299357,1.381205930573644
SW948,46398810,1.81837356763434,2.52870367962008
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.7654863439583812
SW48,5280436,3.9386259808510737,3.19247219601508
NCI-H1568,16013152,3.794215458313736,4.134773581327544
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,0.597385791298478
SaOS-2,72193861,0.3662001709486771,1.3024206976225619
SW1271,6623618,2.240401111492455,2.261933227588414
BICR 31,11964036,0.7129684858082154,1.392194374052361
MOLM-13,71466445,2.28410988708537,2.744301838618394
SW1271,5280436,5.166796757102748,3.1829526514136885
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,1.5462724546609616
SK-HEP-1,5470400,0.5577708849126581,-0.06254244182702318
SW1271,73707398,1.637161284255629,1.7609513156063294
Panc 02.03,24771867,4.320948526904658,2.536556413500835
K-562,11494412,-0.907204058397288,1.4178103622636906
HuP-T3,4477,0.7500067469313434,0.6716023588114207
WM115,44489675,3.6522428576041888,3.810924264035149
IGROV-1,10074640,3.2681490579824426,3.1224113548010193
LCLC-97TM1,387447,-4.752686001320434,-4.343872952530346
NCI-H2452,136227331,4.192235498443636,4.003363995040075
BICR 22,44566777,0.9464577594296588,0.7208793440239559
Daudi,44462760,2.2846011846998184,3.461363727810648
HuP-T3,11222830,1.7699584455080513,1.615896875966654
BFTC-909,10184653,1.6906150005550105,1.3413361380794695
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,1.665947811985922
SK-CO-1,5460769,-0.7722931098274061,2.5081571723772735
IGROV-1,9884685,-0.088911709267569,0.6377364952764413
SW948,10074640,3.6458957710098927,3.118868752831415
RCC10RGB,2729026,3.187414345119047,2.7707850507779583
SU-DHL-1,25105715,2.6102250612439857,3.237117469150275
SaOS-2,2708,4.307882235107384,4.526287059897018
SW48,11485656,-1.6768123952056315,2.020285804111755
LS411N,5738263,3.6843208102291127,3.413036789978636
LCLC-97TM1,89928392,0.9843618500255806,1.6757811998656924
IGROV-1,5328940,0.347812751869877,1.588968131356079
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.3404871842333064
MOLP-8,6184667,3.7618917164892296,2.548813338089711
HEL,9907093,4.271492923268933,3.8343888679109184
SU-DHL-1,409805,5.150132871505728,4.432851573919127
IGROV-1,5287620,-1.5394168430569777,-1.5363638014259582
HCC15,6184667,2.403880665872793,3.0367433845900473
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.195668812055212
BFTC-909,11152667,-0.3524603871752078,-0.19307659016500536
BICR 22,10427712,4.255154443676342,4.060098971374484
RCC10RGB,73707398,3.9170227295506304,1.3932442074127667
SK-HEP-1,4788,5.857315027837397,5.689736101824943
SaOS-2,11167602,3.026359974607451,2.297121384742498
IGROV-1,3825829,4.144093606877803,3.945122673162209
Daudi,53232,2.2893399383043116,2.76127704508023
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.1369790925452286
LS180,5470400,-3.6342626980574657,-0.2603405199814616
NCI-H1568,322968,3.6220797151302673,3.7363965178929477
SU-DHL-1,25150857,1.7165355924738273,2.227541479163429
NCI-H2452,9926054,2.7849990975548726,2.0839492190209934
RKO,5280436,4.655813696583822,3.3099549914522584
Panc 02.03,25126798,4.246913180768056,3.8794679838362724
BICR 22,5460769,-1.4539525700949456,2.2930229776811357
RERF-LC-MS,4521392,4.229663793191115,4.183377202067665
COR-L95,65628,4.016533332946612,4.305138034251476
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,1.1469013960601224
BFTC-909,11507802,1.7199271215311116,1.5415043228196836
HCC15,16115403,-5.315255617661217,-3.92776208497793
Panc 02.03,24797083,1.7288458125332262,1.3446998426666037
Granta-519,16065773,1.8580334509866892,2.301334684022754
MOLP-8,67291369,0.6739245689833524,1.7039172049275026
LCLC-97TM1,71304818,2.70820846116735,2.395790176672805
COR-L105,10113978,3.5062120769458907,3.2002040307772597
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.234021127326354
ALL-SIL,5460769,0.8731159867521163,2.305508255415112
MOLM-13,89928392,-0.0278317389216686,0.8748755517342155
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,2.946355998802969
SaOS-2,6852167,2.181246544986129,2.851730218352495
SK-CO-1,135999136,4.853872243910513,4.219034756135263
LCLC-97TM1,5329102,1.5800226001590805,2.0492848958824834
RCC10RGB,3825829,4.92777419243283,4.1388853382062845
WM115,16722836,2.5522609953991577,1.7990993395528871
KU-19-19,6610355,5.477302473020379,4.650440729116345
HCC15,5311281,-0.1593612251340344,2.2319904353920537
WM115,11656518,-0.7680829336702796,1.572383195247228
IGROV-1,675434,4.336225379212549,4.4946930849708995
BICR 31,322968,4.229982613329669,3.6955514555934417
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,2.0366141013149672
MOLM-13,409805,3.504188648592109,4.032351266626362
NCI-H2452,68056272,5.088176766324353,3.1230801447878593
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,1.1312178284192305
RERF-LC-MS,25102847,0.6953191965745218,2.489416999735028
SU-DHL-1,5278396,2.36959409949266,3.3726962638000217
HCC1500,9935249,2.2800833668468266,3.2332420047504082
HEL,46907787,-1.2802643066913908,0.7058468371391868
Daudi,64971,1.9256728094608813,2.255193345774737
KU-19-19,168313047,3.3084179069540696,2.1838867491443916
HCC1500,9903786,4.21203406645071,2.7147681331868547
BFTC-909,3689413,0.9841636034152118,-0.4046916410546028
MDST8,9911830,3.786562744766562,2.3779705313030144
WM115,262093,2.5199436905866905,2.7215193049598656
IGROV-1,5311281,3.3250623444804206,2.449151739096051
ALL-SIL,4261,-0.4593745111072439,0.8996531849458216
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.6713234449996389
NCI-H1568,25105715,3.512540774448481,3.303008667320085
COR-L95,12001922,1.5177554079359803,1.9998959157170018
Granta-519,25154868,5.041568583050757,4.078436598690174
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,1.1933376158697317
SK-HEP-1,3503,1.99172511033101,2.3936470339992497
BICR 22,2749,1.4483580801045477,1.8565676027063802
SU-DHL-1,10231331,2.149159497852676,1.3936798513864412
SU-DHL-1,132496,3.861580575323874,3.27067036581894
NCI-H1568,11955716,5.84501437277453,-1.3720591126867452
COR-L105,11647372,1.8386560750541856,1.1095896240958312
PaTu 8988t,702558,5.248840045640507,5.088402881484118
RKO,219104,3.7756995047121658,3.478661523810307
RERF-LC-MS,119607,4.38818595494476,5.158829587877483
SK-OV-3,969516,2.624811361400939,2.8901522822933283
SU-DHL-1,67156097,-2.1897423830418155,-1.0771052352866175
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-1.462835678484931
MDST8,10296883,3.644541291105843,3.70193624306058
BICR 31,135411,1.1842135795155395,0.722436898078208
NCI-H1568,17755052,1.5920713080731803,1.8861703724820995
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,1.1655425355268445
Granta-519,3062316,1.222650334372554,0.685262244073436
MOLM-13,11609586,0.2693262849825738,2.172824422007291
MDST8,65628,4.39024768664476,4.3648706568322835
LS411N,11222830,1.85641131377126,1.4052441086509142
P31/FUJ,5278396,3.2564464707559786,3.552446311228816
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,3.2461276166636934
HCC1500,11228183,-3.1075364778620544,2.456058829959476
Panc 02.03,3503,2.8594786206641514,2.3723425626867343
MOLM-13,12001922,1.648284949914827,1.7098368601609841
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,0.18473518505634354
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-0.3007770866696065
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,2.9191729956679127
RCC10RGB,135875424,5.859031260595621,4.184332204215897
LS180,44491742,4.531352051294965,4.029944433361373
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.706518462214989
SW948,5460769,-0.6640669541383749,2.5219053180630286
BFTC-909,9866186,1.150003196853964,0.835106722783316
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-2.6702122550387006
Daudi,322968,1.8489038189519929,2.8454628789674645
LS180,135999136,4.321194581518088,3.534007880496394
MOLP-8,4259181,0.2540996075245788,-0.1273075059916835
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.5126779942606654
BICR 31,17755052,0.616652074058669,1.5717337290324684
Daudi,10427712,3.475831712716563,4.035822407764126
ALL-SIL,6252,-2.462384672511242,-0.8364290473314163
IGROV-1,57330099,4.391385744785918,3.8950738031264063
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.4847157998696983
LS411N,5746,2.615146419652584,0.8666603101003326
WM115,11625818,2.666283825244439,4.469727384427861
SK-CO-1,17755052,1.6143754050867285,1.9367314861343226
BFTC-909,4788,5.986704833543041,5.69909219230197
BFTC-909,613000,3.1980696015333137,2.5266884984244085
RCC10RGB,9933475,1.608288384582936,1.864443369068006
COR-L95,11964036,1.1862097811542611,1.247726268369445
IGROV-1,12003241,-2.0122972114546904,-0.8633002020434121
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,-0.6461008327117537
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.5424821142793035
LS411N,676352,3.0047981548436873,2.0833811000789897
NCI-H1568,6918638,-0.3782949656582497,0.5602999121134491
HCC15,654092,-0.5163256778254894,-0.3402775520288972
MOLM-13,72193870,3.075841334601934,2.5944039749618013
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,3.0071579646151134
SK-HEP-1,1716436,3.791424957504218,3.0575117809797745
IGROV-1,637858,1.814476597989254,1.9923886767217271
IA-LM,44137675,5.685431340913792,3.0776654203902405
RKO,49793307,-1.4433237106321422,-3.390575514787654
Panc 02.03,1750826,-0.0877771412327358,-1.7065985311524157
P31/FUJ,216239,3.114152508734425,2.1530261752144515
BICR 22,9911463,4.403388511465592,3.6731130030860846
LS180,3503,2.1233569957286673,2.2266381229721715
NCI-H1568,135440466,1.9451121966001212,2.41855830664932
LS180,6917907,-5.898955627831861,-5.455389670910712
NCI-H2452,3503,2.8949427881039367,2.368677744732003
LCLC-97TM1,9952709,3.284131025623194,2.94070467718728
MOLM-13,168313047,1.872191765635252,2.08067798243774
RKN,65064,4.855719732775604,4.903216536126894
SK-CO-1,1716436,3.109025551437123,3.018338804331242
Panc 02.03,322968,4.613737356937267,3.910784341631873
SU-DHL-1,16115403,-5.307217729681928,-4.550090297023545
Daudi,5738263,2.220866513982768,3.144808700483878
SW48,10074640,2.891302128524984,3.040545314535004
SW48,3552672,5.820012420560967,2.791241760132497
Daudi,568763,-0.9358982895655849,0.07670037451988204
HCC1500,11234052,4.300499145525321,4.1730564356865685
WM115,16741245,4.109793610684897,3.477937597143573
SK-CO-1,6917907,-6.103253673111458,-4.891376800638528
SW48,100016,6.031440310304127,6.006685623942541
SW948,12003241,-1.7903806895013192,-0.8508025777780125
SK-HEP-1,9840324,5.848573782723059,5.911562157196525
ALL-SIL,5328940,-0.9694628184696558,1.029169067088398
BICR 22,2858523,3.373464702278958,2.997066314072004
NCI-H2452,17755052,2.4746667711045514,1.868372925083991
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-1.3838684260757699
P31/FUJ,654092,-2.277731190350674,-0.35549037869461536
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,3.78853180980597
BICR 22,16736978,1.4452527998079976,1.4476120921410345
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.3471905816667795
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.1949672563732219
ALL-SIL,9843750,4.4328493438561845,3.2081675427568257
IGROV-1,168313047,1.93821625738322,2.3053002345382425
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,1.5598526692559644
RCC10RGB,24797083,3.688734393817597,1.5603513365809518
IGROV-1,67291369,1.8066430555976296,2.232262525456552
SK-HEP-1,135875424,4.97106166770821,3.9865930521726147
SK-OV-3,676352,2.4999853996447423,2.14062110939358
IGROV-1,3689413,-0.3633634632064185,-0.10664326968183895
MOLM-13,2126,3.944929409626795,4.299650748504243
SW1271,25150857,2.216244024484901,2.4347187128201826
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.6943888748869531
Granta-519,3689413,-2.6080640580656977,-1.1573400642883749
UACC-812,11955716,-3.4049141440551765,-1.5256282108970582
WM115,6918638,1.2765614986990457,0.40760177913080875
MOLM-13,119182,-3.013346002661584,-1.6498676417224474
HuP-T3,25150857,2.779922499061356,2.6348012781086965
RKN,400769,-0.3685197718994141,-0.6054767022904328
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.6372144592187403
COR-L95,9927531,5.207677506691081,4.460372994902217
RKO,439501,-1.8401322759847645,-2.3413030584691996
COR-L105,135875424,4.584511127602178,4.127079437270057
MDST8,67156097,-2.036194319435593,-0.4818205260141607
SK-CO-1,11640390,3.1287755311468715,3.456086264981534
NCI-H2452,9915743,1.4140850498548845,1.1141894292710257
COR-L95,54626689,4.626807564914302,4.551993017821511
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,0.7725028402511892
SW48,15983966,-4.810478602921179,-2.0414891562657296
RERF-LC-MS,53495165,1.4938275665549956,-0.008325975248813875
SW1573,10026128,4.237670104162456,3.883953152453772
BICR 22,5328940,1.2238467278980267,1.5222559372177644
IGROV-1,25150857,3.031865110078871,2.355052572228701
SW48,54649381,3.6753624817280706,3.7401398392388137
RKN,11485656,2.343665915939472,2.336946299840499
IGROV-1,216239,2.21703825410177,2.251708247289265
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,1.007266673402626
SaOS-2,675434,4.709862103920263,4.343389445784388
WM115,439501,-0.2667789802830004,-2.090218415960186
RKO,11152667,-2.010180339323448,-0.7093109252075598
BICR 22,702558,5.841545864846151,4.72401867036558
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,1.7581651426256828
IGROV-1,52912189,2.3966568144845666,1.8104421856225474
SU-DHL-1,219104,2.7039031158758395,3.448438777092089
SW1271,19582717,5.373754052547774,3.8531291619677934
IGROV-1,119182,0.2112476135388779,-0.7309402489075728
SW1573,25150857,3.3863948467965717,2.334213579987273
LCLC-97TM1,1566236,1.804143498427706,2.2087129286832194
SW48,6252,-1.782590172996294,0.18616148713686628
MOLP-8,168313200,3.062868142984741,2.8247648109118932
SU-DHL-6,969516,2.321858620209541,2.402626117614953
K-562,44632017,0.5936262556123562,1.1661263870059329
BFTC-909,56973724,3.22598802973391,3.167119154193811
NCI-H1568,24180125,3.319632294157453,3.0953930574358672
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,1.0608400148179233
RKO,15547703,3.988071110220001,2.9509653070394672
COR-L105,446155,1.2274898824574871,2.566491727174597
WM115,25062766,1.993857010637035,1.8828046142983998
HCC15,42642645,-0.8684016042996798,1.0107194332247424
IGROV-1,3136844,5.214591389089975,4.281143062683496
COR-L95,16659841,4.2643844802603725,3.830916029665227
NCI-H1568,107985,-3.6136890416333665,-3.4905583308625374
HEL,9967941,3.646907071964301,3.1882417728705787
NCI-H1568,5311,0.289477139532769,1.3318863928525368
HCC1500,24964624,2.92457410282952,2.5035681856477763
LCLC-97TM1,44185566,1.2712415312804253,2.4144892794575457
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.1813823071725518
RKO,135421197,1.472175761257966,1.669089328061326
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.1907651349329087
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,2.977873100326841
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-3.7895875557747316
P31/FUJ,119607,5.165578068786105,4.974601324025093
SW1271,44507138,3.04083255973368,2.8660454407955904
MOLP-8,72734382,2.92105223846654,3.6968469280704204
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,3.9853710715945754
RKN,12001922,2.582060834791438,2.017226030688113
MOLM-13,3025986,-2.268401268397509,-1.6719740751558638
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,0.30421480173600807
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,4.8697861491112295
BICR 22,387447,-3.632542993789297,-4.172733984686077
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-1.141383708182467
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.4557778715345155
MDST8,44819697,0.5968481057166135,-0.6204786825375408
COR-L95,54613361,1.8571878459944453,-0.178547790278628
PaTu 8988t,25183872,-1.065851307698322,-0.6740989842913889
HCC1500,969516,2.5012208253247374,2.8804700216152463
LS411N,51039095,3.380080993968732,2.5545877174938223
IA-LM,10385095,1.8174613436578264,1.4251888587482262
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,0.2918699232060403
MOLP-8,44589607,1.928632926439859,2.180991094107698
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.7750473516588436
SK-HEP-1,5311,2.3418360503567386,1.5010116674490646
NCI-H2452,24889392,3.037712354939189,4.349949970926916
SU-DHL-1,4378219,1.8683369375684944,2.2900344541342577
NCI-H2452,2858523,2.6943426896823284,3.174080643739975
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,3.55885299779854
IA-LM,119607,5.918153428689206,5.111085676823354
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,1.921541922002351
COR-L105,46224516,3.053099263199949,2.378232645718697
SW948,3062316,3.151526592835161,1.2049911797155524
BICR 22,6610216,4.672862717569176,4.151928779566645
SW948,16736978,1.371465793072688,1.5505369377689198
IGROV-1,2828334,6.070696247039626,6.086803939934271
RCC10RGB,44185566,3.1564704709707856,2.5501147076983095
Granta-519,135999136,4.28714374371566,3.502455244750169
BFTC-909,654092,0.6323398211983356,-0.34583914489242007
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,3.274981519561461
P31/FUJ,17755052,1.7010190253681206,1.5536431602300949
SU-DHL-1,2945648,2.120687124348465,2.7563654381521676
LCLC-97TM1,16720766,-2.0806199642234704,0.3592247610906181
HCC15,3025944,3.8616867083103648,4.157413479413221
LCLC-97TM1,53392493,1.9813066602409652,2.683449486198504
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,3.0877050876565084
COR-L95,675434,4.0325297307826125,4.432203531524072
SaOS-2,11213558,1.0641156085827448,1.79890074953345
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,0.9118651441923415
KU-19-19,1716436,3.531012736022478,2.9420237404119836
SU-DHL-1,11485656,1.6397040363022437,2.0672648505731335
SK-CO-1,16736978,2.1510378918389415,1.7403030393918348
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,1.7954169009581553
HCC1500,136227924,2.675203690625814,2.8253591740818305
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.6404092482369701
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.207343510822612
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.411352616261544
Daudi,219104,1.6178665476553538,2.599276029534641
WM115,5284373,2.6004259651165644,2.7504868936553284
SU-DHL-6,216345,3.116690602340157,3.581759074675304
HuP-T3,5460769,4.291069487745317,2.679868740659821
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,4.776707950653315
Daudi,8515,3.193004700442435,3.4527720051513473
HCC15,3815108,3.1337581441750277,2.763632353848485
IGROV-1,5280436,3.2616766817665086,3.4112386090559825
COR-L95,107970,2.0048060228155333,2.3677185255430637
BICR 31,25150857,2.3687059872087217,2.45175734938964
IA-LM,6918837,-2.975709639111599,-2.511769039503322
WM115,3025986,-1.3268545497049868,-0.7905085829099278
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,1.795760744856324
SW48,17759555,2.861947497664063,3.5559787464097865
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,1.8091300854014343
SW1271,9956119,4.3828310926576375,3.449033303209242
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,1.828821285026005
MDST8,24772860,-2.900176299695688,-2.008306645666998
SaOS-2,4259181,-0.1317601722396107,0.3052543638300566
PaTu 8988t,5746,3.0775825889142543,1.2026072348142782
SaOS-2,4521392,4.5837419847316845,4.278756698392783
SaOS-2,445455,5.662681927298568,4.6949698982506956
IGROV-1,148198,-2.659972993252853,-3.38623078278233
SK-CO-1,11404337,-0.5084033800481932,-0.37493346866142224
Granta-519,4578,4.680400709321271,4.231029057135909
RKO,4261,2.924548439505643,1.4309899609003152
MOLP-8,54618164,3.908946135671936,3.7834565841373733
HCC15,24978538,-1.0517559532383662,1.4926535597483532
COR-L105,2945648,3.0602962908492386,2.9529606442804486
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,4.998655545537885
NCI-H2452,4705,3.641149380662554,2.871027865285322
SK-CO-1,54143018,-0.6826828748975821,0.4837265813483729
MDST8,26596,-1.25574590011264,-1.2132309329698456
NCI-H2452,54454,2.511734775409603,2.8268353621093762
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.1125159603198795
RERF-LC-MS,16038120,1.5599846769821624,0.9554878716582067
SK-OV-3,44185566,3.1295797630764266,2.3978221032052254
BICR 31,148124,2.7085675831815292,-2.3999803475609864
P31/FUJ,439501,-2.3575947617146475,-2.2531236149180964
BICR 22,11152667,-1.8276171650012312,-0.6689781735467651
COR-L95,56973724,4.268430703602559,2.8847154548260936
RERF-LC-MS,54626689,4.221264321270605,4.561204172172311
IGROV-1,1641662,3.5854177848263675,3.5281859689438635
MOLM-13,613753,2.871004682812888,2.9768314680183425
IGROV-1,11404337,-0.7659238947812715,-0.1186730586349198
SW48,219104,2.280685064057957,3.5521831109625857
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,2.040973101858949
Granta-519,9935249,0.0212855082517002,2.2206047980311148
MOLM-13,2749,0.3899767988765278,1.1289214834892156
WM115,1750826,-0.9273267035114736,-1.625287284867366
SK-OV-3,2858523,3.2787147644650716,3.1447179674870487
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,1.3570546376945887
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,2.8943834406174243
SW948,25183872,-1.604238480901096,-0.7836893983679706
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,1.6493314415080471
IGROV-1,6914657,-4.141311308759326,-3.973197813060379
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,4.9662768658461065
HCC15,6610216,4.23435184261858,4.2644498408165195
NCI-H1568,10074640,3.1711026687004855,3.0868110533514272
SW48,4917,2.351047632498956,2.9841495289486217
MOLP-8,46215462,1.266580776259001,1.4613713884821602
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.8546337417651095
COR-L105,387447,-4.5302496546864885,-3.6919481377111163
MOLP-8,44462760,3.111101001788515,3.238202441745238
BICR 31,44819697,0.4590360698509347,-0.8478576183274998
HuP-T3,9956119,4.370077084995815,3.7721285689717625
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,0.6739458916720902
KU-19-19,66577038,3.864819378735941,2.7543283445306996
BICR 22,5746,-1.0393569299451335,0.9616600777329137
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.035691220066286
SW48,67156097,-2.150931452918296,-1.0684133690643636
SaOS-2,25150857,2.491525195617086,2.2187361619372
NCI-H1568,613753,3.056586098825006,3.100694175694
LS180,44137675,2.850653785387247,3.1540686040092796
RKN,11364421,-3.590581417405073,-1.7282205343197454
HuP-T3,23582824,1.5911146583975455,0.9050385136749957
SW48,446155,2.2181780639059907,2.591795955085102
SU-DHL-1,44202524,0.8334918459072751,1.6905719833257615
RERF-LC-MS,11404337,1.609147033115388,-0.5696018072645189
K-562,44486219,4.057183894108205,4.356331586521516
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,2.111449519811139
PaTu 8988t,46199207,3.796589685342678,2.853682080398885
LS180,11964036,0.9251272605785624,0.8763954652708352
SW948,8515,3.759025323790885,3.9311126219560726
SaOS-2,374536,3.743747938767685,2.0793947708898077
SW948,135875424,4.663257041681152,3.8336213615218555
SK-HEP-1,72376,-0.6035227354554765,-1.6588006130665094
SK-CO-1,1242560,3.64748499205759,3.4894602593058606
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.1326161275634887
MOLP-8,3025986,-4.599162344151263,-1.0958389701491857
SW48,25150857,2.2099211562472125,2.2649135391118613
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,3.435137313507946
LCLC-97TM1,3465537,1.1142431298706064,2.273716667201489
NCI-H1568,9887053,3.9549233487650666,3.833520906247768
SW48,5746,-2.6538895977275745,0.791610892729217
LS180,44484440,3.4848015178596343,3.133093338005273
Daudi,25183872,-3.2629659020313393,-2.2275428375259736
IGROV-1,984333,0.6618578113050116,0.7115935227043696
COR-L95,135999136,4.28146486500778,3.881591243557592
RERF-LC-MS,4788,5.0822281264538365,5.421693875995035
HuP-T3,2828334,6.159425491986346,6.090740916167668
RKN,3854666,2.132003481112045,2.135855695534833
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.2815494515325967
PaTu 8902,54639665,4.483683562011812,3.7402087231072723
ALL-SIL,24180125,1.6553840753953686,2.4036764460214597
SK-CO-1,12003241,-0.9578793579943758,-1.0782072411587078
BFTC-909,104842,-1.584917163766509,-2.758522626782607
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-2.0892720648210794
MOLP-8,24772860,-3.493237790177901,-2.852570690495388
SK-OV-3,49836020,-5.2191550029019025,2.4074827293981684
K-562,46199207,1.8646546122938352,3.153186443409684
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,0.6500545483420542
MOLM-13,6450551,0.4092106163446157,1.8665034027317136
BICR 31,1566236,4.637821170940002,2.4167094189633964
SW1271,54454,2.1914366041236204,2.622650962046722
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,3.962480001559216
SaOS-2,9952709,3.1448975558697545,3.235511613700025
HuP-T3,54618771,0.8132197250487964,1.1510478578394732
IGROV-1,6918736,-0.950858733923241,-1.688117902214457
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,-0.06849801242136426
Granta-519,53392493,1.7904738197895116,2.0680888780380373
NCI-H2452,445643,4.078319116283011,4.119992702914853
HuP-T3,5281321,0.1098786391841839,-1.574447973164774
NCI-H2452,654092,0.1220899319284023,-0.07420446152150723
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.63694736264508
MOLM-13,56973724,0.5307136138302019,2.481402533642758
BICR 31,439501,-2.4499261286992007,-2.3776104247643524
MOLP-8,44495899,4.403173191891281,2.836913006711638
Daudi,44632017,0.5148090574579154,0.9419586183150694
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,1.4332111631879934
SU-DHL-1,10077130,2.6641926349973875,2.8511511674224788
SaOS-2,9549297,2.000544043325996,2.1206616190432883
LCLC-97TM1,24785538,-0.7280489014481334,1.205783364479475
HuP-T3,10302451,3.3244038223924868,3.1652698395311636
Panc 02.03,73707398,1.687012904299387,1.512741203650401
SW948,25161177,4.032512886861284,4.02487360535067
COR-L105,17755052,1.2153053156846572,1.3440751068904282
HCC1500,11719255,2.4435237001116685,3.3115456486616313
RERF-LC-MS,5287620,-3.2415128958876123,-2.0144938688160634
WM115,72193861,3.0084505907765795,1.3773945808225228
K-562,2113511,5.3605896450220785,5.3224984674838085
RERF-LC-MS,24772860,-2.3078196081029136,-1.938232478435017
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,-0.8230978242431064
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,1.9240778289240739
MOLP-8,15547703,2.3372930335131663,2.8205354590251037
LS180,4378219,2.066313424484697,2.0934492593412295
SW1271,168313047,1.8206519834924395,2.324096778283369
RKO,123631,2.6120370559458155,2.278745615308881
NCI-H2452,3011155,5.255477653901917,4.059794228069591
Daudi,16722836,0.8830828668869325,1.169348879193498
PaTu 8988t,6505803,-0.6279165545759258,-0.4852118259559679
SW1573,5280436,3.0542460563059253,3.331588419335785
MOLM-13,262093,0.9014616367149992,2.3631835865577853
IGROV-1,BRD-K55473186,4.387806234483854,4.248439036049438
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,2.1705483009582323
SW948,5287969,-2.4513180825948515,-1.7906238224556006
P31/FUJ,54619267,3.5260071244925575,3.929791678978437
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7644504953766773
SW1271,11396600,3.626770708484224,3.7434279898992004
IA-LM,676352,2.5463710414635696,1.9777963199513828
SW48,148198,-2.7635683141359277,-3.584433456503172
K-562,6918328,-1.3297822316036851,-0.6157845696411814
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.4656864047716285
Daudi,135423438,1.6157885595086947,1.7633493654441335
Daudi,6438330,0.2626238759101729,1.866115003753909
Daudi,44543605,5.193449926403497,3.993794721513082
SaOS-2,71751553,4.337892909522829,4.579100685444426
MOLP-8,23939,4.352572888875192,3.564006233443455
SW48,2858523,2.8468158768410965,2.974767789689346
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,3.6109513050166417
COR-L105,9911463,4.222864246171191,3.9012879648010337
SW1271,11167602,2.369450835450289,2.5494548741499243
SW48,135928012,3.696922095661256,4.222578724922022
Granta-519,53232,4.0944047749373915,2.882793075596796
COR-L95,2871966,-0.8178907803151099,0.34749351523402905
MOLM-13,17759555,3.648246486561575,3.5123424979165314
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,1.7379378192684696
SK-OV-3,44589607,4.1377534493712265,2.9544972799499787
RERF-LC-MS,44543605,4.169252612552019,3.9353146384036286
Granta-519,49836020,3.8229564713378057,3.3896655556809145
SW948,5278396,3.777624651516773,3.6241020490378393
HCC15,400769,-0.8695567043490428,-0.3335502837089442
ALL-SIL,3038522,2.34327176020718,2.8397906568564792
SW948,135440466,1.4177296224023617,2.201375918951586
PaTu 8902,400769,0.6580342998730634,-0.5185636671215166
IGROV-1,5746,1.9055212643377857,1.172553297962277
COR-L95,25195348,4.044301101066811,3.0484332876478164
BICR 22,24180125,3.296229177015365,2.9578686643770653
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.2584231603942233
RKO,73707398,0.9128481241529548,1.0889549659500406
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,1.991517867559469
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,1.5340016406065002
IGROV-1,15953870,2.712793598656007,3.4882322728177195
WM115,71466445,4.303064097958205,3.723335152070689
COR-L105,9956119,4.279642090153805,3.639035437039015
BICR 22,168312962,0.5954564951508424,2.1087592355255613
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.4256025090152287
LCLC-97TM1,46843906,2.6060669508648675,2.812359815812096
HCC15,9840324,6.2076616503129,5.9359999366631895
RKN,24964624,2.2448388370498704,2.5826026812444938
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,1.5433287068570092
K-562,10410894,3.650757753763785,3.1499375830904177
SW48,124202324,1.4616392816877528,2.1143461712930143
IA-LM,15547703,3.104636726250569,3.0374945825360045
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,0.655091983036944
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,2.9884521350302116
MDST8,49850262,3.692937134795778,3.6601257924812973
UACC-812,52947716,-6.767186414102593,-1.106312608320944
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.4670738134819863
HEL,11427553,2.263048189869726,2.1204817662616104
IGROV-1,5281321,-1.4962463697398798,-0.7985380739008409
IGROV-1,135421197,1.96820638017286,1.8286060568747664
LCLC-97TM1,104842,-3.469971777740615,-2.9166407542175925
RCC10RGB,374536,3.743226525407361,1.9912671580152865
COR-L95,107985,-2.989419812710682,-3.583066697564549
RCC10RGB,72199289,4.762339751475906,3.486553925841552
NCI-H1568,11485656,1.8106242285910237,2.1694323032448364
MOLP-8,9549297,1.4376511571672042,1.7365679369376203
Daudi,24951314,0.2263717121921743,0.8828100463459804
BFTC-909,7326481,3.4905195575106527,3.0286576481304808
BFTC-909,6623618,2.802037410677928,2.3189753588960347
HuP-T3,5287620,-3.5836939395445913,-2.023399925183663
COR-L95,568763,-0.4949329271490838,0.12120037437577573
SaOS-2,216239,3.028726771334262,2.2101534854250655
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.7977358219703876
Daudi,5311281,1.0302556341787754,2.2025439782980247
LS411N,3503,3.033347172376105,2.180408352405243
BICR 22,4705,3.4365696424802477,2.7605581481977945
Granta-519,6918638,-1.0102021398050984,0.07666100542445675
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.662932615982448
SW48,54618164,3.7830586534540616,3.8214429395903213
MOLM-13,25105715,3.5182090361281326,3.2999406018213273
Daudi,11175137,1.084300991963852,2.213316066432719
SW1573,42642645,1.1024283721976142,1.0182434468292132
P31/FUJ,11364421,-5.080526011220062,-2.5303989584805424
MOLP-8,12003241,-1.4499361325619826,-0.9714690613226494
Granta-519,10410894,1.4137063553430784,3.043912788207123
RCC10RGB,57519531,5.003664553369681,2.698465218194936
HEL,11625818,4.404342627749774,3.9620419792436796
SK-HEP-1,1242560,3.752923936287399,3.6456440750282435
SW48,3062316,-0.5038339303633423,1.2337197435932723
HEL,219104,3.0071408108258253,3.0663928793703135
SK-CO-1,3025944,4.807689572392986,4.209847708136308
SK-OV-3,52912189,0.2062426244094619,2.0038822069647155
COR-L105,51039095,3.4251018662752073,2.784446286088528
HEL,65064,3.1933308972510113,4.574503178143736
Daudi,9929138,3.458684768924583,5.07783492787526
SK-OV-3,11404337,1.4011927232423718,-0.22472715176948943
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,3.0369692628794054
MDST8,11178236,-3.494725666780331,-2.9115436601962146
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.5450119514475334
WM115,119182,-0.4924283039006125,-1.0558354298359918
COR-L95,56649450,4.0191520211736895,3.420163806404567
HCC15,5278396,3.283293724206623,3.6413530086807793
LS180,54143018,-0.5111931850291043,0.18537244729074562
MOLM-13,10427712,3.427914513597021,3.9668102789053177
NCI-H2452,1566236,3.5735792412039022,2.2670495670221196
ALL-SIL,452548,-3.3771532504793194,-1.2421099268780174
KU-19-19,409805,5.730069773001202,4.843605320149907
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.7945218208047468
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.6144860225776902
SW948,11955716,-2.1355637415890323,-1.6843791655392994
RERF-LC-MS,11609586,3.546222239883878,2.801620171784243
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.124150777772284
WM115,5311,1.988201906885666,1.3202554741716204
HCC1500,5311,1.250436307916732,1.4152337830179667
KU-19-19,5282054,4.451216911386669,3.753671041812438
PaTu 8902,4788,6.453607861068675,5.619343952117025
PaTu 8902,4261,2.3507697687761224,1.7019655146867791
SW48,68056272,2.992212540747962,3.4132589562967888
HCC1500,56963564,1.3630245510511625,0.29740573648263774
Panc 02.03,25183872,-0.079390979301081,-0.7231798392845259
LS411N,11964036,1.3999141622104765,0.9819888018894568
BFTC-909,135440466,2.535274686795805,2.2740675600559435
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.9521543347202415
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,4.154947782689369
LS180,25183872,-0.6080839156226316,-0.5766880035761022
PaTu 8902,71304818,2.9919229428361263,2.584990194034886
BICR 22,216345,4.525930969601246,4.127820256557751
NCI-H1568,374536,1.2941902477204823,1.9907786965634144
LCLC-97TM1,135423438,1.8911988038183152,2.3143358617135017
NCI-H1568,56963564,0.2273202395709376,0.07689707273558728
K-562,9927531,3.3022164605184763,4.663137855222777
SW948,2858523,3.1308292618704905,3.0580639512351975
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,0.41864402467275924
SK-OV-3,5287620,-0.5544150043477152,-1.8704428448179382
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.550349232379963
NCI-H1568,5311037,3.1621369524545155,3.925221457302752
WM115,15953870,3.7155207356015207,3.388289641762334
Daudi,445643,2.8458589584694307,3.745665404091257
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.6317843643763723
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.8377108421953703
NCI-H2452,156414,1.7996451609117237,1.6844397685321595
Daudi,53301938,4.372641532954565,1.4739901544019092
PaTu 8902,9907093,4.385383441203628,4.217050671977692
SW48,136227924,1.7122170056378203,2.7735417235521593
P31/FUJ,4096211,0.7441609883240002,1.8186835516553586
IGROV-1,6610355,3.969940996770339,4.15914252645233
PaTu 8902,4917,3.0649190232675525,3.1525418690949216
IGROV-1,613753,3.483244781428779,3.233449447329621
SU-DHL-1,3136844,3.883215489826005,4.216216089613707
HEL,446155,2.11086977892158,2.4064477964594047
HuP-T3,46907787,1.2763139172323097,1.8598111190680244
ALL-SIL,2729026,2.163276094007301,2.1396106377631128
NCI-H2452,54613361,3.2620625907056744,0.06992357708360424
BICR 22,448949,3.2035793217055124,2.007142502029464
SW948,5280436,1.724516723779293,3.4909886252032236
BICR 31,25154868,5.458998944130281,4.491722723220171
LCLC-97TM1,44632017,0.6758650901814578,0.9350432073585145
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-2.202689338072286
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,3.712652869855968
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.311244796772705
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.781515955525013
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,0.9300536838474924
SW948,409805,5.995103866916248,4.860413576706981
P31/FUJ,16736978,2.2012912480094444,1.4495422773094544
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,1.8892871313187718
PaTu 8902,19582717,4.67665303596855,4.121222417739065
SaOS-2,24775005,3.5680490412807555,3.7712778804660605
Granta-519,327653,2.833903719231272,2.7915417933518527
ALL-SIL,446155,2.369103686447931,2.5079220046330697
HCC1500,445643,3.796669497386567,3.928711924596474
COR-L95,7326481,3.0640813007839105,2.8064681202776995
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,1.3125608059448461
LS180,53232,2.536426383073758,2.8962964827501985
P31/FUJ,10127622,1.4388313131004449,4.051591037846801
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,3.0465302584999097
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,-0.04443351392428498
SaOS-2,11214940,4.2656495802712735,1.7831983305673729
RKO,637858,2.400395947377078,1.6535575702980803
NCI-H2452,3552672,4.527548939486843,2.8840043725277447
Daudi,168312962,0.2834059413422853,1.0144366521411308
P31/FUJ,216468,2.1049028903625673,2.8277404179614245
MOLP-8,11656518,1.844531268869525,0.9333283305152115
MOLP-8,5426,4.334733303826167,2.9516709875292655
SW48,54454,2.31662951125423,2.434798256009307
K-562,4521392,4.220123235241678,4.194094882988491
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,3.4495919546630676
RKO,1641662,3.3091455873155367,3.2943792637773934
BICR 31,135875424,5.0736941678127945,3.8861893180636486
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.322139454280052
Daudi,44607530,0.9746569917988196,1.5841057886567986
SK-HEP-1,25150857,3.0587845310763297,2.58174930963257
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,-0.5515356943604818
Granta-519,23635314,-4.977140911540282,-2.4242975975129513
LCLC-97TM1,24753719,4.6973214087473405,4.280185667351106
P31/FUJ,11640390,3.1324724534083277,3.245557636618721
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,0.9839151959346168
K-562,6450551,-0.0734681627771844,2.1448447719174855
Daudi,56946209,-7.191237665956405,-4.5505861008730255
Panc 02.03,25154868,5.464083731960118,4.4012403221218355
P31/FUJ,5311,0.3390662723443479,1.1756740660957217
SaOS-2,11485656,2.155652122560971,2.2050539623969914
IGROV-1,3025944,3.9702787396819503,4.323847233619722
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-4.178179719051734
PaTu 8988t,11494412,2.1257430484232525,1.7976479811776869
IGROV-1,53495165,1.3981720287668329,0.04433620502010572
LCLC-97TM1,42642645,0.0997949580151915,0.8529391588490154
HCC1500,36314,3.7134374865247017,-0.6079320321229996
NCI-H2452,3815108,3.5712952235347455,2.999956040928924
WM115,11214940,3.8761690772861126,1.575184008230444
SW48,676352,1.4830170410483523,2.0691178252056828
MOLM-13,25262965,-3.0495150612642465,-2.442396295408182
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-1.257677938009961
Panc 02.03,148198,-4.053337817942692,-3.619162040042836
SW1573,71466380,3.629171273590213,4.415982824420064
SU-DHL-1,151289,-1.0536473601541108,0.7261264300338715
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,1.1084257502600177
COR-L105,285033,-1.0049053408998423,-1.9215955075370468
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-1.578953847440309
Daudi,135440466,1.490781603812653,2.028658434236412
NCI-H2452,6918878,3.5446658281374277,2.745345061958629
PaTu 8902,123631,3.453096327622384,2.5065726474361933
COR-L95,15547703,3.222652754514603,2.939215294126317
NCI-H1568,123631,1.2596294102093508,2.351220124961055
P31/FUJ,216345,2.9363986514954203,3.8943138049292956
HEL,4261,0.4865008011530605,1.3701086716230393
SK-HEP-1,5280436,-0.1709015599208282,3.6779929653264354
SaOS-2,25062766,1.5016836694759386,2.0514411164204795
RERF-LC-MS,51037431,2.0455212647735364,3.234474281737582
HCC15,11656518,2.9308462534519024,1.7326744041050162
RKO,10127622,3.209405126939437,3.294923272182763
COR-L105,9927531,5.197941564874311,4.845153204035453
NCI-H2452,6623618,2.534886377212576,2.374203704586296
SK-HEP-1,16725315,5.326615386804391,4.3210073908509035
SW1271,11152667,-1.5987482479879582,-0.04549499561683989
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,1.4001530692802049
SU-DHL-6,3825829,3.5283611337160155,3.721310168057323
RCC10RGB,11656518,3.9855029209510215,1.8676771389851459
SaOS-2,67156097,-1.585481519484996,-1.0759249287299317
BFTC-909,5566,2.8568699448622263,3.0301102172674104
SW948,4788,6.033471365822279,5.787277648069372
LCLC-97TM1,1750826,-2.0890062190589544,-1.7132706731963125
MDST8,3689413,-1.6812703512916511,0.13316806987776247
SW48,9926054,0.5681768331785455,1.861404809277652
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,1.186934264884284
SU-DHL-1,262093,1.7952973078733698,2.652368175038742
BFTC-909,439501,-2.4866456286351095,-2.2801069309485005
HCC15,123631,2.7523193051058974,2.4669966934667293
P31/FUJ,60750,-3.4241008025920396,-3.0413615842859567
Daudi,9927531,3.2507934675389447,4.2950276246624135
MOLM-13,5281672,4.456656164404507,4.315381462158899
IGROV-1,11222830,1.5703285223102077,1.6246319906333004
SK-CO-1,5311,2.0479844637297617,1.4323405841761616
COR-L105,15953870,3.0827686267342957,3.645298974788436
PaTu 8988t,9866186,1.4965239773376473,1.0636554244379577
IGROV-1,124202324,2.2563058955522157,2.111060585507935
PaTu 8988t,9936388,-7.900053622036252,-1.2066675425416404
HCC1500,11152667,3.4439033763408644,-0.2543925899306739
MDST8,54618305,4.422279328619345,4.44641648331397
MOLM-13,3825829,3.189823245525434,3.4456662370497186
BICR 22,3081361,1.798482521796042,2.170333730686529
SW1271,3854666,4.252835819462087,2.1504875635027503
HuP-T3,285033,-3.1273004056463916,-1.8491078764562365
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,1.4171472119280215
SK-OV-3,6610216,4.5015440272840275,4.184453668043165
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-3.9471227512752227
SU-DHL-1,10090485,4.45721233802345,3.7480073807495415
COR-L105,54765302,4.547071050564395,3.93119771629024
SaOS-2,44491742,4.263847553999534,4.2898002598822265
RCC10RGB,BRD-K55473186,4.42890698658841,4.143344985302392
SW1271,2742550,3.530952260660614,3.8322111902798532
Daudi,148198,-7.679285276133229,-3.799056338708833
RKN,104842,-2.3241286690000265,-2.6443034952875104
SK-CO-1,3689413,1.2567954519757167,-0.19701017477011565
Panc 02.03,24180719,3.694319415808187,3.5491016475596293
MDST8,637858,1.7716899628344815,2.036412355926973
BICR 22,11404337,-1.5250786338229352,-0.6214449939291656
NCI-H1568,82146,4.486561599154294,3.6685702984884516
LCLC-97TM1,52912189,1.3140510236946998,1.507285512020288
BFTC-909,6918328,0.6354681535452512,0.154132204391308
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,1.5433287068570092
SW48,10385095,0.7767009249070084,1.3044852099546957
RKO,56649450,4.8662264096692684,3.1699631738340197
SW948,45279963,3.8052773477912782,3.706456892280857
RCC10RGB,3038522,2.595581097335362,3.0026512796475573
BICR 31,3689413,0.760898743899782,-0.22586079124651132
RERF-LC-MS,5282054,4.065617468844444,3.5187626971151196
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.669757838816834
K-562,25161177,2.405708421255354,4.113794183479657
ALL-SIL,11497983,-4.396279985993102,1.3821200752801817
SW1271,446155,1.3369653200346725,2.394961883018253
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.35112341861681023
Daudi,10296883,2.545577320776033,3.352044781417226
COR-L105,52912189,0.1952406080619365,1.9660622336428362
RERF-LC-MS,36314,3.6884025033565897,-1.4570917857323975
SU-DHL-1,25062766,2.372674975426994,1.9371579462002342
BICR 22,126941,-2.054722221433598,-2.734750958525278
P31/FUJ,46398810,1.6622931867453647,2.568243681699937
K-562,15953870,3.5143251027161613,3.351504518039882
MOLP-8,89183176,2.6780353354925706,3.3002774452018726
MOLM-13,9967941,3.903949930542719,3.4071576423207044
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.8494967795594732
SW1271,5291,3.239071539524422,3.6650041710186247
K-562,56963564,-0.0263606087054764,0.12462148554732524
LCLC-97TM1,54613361,-0.0023609252607709,-0.16220830093251995
Granta-519,24771867,-1.6352261980607803,1.6195731035595302
RERF-LC-MS,5287969,-2.0564845219287555,-1.793370300935303
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,-0.04831008119583398
IGROV-1,168312962,3.022863957843741,1.3929855108249425
SaOS-2,6505803,-1.001039194104569,-0.5096247994210517
Panc 02.03,5460769,1.6540560754425335,2.6224637972150413
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,1.2892908841105908
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.6498595835675003
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,1.6168860549802506
HCC15,135440466,1.473766152733558,2.1760644651030185
Panc 02.03,448949,3.46549633046868,2.041631770814296
SW48,119182,-2.1563748503052103,-1.466193154359477
SK-OV-3,36462,2.5052417836250496,2.023569706524874
LS411N,46199207,3.2917214979820506,3.1058153806749416
Daudi,71466380,2.956949879575845,4.064876644758873
RCC10RGB,44566777,1.0790521939265936,0.6445167226174232
P31/FUJ,446155,2.867326521256313,2.793747625022137
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.9128253804970736
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,-0.015293928279524773
BICR 31,71576739,4.400142576070014,3.8253630577511184
SW1573,6623618,2.3278245092002936,2.1469647250863795
ALL-SIL,969516,2.19071597716798,2.396555194728164
COR-L105,241158,4.618729119434587,3.991395213192228
Daudi,24797083,-0.0937737057199073,1.1442900129125073
HEL,5566,2.9283259495001133,2.9832309393450345
BICR 22,44137675,4.05989667865121,3.249848429094391
Granta-519,3503,1.8528122642218805,2.1580544868679876
WM115,5287969,-2.3112325385791093,-1.7709658180209815
NCI-H2452,3062316,-0.5574526988915461,1.1705892701889498
PaTu 8988t,12003241,-0.7673639150441187,-0.7369567715587266
SK-CO-1,44589607,2.7511810771029213,2.9688657583394598
RKN,23939,4.640348748177221,4.142306095775536
IGROV-1,72734382,4.633226130326536,4.370016445035165
BICR 22,46215462,1.5294433170369757,1.8987532837088374
MOLM-13,2949965,3.7040534246432624,2.2861728855239782
HCC1500,46215462,1.5254849350202837,1.7444569343549725
K-562,25183872,-1.1768480549542706,-1.368537370241218
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.014146133268087486
IGROV-1,3081361,0.99973562532788,2.228525528613763
NCI-H1568,9908783,4.863315848037401,4.950798087925717
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,2.5533595134818436
SW48,25195348,3.355247289110599,2.7497892772108528
HCC1500,135411,2.801194317933856,0.44761719646497977
BFTC-909,10410894,3.671861694905457,3.1980109343929057
COR-L105,2708,5.5167338716905885,4.886844553448234
SW1271,9927531,4.558020454092029,4.727465490161807
NCI-H1568,44462760,4.02669785413772,3.972024591069336
COR-L95,11612883,2.9601999054336106,2.7576422362376096
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,3.1137729472154563
SaOS-2,46199207,3.779046434903352,3.0661233932759675
MDST8,15547703,1.8320295844693912,3.2777662231011413
SK-HEP-1,23725625,4.972795252846745,4.86883700380119
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.0795684670110814
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.41555999548454
HCC1500,24797083,1.1358144177435396,1.3341413776350237
MOLM-13,11647372,-0.8512376057901615,0.6662636659629709
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,1.1814540444832682
K-562,5335621,4.97915810125604,4.582499958829691
COR-L95,2858523,3.028185885315027,3.0428116371839833
HCC1500,9911463,3.4774936591741703,3.9272919483093567
RKO,452548,0.942587279069954,-0.37792967723364157
MOLP-8,126941,4.086011311839599,-3.1098776130532877
P31/FUJ,3384730,-0.5934712638177775,2.723607101232282
LCLC-97TM1,16725315,3.732120983026874,4.28402525437027
HuP-T3,60700,1.2793809884126126,-0.4284539594687945
SaOS-2,9956119,4.053594307296879,3.6303263461247606
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,-0.1526735720098498
SK-CO-1,46199207,2.9466484543003197,3.1139983895505
SK-OV-3,11175137,3.182781765506491,2.505472455568368
LS180,11222830,1.8684195070218452,1.5968677831362006
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.6587449897110345
K-562,23582824,1.4169931108164455,0.9010596936338718
COR-L95,3025986,-1.3264557881304966,-0.9478445751303144
NCI-H2452,16065773,1.9140766169124153,2.499415970524956
MOLM-13,54454,1.7928295036604598,2.3870955020929863
LS180,119607,5.442141379439383,4.825146754282071
Granta-519,644241,4.377614733152813,1.7942803490614565
IGROV-1,46199207,3.293579955374855,3.0659044279290173
IGROV-1,3038522,3.6829378423722416,3.2294585581623454
HuP-T3,135875424,4.261865095251217,4.009797820810238
IGROV-1,89928392,1.4824233552493276,1.47877937518568
KU-19-19,5280436,3.7375704611092657,3.3848460354223056
SW1573,54678924,1.9184875438403524,2.0223742767482484
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,2.0166959283508294
SK-HEP-1,11364421,3.0648019303900624,-1.6017792608138441
P31/FUJ,11507802,-0.4015560413947272,1.3861626178938309
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,2.923872532484334
NCI-H1568,89928392,1.1949851991515912,1.7331409671559876
WM115,11222830,1.2308018153574234,1.6447579239666248
SU-DHL-6,9908783,5.938767725153886,4.84820843474059
HCC1500,25150857,1.1801270031504156,2.364064184167833
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,0.8381102366782343
NCI-H1568,4521392,3.7910777113602303,4.310340978834373
COR-L95,25183872,0.0728708482253017,-0.8969004984174477
IGROV-1,227681,3.5439813498262347,3.1891957052759325
PaTu 8902,6918878,3.691618711508776,2.722518061636822
K-562,1242560,3.4884556471232293,3.5230542718270415
BICR 31,53495165,2.344314514368125,-0.3612902309418123
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,2.077217162827561
BICR 22,17755052,1.4011116930942769,1.701742156881775
Daudi,17755052,0.1512024273398794,1.0018639398567641
HEL,67156097,-1.6398778776875675,-1.325462119403272
BICR 31,44486219,4.3544536670303025,4.420470046213367
SU-DHL-1,119182,-1.9070320733957784,-1.9088403420296018
WM115,135440466,3.0586385090162085,2.393917591297388
IGROV-1,11152667,-1.4116509977729443,-0.11987650401850933
BICR 31,10385095,1.3759128494100044,1.3737275575722128
RKO,969516,2.537841036798478,2.664386102584227
Granta-519,123631,2.886011281362197,2.187264969757778
HEL,4477,0.140225607998234,0.43158422141021974
HCC15,568763,0.562622735167329,0.35868423273544564
HCC1500,9926054,1.7367797854287812,1.8067414328676419
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.46197784550409
SW948,444795,4.960330673315111,4.516008516888053
SW948,119607,5.410714093672246,5.113198750402268
RERF-LC-MS,9936388,-8.273067767637817,-0.9129372465822361
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.17727793568277822
KU-19-19,4261,0.7367611445661113,1.5659041127685642
SU-DHL-6,387447,-5.553627026103078,-4.744266532614436
SK-HEP-1,3825829,4.395950359013269,4.098877893271046
COR-L95,9903786,3.7357721387912513,2.6674748348978943
SK-HEP-1,44185566,3.236949395761265,2.6435416557842366
COR-L95,73707398,1.0347493154641954,1.0410359455554854
SW1271,66577038,2.7134536861777807,2.791931139275913
RERF-LC-MS,36462,1.1230283698314445,1.9280463059056643
LS180,5278396,3.460947025625347,3.241274146098892
Daudi,3062316,-6.775500959037878,1.3386069036600616
K-562,107970,1.9304513771469212,2.239248646104776
HCC1500,3854666,1.4433352503078565,2.1283012526327263
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,1.2269790890719863
HCC1500,11455910,0.2448151005088887,1.2149614438616887
MOLP-8,46907787,-2.434163875600539,0.4311338262870348
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.6040329110017983
RERF-LC-MS,53392493,1.949934555719578,2.5825757185183047
MDST8,6610216,4.3863838734153,4.295626318822857
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,0.8883966561353032
LS411N,216345,4.369072592416217,3.9181408456610556
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,1.9706652538637235
SW48,2841722,4.762546821441249,4.169567516036533
SW48,9956119,3.393025538441131,3.4855246627146523
PaTu 8988t,44607531,1.764787957031886,1.465889145205844
HCC15,16741245,4.574628343563009,3.4165538966177285
SW948,89928392,1.4444572178844948,1.6238059524608548
SK-OV-3,25126798,3.9960730178767,3.7516833620234307
RKN,54143018,1.3184566027416504,0.523142344099622
NCI-H2452,24180719,2.8480667171601852,3.6743431133478266
COR-L95,9915743,0.942320604231091,0.8002331075122452
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,1.8339526395285792
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,3.103979513067074
ALL-SIL,387447,-4.904935645240703,-4.719400731228336
SW1271,54649381,4.56488530045006,3.732666389664299
KU-19-19,4259181,2.3072251676522835,0.02177762347400937
SW948,25105715,3.628389782970242,3.4941369493665273
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-0.9037589690100618
LS180,19582717,2.9052461851112565,3.637836340027528
Daudi,676352,1.3635905677607614,1.8338935840476196
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.3504653426014677
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,-0.10023206447369215
SW48,9915743,2.691515978939234,0.6809360216524447
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.144089172156812
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,1.2439655023059792
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.6959205313434915
Granta-519,3025944,4.149663954634143,3.845962269075674
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.231231395584919
SW1271,2841722,4.036476035404804,4.268830764557733
SW948,53232,2.3961531254319466,2.7959954919787116
SK-CO-1,25183872,-2.2315902989777725,-0.7208925341640957
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.2035628031013912
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,1.910409444915272
P31/FUJ,6918328,-1.424420935100909,0.002849402549504938
HuP-T3,71680916,4.329506074723249,4.644807965147337
P31/FUJ,262093,1.035147161622815,2.7859668611314294
SaOS-2,11228183,2.7080984165628754,2.148944593892833
NCI-H1568,6852167,2.376266672184036,2.7644130648697107
RKO,4477,1.7070595719756474,0.5976874817873548
Granta-519,46199207,2.493616790778817,3.0775779137293204
IGROV-1,5470400,-0.2457809435208252,-0.1298670157043169
IGROV-1,409805,5.990596261907717,4.8115058059313185
PaTu 8902,15983966,2.4191743534269463,-0.9966966359467629
RERF-LC-MS,31703,0.0184985959907658,-1.0355196803034865
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.0793671648024925
P31/FUJ,46224516,2.421293495972869,2.4127312937981573
BFTC-909,10127622,5.216996592058982,3.730189275026619
HuP-T3,55508,4.397520768584908,3.1794128187757114
HuP-T3,10385095,0.7178899916931367,1.2662412416129214
RKO,16013152,4.038378204585466,3.6343806422896687
RCC10RGB,6918328,1.0053978601828475,0.21210373481099432
SW948,9444,4.221430823371368,4.042609614880505
WM115,53392493,1.845382538513501,2.5954294899972012
HCC15,44185566,3.08334642122707,2.6816673688614334
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.20274032774699718
UACC-812,25262965,-4.249514707304517,-1.6033215700349297
WM115,51037431,2.6247692404465868,3.20351401277596
SW948,5311281,0.0185560472432188,2.4495809461180262
HCC15,44607531,1.6724658843452191,1.5254336882666553
MOLP-8,6450551,1.973885798572914,1.9814195245450015
MOLP-8,7251185,0.7855879803762651,2.1950019641936307
SaOS-2,5479543,4.655800274360292,3.410106612490481
IGROV-1,4917,2.985904350427039,3.168962749631079
Daudi,3825829,3.2006002080342544,3.7519848660213806
UACC-812,148198,-2.7739066615342236,-3.4223380737056077
Granta-519,1242560,3.55554960326222,3.2282081833512812
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.6907915056895817
HEL,17759555,4.966386069896687,3.492104452241007
SW1271,119607,6.141140067390372,4.96120953427172
Daudi,3038522,1.648170780235362,2.8689434350811944
PaTu 8988t,969516,4.442820223092304,2.777830370119354
HuP-T3,4521392,4.351966444408677,4.315930778567573
BFTC-909,2113511,5.65564772398506,5.474345376117202
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,3.0226970180614905
SW1271,24856436,1.0602186643720275,0.7077590257194598
HEL,24180125,3.3188099636510495,2.899200500518364
WM115,10077130,4.784184630126653,3.3413482578320832
SK-HEP-1,5281321,-2.075735756673856,-0.8087143467815308
UACC-812,10184653,-4.111635019949291,1.2528357715460472
BICR 31,55283,4.60336009153674,2.583657107225491
MOLM-13,11178236,-3.317575610691226,-3.4207775546258152
COR-L105,57519531,4.553300256365288,2.675353985479158
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,2.6648997442264526
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,0.552206157648746
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,2.917297471829632
ALL-SIL,11317348,-1.373590167325895,1.8857165016136492
LS411N,6914657,-4.299110458286086,-4.004594300655692
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-1.1002613174599907
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,3.0490394944531767
LS180,57519531,1.9809210286085912,2.088517809377327
LCLC-97TM1,60750,-0.9490237417659374,-2.1729285531459768
SU-DHL-1,49850262,3.2383746822480384,3.2870741532452574
SK-OV-3,9911830,2.8997016876614863,2.3699193477360696
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,0.5862489107350478
RERF-LC-MS,15983966,-4.090154567310139,-1.9325065091433586
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.328608875818779
RERF-LC-MS,24951314,1.4075693116182684,1.3485594148986255
SK-HEP-1,11494412,3.332434654266433,1.8084650442429344
BICR 31,51039095,3.0794813668201546,2.832879745686535
Panc 02.03,11178236,-2.8028080099743624,-3.0979936791251714
SU-DHL-1,24772860,-2.736237819232434,-2.686140863630815
Daudi,6610216,3.2134188501838494,4.053827100228751
NCI-H2452,53392493,2.782389188766079,2.8352892061467996
NCI-H1568,445091,4.097432324473231,4.205393516423382
K-562,9926054,1.8612748023096723,1.875405798794742
HCC1500,24978538,-1.6021545775061432,0.751356102773132
COR-L95,25126798,4.203058281978897,3.9671047902447554
LS180,44819697,-0.9723932292423276,-0.419417054102706
BICR 22,5281321,-1.7077192732848236,-1.2140460114045442
PaTu 8902,656346,4.145274855759625,0.759043087239058
BFTC-909,42642645,1.561027146692027,0.712824816151395
IGROV-1,49836020,5.658436828096057,2.341136084725362
Daudi,168313200,1.4988300519601074,2.804240809351918
MOLM-13,24779724,4.7751629548446894,4.332215245096755
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-2.443135164175839
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.5322709106624546
RKN,2828334,5.965623907482328,6.112889569977646
NCI-H2452,5280436,4.838161671645799,3.3076325452629023
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,1.82186810098851
BICR 22,637858,2.779101364791116,1.7358285988590307
RERF-LC-MS,56963564,0.3267097404636779,0.1404946342089821
RCC10RGB,2949965,2.9970768068045577,2.825911206017526
WM115,10074640,2.7921613557017473,3.111866161542545
KU-19-19,25154868,3.204596310046931,4.2433356749469855
BICR 22,49793307,-5.020228152199773,-2.821700917170511
SU-DHL-1,5460769,-0.475427190707336,2.2055573784790035
NCI-H2452,9868037,3.199558399493599,3.154349686805409
SaOS-2,9823820,4.1201217228566565,3.9558823835705033
SU-DHL-1,9444,2.825333870881758,3.926850488766077
HCC1500,53495165,1.6495193303321407,-0.3585822134530796
RCC10RGB,9952709,4.37754893062567,3.22682509557627
Granta-519,73707398,-0.348610297970246,0.8174206451045662
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.4033617886963523
MOLM-13,26596,-2.2068545341754295,-2.5368645635450857
K-562,52912189,0.5484446218637569,1.532687024430082
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-1.8339846144421283
IGROV-1,375860,0.7731558163124775,-0.045671768332123046
IA-LM,11964036,4.998383188027045,1.2511319547043844
MDST8,387447,-2.914953377887094,-3.8352579156226807
IA-LM,9915743,1.455667571666015,0.7703209184651858
LS180,6918328,-0.1069758097146191,-0.4046428176102257
PaTu 8988t,6610216,5.064895456595333,4.2665884759138235
SU-DHL-1,104842,-6.410970225096146,-3.3741341747348947
P31/FUJ,56946209,-4.67609529352027,-4.171489192404088
SW948,6917907,-5.884345700630281,-5.750072624019769
BICR 22,53232,4.030024483575548,2.580282231274325
PaTu 8902,568763,1.8312011651342244,0.48346360195958094
ALL-SIL,6505803,0.7073572306495796,-0.5750427754491999
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,1.6332705301387276
LS411N,10302451,4.220534629483678,3.0569058393617405
RKN,11238147,3.9265768628415487,2.868472550081998
PaTu 8902,135440466,3.176809791892748,2.209377474127555
MOLM-13,119607,3.836878131829583,4.750603700285981
HEL,11612883,1.9962168488272864,2.551500508695454
COR-L95,11485656,1.8696119642586884,2.2822524908542614
MDST8,675434,4.4652962141660595,4.2886819363106214
IGROV-1,11507802,1.5049911819213722,1.2593548001627175
SK-HEP-1,2708,5.260013220141412,4.8582684277168475
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.335171693299007
SU-DHL-1,5738263,2.757121948334044,3.1735686072477147
Granta-519,54626689,4.523537450364534,4.5680481814064215
SW948,135421197,1.7477185084776832,1.6609096454722974
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.7347483344216172
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-0.8532590809966613
BICR 22,4917,3.6655313291566327,3.1103500775834423
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.2444148508412085
MOLP-8,16736978,0.6033273838828506,1.3520296280807227
SW948,11396600,3.556168564723583,3.7317262235981867
IGROV-1,2113511,5.982902824257526,5.224377451676191
Panc 02.03,16725315,5.289216895099664,4.362924392423744
K-562,9549297,1.810271401171294,2.2399791946556387
SU-DHL-1,60700,-3.861884777487788,-0.9012276008314608
MDST8,89183176,5.515733421140453,4.316403539687159
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,3.121197041631026
WM115,10113978,3.3670712397266698,2.89078854355749
SW48,25154868,5.084018259884556,4.43484789036731
Granta-519,107985,-5.079154139769343,-3.875080568471804
IA-LM,15953870,4.160803294534019,3.56050098186664
RKO,19582717,4.345992572306107,3.690000494808728
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,2.4534808675048834
ALL-SIL,2742550,3.1857763586562577,3.778967716166195
COR-L95,375860,0.21091681928276,-0.18815661889860455
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,0.992382578466023
COR-L95,702558,5.203109308170341,5.047465671377346
ALL-SIL,5329102,0.5818325089631969,1.7397277838606506
MDST8,9911463,4.372295154952754,3.6579316569030373
LS411N,44607531,1.9881484499388475,1.4829435284638597
Daudi,68056272,2.8001037652797818,3.43924129432749
MOLP-8,4521392,3.737637773211522,4.069443098614353
MDST8,20959075,-2.855250986095604,-2.7822625356095494
IA-LM,400769,-0.2498086542393983,-0.6881877236001479
IA-LM,16722836,2.5380745713557893,1.4907332355187983
HCC15,445091,5.451686926059382,4.384501159745822
HCC15,11507802,1.1916077520331714,1.8701188285401233
MOLM-13,9903786,0.7109980532390177,2.244951670319968
SW948,24901704,3.213341299668661,3.330114736113353
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.488808663813735
SU-DHL-1,10427712,3.576020229714379,3.9144455869292294
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-3.397752586816824
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,1.8708178851697375
Granta-519,51039095,1.7779321154646133,2.4548772402444774
RERF-LC-MS,65628,5.693639897620667,4.3545667894746
SaOS-2,2828334,6.074749772556143,6.1914780942715115
SW48,3815108,2.5063295630391806,2.61412871486152
SK-CO-1,11626560,0.3943389380121196,1.7995179680738618
HEL,107985,-3.965696416470184,-3.7903597401125295
KU-19-19,60700,0.8700483452505813,-0.2765521361573419
Daudi,5280436,1.0789231424034973,2.8527416793006846
MOLP-8,54613361,-0.8734170036218252,-0.45892691634409055
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-2.1471409525989387
SK-CO-1,24978538,-0.5683899539074425,1.3947507760872846
SU-DHL-1,54649381,3.644517842316546,3.6636213920968985
SU-DHL-1,44493528,3.922242735424854,4.204795768322598
P31/FUJ,5282054,2.945149434876345,3.603369760143013
SK-OV-3,49850262,4.3958011115665006,3.4393912362534387
IA-LM,10184653,0.8510906912410041,0.9543618215826352
NCI-H1568,36314,4.092621701538515,-0.8234391511707764
BICR 22,46843906,2.889476079217857,2.7245103181848753
SU-DHL-6,9444,3.111459322097769,3.8640408291838573
ALL-SIL,10410894,2.969142576372873,2.900968363139292
ALL-SIL,9549297,0.2429486516660708,2.2979445025275287
Daudi,46926350,-6.041265180126537,-4.458327111761214
RKO,1750826,1.760307875609834,-1.9653549121830727
PaTu 8988t,4477,0.4312443696129938,0.601814742773882
Granta-519,5282054,2.5814189459390957,3.0969018426620187
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.344214340805829
IA-LM,16065773,2.795317455347302,2.352630305492108
RCC10RGB,156422,4.423389512885201,3.8313716569877756
IGROV-1,11214940,1.360660548899077,2.1402135414664896
Panc 02.03,16720766,4.473005389666903,0.8093093939454872
Granta-519,3081361,1.7559432073327723,2.1648765830179584
MOLP-8,52947716,-7.872176911001468,-1.5886509680751555
KU-19-19,5281321,2.871465791170073,-1.2994689507903485
IGROV-1,5282054,3.614574021382022,3.7087348925927817
MDST8,4261,1.8348924416255383,1.7803100018641527
MOLP-8,100016,7.090961588333011,5.886427765877402
Granta-519,168313200,2.290121636997186,2.6309314530568844
HCC1500,462382,0.0787876699821948,0.7685749428817593
IGROV-1,10113978,2.874171865860951,3.2991809111972397
IGROV-1,BRD-K55473186,4.387806234483854,4.248439036049438
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.7061294966457767
P31/FUJ,10410894,5.368264014178215,3.268583626097154
BFTC-909,3025986,-2.0399601309440336,-0.7464787943048192
MOLP-8,24771867,-5.187641849515016,0.8777335627100998
BICR 31,11214940,4.966543096658616,1.6812618364060017
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.2881519081850046
UACC-812,9936388,-5.022392750910281,-1.009168185406407
ALL-SIL,24772860,-3.38763553354356,-2.0980659455456414
MOLP-8,11626560,-0.689912231097504,1.1159090908740346
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,1.1627484189109494
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,1.8855142168189216
SW948,262093,3.1804911198162036,2.934804006529816
SW948,216239,1.8650010893863176,2.2306306711077104
SW948,11364421,-5.809742751249139,-1.0494304620394141
HEL,10302451,3.814274659252608,2.525776795088575
K-562,46398810,1.812730009869126,2.618174992253949
Daudi,216239,1.5780166370194677,2.0322505384739937
LS411N,10231331,0.2083934704449227,1.7246566378342743
MOLP-8,46926350,-5.986975596425451,-4.13293095229449
SK-HEP-1,11964036,3.325100881793091,1.4196213712855832
Granta-519,11485656,1.6660529916447626,2.1269359791449016
K-562,2871966,0.96376622724181,0.34291615027485767
P31/FUJ,54454,2.7341923640247123,2.629805203718248
SW48,54613361,-1.8010952783890095,-0.26437027816253106
NCI-H2452,46843906,4.012061875028764,2.9224615635521722
HEL,135875424,2.9448279330391927,3.697683842425874
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.295315020954212
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.0552433553646465
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,2.6809478227025263
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,1.0707695762420015
HCC1500,54678924,1.846277418486191,1.994612123288843
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,1.0225879413624666
MOLP-8,9927531,5.438833274000949,4.3808223960758745
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.163537963278149
HCC15,9952709,3.084010703088348,3.0908496926670677
K-562,3503,1.244026999465694,2.356042466075319
SaOS-2,3689413,0.0712794264513353,-0.4410299331470244
MDST8,10427712,3.921886084986449,4.180562596609498
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,2.7275678688654192
SU-DHL-1,1716436,3.093009546519781,2.797272808382387
PaTu 8902,25105715,3.5553172149604375,3.362605114618615
HuP-T3,24771867,4.228511460696379,2.6506837539902444
RKN,31703,-0.7196573309741882,-0.5203964731886535
MDST8,60700,1.1908209554887386,-0.39238184851163865
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.387060117436148
HEL,54454,2.1583735480761437,2.574117816790679
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.590734398896625
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,0.4564317658442828
SU-DHL-1,135875424,2.8587183873170847,3.6391714979914864
SU-DHL-1,36462,-1.6063137198477124,1.3552860214282005
MOLM-13,73707386,2.881964792667641,2.424202403544158
P31/FUJ,3854666,0.6136756098719494,1.878012997553749
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,-0.2922268146364154
MOLM-13,159324,-0.2587959593058327,2.2203148343905275
SW948,19582717,2.742329976582949,4.060042245850027
SK-CO-1,444795,5.109688629113172,4.624667118315658
Daudi,400769,-1.3686052359334673,-1.0277338929220639
SK-HEP-1,10296883,4.4971190241998835,3.885011239393082
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-1.14715561521295
LS180,17759555,2.746757712453425,3.5128387717139837
MOLM-13,156414,-0.1970532812518614,1.1487962790022233
ALL-SIL,72376,-2.2514410459425043,-2.316286406720434
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.482401018603483
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.26161623889324287
HCC1500,51039095,2.9997605815390935,2.9591772885813783
WM115,44185566,3.0030021210520794,2.607360103426665
COR-L105,4705,0.5312031062005766,2.874679120223101
Granta-519,8515,3.731909716775835,3.4062244665244874
ALL-SIL,11234052,3.5011978223530926,3.6012701311415447
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.3190583203996253
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.2201486301457019
Granta-519,613753,3.0344429390603493,3.106230852154734
HuP-T3,5329102,2.4996480668272527,1.947563349544535
SU-DHL-1,2828334,5.462697908299577,5.954136049709066
SK-OV-3,51039095,2.3576173335626147,2.5229832532749232
UACC-812,5470400,-2.2578344499942418,-0.14934048830670668
HCC15,9935249,4.091947122155354,3.224279895316919
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,1.0263242977558635
SW1271,322968,3.7653444240208263,3.4812709833943956
COR-L105,54678924,1.4327429630461548,2.2363980335509916
Panc 02.03,31703,0.91391851070637,-0.5309565871411039
NCI-H1568,5329102,1.5348278867114138,2.045161326146992
Granta-519,9887053,0.035640336798207,3.144011522166552
IA-LM,6610216,4.173583896241699,4.239126471325018
NCI-H1568,119182,-0.8732650634834633,-0.8480011830496537
IGROV-1,159324,2.8766947154825044,2.5644209066975203
NCI-H1568,5566,2.911706555521376,3.0088070871044197
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,0.08165530331339298
NCI-H2452,10385095,2.425738192808243,1.3003004638218871
HuP-T3,16065773,2.155269900494742,2.437497171581226
SW948,448949,1.5714288146717783,2.0579609177967275
NCI-H2452,107985,-2.625758680845612,-3.454864783950935
RCC10RGB,1750826,-3.277944046627699,-2.1481367940647877
Granta-519,16736978,1.0160166250823044,1.235899619101658
HEL,104842,-4.135712202151618,-3.0938590378819852
MOLP-8,71466445,1.892906464336944,2.2595606970462456
MDST8,262093,2.389063867163299,2.8558831856824303
COR-L95,4259181,0.8580425806970188,0.23698319321192124
Daudi,45279963,2.6753649589319854,3.502814392025535
IGROV-1,656346,1.6285470744333117,0.7583573929752855
SK-HEP-1,10427712,4.527720982072863,4.241894459212883
SaOS-2,11647372,0.6261520317366223,1.164819775341759
COR-L105,53495165,0.9627099148057476,0.05182117646192412
Granta-519,11404337,-2.8078628280004048,-0.7239578050669749
SW1573,25154868,3.281093993360062,4.3336398638994575
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,2.183870782826397
BICR 31,3503,3.4488620791118993,2.1932371040911236
SK-CO-1,3062316,0.5910144260309655,1.3776174365207523
RKN,6917907,-6.438038185084336,-4.7910922715197115
LS411N,23635314,4.011909681168236,-2.0422710230754078
WM115,11234052,4.1182935305671435,4.055064245487607
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-1.786089364679693
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.8472053295121319
RERF-LC-MS,11485656,1.5190166417661397,2.222594343328372
PaTu 8988t,46224516,2.924922546378164,2.6955012010245536
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,0.6154601149610045
SK-CO-1,5287620,-2.837552470898679,-2.120798143522942
PaTu 8988t,24772860,-1.5593380796956875,-1.5638660667889914
PaTu 8988t,6184667,3.5063575702163345,2.927515995516487
BICR 22,36462,0.4717839486114671,2.0844264298955624
RKN,16722836,2.340122812915413,1.6982421740604943
Panc 02.03,54618164,4.482290203520866,4.108872632558717
BFTC-909,2841722,4.3094465275997536,4.412898385657357
COR-L105,2746,3.1035280268076217,3.297280577772235
IGROV-1,9929138,6.483056540257463,5.230881630661155
HCC1500,2708,5.151987441269929,4.886288006297978
MOLM-13,11238147,1.4582306649534449,2.437877802871223
RERF-LC-MS,11364421,-3.8493036468537265,-2.258703140342069
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,6.247110634372785
RERF-LC-MS,16736978,2.30801467798398,1.8423533412577808
LS180,44241473,4.435457667187811,4.738039405072213
SW48,16722836,0.2197322523934369,1.4974086381660527
NCI-H2452,9444,3.5242093703527697,4.266793605803853
SU-DHL-1,5284616,2.4488241799592143,1.5986507441080693
K-562,54454,3.689215856042272,2.5374718754914096
HEL,2945648,2.719646445320408,2.8080223827173114
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.5364340830648227
HuP-T3,9936388,0.6940852338085793,-1.16717774588709
LCLC-97TM1,10427712,4.124790087544491,4.264093091488007
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.4946485322548186
SW1271,135398738,5.657599080768866,4.310710466974322
RKN,216468,4.351451769225332,2.996958700283153
SW1271,46224516,1.263100640010589,2.7697316739636784
SK-OV-3,60750,-4.210978436614257,-1.9057668599047195
SU-DHL-1,11455910,0.1271925880707346,0.6583518786358669
Granta-519,25161177,3.429453868131532,3.892229257557066
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.3879695203191935
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,3.0477665496345496
UACC-812,16065773,1.9582746458630844,2.3975012666531517
MOLP-8,2858523,3.112163707938977,2.9338596072583094
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,0.8067617678585453
IGROV-1,6505803,-0.2382223795960626,-0.558838185656558
HEL,24772860,-2.0205510075596425,-2.258688312065345
HCC15,4917,3.2753021602409267,3.054412295659995
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,0.26793182709347635
P31/FUJ,6184667,2.9500590386465393,2.877717048957842
MOLP-8,46843906,0.174682801852784,2.374227948492628
NCI-H2452,54618305,4.302077073898344,4.237096309220266
BICR 22,8515,4.348804794701894,3.7194072805018057
COR-L105,24821094,-1.121187296223131,3.03427407011583
HCC1500,4788,5.676843976237076,5.582735132824207
SK-HEP-1,2746,4.04921422913523,3.2582852397559865
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.2552386062697323
COR-L95,46199207,3.11604668311128,3.1173961303276583
MOLM-13,1641662,2.418131669664625,3.0667048912656116
WM115,135984461,4.094268409164816,3.76577565661954
LS411N,10127622,0.4126946340819594,3.086834091533071
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,3.491469200298167
ALL-SIL,11364421,-5.245070547120315,-3.1764958497298337
NCI-H1568,44607531,1.2688225542701184,1.2651140490187416
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.8151265825892859
SW948,104842,-0.6555530305877334,-2.6082386022872526
SK-CO-1,46907787,4.316773762169295,1.8711474359475744
HuP-T3,104842,-2.1883971380944054,-2.7029356666031084
IGROV-1,11178236,-2.8618715106425725,-3.4209748756598293
HCC1500,71751553,4.671922723370954,4.4187130752180295
SW1271,54618771,-0.1319273231055389,1.4389520846387265
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,3.2205792240825546
IGROV-1,654092,-1.340387623873854,-0.13259113688512408
HCC1500,44819697,2.691999336982048,-0.4592234492451432
HEL,44137675,4.224171499328968,3.066711625066188
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-1.5969457364952615
COR-L95,5328940,2.113977806947162,1.8231133444860195
SK-OV-3,3825829,4.139200001280225,3.8818207643112754
Panc 02.03,216468,3.8655539989600176,3.399847752728127
SW948,25195348,3.534636067330416,3.1506372575596244
MOLM-13,9444,3.2439366633039426,3.2791205652072795
NCI-H1568,24821094,1.7576462865100984,3.0070954051706194
MOLP-8,1566236,0.7132031003128095,1.787551722163215
HuP-T3,11455910,1.0919804440303738,1.3642499069817464
MDST8,44185566,3.0590843033834116,2.671483963477377
NCI-H2452,216345,4.1608899350266615,3.704882467868221
SaOS-2,23635314,-2.530968731721941,-1.6825899597153577
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,1.6255098633025775
LS180,168312962,-1.039638615515642,1.4962881487339907
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,2.0881352463803697
BICR 22,322968,4.6496227244818416,3.7132107313473677
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,3.0527685761819523
RKO,6918837,-1.4612228483082623,-3.115185115638531
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,1.6050504285469145
SW48,613753,3.5910736246612323,3.163003784589647
IGROV-1,44507138,2.359177395411688,2.850632343909478
WM115,52947716,-6.8465929822900815,-0.555005666476028
RKN,73707398,1.136221501718042,1.4273377217968912
HCC1500,4477,0.2789780560390432,0.4732100805156854
Granta-519,11719255,2.4006867045586953,2.841545308400219
HCC1500,6918736,0.2919336581768246,-1.7995453695785457
IGROV-1,4477,1.1767656777594142,0.5340922072765065
IA-LM,11609586,4.073174168632335,2.5530249799201283
NCI-H2452,11404337,-0.3859535574072682,0.029925352184805583
Daudi,136227924,1.3476403322374937,2.633497782034287
SK-OV-3,387447,-3.0618968905277164,-3.9722473404835834
MOLM-13,3854666,0.5101644656521153,1.2677460745402136
RKN,46843906,3.906010302389018,3.0374603702541183
ALL-SIL,1641662,2.105441320822025,2.967332721982986
MOLP-8,46199207,3.622115707782432,2.8935567990370816
HEL,17755052,2.5427584711612554,1.3110940158469708
MOLP-8,9915743,0.5160575940701332,0.8685537073399057
NCI-H2452,135398516,0.2354885350790482,2.558721794483516
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,0.9554304121227897
SW1573,9911463,3.734935340044018,3.752040886031412
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,2.2976315729990717
IGROV-1,23725625,5.712368491237602,4.864744910243981
IGROV-1,54143018,0.8385018685685798,0.7944967927156051
WM115,135875424,2.968517855352779,3.5061350668558533
SW948,16659841,2.968981271202921,3.7125632794017367
SW48,25183872,-1.521332471338628,-1.2720655839771164
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,1.3529341031018143
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.7526247421931915
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,1.55459894395614
WM115,5284616,2.9108529677003565,2.1671849146962834
SW948,4705,1.720002028261835,2.7859625999539985
HCC1500,71680916,4.362866442203444,4.595978996598213
PaTu 8902,17755052,3.1533076581920936,1.8170546417533615
COR-L95,11427553,2.745819698220539,2.64961547699381
MOLP-8,11707110,-0.9708482925672104,-0.07112044372206676
HCC15,5351362,1.1207822529279785,1.8290272643366818
SaOS-2,11234052,4.364959006359101,3.892990232337295
SK-OV-3,6918837,-1.7709381590236568,-2.399827633761993
RKN,10113978,4.430129932581481,3.2182343041301307
Panc 02.03,5566,2.8367562997211815,3.1164890564080485
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.9170753840076054
Granta-519,4096211,0.4087245803445845,1.5101908455892856
SK-HEP-1,72193861,3.0367238048594603,1.9506129015349425
SW948,9933475,1.7222383900333498,1.9082120824499305
SW48,9936388,-6.68623848822316,-3.054178794592713
NCI-H1568,11222830,1.5738139714037271,1.5146105205533364
IGROV-1,24856436,0.4840146383282276,0.5782886812857911
SW1271,25105715,2.9104912505007143,3.3119964396774026
IA-LM,11238147,3.064975348903814,2.716801347541067
PaTu 8988t,23635314,0.3317794086663004,-0.848760161690656
Granta-519,3136844,3.153984140395424,3.8864546547198056
COR-L105,24951314,2.139685821030411,1.2854340487794846
IGROV-1,135398744,6.402844237905131,6.51936572083013
LCLC-97TM1,156414,1.5907536031970133,1.2836232388584528
BICR 22,46926350,-6.042960620867506,-4.011609162969903
Granta-519,387447,-5.4996124066637435,-4.501158571370119
BFTC-909,51039095,2.7594177275421403,2.6293355649165404
Panc 02.03,5746,2.615751109567445,1.0421937234537066
SW948,71466380,3.8629020707603914,4.465695000521087
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-0.8698758577903589
COR-L105,24856436,1.5602990639828938,0.7341589129217823
K-562,327653,3.3038748071855175,2.955659318366728
Daudi,16725315,3.035985748437892,3.7107839878068383
LCLC-97TM1,6917907,-8.098980466082804,-5.525736179066191
NCI-H2452,4261,1.8682088943565944,1.6805887754044588
SU-DHL-6,241158,1.5794519300851928,3.3945897224491666
IGROV-1,9840324,5.720969888694302,5.863076155011879
COR-L95,10074640,3.0551355702246292,3.117342904664402
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,0.32112684317437157
BICR 31,5460769,3.9433617709959696,2.3208809798638965
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.8891781644436972
ALL-SIL,171352865,4.1926931777749346,2.7207431906492676
PaTu 8988t,5351362,2.286773409161727,1.6201303603222033
COR-L105,54618164,4.149947168538197,4.071004590760753
K-562,168312962,1.3008721680360658,1.7354709470555647
NCI-H2452,3634881,3.1517111283550854,3.376247617518899
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.668139135485393
LS411N,2858523,3.1062955336512603,3.0976416794419612
NCI-H1568,65628,3.926137474064237,4.369676498828774
SW1573,25126798,4.147065453172024,3.8906387681654677
SU-DHL-1,9868037,1.568771805047012,2.654987256439517
HCC15,46174525,4.292402667650191,4.187203687662119
HCC15,54626689,4.436341034968849,4.623360823631204
K-562,241158,3.183928650435804,3.4205396605488723
HEL,400769,-1.0010167847558078,-1.1955847947008293
MOLP-8,24180125,2.8280981087253605,2.6461129340400054
LCLC-97TM1,6918837,-2.241539398034031,-2.879062369002777
SW948,52947716,2.6983492764143984,-1.065814197004117
HuP-T3,11609586,3.0975126346448056,3.061333434483946
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,2.738207025103963
K-562,9911830,-1.954559593888618,2.489621522150529
Panc 02.03,54454,5.027619058009229,2.573871834822455
Daudi,9967941,1.9498714635628245,3.316156975504339
SK-CO-1,46224516,2.9108482414820833,2.6055626837261143
IGROV-1,56963564,1.8260986108097368,0.31249781201577376
PaTu 8902,119607,6.110313748168657,5.23062648960581
SK-OV-3,1750826,-0.3132155362058529,-0.9115642580248395
NCI-H1568,11507802,1.223292685938289,1.471194728430972
SU-DHL-1,6918736,-2.1290482192432396,-2.180000677169433
MOLM-13,6252,-1.803091878000868,-0.7031846103595187
HuP-T3,16659841,4.694527425679891,3.8814364564915578
COR-L105,135440466,2.282908830244017,2.409507749360739
COR-L105,36462,5.237060103367249,1.896043139537259
LS180,16038120,0.768362963165676,0.5693384802713437
COR-L95,11719255,2.8113582651389684,3.1567385433587574
K-562,71466380,4.109476883218819,4.420027750400573
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,1.2756996831832106
LCLC-97TM1,65064,4.239331302053654,4.896929265875772
ALL-SIL,11626560,-1.2475078800938888,0.8338837955806311
IGROV-1,9903786,1.7387584479757865,2.7155260484885404
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.086109164754243
UACC-812,3025944,3.7003704595595894,4.305146328509623
HCC15,52912189,2.9796194932949875,1.945159758060055
SK-CO-1,24951314,2.193758155281627,1.3480989960702874
IGROV-1,208908,2.822483792004996,2.1427632223799025
BICR 31,2945648,3.0787524499283023,2.9067335315223435
WM115,11485656,3.738489726762909,2.340577595379477
IGROV-1,126941,-2.246216453812328,-2.350553410885426
KU-19-19,135411,0.3258457054887789,0.8028287467564392
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-0.5631654410577138
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,2.1949690981936585
MOLP-8,25105715,3.7016775455761968,3.2331569810108896
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-0.9846737735432315
NCI-H1568,25126798,3.633705991567496,3.852663133251617
LCLC-97TM1,3689413,0.1289764847745495,-0.15946191603102297
SW48,5311,0.4861581581750583,1.233053513726922
LS180,409805,6.164182483443964,4.7929712643265665
ALL-SIL,17759555,3.7861470032844418,3.5175750399134564
K-562,7326481,2.6072018104551824,2.938750454304656
SK-CO-1,8515,5.207883928071115,4.026913454034432
NCI-H1568,439501,-2.6831567396736022,-2.2608546858808847
BICR 31,3634881,3.594506321194918,3.202870554490471
KU-19-19,656346,4.826208082880011,0.9902777708700828
SW1271,10410894,3.9794007270318903,3.4590301949861657
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,-0.14627975309125824
SK-HEP-1,16722836,2.576451725849178,1.6980511957806703
RERF-LC-MS,10113978,3.210216765519601,3.2409087057684984
LS180,54454,2.0147485365690945,2.5375045715812035
NCI-H1568,9866186,-0.23967308205821,0.9752647553911206
IGROV-1,10302451,0.4135234554742116,2.8377535734831274
PaTu 8988t,9935249,3.4642640806067897,2.7575461223314575
HuP-T3,65064,5.168937665689206,4.88393705204164
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,1.9360201949845857
LCLC-97TM1,44543605,5.020704141539917,4.0031743880746715
KU-19-19,3062316,3.300727237006398,1.1272387065730802
IA-LM,54143018,6.360653223606267,0.5428385014493624
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,1.945605149177901
PaTu 8988t,11497983,4.771256524847766,3.0982661322717218
IA-LM,7326481,3.2597510497719964,2.9479309989268234
MOLP-8,57519531,1.794840771759573,1.8725486276347478
Panc 02.03,387447,-4.21908064053878,-4.222202054332413
Panc 02.03,9866186,1.4364847380387245,0.7378127351842213
BFTC-909,56946209,-2.8280109825858943,-3.9356726249789813
K-562,46843906,1.6079735978006011,2.406817151077549
IGROV-1,3038522,3.6829378423722416,3.2294585581623454
COR-L95,9933475,1.8209744616881691,1.9729807169801417
NCI-H1568,54613361,-1.9115789745186575,-0.13525036586961062
PaTu 8988t,11178236,-5.843883599227575,-3.065860384307237
IGROV-1,24856436,0.4840146383282276,0.5782886812857911
HEL,5746,-1.0378501544368317,0.6313238996424361
LS180,216345,2.343571728213523,3.3614328062470364
MOLM-13,11234052,1.8885372726820036,3.583970277915765
IGROV-1,656346,1.6285470744333117,0.7583573929752855
IGROV-1,613753,3.483244781428779,3.233449447329621
RERF-LC-MS,44632017,0.7768655843829712,1.367993760187509
LCLC-97TM1,10113978,4.598206277837053,3.0681127693052326
LS180,136227924,2.415770069388299,2.7780076500570208
Granta-519,5978,-7.678617575463935,-2.557877494128048
MOLM-13,2828334,5.861258184508348,5.967623877246594
ALL-SIL,3815108,1.81429533281988,2.3668059584647083
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.054274062226707
LS180,10385095,1.937933801431244,1.2590697409394647
SW1271,7326481,3.1173859417421985,2.824432972676899
COR-L105,176870,-0.2151307909405896,3.0960002840767746
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.570867078231123
HEL,6918878,-0.4197772532459504,1.2625842958897815
RCC10RGB,44589607,3.0966280095343777,2.987322676679018
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.7442813986604611
SW48,89183176,5.513741245898386,3.4916290768546334
KU-19-19,168312962,-2.211081322704064,1.5052019339459008
LCLC-97TM1,11656518,-4.424964199082896,1.301877927612977
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.274540393729634
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,2.2591240008240696
WM115,6918328,0.4200257259119496,-0.024249186720829874
RKO,44491742,4.905526099010324,4.090471636633693
SU-DHL-1,5280436,3.4353188558540895,3.1616867706222904
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.0118077105908596
P31/FUJ,702558,3.294053878414949,4.962513305671524
MDST8,322968,3.292336134337166,3.7304062817798473
MOLP-8,66577038,2.4807994544381997,2.9592696078393943
NCI-H2452,216239,2.289885444542123,2.3113973708909055
LS411N,24951314,1.1768436480242177,1.187545274899469
HCC15,5291,3.948819619575577,3.544694793935184
RERF-LC-MS,11152667,0.0782441689403026,-0.3987775376591931
NCI-H1568,285033,-1.965656578387781,-1.9672459609848707
K-562,119607,4.708269214175102,5.152535558109025
MOLM-13,6918328,-1.6668605659600593,-0.9376500714695131
HuP-T3,51039095,3.318948357155543,2.8465859724507823
COR-L105,3025944,3.915005293474353,4.34395951248696
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.422394253940676
NCI-H2452,42642645,0.8357005775142816,1.1900463412703333
PaTu 8988t,67156097,0.822255948885768,0.08115477449866974
P31/FUJ,44507138,1.0120664141515707,2.4594443645003214
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,0.17411838540515556
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,0.6409207961696168
HCC15,10074640,3.1199478074334106,3.223395176309544
IGROV-1,53392493,2.352084848618059,2.50449956743469
SK-HEP-1,135398516,1.8011759760648425,2.136952135553471
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,2.387092090839666
IGROV-1,1242560,3.902441161940491,3.5152837013387925
IGROV-1,24901704,3.0789156375765936,2.991870520126908
RERF-LC-MS,23635314,-3.639251677232653,-1.8033605815361398
KU-19-19,56946209,-3.434845070293707,-4.017759185787264
SK-CO-1,11427553,2.3636745936222177,3.0429031366725074
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,3.068835973521611
Panc 02.03,6852167,4.143336119644561,2.991205088043302
NCI-H1568,26596,-1.690126811671561,-1.5327452836093003
ALL-SIL,100016,4.099229681419155,5.724128951912335
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-0.6014194372046838
BICR 22,219104,4.618531153522784,3.7908438659754666
HuP-T3,4378219,2.0668857590794767,2.556300021569074
IGROV-1,11647372,-0.6595372928368528,1.2241370433829772
BICR 31,46843906,2.802485697538939,2.891690849457824
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,1.5746870009911555
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,2.1746464183541394
PaTu 8902,65064,4.553320484088526,4.926531183167465
NCI-H1568,10410894,1.924104691976128,3.2891980406333134
SU-DHL-1,72376,-3.386078956410557,-2.913386025216995
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.5706176227548716
NCI-H1568,16659841,3.88074746768202,4.097871569441372
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,1.7700110971092438
LS411N,54618164,4.167426775220608,4.0049943609261955
MOLP-8,5287969,-2.4943575090146903,-2.172086269785975
Granta-519,24856436,-2.399051702227432,0.2259729265614532
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.6302181516970701
BICR 22,3689413,1.1307119933583345,-0.13705503310969083
SW948,11494412,0.3616963479580831,1.5776411727694772
RCC10RGB,3552672,3.073432883089278,2.861052431695193
LCLC-97TM1,72376,-4.375427192181232,-2.2300501771697823
SW948,11234052,4.776317924055416,4.141442919771927
P31/FUJ,89928392,-0.2575535361410093,1.4074689166429564
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.6994178464216034
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,1.9044066025205375
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.6194668779769072
NCI-H2452,2742550,5.209305166760603,4.115276303289031
SW48,9884685,-1.5395746259931604,0.3857564734368416
SU-DHL-1,16722836,1.4294085247204618,1.264408281945339
MOLP-8,11640390,2.6566405323234057,2.7402607927655542
RKN,5113032,5.131058822839954,4.774983969482979
Panc 02.03,5311,2.7910052639268415,1.534015575887021
HuP-T3,36462,3.380707637397105,2.316012852487968
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.5928712016728584
K-562,6852167,3.2696177089982807,2.7085945708230077
KU-19-19,16725315,4.810213458660102,4.216219652223977
Daudi,44819697,-3.048561633253287,-1.0746490384711607
NCI-H2452,73707398,1.4673083704761625,1.3581699423209033
SU-DHL-1,6438330,0.8462618394668467,1.920346186084145
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,2.27979022461348
IGROV-1,400769,-0.5589612210030486,-0.3761225714588028
PaTu 8988t,6918736,-0.015847459349983,-1.4425427262846326
NCI-H2452,12003241,-1.7557808561862691,-1.0253922736857561
SW48,89928392,0.7467993581529679,1.4171640261296847
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,4.0121536411651855
NCI-H2452,71466380,5.164331301376758,4.334235120796944
Panc 02.03,4917,3.7856869354758342,3.1602351008052496
SW48,25062766,1.0755009410821956,1.6226440293006434
IGROV-1,4259181,0.1937358171291443,0.11808810178713863
BICR 31,46926350,-4.294934659479777,-4.02359849561278
Granta-519,72199292,2.8103945289975623,0.6295497589183592
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.15481300702712
MOLM-13,11222830,0.9845802392597008,1.181009233310347
SK-HEP-1,676352,1.798347685811885,2.1733199581851457
SK-CO-1,36314,-5.371942323616045,-1.1718296311259577
P31/FUJ,71466380,4.574945433624961,4.210917574949156
PaTu 8988t,11427553,3.005069211450264,2.5923691924634125
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.2788059315293934
NCI-H1568,151289,0.8908355813530987,0.831524313313395
SW48,216345,1.323366684487305,3.336847959249265
SK-HEP-1,44819697,-0.1381867301228731,-0.46589270876661437
BFTC-909,24951314,2.3445794180209565,1.468837277243519
SK-CO-1,107985,-2.728069079888901,-3.7333936254218663
BICR 22,168313016,4.910867780923905,4.730299338140213
SW48,3025986,-2.1875732043663048,-0.9465968496792745
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-2.498077590197552
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,3.239145079350725
HCC15,446155,0.1844871361320988,2.572129852329023
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.08486511865559254
BFTC-909,56963564,-0.1720168824982637,0.4817777738228664
MOLP-8,151289,0.9447515089929442,0.6521893121589482
HEL,11609586,2.7821230127549663,2.38816232777968
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,3.068097272507832
SW948,46174525,3.747184504681747,4.327520199047628
HCC15,11964036,0.8100768326008368,1.4535782708508496
SK-OV-3,53232,3.610813443380856,2.9756879057965904
NCI-H2452,9884685,3.2183676658345868,0.5815150538031216
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.6052092505134382
K-562,44241473,4.342180714885996,4.832676618971802
HCC1500,65628,4.452955395596753,4.382543100749289
MOLM-13,24771867,-2.755307399303063,1.0690774458966639
RERF-LC-MS,168312962,0.3496483928324376,1.536512755774991
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,3.4037749094844862
NCI-H1568,44589607,2.521775448277625,2.8195676173557525
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.950589335766066
Granta-519,5280436,1.7342596657129103,2.624921380470545
NCI-H1568,72199292,0.3941551729128716,0.7582197011831375
SK-CO-1,439501,-2.410857533331093,-2.1889603498537467
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,2.306109225519105
PaTu 8902,3038522,3.855914834510199,3.1695485728184996
SU-DHL-1,159324,0.2044468524757833,2.314971389753793
BFTC-909,46398810,2.674147192871529,2.515919601960825
LCLC-97TM1,148198,-1.8422045751990368,-3.449426940679234
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,1.5777602347706903
LS180,5351362,1.0497784443121565,1.2988134181086923
NCI-H1568,5311281,2.6261557759532974,2.415380364077391
SW1271,44589607,3.6432775089048888,2.935314643779798
RKO,54143018,-0.3751060369564643,0.1709885897793068
COR-L105,44607530,0.5885750535327339,1.9286581052963596
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-1.1429079944923424
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,1.4502186122810057
SW948,387447,-4.931777613053621,-4.353667378250289
BICR 31,168313016,4.3680397842259095,4.691621098308104
LS411N,36314,3.823716751686664,-1.254162978853421
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,1.2831454393667598
MDST8,67291369,1.5579520311273356,2.417019652318368
RERF-LC-MS,3062316,3.070306969339253,1.1277620247709181
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-1.368888965587534
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-1.257723732425095
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,0.7931136526441115
MOLP-8,11964036,0.2292639686830329,0.9129573608114425
RKN,66577038,3.4891743358782104,3.0987056328900007
PaTu 8988t,5978,-2.779195325360685,-1.5773872271911773
RKO,8515,4.32265921632429,3.555279196291412
SU-DHL-1,46907787,0.92481130470373,0.7680948145135196
COR-L95,216468,4.837628080392179,2.954663903066885
SW948,462382,0.505941174695894,0.4279177452925032
NCI-H1568,448949,1.6827994040181535,2.1158775536689127
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,1.741443485272821
NCI-H2452,10184653,1.4868368660739673,1.7883199366346454
NCI-H2452,1285940,4.318373702463549,3.8199608802770832
SW48,52912189,0.0060801339095902,1.4030202346346632
RERF-LC-MS,46926350,-4.177207395055215,-4.133853897329754
P31/FUJ,5978,-3.805650321394954,-2.5278863238144376
Daudi,4917,1.6956741153412938,2.9856754823180442
LS411N,44507138,1.8249335905604152,2.2400770102783727
RERF-LC-MS,10231331,0.9954911948227504,1.842740893279103
HCC15,4261,-0.2961876318733478,1.479872875500898
P31/FUJ,16722836,0.3472605187822769,1.3379118497636286
MOLP-8,45279963,3.839697844480557,3.2496212402810505
NCI-H2452,446155,1.665772886963468,2.583943223145437
NCI-H2452,11609586,3.752552997604344,2.849907600232985
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,1.3424419003521109
IA-LM,9933475,1.89794527933904,1.713725704997509
MOLP-8,4477,0.6768027916096236,0.468605545932847
IGROV-1,42642645,0.3750175292659389,0.8498432951002328
IGROV-1,6852167,1.5305143027352028,2.7096955370709095
Daudi,5287969,-2.32062356362434,-2.5295299942018348
WM115,44607530,1.3586937130527126,1.6768501879722169
SU-DHL-6,5291,3.0098231219330422,3.5500982853007037
IA-LM,53392493,3.818463276064527,2.6762674733626692
MOLP-8,5328940,1.3442597724286955,1.250193375739331
NCI-H1568,11626560,1.7284579168385834,1.975396221785319
NCI-H1568,9967941,2.084939505363619,3.544410708431096
BICR 31,24856436,1.9770307243044476,0.43910775398143564
LS411N,6918289,4.168112514533401,1.9405063856834357
SK-CO-1,49766530,2.416603727276247,-0.7535788714188156
LS180,15547703,3.0095925001469577,3.040692879849787
SK-CO-1,24771867,2.6665073598645086,2.573825257939273
MOLP-8,17755052,-0.3093261728985458,0.9579525031173829
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.8690071430408741
NCI-H2452,6610216,4.12804282735119,4.366089381636425
RERF-LC-MS,16065773,2.958049600168222,2.327143266167
SaOS-2,6610216,4.351676798413151,4.252826662623532
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,1.581723875294164
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,4.459739222734903
NCI-H1568,3854666,0.7326561551321923,1.9179990921463794
SU-DHL-1,11404337,-0.9851913382580488,-0.7290280118392686
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,4.911953406086676
K-562,2746,2.4328857060914797,2.8253375522476465
Daudi,16038120,0.2901991168563289,0.7872701779738438
MOLM-13,71466380,3.777949844495899,3.9448954999135872
Panc 02.03,11955716,-1.8470517927785437,-1.6508967563817096
LCLC-97TM1,2858523,3.382646598163124,2.9545962797411427
SK-HEP-1,11234052,4.66363668535284,4.211038982934976
HCC1500,322968,2.559368987278369,3.5651039675866336
COR-L95,24772860,-0.7858558168975444,-2.040970811813791
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,2.056381054863867
SW1271,89928392,3.428275427880058,1.7276636737053133
RCC10RGB,24821094,3.8097926200280225,3.0048293469553693
HEL,24753719,3.7144242054355985,3.792298358738999
K-562,445091,4.14956176193418,4.1151008814095045
HEL,136227924,2.725456875957553,2.6746860972658744
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.6096381309783006
LCLC-97TM1,159324,3.194316902825419,2.9442139398468274
RERF-LC-MS,57519531,1.5399611647939,2.4535176993269685
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.2825206094318818
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.691036420754824
HCC1500,51037431,2.242858518427135,3.063418391779909
ALL-SIL,12003241,-5.746631994241774,-1.5727335635245105
P31/FUJ,44819697,-1.8374306821299025,-0.5054257896252082
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.313268886478837
MDST8,107970,2.8941750874079744,2.38710770440189
SK-OV-3,3503,3.0304882575129497,2.4427459087098815
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,3.232837239242569
HCC1500,9927531,5.051014893697188,4.753320517258212
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,3.6896484774953144
HCC15,5328940,2.162982624771584,1.6230204124290475
Panc 02.03,11626927,4.481877662185247,3.1070163679921268
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-2.160172402967604
SU-DHL-6,2749,-0.5951367082815587,1.5054878878126559
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.0636464214808363
MDST8,135398516,1.8788362071916904,2.2699928985439968
MOLM-13,5328940,0.1532905912336842,1.1974384971566392
WM115,4477,-0.2872762876800434,0.40003574976639017
ALL-SIL,5746,-1.6673474530311534,0.5126246314169979
PaTu 8902,25150857,2.644837375624729,2.333182205695492
MDST8,219104,3.7181204954875864,3.7248144498808937
Daudi,11228183,2.4864875823277557,1.6145130045081362
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.234761010400212
Daudi,984333,-2.2486456844128333,0.31285742898404406
Granta-519,12003241,-2.1147517064841925,-1.1882969095237614
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,4.271939696809624
SW48,387447,-4.885505238560258,-4.624235880306654
COR-L105,36314,4.185071185075879,-0.43837980730251025
HuP-T3,4705,2.7233440783632608,3.0440411832500702
Panc 02.03,54678924,2.4878586568917536,2.079215798037381
SW1573,16065773,3.287625611468905,2.4486662925306555
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.376416196457525
COR-L95,10385095,1.3959867651371194,1.1053535147244233
P31/FUJ,2945648,2.3869646223252365,2.821142335305152
PaTu 8902,55283,3.4956890773009097,2.4526590963691417
COR-L105,89183176,5.033590250009003,4.200344084178769
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,0.47620282331766867
HCC1500,445091,4.393350110080019,4.153649339609922
SK-CO-1,11175137,2.477148698701912,2.815102791068201
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,0.8491209319049996
BFTC-909,54618771,2.8225313881877545,1.103307769113533
HCC1500,73707398,0.9868057798362108,1.3006047384340942
WM115,135398516,0.1940094116062491,2.5057127057814648
SW948,11977753,-4.015233583581633,-1.7588478849709093
KU-19-19,446155,2.785852834205258,3.048464194322629
BFTC-909,3854666,1.1654585644167257,2.165985544975157
ALL-SIL,327653,2.0915878780614623,2.70472573165455
RERF-LC-MS,2749,2.1448012118135176,1.8076444132711584
SK-CO-1,3503,2.662166466999906,2.2796105922127885
IA-LM,60700,0.8821511316384938,-0.09748682859533873
Panc 02.03,10302451,3.706546166543765,3.0711108123203603
SaOS-2,45279963,3.893370234288743,3.7360356655104754
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,3.0856334542836112
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-1.635418746769446
K-562,11626560,-0.7477726232652755,1.5892257127003628
PaTu 8902,252682,7.782026892174048,6.628957161019775
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.3837144858661741
HCC1500,9887053,4.8738692747205175,3.699306578578774
IGROV-1,11717001,4.394306548697183,3.9122860990174457
NCI-H2452,9911463,3.657985193851277,3.737635725039757
HuP-T3,11707110,2.782188957571083,0.41268364370348415
COR-L105,5287620,-2.2558017577268665,-1.977281929037887
K-562,9907093,4.115761716505682,4.099092523459474
SW1573,53245473,3.5468633352222287,3.4922137192000178
COR-L95,100016,6.620829555802918,6.01813649642719
Granta-519,11178236,-5.517610268531398,-3.5331444619543415
IA-LM,3503,2.293282991199797,2.287968627686725
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,-0.4894045457318987
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-0.9907784531559143
MOLM-13,23635314,-2.1464398793300408,-2.3180659786761684
WM115,45100481,5.666571363096329,3.660391176250627
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-2.095328798657089
COR-L105,5351362,1.5942690709113274,1.5364387513311433
IGROV-1,6610216,4.310938387105607,4.143858380833176
SK-CO-1,4521392,4.292734672993078,4.272794527151962
RERF-LC-MS,53232,1.207294902086358,2.6930869469869507
NCI-H2452,16038120,1.767482091574877,1.2982537731072856
LS180,107985,-4.080313435814333,-3.7023818888246267
SU-DHL-1,24785538,0.8988368126388477,1.2792195673639637
IGROV-1,11977753,-2.2284230058029433,-1.2936635320544756
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.182599738419003
SW48,24964624,1.8073600797801577,2.133938835236864
RKO,9911830,2.9376280530386123,2.303391494049568
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,1.0533825617417998
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.9683202630504311
HEL,5287620,-1.51108604946339,-2.1284081242116146
MDST8,11964036,-0.5107320494490124,1.6015336572455519
HCC1500,10385095,0.8648832931247582,1.2151125878618654
SW48,702558,4.851481027043998,4.855940869651504
BICR 22,15547703,3.054989624104991,2.970676599395477
LCLC-97TM1,375860,-0.9613247940016756,-0.36795063539751
BICR 22,5566,3.0896765386345244,3.00783230702744
SW948,36462,2.9711779559511604,2.5163014905019083
SaOS-2,135411,0.7043200334589346,0.5497231275696406
SW1271,24889392,3.729104653817525,4.30371889461629
K-562,4917,1.7461656699737091,3.0590819945927152
MOLM-13,11964036,-0.3903680086882432,0.7366895837622112
SU-DHL-1,9907093,3.802209526559384,3.952794179835655
MOLP-8,44507138,3.0437239609683515,2.2354353712966866
HCC15,441298,2.404091830829315,2.3237186459937624
IGROV-1,246676,4.485924799339535,4.348558712878402
IGROV-1,3136844,5.214591389089975,4.281143062683496
Daudi,119182,-1.0022442636317743,-2.5697060104304423
SK-CO-1,2742550,3.074063089907043,3.8642603368369293
COR-L95,5291,3.794551144961864,3.707936446641314
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,3.0860420017716494
WM115,16219061,2.9198343751130036,3.4017965342829144
RERF-LC-MS,2871966,0.0193381278585586,0.5005721223112557
SW1271,44607531,2.0262821909932964,1.5513628813240516
NCI-H2452,53495165,2.6100799702143824,0.5636846833599016
SaOS-2,3825829,3.573326366415088,3.947620667071932
HEL,1242560,2.170830105823081,3.3087527300350157
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,2.926252361517464
MOLM-13,135423438,-5.2048777869707035,1.935694517094309
RKO,3815108,2.4813915623878264,2.752079733532778
SK-CO-1,57519531,1.3464743023672243,2.5944330518600065
SU-DHL-1,2729026,1.1961155288156848,2.4485389646772506
MOLP-8,57330099,4.408814311331857,4.001817612805946
SK-HEP-1,25262965,-1.9202339310426983,-1.2195852724044844
HCC15,71466445,3.952377160133232,3.9769144050723524
Daudi,49793307,-5.375388093698208,-3.612593140817185
RCC10RGB,52947716,3.397847809230189,-1.0224058610912143
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,2.4980856389869754
MOLM-13,10074640,2.6694741782411975,2.943849014884464
HCC1500,16736978,0.2362509616809698,1.4676959947286272
WM115,11228183,1.7654096487865938,2.0867115832242003
Granta-519,25150857,0.8022216450857215,1.8832527044029885
RERF-LC-MS,2858523,3.0171071482923826,3.020148567322776
K-562,71466578,3.85538032532176,3.9714411054002223
RKO,135875424,3.829354185480349,3.468007572503976
HEL,4096211,2.9626104821001524,1.5858789440660486
LCLC-97TM1,67156097,-2.339870774569048,-0.7157033352001569
COR-L95,3503,2.5200783295079834,2.203236061218915
SW48,11609586,2.634017068041322,2.5500210032183923
SU-DHL-1,375860,-0.8487932986720208,-0.38142649889334945
SU-DHL-1,5351362,0.9282229173955964,1.2204252946405278
SK-OV-3,6917907,1.1533351492785058,-4.696764890377457
PaTu 8988t,65064,5.1728218990125,4.862349540065145
RKN,3503,2.6546301780010144,2.366682345022874
IA-LM,23582824,0.7235929041173603,0.7641355821198242
IGROV-1,54143018,0.8385018685685798,0.7944967927156051
Daudi,11214940,1.5157277988308535,1.5956297474878207
SW948,4261,0.2066749270482282,1.5061740011177107
HuP-T3,15547703,4.355520728687953,3.213778325765009
NCI-H2452,24748573,1.1942514329138498,2.360591896252035
IGROV-1,159324,2.8766947154825044,2.5644209066975203
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,0.31439090094490496
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,1.2257659497689628
SU-DHL-1,3465537,3.713885766889003,2.141838512993817
NCI-H1568,60700,-0.8736945480852499,-0.2134350728422758
P31/FUJ,3689413,-2.495432751898851,-0.16966365613294973
PaTu 8902,16722836,2.3982166809874768,1.6217301779393738
SW1271,452548,-0.0979853591066759,0.45567954329996824
HCC1500,9444,4.370086947523025,3.9612466984484795
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-0.9176632747205313
MDST8,44137675,1.8173250203578384,3.560356721982601
IGROV-1,5460769,1.6083174601829917,2.5705620072703437
SK-CO-1,10302451,2.4520332675877605,3.0541597387579236
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.3213670927392061
SU-DHL-1,3384730,1.173741268518712,2.1811658879126785
LS411N,11178236,-2.533537215148808,-3.3828180037715665
COR-L105,216239,2.81147830727615,2.3583611265434223
MDST8,1750826,-3.2078848487443716,-1.43975098401713
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-1.0589492604342958
SW1573,3025986,2.659291536752942,-0.6418548041830711
SK-OV-3,73707398,1.4890038437616029,1.4718135359490825
LCLC-97TM1,12003241,-0.8351557307101188,-0.7546481195217193
BFTC-909,1750826,-0.1726466566192349,-1.5812095117388478
WM115,44819697,0.4217395821242636,-0.08256376040287847
Daudi,57330099,4.348234162675926,3.900554679123067
HCC15,6852167,3.485797740848402,2.8850661774884645
IGROV-1,23939,4.412541857664819,3.8817220343543295
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,3.123897308875935
MDST8,159324,4.143261975826356,3.3879006418953153
IGROV-1,9840324,5.720969888694302,5.863076155011879
LCLC-97TM1,36314,-6.600382606146434,-0.8399735997071699
UACC-812,11494412,1.976870257251046,1.7013039982678628
LS180,24785538,2.36344296814186,0.9612341595992963
SW1271,46398810,2.1181317502001864,2.520177961434743
COR-L95,8515,4.297389552329342,3.946951215169221
HEL,67291369,-0.0398574366947598,1.892085262785051
WM115,65064,5.519507799834776,4.737458783529531
K-562,11178236,-5.937287665657859,-3.3105000826244293
MOLM-13,46398810,-0.3461491770759903,2.0941204315315285
Daudi,49836020,3.49644839546437,3.013741691451963
SaOS-2,135659046,3.828911922642458,3.721589175179111
MOLM-13,156422,2.6570896066322054,3.7281599020374894
IGROV-1,11222830,1.5703285223102077,1.6246319906333004
MOLM-13,3062316,-0.5121609334560062,0.8488061614310412
RCC10RGB,24775005,3.7293513155953737,3.665589152823114
Daudi,135411,0.411387979123234,0.3674466300267411
HEL,6623618,1.8836955043929509,2.0790553446174447
IGROV-1,5702613,4.420745339537274,2.821968350756947
BICR 31,3025986,-1.7152493432112506,-0.5936154657351489
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,1.1657312261312278
HuP-T3,46926350,-3.9956296104835447,-3.8742321593429763
SW948,11964036,0.9329377934210036,1.2873432869623858
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-1.8097967870380993
BICR 31,168313200,4.293337148285007,2.9507219482012776
LCLC-97TM1,613753,3.2994086878019693,3.141203680756673
NCI-H1568,2858523,2.9099207435493306,3.0168320837587923
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,3.165593897057718
WM115,168312962,-0.8720769549309708,1.995645578233394
COR-L105,3136844,4.323289843330604,4.37952249292046
SaOS-2,24964624,2.194529135867758,2.355221845678294
IGROV-1,322968,4.140599241163106,3.4500796643951577
SU-DHL-1,44259,0.9870469643742532,0.6852015635646588
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,3.200590065590837
Daudi,7326481,2.37278983949268,2.797913809028017
HCC1500,5284616,3.2143502285360395,1.95532072427507
Granta-519,6918736,-3.0470654964091346,-2.272970276506556
K-562,53232,2.317344808959498,2.652501751795265
KU-19-19,6914657,-4.990300196809823,-3.801025461679874
Granta-519,72376,-3.0273971733074463,-2.714798922225455
SW948,54678924,1.3690911042909353,2.200393514534455
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,4.005233370497144
SU-DHL-1,2858523,2.096941494706986,2.950809994179458
HCC15,11427553,0.4296382841284133,2.912863165928924
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.2724722842881926
PaTu 8902,9444,4.223556509018044,4.071480879214084
Granta-519,10074640,3.4462174196318864,3.044284237751944
NCI-H2452,11213558,2.927858740250081,1.882014050518587
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,2.8108247539149
SU-DHL-1,17755052,1.573040093702568,1.4844647661344303
HCC1500,44185566,2.7833515387265435,2.7047459713192614
BFTC-909,107970,2.2861723254681774,2.420714496717059
WM115,46191454,1.770414974730312,1.615253649162332
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,3.4298452493336
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,1.1046603802510553
SW48,984333,0.702746968378095,0.7723297758350856
MOLM-13,4378219,1.3750720877022855,2.1335847007816584
SK-CO-1,104842,-6.47047720162668,-2.745933213546349
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.344520927242
SU-DHL-1,753704,3.8222320630358344,4.634877621835818
NCI-H2452,11640390,3.686004280320225,3.5602234251737883
IA-LM,44185566,3.1900951690600596,2.517395770610754
SW948,24748573,3.0928652753553685,2.1960749955855383
HCC15,16722836,0.9313515315756092,1.6723147379875671
SK-CO-1,2858523,3.0692168261278345,3.095415023980874
BICR 22,984333,1.5288435331300914,0.8674124741135294
WM115,46907787,1.8634039559333693,1.9556671896932258
K-562,135398516,2.1877631842117315,1.9299249026871452
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.4930023482549025
SW1271,56649450,5.123918884487689,3.0229948429355056
MOLM-13,73707438,4.222752629567675,4.155173820232884
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,1.5981430980372686
IGROV-1,9908783,5.873270433212515,4.726498786883154
COR-L105,100016,7.1590039780101895,6.208846049192509
MOLP-8,2733487,6.371854996101937,6.047459672415042
HuP-T3,40482356,5.071639396405957,3.849428074974597
Daudi,10231331,6.134507235467236,1.8919242603160271
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.61482478564075
ALL-SIL,135398738,2.8388897343309214,3.142723957046227
Granta-519,15953870,3.078322892664931,3.1391932320941254
SW1573,16722836,2.4665820842388606,1.617170603786429
RKN,262093,2.5285063130840344,3.059637196235751
COR-L105,16736978,0.0668136597141226,1.7988473360351174
SU-DHL-1,3854666,0.5155348387571919,1.421253846627464
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-3.636601387002209
HCC15,1242560,4.141842055686159,3.688107644719528
Daudi,227681,2.3413610492173533,2.733432690857368
BICR 22,9825149,1.9632507246672848,2.0960939656809394
KU-19-19,57519531,2.7709295903751987,2.68192993081543
HEL,675434,4.82305615478698,4.31078501809798
LCLC-97TM1,9927531,5.703886109604247,4.733160577083157
HCC1500,60700,0.3261825799377537,-0.3589128546593285
SK-HEP-1,3025986,-0.7748266135658505,-0.8403097117351197
LS180,5281321,-2.3743222213125703,-1.6143398137998324
RERF-LC-MS,11234052,4.094456859515875,4.080820806537306
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.3063633247678936
RERF-LC-MS,753704,5.128075002459309,4.832673874058868
ALL-SIL,71304818,1.8469641946240791,2.138685932305586
LCLC-97TM1,2733526,4.142341185184233,3.9853512571216005
SW1271,6918328,0.5991052607451842,-0.0949772188832028
SW1271,24901704,3.681572165465946,3.1635561354379047
Granta-519,11656518,1.6452745070498538,1.0845451535541708
NCI-H2452,3025944,3.797054601848671,4.368748619947363
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,0.9262163767206036
RKN,24951314,1.3743916622304369,1.5100591426051286
SW1271,25126798,3.686543071113652,3.69413418931204
IGROV-1,6450551,2.579641476451469,2.5263184406986277
IGROV-1,54454,2.453541831966438,2.5749396607567085
COR-L95,9936388,1.0197606854481494,-1.1953640537709929
Daudi,42611257,3.0497080994784307,3.1757325405425285
BICR 22,54618771,-1.5156377594303725,0.9777552930154181
LCLC-97TM1,23939,4.339779460008714,3.677350334813785
NCI-H2452,46191454,2.4313233431346366,1.8180154454212398
COR-L105,42642645,1.1549939076973508,1.1894638260337629
MOLP-8,11609586,0.3617141221652126,2.443567384199533
BICR 31,613753,3.1747241586791772,3.175378092972279
SU-DHL-1,5328940,1.3431964509037,1.5162574314800263
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-2.1906037942497463
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.297075777954059
BFTC-909,11455910,1.958059547603208,1.159749637187665
RERF-LC-MS,322968,4.758979615786181,3.459102340249376
KU-19-19,5351362,1.814646406429004,1.6267494494448826
MOLM-13,54649381,3.864277780400009,3.582005950510124
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,2.004573444993674
NCI-H2452,72199292,1.1345413256627164,0.8535162908969572
MOLP-8,676352,1.5936675202889017,1.7922121873931756
HCC1500,676352,1.5631676801704226,2.120806333239216
COR-L95,51037431,4.395819234826154,3.10325152534288
Daudi,5328940,0.4604914818199462,1.460176302182213
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,0.2900721795871722
IA-LM,168313200,3.804941602819176,2.9696746923205466
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.1556672696306263
RKO,119182,-2.4803685643523,-1.499228330804159
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.5724708149659232
PaTu 8988t,25227462,0.2940996568558364,0.10592871448619881
SU-DHL-1,9929138,3.6810672504095385,5.167188170412933
SU-DHL-1,12003241,0.0778318253848937,-1.7182017622196388
RKN,15547703,3.1395613683678287,3.344458832403677
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,2.1757284541216677
MOLP-8,375860,-0.9263291950812266,-0.4726845323928481
PaTu 8988t,11234052,5.58672838892775,4.124192903461778
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.907997273609029
SK-CO-1,126941,-2.257482818819106,-2.7988123152399935
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.4093589988014892
LS180,3038522,3.8311766422201727,3.0345486121275065
SW948,1566236,2.0550116218076235,2.0288273480153314
Granta-519,89928392,0.2978525114312038,0.8852338234096172
MOLP-8,19582717,2.2376953494036624,3.3056115229051013
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,0.6385742850017968
K-562,2874250,4.395305106833161,4.667442475693302
SU-DHL-1,11234052,1.0073590907004168,3.686932409654797
BICR 22,73707398,1.4183060149157571,1.098616678152504
COR-L95,46926350,-4.41571269577794,-4.140821667427536
Daudi,25154868,2.925803317483448,4.237976161594079
HEL,16725315,4.4825385691379145,3.9131632268187895
IGROV-1,67291369,1.8066430555976296,2.232262525456552
PaTu 8988t,11404337,-0.5897258437911538,-0.028802969332305674
SK-CO-1,9911463,3.850014047184169,3.872200794439634
LS411N,89928392,2.6081309937571655,1.3877832068380327
SW948,374536,1.478775672326772,2.1716737303690614
Daudi,3543504,2.1992036346279997,4.020743015025607
NCI-H2452,5746,2.2152642195731818,1.5196416666038777
K-562,451668,2.928523807666895,2.0686823850360416
RERF-LC-MS,71680916,4.2559060280924665,4.585626075603281
BFTC-909,5311281,3.2468587214362175,2.2116824568905225
HCC15,54649381,3.779002151510325,3.987064261716591
SaOS-2,6252,5.899001284083339,0.16982974462975484
SK-CO-1,2828334,6.603893313093487,6.04275505403157
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,3.947095609597589
RKN,56946209,-4.407104587623599,-3.814048128475862
P31/FUJ,54618164,3.783909273991047,3.9300396991065867
P31/FUJ,46943432,0.8368365469264624,1.756986859925721
SU-DHL-1,24180719,4.350105317542874,3.412512614551964
SK-CO-1,10113978,3.831664495659769,3.047923873212277
Granta-519,16659841,3.0104726191973756,3.4526864396681844
HCC15,5329102,1.9423862085433257,2.2280272435283934
RKO,9903786,4.184024439899693,2.512685303798495
Daudi,76446078,6.274042769130843,4.0684047529620635
SU-DHL-1,5113032,6.615586057729586,4.716616836450998
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,2.604154222475498
IA-LM,219104,4.299166533144503,3.8950682332469375
P31/FUJ,5329102,0.6917422477571054,1.8549843712295013
PaTu 8988t,5278396,4.086122365965545,3.5395650451352316
LCLC-97TM1,8515,3.105500626842055,3.9855351097092298
ALL-SIL,36314,-6.574209880787115,-2.535302270922188
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,0.72039766773741
SU-DHL-1,252682,6.908372017357921,6.339677965395194
MOLM-13,24753719,4.086009941734247,3.7560115717154874
LS411N,119607,5.818355117504778,4.98645460727546
MOLM-13,66577038,2.3893764671204853,2.876894951128259
HCC1500,25183872,-1.4621663438631347,-0.7641136710776779
KU-19-19,6917907,-4.52253618895935,-4.274852765742156
MOLM-13,11396600,-0.7885098330267027,3.0659281756719166
SW1271,25195348,2.4923805554625407,3.2169483839215087
NCI-H2452,15983966,-3.826639310361129,-1.001915762664742
BICR 22,6184667,3.547514920621151,2.8985033947087193
IGROV-1,11396600,3.99372654279783,3.5690589960856185
PaTu 8902,24748573,3.607230896648149,2.124643262218776
MDST8,54613361,0.3905773320508885,0.20061344050196012
SW948,136227924,2.9576701343794145,2.9060775763067768
HEL,135411,-2.1892340188273836,0.1945909782742664
RKN,322968,3.2277505791227776,3.768906297101284
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.56860941949341
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,0.6064067319206626
COR-L105,444795,5.02091820523187,4.289099277309919
RERF-LC-MS,11175137,3.6286013190581503,2.5568417634532117
RKN,54619267,4.894700718514424,4.129006480650207
MDST8,54143018,0.2489025697900608,1.0203069463301053
LCLC-97TM1,4917,2.8423920861921803,2.988110927898475
Granta-519,60700,-4.015034522335836,-1.131404101068877
MOLP-8,56649450,1.2499213171679169,2.6683178930005136
RERF-LC-MS,11719255,3.775646564562419,3.2753890705746627
BFTC-909,12001922,1.803559970478093,2.003051834166042
MOLP-8,3384730,1.892166165987978,1.8837295399531622
RKO,176870,5.862868084879783,2.9782521288336854
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.3644617263066663
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,1.2040142628054404
IGROV-1,24772860,-3.2892316801587835,-1.7234643803312069
IA-LM,6450551,2.2909353415785403,2.840921528597076
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.4570415452614167
BFTC-909,6252,5.031852570794812,0.6444182818216193
BICR 31,9907093,4.585915925811977,4.15121767056968
MDST8,285033,-1.9150900594470792,-2.028328299110235
MOLM-13,375860,-1.005106987112833,-0.6226996809506599
P31/FUJ,16725315,4.109597365862544,4.086694035753033
IGROV-1,216345,3.498629789107092,3.8761286525031426
SW1271,208908,1.7498569635536685,2.073370433868418
COR-L95,11507802,0.9381723124038672,1.3822092560759651
RERF-LC-MS,6918328,0.3946668064090056,0.033225710743898504
NCI-H1568,426756,4.294080241318686,4.393256642151059
K-562,67156097,-2.769244311294464,-1.521073991724549
LS411N,2729026,2.9791300415919646,2.555367262461414
SK-HEP-1,2729026,3.094345392685322,2.7532423135324557
Panc 02.03,54618771,1.0884531427161812,1.0711680955384695
MDST8,5282054,3.0885738072945776,3.842097160634612
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-1.0085418478025878
HEL,54143018,-0.2807045945993052,-0.05294057817621122
COR-L105,5278396,3.038896363429305,3.6598333412194055
SU-DHL-6,6450551,1.9173550036200224,2.1425909133563574
LCLC-97TM1,1716436,2.9898763561132276,2.9368395159989746
K-562,54619267,3.679496217482672,3.9244359790583174
Granta-519,1641662,2.857235389717828,3.2218854290631715
PaTu 8902,219104,4.25826825351418,3.7451463191039767
NCI-H2452,24779724,6.409137734448782,4.687550971567078
RCC10RGB,2126,5.809199309072596,4.782681654188263
HuP-T3,24753719,4.122061219367772,4.353658180148502
RKN,44197249,3.9607888926275217,4.053340189191005
SU-DHL-1,44543605,4.013392575246718,3.8434440369126253
HEL,11455910,0.7002369428142345,0.6653477805427848
SK-HEP-1,5281672,4.68841423543723,4.41494645193142
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-0.8625381809582887
BICR 31,23582824,0.6119811525421108,0.7996201901635084
SW48,57330099,4.121753491452113,4.077109195397641
MOLP-8,3825829,4.0673932001437,3.676817687741595
Granta-519,5746,-3.467826904777232,0.0498368386686527
K-562,46215462,1.6076592131491731,1.653587551102258
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,-0.22622082472648708
MOLM-13,6852167,0.0474303723036755,2.136903373681307
PaTu 8902,44819697,-0.6077719001286086,-0.9201827650549725
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,4.042920841459029
HCC15,135875424,4.57405525423842,3.976493221730647
BFTC-909,6918736,-1.9066217610366931,-1.5772154942318977
MOLP-8,25195348,2.8158250690550215,2.7822901134122464
KU-19-19,11175137,2.6409229524549858,2.6572555096004873
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,2.1322724024223403
SU-DHL-1,15983966,-4.109397573586815,-2.1247976255148098
Granta-519,4705,3.4024179319436483,2.8224718699295797
SaOS-2,6450551,2.5324870379200113,2.8130230373503506
SU-DHL-1,6918837,-2.995399398295858,-3.3549245341183416
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,4.261814321614416
SW1573,159324,2.9705070550476274,2.684161833778278
LS180,11625818,4.457813695022962,4.2205792571643
Granta-519,10296883,3.749738066673353,3.109395870868616
Panc 02.03,285033,-1.023489563814438,-1.839775133151009
SU-DHL-1,11175137,1.828860424721981,2.3258154332248666
HEL,124202324,1.0355607531680788,1.7328624081574142
NCI-H1568,702558,5.469457182473135,5.259836223713028
IGROV-1,46191454,1.3777495915525844,1.5417409034027687
WM115,55283,3.7426713954425415,2.03666726027654
SW948,7251185,1.827873481109932,2.810073994310144
MDST8,4521392,4.294685623216763,4.524164333130969
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.695153671054492
LS180,11455910,2.088798844266998,0.9766560501515821
NCI-H2452,151289,3.721937933525537,0.9041278202472443
LCLC-97TM1,11214940,1.4536772193180694,1.8372950751335357
RKO,25062766,2.7314931301361476,1.760209902476218
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,1.3819799009184899
COR-L105,3385,6.244906352702261,4.146796254095947
IGROV-1,375860,0.7731558163124775,-0.045671768332123046
SU-DHL-1,9936388,0.846879508636978,-2.606433624280639
MOLP-8,11955716,-2.2423093620343666,-1.8635192735014598
IGROV-1,11455910,-0.2792640061206097,0.9550249751381678
HEL,216468,1.594172428774628,2.0319268372018415
K-562,216345,3.9110155346915088,3.9891141291758077
SK-HEP-1,6450551,3.663777137244395,2.7764873194836057
Daudi,5460769,0.2326576177581661,2.442359676224518
BICR 22,1750826,0.8880077925102622,-1.703232387150529
RERF-LC-MS,11238147,2.4729298726299147,2.665873341452814
BFTC-909,54649381,4.487285574329416,3.7901572414878872
RERF-LC-MS,9926054,1.8051014319834384,1.9424082577880524
IA-LM,1750826,-4.675530321169698,-1.2621436564562318
BICR 22,46398810,2.733805979632988,2.3042898596199803
WM115,445643,3.76443753653658,3.9387726229800553
LS411N,3689413,2.701640891749041,-0.4153826119174018
SW48,71304818,2.1411626536950323,2.140716449823223
HuP-T3,5291,4.150853397708747,3.686940165307312
SW48,9911463,3.374803590447597,3.4855915339895645
Daudi,16219061,1.2860438148144782,2.694868743785723
SaOS-2,9911830,2.995519789289086,2.5079640940453056
BFTC-909,5329102,1.9658448878596055,2.0056747828203227
NCI-H1568,53495165,-0.6133813456223128,-0.31848733273229773
BICR 22,6918878,1.3704913724877863,2.2628242354951285
SK-OV-3,4259181,0.9080230343390464,0.04321489505813166
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,2.6150499217930148
BFTC-909,445091,4.3207806819680625,4.285853193195945
WM115,2130404,3.451007656106494,3.1853364646865128
RCC10RGB,11152667,2.8531679730856268,-0.12309666611866524
HEL,5460769,3.63888115942649,2.6478019230046437
HEL,969516,2.4495484774391296,2.560497440226011
MDST8,11152667,-1.6082048518025778,-0.10646212110411307
WM115,54596490,4.400808012137458,4.320501845340888
NCI-H2452,1716436,2.783046357832639,3.0014240908398597
MOLM-13,4917,2.9272389210025955,2.9423598566915588
ALL-SIL,119182,-4.503247338331098,-1.867888717595354
MDST8,3552672,1.9687663546279843,2.8255249752139817
HCC15,16720766,-0.3160262480808965,0.6805442916768021
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,1.8833489343117693
MOLM-13,12003241,-3.578107028375036,-1.1283189510999179
SW948,24856436,-0.402936098482521,0.4208987358748233
HCC1500,44202524,3.676243999694772,1.552845704629075
Daudi,4261,-0.6156785773872924,0.8872312745336045
MDST8,11507802,0.9258202338292296,1.3657905724401003
BFTC-909,54626689,4.365294423210906,4.5233033761868855
NCI-H1568,16741245,4.262204040009308,3.906332890677499
HCC1500,25154868,1.8923567203600569,4.403339166885828
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,1.7313906824430547
COR-L105,3825829,4.424164708702568,4.26647215954915
HEL,10074640,3.098757234686198,2.9707501931868894
RKO,44202524,1.4476976505001866,1.9151429565690798
SK-HEP-1,6852167,5.53454213252302,2.7933852015807377
